cancer_type	qtl_type	tag_SNP	LD	SNP_id	gene_id	gene_symbol	t-stat	p-value	beta	r	Traits	SNP_position	Gene_position
THCA	cis	rs75358501	0.636	rs2241347	MIMAT0014995	hsa-miR-3130-5p	-23.81	6.47e-83	-0.84	-0.74	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783276~206783296:-
THCA	cis	rs75358501	0.636	rs2241347	MIMAT0014995_1	hsa-miR-3130-5p	-23.81	6.47e-83	-0.84	-0.74	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783246~206783266:+
THCA	cis	rs1712517	0.588	rs12220267	MIMAT0005951	hsa-miR-1307-3p	-23.66	3.5e-82	-0.51	-0.74	Migraine;	chr10:103315955	chr10:103394301~103394322:-
THCA	cis	rs75358501	0.636	rs12471008	MIMAT0014995	hsa-miR-3130-5p	-23.64	4.14e-82	-0.84	-0.74	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783276~206783296:-
THCA	cis	rs75358501	0.636	rs12471008	MIMAT0014995_1	hsa-miR-3130-5p	-23.64	4.14e-82	-0.84	-0.74	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783246~206783266:+
THCA	cis	rs75358501	0.636	rs768533	MIMAT0014995	hsa-miR-3130-5p	-23.64	4.14e-82	-0.84	-0.74	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783276~206783296:-
THCA	cis	rs75358501	0.636	rs768533	MIMAT0014995_1	hsa-miR-3130-5p	-23.64	4.14e-82	-0.84	-0.74	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783246~206783266:+
THCA	cis	rs1712517	0.503	rs72846198	MIMAT0005951	hsa-miR-1307-3p	-23.62	5.29e-82	-0.51	-0.74	Migraine;	chr10:103338267	chr10:103394301~103394322:-
THCA	cis	rs75358501	0.688	rs2287629	MIMAT0014995	hsa-miR-3130-5p	23.6	6.72e-82	0.84	0.74	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783276~206783296:-
THCA	cis	rs75358501	0.688	rs2287629	MIMAT0014995_1	hsa-miR-3130-5p	23.6	6.72e-82	0.84	0.74	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783246~206783266:+
THCA	cis	rs75358501	0.636	rs13427002	MIMAT0014995	hsa-miR-3130-5p	-23.6	6.72e-82	-0.84	-0.74	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783276~206783296:-
THCA	cis	rs75358501	0.636	rs13427002	MIMAT0014995_1	hsa-miR-3130-5p	-23.6	6.72e-82	-0.84	-0.74	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783246~206783266:+
THCA	cis	rs75358501	0.636	rs7576591	MIMAT0014995	hsa-miR-3130-5p	-23.43	4.2e-81	-0.84	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783276~206783296:-
THCA	cis	rs75358501	0.636	rs7576591	MIMAT0014995_1	hsa-miR-3130-5p	-23.43	4.2e-81	-0.84	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783246~206783266:+
THCA	cis	rs75358501	0.636	rs2287628	MIMAT0014995	hsa-miR-3130-5p	-23.43	4.2e-81	-0.84	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783276~206783296:-
THCA	cis	rs75358501	0.636	rs2287628	MIMAT0014995_1	hsa-miR-3130-5p	-23.43	4.2e-81	-0.84	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783246~206783266:+
THCA	cis	rs1712517	0.526	rs113528138	MIMAT0005951	hsa-miR-1307-3p	-23.35	9.91e-81	-0.5	-0.73	Migraine;	chr10:103365694	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.525	rs11191667	MIMAT0005951	hsa-miR-1307-3p	-23.35	9.91e-81	-0.5	-0.73	Migraine;	chr10:103369141	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.566	rs7917388	MIMAT0005951	hsa-miR-1307-3p	-23.35	1.02e-80	-0.5	-0.73	Migraine;	chr10:103295206	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.525	rs11191642	MIMAT0005951	hsa-miR-1307-3p	-23.35	1.02e-80	-0.5	-0.73	Migraine;	chr10:103296155	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.525	rs7911488	MIMAT0005951	hsa-miR-1307-3p	-23.34	1.16e-80	-0.5	-0.73	Migraine;	chr10:103394332	chr10:103394301~103394322:-
THCA	cis	rs75358501	0.636	rs725980	MIMAT0014995	hsa-miR-3130-5p	-23.31	1.53e-80	-0.84	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783276~206783296:-
THCA	cis	rs75358501	0.636	rs725980	MIMAT0014995_1	hsa-miR-3130-5p	-23.31	1.53e-80	-0.84	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783246~206783266:+
THCA	cis	rs75358501	0.636	rs10199766	MIMAT0014995	hsa-miR-3130-5p	-23.31	1.53e-80	-0.84	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783276~206783296:-
THCA	cis	rs75358501	0.636	rs10199766	MIMAT0014995_1	hsa-miR-3130-5p	-23.31	1.53e-80	-0.84	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783246~206783266:+
THCA	cis	rs1712517	0.566	rs7076274	MIMAT0005951	hsa-miR-1307-3p	-23.17	6.87e-80	-0.5	-0.73	Migraine;	chr10:103286250	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.545	rs3740381	MIMAT0005951	hsa-miR-1307-3p	-23.17	6.87e-80	-0.5	-0.73	Migraine;	chr10:103286932	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.525	rs2271751	MIMAT0005951	hsa-miR-1307-3p	-23.12	1.2e-79	-0.5	-0.73	Migraine;	chr10:103415374	chr10:103394301~103394322:-
THCA	cis	rs75358501	0.636	rs888621	MIMAT0014995	hsa-miR-3130-5p	23	4.25e-79	0.83	0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783276~206783296:-
THCA	cis	rs75358501	0.636	rs888621	MIMAT0014995_1	hsa-miR-3130-5p	23	4.25e-79	0.83	0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783246~206783266:+
THCA	cis	rs75358501	0.636	rs11895370	MIMAT0014995	hsa-miR-3130-5p	-22.96	6.8e-79	-0.83	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783276~206783296:-
THCA	cis	rs75358501	0.636	rs11895370	MIMAT0014995_1	hsa-miR-3130-5p	-22.96	6.8e-79	-0.83	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783246~206783266:+
THCA	cis	rs75358501	0.636	rs3815686	MIMAT0014995	hsa-miR-3130-5p	-22.68	1.4e-77	-0.83	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783276~206783296:-
THCA	cis	rs75358501	0.636	rs3815686	MIMAT0014995_1	hsa-miR-3130-5p	-22.68	1.4e-77	-0.83	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783246~206783266:+
THCA	cis	rs75358501	0.688	rs28365797	MIMAT0014995	hsa-miR-3130-5p	-22.5	9.88e-77	-0.82	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783276~206783296:-
THCA	cis	rs75358501	0.688	rs28365797	MIMAT0014995_1	hsa-miR-3130-5p	-22.5	9.88e-77	-0.82	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783246~206783266:+
THCA	cis	rs75358501	0.636	rs16838834	MIMAT0014995	hsa-miR-3130-5p	-22.32	6.95e-76	-0.82	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783276~206783296:-
THCA	cis	rs75358501	0.636	rs16838834	MIMAT0014995_1	hsa-miR-3130-5p	-22.32	6.95e-76	-0.82	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783246~206783266:+
THCA	cis	rs1712517	0.524	rs1712509	MIMAT0005951	hsa-miR-1307-3p	-22.05	1.31e-74	-0.49	-0.71	Migraine;	chr10:103254113	chr10:103394301~103394322:-
THCA	cis	rs4917385	1	rs4917385	MIMAT0005951	hsa-miR-1307-3p	21.9	6.78e-74	0.49	0.71	Systemic lupus erythematosus;	chr10:103243964	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.524	rs4917384	MIMAT0005951	hsa-miR-1307-3p	21.85	1.16e-73	0.49	0.71	Migraine;	chr10:103236031	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.566	rs1163073	MIMAT0005951	hsa-miR-1307-3p	21.34	3.21e-71	0.48	0.7	Migraine;	chr10:103263177	chr10:103394301~103394322:-
THCA	cis	rs75358501	0.584	rs11894165	MIMAT0014995	hsa-miR-3130-5p	-21.33	3.65e-71	-0.82	-0.7	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783276~206783296:-
THCA	cis	rs75358501	0.584	rs11894165	MIMAT0014995_1	hsa-miR-3130-5p	-21.33	3.65e-71	-0.82	-0.7	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783246~206783266:+
THCA	cis	rs75358501	0.688	rs1862087	MIMAT0014995	hsa-miR-3130-5p	-21.33	3.65e-71	-0.82	-0.7	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783276~206783296:-
THCA	cis	rs75358501	0.688	rs1862087	MIMAT0014995_1	hsa-miR-3130-5p	-21.33	3.65e-71	-0.82	-0.7	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783246~206783266:+
THCA	cis	rs75358501	0.636	rs1862089	MIMAT0014995	hsa-miR-3130-5p	-20.3	2.42e-66	-0.81	-0.68	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783276~206783296:-
THCA	cis	rs75358501	0.636	rs1862089	MIMAT0014995_1	hsa-miR-3130-5p	-20.3	2.42e-66	-0.81	-0.68	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783246~206783266:+
THCA	cis	rs75358501	0.636	rs7580138	MIMAT0014995	hsa-miR-3130-5p	-19.69	1.88e-63	-0.79	-0.67	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783276~206783296:-
THCA	cis	rs75358501	0.636	rs7580138	MIMAT0014995_1	hsa-miR-3130-5p	-19.69	1.88e-63	-0.79	-0.67	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783246~206783266:+
THCA	cis	rs75358501	0.636	rs10932164	MIMAT0014995	hsa-miR-3130-5p	-19.13	8.23e-61	-0.78	-0.66	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783276~206783296:-
THCA	cis	rs75358501	0.636	rs10932164	MIMAT0014995_1	hsa-miR-3130-5p	-19.13	8.23e-61	-0.78	-0.66	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783246~206783266:+
THCA	cis	rs1712517	0.873	rs1163086	MIMAT0005951	hsa-miR-1307-3p	-15.86	1.01e-45	-0.39	-0.59	Migraine;	chr10:103279822	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.873	rs1712516	MIMAT0005951	hsa-miR-1307-3p	-15.82	1.6e-45	-0.39	-0.59	Migraine;	chr10:103273871	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.873	rs7913461	MIMAT0005951	hsa-miR-1307-3p	-15.8	1.91e-45	-0.38	-0.59	Migraine;	chr10:103241568	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.873	rs7916056	MIMAT0005951	hsa-miR-1307-3p	15.78	2.27e-45	0.39	0.59	Migraine;	chr10:103238157	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.844	rs1163087	MIMAT0005951	hsa-miR-1307-3p	-15.56	2.23e-44	-0.39	-0.58	Migraine;	chr10:103283532	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.787	rs1163089	MIMAT0005951	hsa-miR-1307-3p	-15.56	2.37e-44	-0.39	-0.58	Migraine;	chr10:103284207	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.74	rs4917387	MIMAT0005951	hsa-miR-1307-3p	-15.24	6.24e-43	-0.37	-0.57	Migraine;	chr10:103348698	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.844	rs4918003	MIMAT0005951	hsa-miR-1307-3p	-15.2	9.61e-43	-0.37	-0.57	Migraine;	chr10:103284400	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.771	rs2008530	MIMAT0005951	hsa-miR-1307-3p	-15.19	9.86e-43	-0.38	-0.57	Migraine;	chr10:103299082	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.773	rs1063461	MIMAT0005951	hsa-miR-1307-3p	-15.16	1.37e-42	-0.37	-0.57	Migraine;	chr10:103289348	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.74	rs4293062	MIMAT0005951	hsa-miR-1307-3p	-15.15	1.49e-42	-0.37	-0.57	Migraine;	chr10:103292867	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.744	rs11191641	MIMAT0005951	hsa-miR-1307-3p	-15.15	1.49e-42	-0.37	-0.57	Migraine;	chr10:103293183	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.744	rs4293063	MIMAT0005951	hsa-miR-1307-3p	-15.15	1.49e-42	-0.37	-0.57	Migraine;	chr10:103293219	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.771	rs11191672	MIMAT0005951	hsa-miR-1307-3p	-15.14	1.66e-42	-0.37	-0.57	Migraine;	chr10:103379204	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.771	rs7921655	MIMAT0005951	hsa-miR-1307-3p	-15.14	1.68e-42	-0.37	-0.57	Migraine;	chr10:103353944	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.771	rs7074749	MIMAT0005951	hsa-miR-1307-3p	-15.14	1.68e-42	-0.37	-0.57	Migraine;	chr10:103356299	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.74	rs11191663	MIMAT0005951	hsa-miR-1307-3p	-15.14	1.68e-42	-0.37	-0.57	Migraine;	chr10:103358705	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.771	rs11191664	MIMAT0005951	hsa-miR-1307-3p	-15.14	1.68e-42	-0.37	-0.57	Migraine;	chr10:103358719	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.771	rs11191666	MIMAT0005951	hsa-miR-1307-3p	-15.14	1.68e-42	-0.37	-0.57	Migraine;	chr10:103367521	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.771	rs10883858	MIMAT0005951	hsa-miR-1307-3p	-15.14	1.68e-42	-0.37	-0.57	Migraine;	chr10:103367951	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.771	rs59744322	MIMAT0005951	hsa-miR-1307-3p	-15.14	1.68e-42	-0.37	-0.57	Migraine;	chr10:103386935	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.771	rs11191676	MIMAT0005951	hsa-miR-1307-3p	-15.14	1.7e-42	-0.37	-0.57	Migraine;	chr10:103395309	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.771	rs2292807	MIMAT0005951	hsa-miR-1307-3p	-15.14	1.7e-42	-0.37	-0.57	Migraine;	chr10:103395888	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.771	rs10883857	MIMAT0005951	hsa-miR-1307-3p	15.09	2.88e-42	0.37	0.57	Migraine;	chr10:103367830	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.873	rs1163083	MIMAT0005951	hsa-miR-1307-3p	-15.09	2.9e-42	-0.37	-0.57	Migraine;	chr10:103278698	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.844	rs1163075	MIMAT0005951	hsa-miR-1307-3p	15.04	4.85e-42	0.37	0.57	Migraine;	chr10:103261506	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.844	rs1163074	MIMAT0005951	hsa-miR-1307-3p	-15.03	5.38e-42	-0.37	-0.57	Migraine;	chr10:103262005	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.771	rs61871160	MIMAT0005951	hsa-miR-1307-3p	-15.02	5.66e-42	-0.37	-0.57	Migraine;	chr10:103384531	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.844	rs1163081	MIMAT0005951	hsa-miR-1307-3p	-14.89	2.16e-41	-0.37	-0.57	Migraine;	chr10:103270083	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.835	rs2506961	MIMAT0005951	hsa-miR-1307-3p	14.87	2.58e-41	0.37	0.56	Migraine;	chr10:103248169	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.873	rs1712510	MIMAT0005951	hsa-miR-1307-3p	14.87	2.58e-41	0.37	0.56	Migraine;	chr10:103249329	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.771	rs61350103	MIMAT0005951	hsa-miR-1307-3p	-14.86	3.02e-41	-0.37	-0.56	Migraine;	chr10:103309363	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.771	rs11191654	MIMAT0005951	hsa-miR-1307-3p	-14.86	3.02e-41	-0.37	-0.56	Migraine;	chr10:103317367	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.771	rs61869827	MIMAT0005951	hsa-miR-1307-3p	-14.86	3.02e-41	-0.37	-0.56	Migraine;	chr10:103319682	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.838	rs6584543	MIMAT0005951	hsa-miR-1307-3p	14.72	1.22e-40	0.36	0.56	Migraine;	chr10:103237257	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.74	rs11191643	MIMAT0005951	hsa-miR-1307-3p	-14.68	1.81e-40	-0.36	-0.56	Migraine;	chr10:103297804	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.771	rs11191645	MIMAT0005951	hsa-miR-1307-3p	-14.68	1.86e-40	-0.36	-0.56	Migraine;	chr10:103299551	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.873	rs7894240	MIMAT0005951	hsa-miR-1307-3p	14.66	2.29e-40	0.37	0.56	Migraine;	chr10:103240612	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.873	rs7903004	MIMAT0005951	hsa-miR-1307-3p	14.63	3.23e-40	0.37	0.56	Migraine;	chr10:103244344	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.873	rs1891292	MIMAT0005951	hsa-miR-1307-3p	14.61	3.94e-40	0.36	0.56	Migraine;	chr10:103241753	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.836	rs7093039	MIMAT0005951	hsa-miR-1307-3p	-14.47	1.59e-39	-0.36	-0.55	Migraine;	chr10:103389790	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.904	rs7905968	MIMAT0005951	hsa-miR-1307-3p	-14.47	1.6e-39	-0.36	-0.55	Migraine;	chr10:103375562	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.838	rs1891293	MIMAT0005951	hsa-miR-1307-3p	14.26	1.33e-38	0.36	0.55	Migraine;	chr10:103242040	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.904	rs4918007	MIMAT0005951	hsa-miR-1307-3p	14.18	2.91e-38	0.36	0.55	Migraine;	chr10:103347713	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.904	rs6584547	MIMAT0005951	hsa-miR-1307-3p	-14.15	3.87e-38	-0.35	-0.55	Migraine;	chr10:103305652	chr10:103394301~103394322:-
THCA	cis	rs1712517	1	rs3123794	MIMAT0005951	hsa-miR-1307-3p	-14.14	4.04e-38	-0.35	-0.55	Migraine;	chr10:103273985	chr10:103394301~103394322:-
THCA	cis	rs1712517	1	rs1712517	MIMAT0005951	hsa-miR-1307-3p	-14.09	7.25e-38	-0.35	-0.54	Migraine;	chr10:103273258	chr10:103394301~103394322:-
THCA	cis	rs1712517	1	rs1163084	MIMAT0005951	hsa-miR-1307-3p	-14.08	7.39e-38	-0.35	-0.54	Migraine;	chr10:103279291	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.904	rs10883863	MIMAT0005951	hsa-miR-1307-3p	14.07	8.4e-38	0.35	0.54	Migraine;	chr10:103402122	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.836	rs11191649	MIMAT0005951	hsa-miR-1307-3p	-13.99	1.95e-37	-0.35	-0.54	Migraine;	chr10:103307280	chr10:103394301~103394322:-
THCA	cis	rs7894407	0.504	rs7089271	MIMAT0005951	hsa-miR-1307-3p	-13.78	1.55e-36	-0.35	-0.54	White matter hyperintensity burden;	chr10:103417157	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.588	rs12220267	MIMAT0022727	hsa-miR-1307-5p	-11.85	1.5e-28	-0.39	-0.48	Migraine;	chr10:103315955	chr10:103394341~103394361:-
THCA	cis	rs1712517	0.566	rs7076274	MIMAT0022727	hsa-miR-1307-5p	-11.76	3.51e-28	-0.38	-0.48	Migraine;	chr10:103286250	chr10:103394341~103394361:-
THCA	cis	rs1712517	0.545	rs3740381	MIMAT0022727	hsa-miR-1307-5p	-11.76	3.51e-28	-0.38	-0.48	Migraine;	chr10:103286932	chr10:103394341~103394361:-
THCA	cis	rs1712517	0.503	rs72846198	MIMAT0022727	hsa-miR-1307-5p	-11.75	3.98e-28	-0.38	-0.48	Migraine;	chr10:103338267	chr10:103394341~103394361:-
THCA	cis	rs7072216	0.763	rs7091709	MIMAT0005878	hsa-miR-1287-5p	11.73	4.56e-28	0.42	0.48	Metabolite levels;	chr10:98407848	chr10:98395271~98395292:-
THCA	cis	rs1712517	0.566	rs7917388	MIMAT0022727	hsa-miR-1307-5p	-11.71	5.37e-28	-0.38	-0.47	Migraine;	chr10:103295206	chr10:103394341~103394361:-
THCA	cis	rs1712517	0.525	rs11191642	MIMAT0022727	hsa-miR-1307-5p	-11.71	5.37e-28	-0.38	-0.47	Migraine;	chr10:103296155	chr10:103394341~103394361:-
THCA	cis	rs7072216	0.763	rs942803	MIMAT0005878	hsa-miR-1287-5p	11.71	5.81e-28	0.42	0.47	Metabolite levels;	chr10:98408874	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs7923729	MIMAT0005878	hsa-miR-1287-5p	11.71	5.81e-28	0.42	0.47	Metabolite levels;	chr10:98409708	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs6584198	MIMAT0005878	hsa-miR-1287-5p	11.71	5.81e-28	0.42	0.47	Metabolite levels;	chr10:98410149	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.727	rs6584199	MIMAT0005878	hsa-miR-1287-5p	11.71	5.81e-28	0.42	0.47	Metabolite levels;	chr10:98410226	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs6584201	MIMAT0005878	hsa-miR-1287-5p	11.71	5.81e-28	0.42	0.47	Metabolite levels;	chr10:98410452	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs6584202	MIMAT0005878	hsa-miR-1287-5p	11.71	5.81e-28	0.42	0.47	Metabolite levels;	chr10:98410626	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.727	rs7913541	MIMAT0005878	hsa-miR-1287-5p	11.69	6.48e-28	0.42	0.47	Metabolite levels;	chr10:98412722	chr10:98395271~98395292:-
THCA	cis	rs1712517	0.526	rs113528138	MIMAT0022727	hsa-miR-1307-5p	-11.69	6.83e-28	-0.38	-0.47	Migraine;	chr10:103365694	chr10:103394341~103394361:-
THCA	cis	rs1712517	0.525	rs11191667	MIMAT0022727	hsa-miR-1307-5p	-11.69	6.83e-28	-0.38	-0.47	Migraine;	chr10:103369141	chr10:103394341~103394361:-
THCA	cis	rs7072216	0.763	rs10736129	MIMAT0005878	hsa-miR-1287-5p	-11.68	7.09e-28	-0.42	-0.47	Metabolite levels;	chr10:98411814	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs7909822	MIMAT0005878	hsa-miR-1287-5p	11.67	8.18e-28	0.42	0.47	Metabolite levels;	chr10:98412278	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs7910014	MIMAT0005878	hsa-miR-1287-5p	11.67	8.18e-28	0.42	0.47	Metabolite levels;	chr10:98412353	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs7910247	MIMAT0005878	hsa-miR-1287-5p	11.67	8.18e-28	0.42	0.47	Metabolite levels;	chr10:98412495	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs6584205	MIMAT0005878	hsa-miR-1287-5p	11.67	8.18e-28	0.42	0.47	Metabolite levels;	chr10:98414049	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs3750601	MIMAT0005878	hsa-miR-1287-5p	11.67	8.18e-28	0.42	0.47	Metabolite levels;	chr10:98414804	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs2147900	MIMAT0005878	hsa-miR-1287-5p	11.67	8.18e-28	0.42	0.47	Metabolite levels;	chr10:98414964	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs2274246	MIMAT0005878	hsa-miR-1287-5p	11.67	8.18e-28	0.42	0.47	Metabolite levels;	chr10:98415303	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs2274244	MIMAT0005878	hsa-miR-1287-5p	11.67	8.18e-28	0.42	0.47	Metabolite levels;	chr10:98415461	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.806	rs9804285	MIMAT0005878	hsa-miR-1287-5p	11.67	8.27e-28	0.42	0.47	Metabolite levels;	chr10:98409715	chr10:98395271~98395292:-
THCA	cis	rs1712517	0.525	rs7911488	MIMAT0022727	hsa-miR-1307-5p	-11.66	8.63e-28	-0.38	-0.47	Migraine;	chr10:103394332	chr10:103394341~103394361:-
THCA	cis	rs7072216	0.763	rs2274245	MIMAT0005878	hsa-miR-1287-5p	11.66	8.64e-28	0.42	0.47	Metabolite levels;	chr10:98415325	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs12259939	MIMAT0005878	hsa-miR-1287-5p	11.65	9.29e-28	0.42	0.47	Metabolite levels;	chr10:98409264	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs3814140	MIMAT0005878	hsa-miR-1287-5p	11.64	1.1e-27	0.42	0.47	Metabolite levels;	chr10:98411005	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs3814142	MIMAT0005878	hsa-miR-1287-5p	11.64	1.1e-27	0.42	0.47	Metabolite levels;	chr10:98411347	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.691	rs3829853	MIMAT0005878	hsa-miR-1287-5p	11.64	1.1e-27	0.42	0.47	Metabolite levels;	chr10:98411417	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.727	rs10748728	MIMAT0005878	hsa-miR-1287-5p	11.64	1.1e-27	0.42	0.47	Metabolite levels;	chr10:98411441	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs10748729	MIMAT0005878	hsa-miR-1287-5p	11.64	1.1e-27	0.42	0.47	Metabolite levels;	chr10:98411614	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs10748730	MIMAT0005878	hsa-miR-1287-5p	11.64	1.1e-27	0.42	0.47	Metabolite levels;	chr10:98411683	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs2274243	MIMAT0005878	hsa-miR-1287-5p	11.61	1.39e-27	0.42	0.47	Metabolite levels;	chr10:98415510	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs8181292	MIMAT0005878	hsa-miR-1287-5p	11.61	1.39e-27	0.42	0.47	Metabolite levels;	chr10:98415720	chr10:98395271~98395292:-
THCA	cis	rs1712517	0.524	rs1712509	MIMAT0022727	hsa-miR-1307-5p	-11.58	1.77e-27	-0.37	-0.47	Migraine;	chr10:103254113	chr10:103394341~103394361:-
THCA	cis	rs1712517	0.566	rs1163073	MIMAT0022727	hsa-miR-1307-5p	11.56	2.11e-27	0.38	0.47	Migraine;	chr10:103263177	chr10:103394341~103394361:-
THCA	cis	rs1712517	0.525	rs2271751	MIMAT0022727	hsa-miR-1307-5p	-11.55	2.45e-27	-0.38	-0.47	Migraine;	chr10:103415374	chr10:103394341~103394361:-
THCA	cis	rs7072216	0.69	rs113195335	MIMAT0005878	hsa-miR-1287-5p	11.54	2.57e-27	0.42	0.47	Metabolite levels;	chr10:98415775	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.727	rs3750603	MIMAT0005878	hsa-miR-1287-5p	11.54	2.57e-27	0.42	0.47	Metabolite levels;	chr10:98415779	chr10:98395271~98395292:-
THCA	cis	rs4917385	1	rs4917385	MIMAT0022727	hsa-miR-1307-5p	11.54	2.64e-27	0.37	0.47	Systemic lupus erythematosus;	chr10:103243964	chr10:103394341~103394361:-
THCA	cis	rs7072216	0.763	rs6584204	MIMAT0005878	hsa-miR-1287-5p	11.54	2.67e-27	0.42	0.47	Metabolite levels;	chr10:98413823	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs6584200	MIMAT0005878	hsa-miR-1287-5p	11.47	5.12e-27	0.42	0.47	Metabolite levels;	chr10:98410280	chr10:98395271~98395292:-
THCA	cis	rs1712517	0.524	rs4917384	MIMAT0022727	hsa-miR-1307-5p	11.34	1.6e-26	0.37	0.46	Migraine;	chr10:103236031	chr10:103394341~103394361:-
THCA	cis	rs7072216	0.763	rs1061437	MIMAT0005878	hsa-miR-1287-5p	11.31	2.14e-26	0.41	0.46	Metabolite levels;	chr10:98416397	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs942805	MIMAT0005878	hsa-miR-1287-5p	11.27	2.94e-26	0.41	0.46	Metabolite levels;	chr10:98408615	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs10883090	MIMAT0005878	hsa-miR-1287-5p	11.17	7.49e-26	0.41	0.46	Metabolite levels;	chr10:98407479	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs10883091	MIMAT0005878	hsa-miR-1287-5p	11.17	7.49e-26	0.41	0.46	Metabolite levels;	chr10:98407482	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs10732782	MIMAT0005878	hsa-miR-1287-5p	11.12	1.11e-25	0.4	0.46	Metabolite levels;	chr10:98406749	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs7911036	MIMAT0005878	hsa-miR-1287-5p	11.12	1.11e-25	0.4	0.46	Metabolite levels;	chr10:98407258	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs10883092	MIMAT0005878	hsa-miR-1287-5p	11.12	1.11e-25	0.4	0.46	Metabolite levels;	chr10:98407519	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs45523432	MIMAT0005878	hsa-miR-1287-5p	11.12	1.11e-25	0.4	0.46	Metabolite levels;	chr10:98407679	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs12763044	MIMAT0005878	hsa-miR-1287-5p	11.12	1.11e-25	0.4	0.46	Metabolite levels;	chr10:98407694	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.727	rs942809	MIMAT0005878	hsa-miR-1287-5p	11.12	1.11e-25	0.4	0.46	Metabolite levels;	chr10:98408244	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.727	rs942808	MIMAT0005878	hsa-miR-1287-5p	11.12	1.11e-25	0.4	0.46	Metabolite levels;	chr10:98408345	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.727	rs942807	MIMAT0005878	hsa-miR-1287-5p	11.12	1.11e-25	0.4	0.46	Metabolite levels;	chr10:98408462	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs4475861	MIMAT0005878	hsa-miR-1287-5p	11.12	1.15e-25	0.4	0.46	Metabolite levels;	chr10:98405232	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs9787550	MIMAT0005878	hsa-miR-1287-5p	11.07	1.72e-25	0.4	0.45	Metabolite levels;	chr10:98409294	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs942804	MIMAT0005878	hsa-miR-1287-5p	11.04	2.27e-25	0.4	0.45	Metabolite levels;	chr10:98408742	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs2147901	MIMAT0005878	hsa-miR-1287-5p	-11.02	2.77e-25	-0.4	-0.45	Metabolite levels;	chr10:98405739	chr10:98395271~98395292:-
THCA	cis	rs6841433	1	rs34115976	MIMAT0003242	hsa-miR-577	11.02	2.85e-25	0.61	0.45	Hemoglobin concentration;	chr4:114656841	chr4:114656774~114656794:+
THCA	cis	rs6841433	1	rs13133899	MIMAT0003242	hsa-miR-577	11.02	2.85e-25	0.61	0.45	Hemoglobin concentration;	chr4:114661153	chr4:114656774~114656794:+
THCA	cis	rs7072216	0.763	rs7914401	MIMAT0005878	hsa-miR-1287-5p	11	3.18e-25	0.4	0.45	Metabolite levels;	chr10:98404171	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs733345	MIMAT0005878	hsa-miR-1287-5p	10.99	3.59e-25	0.4	0.45	Metabolite levels;	chr10:98404458	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs733346	MIMAT0005878	hsa-miR-1287-5p	10.99	3.59e-25	0.4	0.45	Metabolite levels;	chr10:98404568	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.726	rs4474372	MIMAT0005878	hsa-miR-1287-5p	10.99	3.59e-25	0.4	0.45	Metabolite levels;	chr10:98404814	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.691	rs7910973	MIMAT0005878	hsa-miR-1287-5p	10.95	5.23e-25	0.4	0.45	Metabolite levels;	chr10:98406975	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.655	rs3830025	MIMAT0005878	hsa-miR-1287-5p	10.94	5.39e-25	0.41	0.45	Metabolite levels;	chr10:98416347	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.655	rs3830024	MIMAT0005878	hsa-miR-1287-5p	10.94	5.39e-25	0.41	0.45	Metabolite levels;	chr10:98416349	chr10:98395271~98395292:-
THCA	cis	rs6841433	1	rs34546485	MIMAT0003242	hsa-miR-577	10.94	5.6e-25	0.62	0.45	Hemoglobin concentration;	chr4:114693882	chr4:114656774~114656794:+
THCA	cis	rs6841433	1	rs13133286	MIMAT0003242	hsa-miR-577	10.93	5.92e-25	0.62	0.45	Hemoglobin concentration;	chr4:114701654	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.948	rs34110012	MIMAT0003242	hsa-miR-577	10.93	5.92e-25	0.62	0.45	Hemoglobin concentration;	chr4:114710498	chr4:114656774~114656794:+
THCA	cis	rs6841433	1	rs10008981	MIMAT0003242	hsa-miR-577	10.89	8.87e-25	0.6	0.45	Hemoglobin concentration;	chr4:114650189	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.948	rs35736852	MIMAT0003242	hsa-miR-577	10.86	1.12e-24	0.61	0.45	Hemoglobin concentration;	chr4:114687255	chr4:114656774~114656794:+
THCA	cis	rs6841433	1	rs10011293	MIMAT0003242	hsa-miR-577	10.85	1.2e-24	0.6	0.45	Hemoglobin concentration;	chr4:114656225	chr4:114656774~114656794:+
THCA	cis	rs7072216	0.727	rs7915108	MIMAT0005878	hsa-miR-1287-5p	10.83	1.47e-24	0.39	0.45	Metabolite levels;	chr10:98404684	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.727	rs7901577	MIMAT0005878	hsa-miR-1287-5p	10.83	1.47e-24	0.39	0.45	Metabolite levels;	chr10:98404685	chr10:98395271~98395292:-
THCA	cis	rs6841433	1	rs7677294	MIMAT0003242	hsa-miR-577	10.83	1.5e-24	0.6	0.45	Hemoglobin concentration;	chr4:114633283	chr4:114656774~114656794:+
THCA	cis	rs6841433	1	rs55875005	MIMAT0003242	hsa-miR-577	10.78	2.3e-24	0.6	0.44	Hemoglobin concentration;	chr4:114691920	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.948	rs9884805	MIMAT0003242	hsa-miR-577	10.76	2.67e-24	0.6	0.44	Hemoglobin concentration;	chr4:114697040	chr4:114656774~114656794:+
THCA	cis	rs6841433	1	rs35217170	MIMAT0003242	hsa-miR-577	10.73	3.64e-24	0.6	0.44	Hemoglobin concentration;	chr4:114672701	chr4:114656774~114656794:+
THCA	cis	rs7072216	0.763	rs12763326	MIMAT0005878	hsa-miR-1287-5p	-10.72	3.84e-24	-0.39	-0.44	Metabolite levels;	chr10:98407639	chr10:98395271~98395292:-
THCA	cis	rs6841433	0.948	rs13135834	MIMAT0003242	hsa-miR-577	10.71	4.25e-24	0.6	0.44	Hemoglobin concentration;	chr4:114678835	chr4:114656774~114656794:+
THCA	cis	rs6841433	1	rs28390138	MIMAT0003242	hsa-miR-577	10.71	4.25e-24	0.6	0.44	Hemoglobin concentration;	chr4:114687320	chr4:114656774~114656794:+
THCA	cis	rs6841433	1	rs6841433	MIMAT0003242	hsa-miR-577	10.63	8.26e-24	0.59	0.44	Hemoglobin concentration;	chr4:114647874	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.948	rs7671477	MIMAT0003242	hsa-miR-577	10.61	9.71e-24	0.58	0.44	Hemoglobin concentration;	chr4:114632518	chr4:114656774~114656794:+
THCA	cis	rs6841433	1	rs6533803	MIMAT0003242	hsa-miR-577	10.6	1.04e-23	0.58	0.44	Hemoglobin concentration;	chr4:114637085	chr4:114656774~114656794:+
THCA	cis	rs6841433	1	rs10049660	MIMAT0003242	hsa-miR-577	10.6	1.04e-23	0.58	0.44	Hemoglobin concentration;	chr4:114637758	chr4:114656774~114656794:+
THCA	cis	rs6841433	1	rs35271056	MIMAT0003242	hsa-miR-577	10.6	1.04e-23	0.58	0.44	Hemoglobin concentration;	chr4:114642195	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.848	rs13328022	MIMAT0003242	hsa-miR-577	10.6	1.07e-23	0.59	0.44	Hemoglobin concentration;	chr4:114700701	chr4:114656774~114656794:+
THCA	cis	rs6841433	1	rs34403669	MIMAT0003242	hsa-miR-577	10.6	1.07e-23	0.59	0.44	Hemoglobin concentration;	chr4:114703735	chr4:114656774~114656794:+
THCA	cis	rs6841433	1	rs6828127	MIMAT0003242	hsa-miR-577	10.57	1.41e-23	0.59	0.44	Hemoglobin concentration;	chr4:114689927	chr4:114656774~114656794:+
THCA	cis	rs7072216	0.77	rs942810	MIMAT0005878	hsa-miR-1287-5p	10.43	4.57e-23	0.37	0.43	Metabolite levels;	chr10:98408103	chr10:98395271~98395292:-
THCA	cis	rs7255436	0.965	rs11666233	MIMAT0021017	hsa-miR-4999-5p	10.41	5.7e-23	0.57	0.43	HDL cholesterol;	chr19:8387161	chr19:8389340~8389360:-
THCA	cis	rs7255436	0.965	rs7254882	MIMAT0021017	hsa-miR-4999-5p	10.39	6.48e-23	0.57	0.43	HDL cholesterol;	chr19:8388938	chr19:8389340~8389360:-
THCA	cis	rs7255436	0.928	rs7250870	MIMAT0021017	hsa-miR-4999-5p	10.39	6.69e-23	0.57	0.43	HDL cholesterol;	chr19:8388798	chr19:8389340~8389360:-
THCA	cis	rs7072216	0.77	rs7896828	MIMAT0005878	hsa-miR-1287-5p	10.33	1.14e-22	0.37	0.43	Metabolite levels;	chr10:98410750	chr10:98395271~98395292:-
THCA	cis	rs7255436	0.965	rs11668346	MIMAT0021017	hsa-miR-4999-5p	10.3	1.36e-22	0.56	0.43	HDL cholesterol;	chr19:8385970	chr19:8389340~8389360:-
THCA	cis	rs7255436	0.965	rs12981318	MIMAT0021017	hsa-miR-4999-5p	10.3	1.37e-22	0.56	0.43	HDL cholesterol;	chr19:8386546	chr19:8389340~8389360:-
THCA	cis	rs7255436	0.965	rs7351098	MIMAT0021017	hsa-miR-4999-5p	10.3	1.37e-22	0.56	0.43	HDL cholesterol;	chr19:8386787	chr19:8389340~8389360:-
THCA	cis	rs7255436	0.965	rs11666003	MIMAT0021017	hsa-miR-4999-5p	10.3	1.37e-22	0.56	0.43	HDL cholesterol;	chr19:8387218	chr19:8389340~8389360:-
THCA	cis	rs7255436	0.931	rs7249520	MIMAT0021017	hsa-miR-4999-5p	10.3	1.38e-22	0.56	0.43	HDL cholesterol;	chr19:8381172	chr19:8389340~8389360:-
THCA	cis	rs7255436	0.965	rs7249624	MIMAT0021017	hsa-miR-4999-5p	10.3	1.38e-22	0.56	0.43	HDL cholesterol;	chr19:8381251	chr19:8389340~8389360:-
THCA	cis	rs7255436	0.83	rs4350678	MIMAT0021017	hsa-miR-4999-5p	10.3	1.38e-22	0.56	0.43	HDL cholesterol;	chr19:8382482	chr19:8389340~8389360:-
THCA	cis	rs7072216	0.77	rs7909131	MIMAT0005878	hsa-miR-1287-5p	10.27	1.78e-22	0.37	0.43	Metabolite levels;	chr10:98411714	chr10:98395271~98395292:-
THCA	cis	rs75358501	0.901	rs76270461	MIMAT0014995	hsa-miR-3130-5p	-10.25	2.16e-22	-0.66	-0.43	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206788929	chr2:206783276~206783296:-
THCA	cis	rs75358501	0.901	rs76270461	MIMAT0014995_1	hsa-miR-3130-5p	-10.25	2.16e-22	-0.66	-0.43	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206788929	chr2:206783246~206783266:+
THCA	cis	rs7255436	0.965	rs62117510	MIMAT0021017	hsa-miR-4999-5p	10.24	2.38e-22	0.56	0.43	HDL cholesterol;	chr19:8387729	chr19:8389340~8389360:-
THCA	cis	rs7255436	0.965	rs28729307	MIMAT0021017	hsa-miR-4999-5p	10.24	2.38e-22	0.56	0.43	HDL cholesterol;	chr19:8387858	chr19:8389340~8389360:-
THCA	cis	rs7255436	0.894	rs10413136	MIMAT0021017	hsa-miR-4999-5p	10.24	2.38e-22	0.56	0.43	HDL cholesterol;	chr19:8387995	chr19:8389340~8389360:-
THCA	cis	rs7072216	0.77	rs7897357	MIMAT0005878	hsa-miR-1287-5p	10.24	2.4e-22	0.37	0.43	Metabolite levels;	chr10:98403840	chr10:98395271~98395292:-
THCA	cis	rs6841433	0.95	rs28696112	MIMAT0003242	hsa-miR-577	10.22	2.7e-22	0.58	0.43	Hemoglobin concentration;	chr4:114601833	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.904	rs4130705	MIMAT0003242	hsa-miR-577	10.22	2.7e-22	0.58	0.43	Hemoglobin concentration;	chr4:114609479	chr4:114656774~114656794:+
THCA	cis	rs7255436	1	rs7255436	MIMAT0021017	hsa-miR-4999-5p	10.2	3.3e-22	0.56	0.42	HDL cholesterol;	chr19:8368312	chr19:8389340~8389360:-
THCA	cis	rs7255436	0.965	rs4044435	MIMAT0021017	hsa-miR-4999-5p	10.16	4.69e-22	0.56	0.42	HDL cholesterol;	chr19:8383293	chr19:8389340~8389360:-
THCA	cis	rs6841433	0.904	rs11731984	MIMAT0003242	hsa-miR-577	-10.14	5.58e-22	-0.52	-0.42	Hemoglobin concentration;	chr4:114663873	chr4:114656774~114656794:+
THCA	cis	rs1712517	0.873	rs7916056	MIMAT0022727	hsa-miR-1307-5p	10.13	5.99e-22	0.32	0.42	Migraine;	chr10:103238157	chr10:103394341~103394361:-
THCA	cis	rs7894407	0.892	rs10883859	MIMAT0005951	hsa-miR-1307-3p	10.04	1.28e-21	0.3	0.42	White matter hyperintensity burden;	chr10:103368377	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.873	rs1712516	MIMAT0022727	hsa-miR-1307-5p	-10	1.74e-21	-0.32	-0.42	Migraine;	chr10:103273871	chr10:103394341~103394361:-
THCA	cis	rs1712517	0.873	rs1163086	MIMAT0022727	hsa-miR-1307-5p	-10	1.79e-21	-0.32	-0.42	Migraine;	chr10:103279822	chr10:103394341~103394361:-
THCA	cis	rs7072216	0.77	rs1061115	MIMAT0005878	hsa-miR-1287-5p	9.99	1.93e-21	0.36	0.42	Metabolite levels;	chr10:98417292	chr10:98395271~98395292:-
THCA	cis	rs1712517	0.873	rs7913461	MIMAT0022727	hsa-miR-1307-5p	-9.98	2.09e-21	-0.32	-0.42	Migraine;	chr10:103241568	chr10:103394341~103394361:-
THCA	cis	rs7072216	0.65	rs10883089	MIMAT0005878	hsa-miR-1287-5p	9.97	2.28e-21	0.37	0.42	Metabolite levels;	chr10:98403363	chr10:98395271~98395292:-
THCA	cis	rs7894407	0.76	rs1163085	MIMAT0005951	hsa-miR-1307-3p	-9.95	2.67e-21	-0.29	-0.42	White matter hyperintensity burden;	chr10:103279484	chr10:103394301~103394322:-
THCA	cis	rs4713675	0.546	rs10947434	MIMAT0022975	hsa-miR-3934-3p	-9.94	2.94e-21	-0.47	-0.42	Plateletcrit;	chr6:33723724	chr6:33698191~33698212:+
THCA	cis	rs7072216	0.922	rs4488133	MIMAT0005878	hsa-miR-1287-5p	-9.93	3.05e-21	-0.35	-0.42	Metabolite levels;	chr10:98399379	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.853	rs6584194	MIMAT0005878	hsa-miR-1287-5p	9.93	3.18e-21	0.36	0.42	Metabolite levels;	chr10:98400642	chr10:98395271~98395292:-
THCA	cis	rs4713675	0.565	rs4711340	MIMAT0022975	hsa-miR-3934-3p	-9.91	3.72e-21	-0.47	-0.41	Plateletcrit;	chr6:33713354	chr6:33698191~33698212:+
THCA	cis	rs4713675	0.565	rs9368773	MIMAT0022975	hsa-miR-3934-3p	-9.91	3.72e-21	-0.47	-0.41	Plateletcrit;	chr6:33714764	chr6:33698191~33698212:+
THCA	cis	rs1712517	0.787	rs1163089	MIMAT0022727	hsa-miR-1307-5p	-9.9	3.98e-21	-0.32	-0.41	Migraine;	chr10:103284207	chr10:103394341~103394361:-
THCA	cis	rs4713675	0.565	rs9469566	MIMAT0022975	hsa-miR-3934-3p	-9.9	4.03e-21	-0.47	-0.41	Plateletcrit;	chr6:33699828	chr6:33698191~33698212:+
THCA	cis	rs4713675	0.584	rs3818527	MIMAT0022975	hsa-miR-3934-3p	9.87	5.01e-21	0.48	0.41	Plateletcrit;	chr6:33693258	chr6:33698191~33698212:+
THCA	cis	rs4713675	0.565	rs4713668	MIMAT0022975	hsa-miR-3934-3p	-9.86	5.75e-21	-0.47	-0.41	Plateletcrit;	chr6:33723019	chr6:33698191~33698212:+
THCA	cis	rs4713675	0.565	rs2281829	MIMAT0022975	hsa-miR-3934-3p	-9.86	5.77e-21	-0.47	-0.41	Plateletcrit;	chr6:33707865	chr6:33698191~33698212:+
THCA	cis	rs4713675	0.565	rs6904816	MIMAT0022975	hsa-miR-3934-3p	-9.86	5.77e-21	-0.47	-0.41	Plateletcrit;	chr6:33708379	chr6:33698191~33698212:+
THCA	cis	rs4713675	0.565	rs6928010	MIMAT0022975	hsa-miR-3934-3p	-9.86	5.77e-21	-0.47	-0.41	Plateletcrit;	chr6:33708813	chr6:33698191~33698212:+
THCA	cis	rs7894407	1	rs7894407	MIMAT0005951	hsa-miR-1307-3p	9.85	5.97e-21	0.29	0.41	White matter hyperintensity burden;	chr10:103416422	chr10:103394301~103394322:-
THCA	cis	rs4713675	0.584	rs6457739	MIMAT0022975	hsa-miR-3934-3p	-9.84	6.36e-21	-0.47	-0.41	Plateletcrit;	chr6:33706054	chr6:33698191~33698212:+
THCA	cis	rs4713675	0.565	rs4713665	MIMAT0022975	hsa-miR-3934-3p	-9.84	6.36e-21	-0.47	-0.41	Plateletcrit;	chr6:33706642	chr6:33698191~33698212:+
THCA	cis	rs4713675	0.565	rs9366828	MIMAT0022975	hsa-miR-3934-3p	-9.84	6.38e-21	-0.47	-0.41	Plateletcrit;	chr6:33705021	chr6:33698191~33698212:+
THCA	cis	rs7072216	0.77	rs1739	MIMAT0005878	hsa-miR-1287-5p	9.83	7.13e-21	0.36	0.41	Metabolite levels;	chr10:98416582	chr10:98395271~98395292:-
THCA	cis	rs7894407	0.856	rs10883855	MIMAT0005951	hsa-miR-1307-3p	-9.82	7.53e-21	-0.29	-0.41	White matter hyperintensity burden;	chr10:103332690	chr10:103394301~103394322:-
THCA	cis	rs7072216	0.77	rs1061123	MIMAT0005878	hsa-miR-1287-5p	9.82	7.84e-21	0.36	0.41	Metabolite levels;	chr10:98417240	chr10:98395271~98395292:-
THCA	cis	rs7894407	0.856	rs7093667	MIMAT0005951	hsa-miR-1307-3p	-9.81	8.35e-21	-0.29	-0.41	White matter hyperintensity burden;	chr10:103320818	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.844	rs4918003	MIMAT0022727	hsa-miR-1307-5p	-9.8	8.93e-21	-0.31	-0.41	Migraine;	chr10:103284400	chr10:103394341~103394361:-
THCA	cis	rs1712517	0.844	rs1163087	MIMAT0022727	hsa-miR-1307-5p	-9.79	9.71e-21	-0.32	-0.41	Migraine;	chr10:103283532	chr10:103394341~103394361:-
THCA	cis	rs7072216	0.77	rs1737	MIMAT0005878	hsa-miR-1287-5p	9.78	1.06e-20	0.36	0.41	Metabolite levels;	chr10:98416609	chr10:98395271~98395292:-
THCA	cis	rs1712517	0.844	rs1163074	MIMAT0022727	hsa-miR-1307-5p	-9.78	1.12e-20	-0.31	-0.41	Migraine;	chr10:103262005	chr10:103394341~103394361:-
THCA	cis	rs1712517	0.844	rs1163075	MIMAT0022727	hsa-miR-1307-5p	9.76	1.24e-20	0.31	0.41	Migraine;	chr10:103261506	chr10:103394341~103394361:-
THCA	cis	rs1712517	0.835	rs2506961	MIMAT0022727	hsa-miR-1307-5p	9.74	1.44e-20	0.31	0.41	Migraine;	chr10:103248169	chr10:103394341~103394361:-
THCA	cis	rs1712517	0.873	rs1712510	MIMAT0022727	hsa-miR-1307-5p	9.74	1.44e-20	0.31	0.41	Migraine;	chr10:103249329	chr10:103394341~103394361:-
THCA	cis	rs4713675	0.584	rs2966	MIMAT0022975	hsa-miR-3934-3p	-9.74	1.55e-20	-0.46	-0.41	Plateletcrit;	chr6:33721743	chr6:33698191~33698212:+
THCA	cis	rs4713675	0.565	rs4711341	MIMAT0022975	hsa-miR-3934-3p	-9.74	1.55e-20	-0.46	-0.41	Plateletcrit;	chr6:33723020	chr6:33698191~33698212:+
THCA	cis	rs4711336	0.638	rs4713664	MIMAT0022975	hsa-miR-3934-3p	-9.71	1.88e-20	-0.46	-0.41	Height;	chr6:33706421	chr6:33698191~33698212:+
THCA	cis	rs4713675	0.565	rs942640	MIMAT0022975	hsa-miR-3934-3p	-9.71	1.9e-20	-0.46	-0.41	Plateletcrit;	chr6:33718665	chr6:33698191~33698212:+
THCA	cis	rs4713675	0.584	rs9380375	MIMAT0022975	hsa-miR-3934-3p	-9.71	1.96e-20	-0.46	-0.41	Plateletcrit;	chr6:33714614	chr6:33698191~33698212:+
THCA	cis	rs1712517	0.838	rs6584543	MIMAT0022727	hsa-miR-1307-5p	9.7	2.12e-20	0.31	0.41	Migraine;	chr10:103237257	chr10:103394341~103394361:-
THCA	cis	rs4713675	0.584	rs4713667	MIMAT0022975	hsa-miR-3934-3p	-9.7	2.13e-20	-0.46	-0.41	Plateletcrit;	chr6:33712239	chr6:33698191~33698212:+
THCA	cis	rs1712517	0.873	rs7894240	MIMAT0022727	hsa-miR-1307-5p	9.7	2.15e-20	0.31	0.41	Migraine;	chr10:103240612	chr10:103394341~103394361:-
THCA	cis	rs1712517	0.873	rs7903004	MIMAT0022727	hsa-miR-1307-5p	9.69	2.3e-20	0.31	0.41	Migraine;	chr10:103244344	chr10:103394341~103394361:-
THCA	cis	rs4713675	0.584	rs9394163	MIMAT0022975	hsa-miR-3934-3p	-9.69	2.36e-20	-0.46	-0.41	Plateletcrit;	chr6:33714637	chr6:33698191~33698212:+
THCA	cis	rs4713675	0.565	rs3818530	MIMAT0022975	hsa-miR-3934-3p	-9.68	2.4e-20	-0.46	-0.41	Plateletcrit;	chr6:33693445	chr6:33698191~33698212:+
THCA	cis	rs1712517	0.873	rs1163083	MIMAT0022727	hsa-miR-1307-5p	-9.68	2.51e-20	-0.31	-0.41	Migraine;	chr10:103278698	chr10:103394341~103394361:-
THCA	cis	rs1712517	0.873	rs1891292	MIMAT0022727	hsa-miR-1307-5p	9.67	2.67e-20	0.31	0.41	Migraine;	chr10:103241753	chr10:103394341~103394361:-
THCA	cis	rs7072216	0.621	rs11189595	MIMAT0005878	hsa-miR-1287-5p	9.67	2.68e-20	0.39	0.41	Metabolite levels;	chr10:98407565	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.621	rs3750604	MIMAT0005878	hsa-miR-1287-5p	9.67	2.69e-20	0.39	0.41	Metabolite levels;	chr10:98415824	chr10:98395271~98395292:-
THCA	cis	rs4713675	0.565	rs4713670	MIMAT0022975	hsa-miR-3934-3p	9.67	2.73e-20	0.46	0.41	Plateletcrit;	chr6:33732105	chr6:33698191~33698212:+
THCA	cis	rs7894407	0.76	rs4917386	MIMAT0005951	hsa-miR-1307-3p	9.66	2.86e-20	0.28	0.41	White matter hyperintensity burden;	chr10:103247771	chr10:103394301~103394322:-
THCA	cis	rs4713675	0.51	rs1014933	MIMAT0022975	hsa-miR-3934-3p	-9.65	3.09e-20	-0.46	-0.41	Plateletcrit;	chr6:33709458	chr6:33698191~33698212:+
THCA	cis	rs4713675	0.565	rs1555965	MIMAT0022975	hsa-miR-3934-3p	-9.65	3.09e-20	-0.46	-0.41	Plateletcrit;	chr6:33709623	chr6:33698191~33698212:+
THCA	cis	rs4713675	0.584	rs6916949	MIMAT0022975	hsa-miR-3934-3p	-9.65	3.09e-20	-0.46	-0.41	Plateletcrit;	chr6:33710513	chr6:33698191~33698212:+
THCA	cis	rs4713675	0.584	rs6917140	MIMAT0022975	hsa-miR-3934-3p	-9.65	3.09e-20	-0.46	-0.41	Plateletcrit;	chr6:33710617	chr6:33698191~33698212:+
THCA	cis	rs4713675	0.584	rs4713666	MIMAT0022975	hsa-miR-3934-3p	-9.65	3.14e-20	-0.46	-0.41	Plateletcrit;	chr6:33711284	chr6:33698191~33698212:+
THCA	cis	rs4713675	0.565	rs2274458	MIMAT0022975	hsa-miR-3934-3p	-9.65	3.14e-20	-0.46	-0.41	Plateletcrit;	chr6:33711819	chr6:33698191~33698212:+
THCA	cis	rs1712517	0.844	rs1163081	MIMAT0022727	hsa-miR-1307-5p	-9.64	3.3e-20	-0.31	-0.41	Migraine;	chr10:103270083	chr10:103394341~103394361:-
THCA	cis	rs4711336	0.664	rs4713663	MIMAT0022975	hsa-miR-3934-3p	-9.64	3.45e-20	-0.46	-0.41	Height;	chr6:33706420	chr6:33698191~33698212:+
THCA	cis	rs7072216	0.77	rs3830020	MIMAT0005878	hsa-miR-1287-5p	-9.62	3.98e-20	-0.35	-0.4	Metabolite levels;	chr10:98416858	chr10:98395271~98395292:-
THCA	cis	rs4713675	0.565	rs4713659	MIMAT0022975	hsa-miR-3934-3p	-9.62	4.04e-20	-0.46	-0.4	Plateletcrit;	chr6:33700062	chr6:33698191~33698212:+
THCA	cis	rs7894407	0.76	rs1163072	MIMAT0005951	hsa-miR-1307-3p	9.61	4.49e-20	0.28	0.4	White matter hyperintensity burden;	chr10:103264621	chr10:103394301~103394322:-
THCA	cis	rs7072216	0.587	rs3814141	MIMAT0005878	hsa-miR-1287-5p	9.6	4.66e-20	0.38	0.4	Metabolite levels;	chr10:98411271	chr10:98395271~98395292:-
THCA	cis	rs4713675	0.584	rs9368776	MIMAT0022975	hsa-miR-3934-3p	-9.6	4.77e-20	-0.46	-0.4	Plateletcrit;	chr6:33728628	chr6:33698191~33698212:+
THCA	cis	rs7072216	0.621	rs3750605	MIMAT0005878	hsa-miR-1287-5p	9.59	5.31e-20	0.38	0.4	Metabolite levels;	chr10:98415897	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.922	rs10786415	MIMAT0005878	hsa-miR-1287-5p	9.58	5.45e-20	0.34	0.4	Metabolite levels;	chr10:98391509	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.922	rs942814	MIMAT0005878	hsa-miR-1287-5p	9.58	5.45e-20	0.34	0.4	Metabolite levels;	chr10:98391548	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.922	rs6584191	MIMAT0005878	hsa-miR-1287-5p	9.58	5.45e-20	0.34	0.4	Metabolite levels;	chr10:98392298	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.922	rs942813	MIMAT0005878	hsa-miR-1287-5p	9.57	6.15e-20	0.35	0.4	Metabolite levels;	chr10:98393851	chr10:98395271~98395292:-
THCA	cis	rs4713675	0.584	rs3227	MIMAT0022975	hsa-miR-3934-3p	-9.56	6.43e-20	-0.46	-0.4	Plateletcrit;	chr6:33694518	chr6:33698191~33698212:+
THCA	cis	rs4713675	0.584	rs749847	MIMAT0022975	hsa-miR-3934-3p	-9.56	6.43e-20	-0.46	-0.4	Plateletcrit;	chr6:33697224	chr6:33698191~33698212:+
THCA	cis	rs4713675	0.584	rs7770465	MIMAT0022975	hsa-miR-3934-3p	-9.52	8.68e-20	-0.45	-0.4	Plateletcrit;	chr6:33706379	chr6:33698191~33698212:+
THCA	cis	rs4713675	0.584	rs4713661	MIMAT0022975	hsa-miR-3934-3p	-9.52	8.68e-20	-0.45	-0.4	Plateletcrit;	chr6:33706397	chr6:33698191~33698212:+
THCA	cis	rs4711336	0.664	rs4713662	MIMAT0022975	hsa-miR-3934-3p	-9.52	8.68e-20	-0.45	-0.4	Height;	chr6:33706411	chr6:33698191~33698212:+
THCA	cis	rs7072216	0.922	rs4539242	MIMAT0005878	hsa-miR-1287-5p	9.52	8.84e-20	0.34	0.4	Metabolite levels;	chr10:98388301	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.881	rs2147896	MIMAT0005878	hsa-miR-1287-5p	9.52	8.84e-20	0.34	0.4	Metabolite levels;	chr10:98388419	chr10:98395271~98395292:-
THCA	cis	rs4713675	0.546	rs2296739	MIMAT0022975	hsa-miR-3934-3p	-9.52	9.01e-20	-0.46	-0.4	Plateletcrit;	chr6:33689192	chr6:33698191~33698212:+
THCA	cis	rs4713675	0.546	rs3818521	MIMAT0022975	hsa-miR-3934-3p	-9.52	9.01e-20	-0.46	-0.4	Plateletcrit;	chr6:33689469	chr6:33698191~33698212:+
THCA	cis	rs4713675	0.546	rs10947430	MIMAT0022975	hsa-miR-3934-3p	-9.52	9.01e-20	-0.46	-0.4	Plateletcrit;	chr6:33690757	chr6:33698191~33698212:+
THCA	cis	rs1712517	0.773	rs1063461	MIMAT0022727	hsa-miR-1307-5p	-9.51	9.8e-20	-0.31	-0.4	Migraine;	chr10:103289348	chr10:103394341~103394361:-
THCA	cis	rs1712517	0.74	rs4293062	MIMAT0022727	hsa-miR-1307-5p	-9.5	1.04e-19	-0.31	-0.4	Migraine;	chr10:103292867	chr10:103394341~103394361:-
THCA	cis	rs1712517	0.744	rs11191641	MIMAT0022727	hsa-miR-1307-5p	-9.5	1.04e-19	-0.31	-0.4	Migraine;	chr10:103293183	chr10:103394341~103394361:-
THCA	cis	rs1712517	0.744	rs4293063	MIMAT0022727	hsa-miR-1307-5p	-9.5	1.04e-19	-0.31	-0.4	Migraine;	chr10:103293219	chr10:103394341~103394361:-
THCA	cis	rs4713675	0.584	rs4711339	MIMAT0022975	hsa-miR-3934-3p	-9.48	1.24e-19	-0.45	-0.4	Plateletcrit;	chr6:33699422	chr6:33698191~33698212:+
THCA	cis	rs1712517	0.771	rs10883857	MIMAT0022727	hsa-miR-1307-5p	9.47	1.29e-19	0.3	0.4	Migraine;	chr10:103367830	chr10:103394341~103394361:-
THCA	cis	rs7072216	0.843	rs4400721	MIMAT0005878	hsa-miR-1287-5p	9.47	1.32e-19	0.36	0.4	Metabolite levels;	chr10:98387340	chr10:98395271~98395292:-
THCA	cis	rs74233809	0.748	rs10786736	MIMAT0005951	hsa-miR-1307-3p	-9.44	1.69e-19	-0.4	-0.4	Birth weight;	chr10:103089359	chr10:103394301~103394322:-
THCA	cis	rs4713675	0.584	rs6938056	MIMAT0022975	hsa-miR-3934-3p	-9.43	1.81e-19	-0.45	-0.4	Plateletcrit;	chr6:33701800	chr6:33698191~33698212:+
THCA	cis	rs4713675	0.565	rs9394161	MIMAT0022975	hsa-miR-3934-3p	-9.43	1.81e-19	-0.45	-0.4	Plateletcrit;	chr6:33702016	chr6:33698191~33698212:+
THCA	cis	rs4713675	0.584	rs7739505	MIMAT0022975	hsa-miR-3934-3p	-9.43	1.81e-19	-0.45	-0.4	Plateletcrit;	chr6:33702593	chr6:33698191~33698212:+
THCA	cis	rs7072216	1	rs7072216	MIMAT0005878	hsa-miR-1287-5p	9.43	1.87e-19	0.34	0.4	Metabolite levels;	chr10:98397096	chr10:98395271~98395292:-
THCA	cis	rs1712517	0.771	rs11191672	MIMAT0022727	hsa-miR-1307-5p	-9.41	2.18e-19	-0.3	-0.4	Migraine;	chr10:103379204	chr10:103394341~103394361:-
THCA	cis	rs1712517	0.771	rs7921655	MIMAT0022727	hsa-miR-1307-5p	-9.41	2.19e-19	-0.3	-0.4	Migraine;	chr10:103353944	chr10:103394341~103394361:-
THCA	cis	rs1712517	0.771	rs7074749	MIMAT0022727	hsa-miR-1307-5p	-9.41	2.19e-19	-0.3	-0.4	Migraine;	chr10:103356299	chr10:103394341~103394361:-
THCA	cis	rs1712517	0.74	rs11191663	MIMAT0022727	hsa-miR-1307-5p	-9.41	2.19e-19	-0.3	-0.4	Migraine;	chr10:103358705	chr10:103394341~103394361:-
THCA	cis	rs1712517	0.771	rs11191664	MIMAT0022727	hsa-miR-1307-5p	-9.41	2.19e-19	-0.3	-0.4	Migraine;	chr10:103358719	chr10:103394341~103394361:-
THCA	cis	rs1712517	0.771	rs11191666	MIMAT0022727	hsa-miR-1307-5p	-9.41	2.19e-19	-0.3	-0.4	Migraine;	chr10:103367521	chr10:103394341~103394361:-
THCA	cis	rs1712517	0.771	rs10883858	MIMAT0022727	hsa-miR-1307-5p	-9.41	2.19e-19	-0.3	-0.4	Migraine;	chr10:103367951	chr10:103394341~103394361:-
THCA	cis	rs1712517	0.771	rs59744322	MIMAT0022727	hsa-miR-1307-5p	-9.41	2.19e-19	-0.3	-0.4	Migraine;	chr10:103386935	chr10:103394341~103394361:-
THCA	cis	rs1712517	0.771	rs11191676	MIMAT0022727	hsa-miR-1307-5p	-9.41	2.24e-19	-0.3	-0.4	Migraine;	chr10:103395309	chr10:103394341~103394361:-
THCA	cis	rs1712517	0.771	rs2292807	MIMAT0022727	hsa-miR-1307-5p	-9.41	2.24e-19	-0.3	-0.4	Migraine;	chr10:103395888	chr10:103394341~103394361:-
THCA	cis	rs4713675	0.565	rs3818524	MIMAT0022975	hsa-miR-3934-3p	-9.4	2.41e-19	-0.45	-0.4	Plateletcrit;	chr6:33692918	chr6:33698191~33698212:+
THCA	cis	rs7072216	0.691	rs7910973	MIMAT0026738	hsa-miR-1287-3p	9.39	2.46e-19	0.3	0.4	Metabolite levels;	chr10:98406975	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs942805	MIMAT0026738	hsa-miR-1287-3p	9.39	2.47e-19	0.3	0.4	Metabolite levels;	chr10:98408615	chr10:98395232~98395253:-
THCA	cis	rs1712517	0.771	rs2008530	MIMAT0022727	hsa-miR-1307-5p	-9.39	2.56e-19	-0.3	-0.4	Migraine;	chr10:103299082	chr10:103394341~103394361:-
THCA	cis	rs4713675	0.584	rs7759668	MIMAT0022975	hsa-miR-3934-3p	9.39	2.57e-19	0.45	0.4	Plateletcrit;	chr6:33702629	chr6:33698191~33698212:+
THCA	cis	rs7072216	0.763	rs10883090	MIMAT0026738	hsa-miR-1287-3p	9.36	3.35e-19	0.3	0.4	Metabolite levels;	chr10:98407479	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs10883091	MIMAT0026738	hsa-miR-1287-3p	9.36	3.35e-19	0.3	0.4	Metabolite levels;	chr10:98407482	chr10:98395232~98395253:-
THCA	cis	rs1712517	0.74	rs4917387	MIMAT0022727	hsa-miR-1307-5p	-9.35	3.41e-19	-0.3	-0.4	Migraine;	chr10:103348698	chr10:103394341~103394361:-
THCA	cis	rs7072216	0.763	rs9787550	MIMAT0026738	hsa-miR-1287-3p	9.35	3.48e-19	0.29	0.4	Metabolite levels;	chr10:98409294	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs10732782	MIMAT0026738	hsa-miR-1287-3p	9.35	3.55e-19	0.29	0.4	Metabolite levels;	chr10:98406749	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs7911036	MIMAT0026738	hsa-miR-1287-3p	9.35	3.55e-19	0.29	0.4	Metabolite levels;	chr10:98407258	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs10883092	MIMAT0026738	hsa-miR-1287-3p	9.35	3.55e-19	0.29	0.4	Metabolite levels;	chr10:98407519	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs45523432	MIMAT0026738	hsa-miR-1287-3p	9.35	3.55e-19	0.29	0.4	Metabolite levels;	chr10:98407679	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs12763044	MIMAT0026738	hsa-miR-1287-3p	9.35	3.55e-19	0.29	0.4	Metabolite levels;	chr10:98407694	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.727	rs942809	MIMAT0026738	hsa-miR-1287-3p	9.35	3.55e-19	0.29	0.4	Metabolite levels;	chr10:98408244	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.727	rs942808	MIMAT0026738	hsa-miR-1287-3p	9.35	3.55e-19	0.29	0.4	Metabolite levels;	chr10:98408345	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.727	rs942807	MIMAT0026738	hsa-miR-1287-3p	9.35	3.55e-19	0.29	0.4	Metabolite levels;	chr10:98408462	chr10:98395232~98395253:-
THCA	cis	rs4713675	0.584	rs942643	MIMAT0022975	hsa-miR-3934-3p	-9.35	3.66e-19	-0.45	-0.4	Plateletcrit;	chr6:33700593	chr6:33698191~33698212:+
THCA	cis	rs7072216	0.763	rs942804	MIMAT0026738	hsa-miR-1287-3p	9.34	3.81e-19	0.3	0.39	Metabolite levels;	chr10:98408742	chr10:98395232~98395253:-
THCA	cis	rs4711336	1	rs2296741	MIMAT0022975	hsa-miR-3934-3p	-9.33	4.18e-19	-0.46	-0.39	Height;	chr6:33691780	chr6:33698191~33698212:+
THCA	cis	rs4713675	0.604	rs791902	MIMAT0022975	hsa-miR-3934-3p	9.3	5.44e-19	0.45	0.39	Plateletcrit;	chr6:33734840	chr6:33698191~33698212:+
THCA	cis	rs7072216	0.922	rs59667296	MIMAT0005878	hsa-miR-1287-5p	9.28	5.99e-19	0.33	0.39	Metabolite levels;	chr10:98386556	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.587	rs2296435	MIMAT0005878	hsa-miR-1287-5p	-9.28	6.31e-19	-0.37	-0.39	Metabolite levels;	chr10:98422528	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs7914401	MIMAT0026738	hsa-miR-1287-3p	9.24	8.25e-19	0.29	0.39	Metabolite levels;	chr10:98404171	chr10:98395232~98395253:-
THCA	cis	rs1712517	0.838	rs1891293	MIMAT0022727	hsa-miR-1307-5p	9.22	9.53e-19	0.3	0.39	Migraine;	chr10:103242040	chr10:103394341~103394361:-
THCA	cis	rs1712517	0.771	rs61871160	MIMAT0022727	hsa-miR-1307-5p	-9.22	9.54e-19	-0.3	-0.39	Migraine;	chr10:103384531	chr10:103394341~103394361:-
THCA	cis	rs7072216	0.763	rs12763326	MIMAT0026738	hsa-miR-1287-3p	-9.22	9.94e-19	-0.29	-0.39	Metabolite levels;	chr10:98407639	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs733345	MIMAT0026738	hsa-miR-1287-3p	9.21	1.09e-18	0.29	0.39	Metabolite levels;	chr10:98404458	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs733346	MIMAT0026738	hsa-miR-1287-3p	9.21	1.09e-18	0.29	0.39	Metabolite levels;	chr10:98404568	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.726	rs4474372	MIMAT0026738	hsa-miR-1287-3p	9.21	1.09e-18	0.29	0.39	Metabolite levels;	chr10:98404814	chr10:98395232~98395253:-
THCA	cis	rs1712517	0.771	rs61350103	MIMAT0022727	hsa-miR-1307-5p	-9.21	1.09e-18	-0.3	-0.39	Migraine;	chr10:103309363	chr10:103394341~103394361:-
THCA	cis	rs1712517	0.771	rs11191654	MIMAT0022727	hsa-miR-1307-5p	-9.21	1.09e-18	-0.3	-0.39	Migraine;	chr10:103317367	chr10:103394341~103394361:-
THCA	cis	rs1712517	0.771	rs61869827	MIMAT0022727	hsa-miR-1307-5p	-9.21	1.09e-18	-0.3	-0.39	Migraine;	chr10:103319682	chr10:103394341~103394361:-
THCA	cis	rs7072216	0.763	rs7091709	MIMAT0026738	hsa-miR-1287-3p	9.19	1.26e-18	0.29	0.39	Metabolite levels;	chr10:98407848	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.727	rs7913541	MIMAT0026738	hsa-miR-1287-3p	9.18	1.35e-18	0.29	0.39	Metabolite levels;	chr10:98412722	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs6584204	MIMAT0026738	hsa-miR-1287-3p	9.18	1.37e-18	0.29	0.39	Metabolite levels;	chr10:98413823	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs7909822	MIMAT0026738	hsa-miR-1287-3p	9.17	1.46e-18	0.29	0.39	Metabolite levels;	chr10:98412278	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs7910014	MIMAT0026738	hsa-miR-1287-3p	9.17	1.46e-18	0.29	0.39	Metabolite levels;	chr10:98412353	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs7910247	MIMAT0026738	hsa-miR-1287-3p	9.17	1.46e-18	0.29	0.39	Metabolite levels;	chr10:98412495	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs6584205	MIMAT0026738	hsa-miR-1287-3p	9.17	1.46e-18	0.29	0.39	Metabolite levels;	chr10:98414049	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs3750601	MIMAT0026738	hsa-miR-1287-3p	9.17	1.46e-18	0.29	0.39	Metabolite levels;	chr10:98414804	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs2147900	MIMAT0026738	hsa-miR-1287-3p	9.17	1.46e-18	0.29	0.39	Metabolite levels;	chr10:98414964	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs2274246	MIMAT0026738	hsa-miR-1287-3p	9.17	1.46e-18	0.29	0.39	Metabolite levels;	chr10:98415303	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs2274244	MIMAT0026738	hsa-miR-1287-3p	9.17	1.46e-18	0.29	0.39	Metabolite levels;	chr10:98415461	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs12259939	MIMAT0026738	hsa-miR-1287-3p	9.17	1.5e-18	0.29	0.39	Metabolite levels;	chr10:98409264	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs942803	MIMAT0026738	hsa-miR-1287-3p	9.16	1.53e-18	0.29	0.39	Metabolite levels;	chr10:98408874	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs7923729	MIMAT0026738	hsa-miR-1287-3p	9.16	1.53e-18	0.29	0.39	Metabolite levels;	chr10:98409708	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs6584198	MIMAT0026738	hsa-miR-1287-3p	9.16	1.53e-18	0.29	0.39	Metabolite levels;	chr10:98410149	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.727	rs6584199	MIMAT0026738	hsa-miR-1287-3p	9.16	1.53e-18	0.29	0.39	Metabolite levels;	chr10:98410226	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs6584201	MIMAT0026738	hsa-miR-1287-3p	9.16	1.53e-18	0.29	0.39	Metabolite levels;	chr10:98410452	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs6584202	MIMAT0026738	hsa-miR-1287-3p	9.16	1.53e-18	0.29	0.39	Metabolite levels;	chr10:98410626	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs2274245	MIMAT0026738	hsa-miR-1287-3p	9.16	1.55e-18	0.29	0.39	Metabolite levels;	chr10:98415325	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs3814140	MIMAT0026738	hsa-miR-1287-3p	9.16	1.58e-18	0.29	0.39	Metabolite levels;	chr10:98411005	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs3814142	MIMAT0026738	hsa-miR-1287-3p	9.16	1.58e-18	0.29	0.39	Metabolite levels;	chr10:98411347	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.691	rs3829853	MIMAT0026738	hsa-miR-1287-3p	9.16	1.58e-18	0.29	0.39	Metabolite levels;	chr10:98411417	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.727	rs10748728	MIMAT0026738	hsa-miR-1287-3p	9.16	1.58e-18	0.29	0.39	Metabolite levels;	chr10:98411441	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs10748729	MIMAT0026738	hsa-miR-1287-3p	9.16	1.58e-18	0.29	0.39	Metabolite levels;	chr10:98411614	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs10748730	MIMAT0026738	hsa-miR-1287-3p	9.16	1.58e-18	0.29	0.39	Metabolite levels;	chr10:98411683	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs2274243	MIMAT0026738	hsa-miR-1287-3p	9.15	1.66e-18	0.29	0.39	Metabolite levels;	chr10:98415510	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs8181292	MIMAT0026738	hsa-miR-1287-3p	9.15	1.66e-18	0.29	0.39	Metabolite levels;	chr10:98415720	chr10:98395232~98395253:-
THCA	cis	rs4711336	1	rs764752	MIMAT0022975	hsa-miR-3934-3p	-9.15	1.69e-18	-0.45	-0.39	Height;	chr6:33690289	chr6:33698191~33698212:+
THCA	cis	rs4711336	1	rs764754	MIMAT0022975	hsa-miR-3934-3p	-9.15	1.69e-18	-0.45	-0.39	Height;	chr6:33690533	chr6:33698191~33698212:+
THCA	cis	rs7072216	0.806	rs9804285	MIMAT0026738	hsa-miR-1287-3p	9.15	1.71e-18	0.29	0.39	Metabolite levels;	chr10:98409715	chr10:98395232~98395253:-
THCA	cis	rs4713675	0.546	rs791903	MIMAT0022975	hsa-miR-3934-3p	9.15	1.78e-18	0.45	0.39	Plateletcrit;	chr6:33734868	chr6:33698191~33698212:+
THCA	cis	rs7072216	0.763	rs4475861	MIMAT0026738	hsa-miR-1287-3p	9.14	1.79e-18	0.29	0.39	Metabolite levels;	chr10:98405232	chr10:98395232~98395253:-
THCA	cis	rs1712517	0.771	rs11191645	MIMAT0022727	hsa-miR-1307-5p	-9.13	1.94e-18	-0.29	-0.39	Migraine;	chr10:103299551	chr10:103394341~103394361:-
THCA	cis	rs1712517	0.74	rs11191643	MIMAT0022727	hsa-miR-1307-5p	-9.13	2e-18	-0.29	-0.39	Migraine;	chr10:103297804	chr10:103394341~103394361:-
THCA	cis	rs7072216	0.691	rs10786419	MIMAT0005878	hsa-miR-1287-5p	9.1	2.48e-18	0.34	0.39	Metabolite levels;	chr10:98421183	chr10:98395271~98395292:-
THCA	cis	rs4713675	0.565	rs4713671	MIMAT0022975	hsa-miR-3934-3p	-9.07	3.11e-18	-0.43	-0.39	Plateletcrit;	chr6:33732122	chr6:33698191~33698212:+
THCA	cis	rs4713675	0.524	rs4713672	MIMAT0022975	hsa-miR-3934-3p	-9.06	3.58e-18	-0.44	-0.38	Plateletcrit;	chr6:33737289	chr6:33698191~33698212:+
THCA	cis	rs4713675	0.565	rs9348924	MIMAT0022975	hsa-miR-3934-3p	-9.06	3.58e-18	-0.44	-0.38	Plateletcrit;	chr6:33737659	chr6:33698191~33698212:+
THCA	cis	rs7072216	0.763	rs2147901	MIMAT0026738	hsa-miR-1287-3p	-9.03	4.4e-18	-0.29	-0.38	Metabolite levels;	chr10:98405739	chr10:98395232~98395253:-
THCA	cis	rs4711336	1	rs11759396	MIMAT0022975	hsa-miR-3934-3p	-9.02	4.92e-18	-0.45	-0.38	Height;	chr6:33688877	chr6:33698191~33698212:+
THCA	cis	rs7072216	0.763	rs10736129	MIMAT0026738	hsa-miR-1287-3p	-9.01	5.02e-18	-0.29	-0.38	Metabolite levels;	chr10:98411814	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.69	rs113195335	MIMAT0026738	hsa-miR-1287-3p	9.01	5.16e-18	0.29	0.38	Metabolite levels;	chr10:98415775	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.727	rs3750603	MIMAT0026738	hsa-miR-1287-3p	9.01	5.16e-18	0.29	0.38	Metabolite levels;	chr10:98415779	chr10:98395232~98395253:-
THCA	cis	rs4713675	0.505	rs2395450	MIMAT0022975	hsa-miR-3934-3p	-9.01	5.29e-18	-0.44	-0.38	Plateletcrit;	chr6:33686811	chr6:33698191~33698212:+
THCA	cis	rs8064299	1	rs8064299	MIMAT0017994	hsa-miR-3615	-8.99	5.91e-18	-0.4	-0.38	Monocyte count;	chr17:74766507	chr17:74748663~74748683:+
THCA	cis	rs7072216	0.727	rs7915108	MIMAT0026738	hsa-miR-1287-3p	8.97	6.74e-18	0.28	0.38	Metabolite levels;	chr10:98404684	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.727	rs7901577	MIMAT0026738	hsa-miR-1287-3p	8.97	6.74e-18	0.28	0.38	Metabolite levels;	chr10:98404685	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.763	rs1061437	MIMAT0026738	hsa-miR-1287-3p	8.97	6.87e-18	0.29	0.38	Metabolite levels;	chr10:98416397	chr10:98395232~98395253:-
THCA	cis	rs8064299	0.967	rs3744208	MIMAT0017994	hsa-miR-3615	-8.96	7.5e-18	-0.4	-0.38	Monocyte count;	chr17:74771426	chr17:74748663~74748683:+
THCA	cis	rs7072216	0.881	rs2274247	MIMAT0005878	hsa-miR-1287-5p	8.93	9.68e-18	0.32	0.38	Metabolite levels;	chr10:98390391	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.763	rs6584200	MIMAT0026738	hsa-miR-1287-3p	8.92	9.97e-18	0.29	0.38	Metabolite levels;	chr10:98410280	chr10:98395232~98395253:-
THCA	cis	rs4711336	1	rs2296738	MIMAT0022975	hsa-miR-3934-3p	-8.92	1.06e-17	-0.44	-0.38	Height;	chr6:33689073	chr6:33698191~33698212:+
THCA	cis	rs4711336	1	rs4711336	MIMAT0022975	hsa-miR-3934-3p	8.91	1.07e-17	0.44	0.38	Height;	chr6:33691269	chr6:33698191~33698212:+
THCA	cis	rs7072216	0.881	rs10883084	MIMAT0005878	hsa-miR-1287-5p	8.91	1.15e-17	0.32	0.38	Metabolite levels;	chr10:98391432	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.922	rs7097824	MIMAT0005878	hsa-miR-1287-5p	8.91	1.15e-17	0.32	0.38	Metabolite levels;	chr10:98392042	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.881	rs6584192	MIMAT0005878	hsa-miR-1287-5p	8.91	1.15e-17	0.32	0.38	Metabolite levels;	chr10:98392616	chr10:98395271~98395292:-
THCA	cis	rs4711336	1	rs2296736	MIMAT0022975	hsa-miR-3934-3p	-8.87	1.47e-17	-0.44	-0.38	Height;	chr6:33688473	chr6:33698191~33698212:+
THCA	cis	rs4713675	0.546	rs9348925	MIMAT0022975	hsa-miR-3934-3p	-8.86	1.58e-17	-0.43	-0.38	Plateletcrit;	chr6:33742919	chr6:33698191~33698212:+
THCA	cis	rs8064299	0.967	rs7420	MIMAT0017994	hsa-miR-3615	8.85	1.76e-17	0.4	0.38	Monocyte count;	chr17:74769076	chr17:74748663~74748683:+
THCA	cis	rs7072216	0.555	rs2296433	MIMAT0005878	hsa-miR-1287-5p	8.85	1.79e-17	0.37	0.38	Metabolite levels;	chr10:98424305	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.555	rs2296432	MIMAT0005878	hsa-miR-1287-5p	8.85	1.79e-17	0.37	0.38	Metabolite levels;	chr10:98424306	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.881	rs7082192	MIMAT0005878	hsa-miR-1287-5p	8.8	2.56e-17	0.32	0.38	Metabolite levels;	chr10:98392087	chr10:98395271~98395292:-
THCA	cis	rs4713675	0.584	rs560111	MIMAT0022975	hsa-miR-3934-3p	-8.76	3.51e-17	-0.42	-0.37	Plateletcrit;	chr6:33738500	chr6:33698191~33698212:+
THCA	cis	rs4713675	0.565	rs4711343	MIMAT0022975	hsa-miR-3934-3p	-8.75	3.72e-17	-0.43	-0.37	Plateletcrit;	chr6:33746771	chr6:33698191~33698212:+
THCA	cis	rs1712517	1	rs3123794	MIMAT0022727	hsa-miR-1307-5p	-8.74	4.14e-17	-0.28	-0.37	Migraine;	chr10:103273985	chr10:103394341~103394361:-
THCA	cis	rs4711336	1	rs2229642	MIMAT0022975	hsa-miR-3934-3p	-8.74	4.15e-17	-0.42	-0.37	Height;	chr6:33691695	chr6:33698191~33698212:+
THCA	cis	rs4711336	1	rs2296742	MIMAT0022975	hsa-miR-3934-3p	-8.74	4.15e-17	-0.42	-0.37	Height;	chr6:33692016	chr6:33698191~33698212:+
THCA	cis	rs4711336	1	rs4711337	MIMAT0022975	hsa-miR-3934-3p	-8.74	4.15e-17	-0.42	-0.37	Height;	chr6:33692210	chr6:33698191~33698212:+
THCA	cis	rs1712517	0.836	rs7093039	MIMAT0022727	hsa-miR-1307-5p	-8.73	4.55e-17	-0.28	-0.37	Migraine;	chr10:103389790	chr10:103394341~103394361:-
THCA	cis	rs4713675	0.565	rs4713674	MIMAT0022975	hsa-miR-3934-3p	8.73	4.56e-17	0.43	0.37	Plateletcrit;	chr6:33740392	chr6:33698191~33698212:+
THCA	cis	rs7072216	0.881	rs1079179	MIMAT0005878	hsa-miR-1287-5p	8.73	4.56e-17	0.32	0.37	Metabolite levels;	chr10:98389589	chr10:98395271~98395292:-
THCA	cis	rs1712517	0.904	rs7905968	MIMAT0022727	hsa-miR-1307-5p	-8.73	4.58e-17	-0.28	-0.37	Migraine;	chr10:103375562	chr10:103394341~103394361:-
THCA	cis	rs7072216	0.881	rs755126	MIMAT0005878	hsa-miR-1287-5p	8.72	4.67e-17	0.32	0.37	Metabolite levels;	chr10:98389194	chr10:98395271~98395292:-
THCA	cis	rs1712517	1	rs1163084	MIMAT0022727	hsa-miR-1307-5p	-8.72	4.87e-17	-0.28	-0.37	Migraine;	chr10:103279291	chr10:103394341~103394361:-
THCA	cis	rs1712517	1	rs1712517	MIMAT0022727	hsa-miR-1307-5p	-8.72	4.88e-17	-0.28	-0.37	Migraine;	chr10:103273258	chr10:103394341~103394361:-
THCA	cis	rs8064299	0.934	rs895692	MIMAT0017994	hsa-miR-3615	-8.71	5e-17	-0.39	-0.37	Monocyte count;	chr17:74770113	chr17:74748663~74748683:+
THCA	cis	rs7072216	0.881	rs7916469	MIMAT0005878	hsa-miR-1287-5p	8.7	5.39e-17	0.32	0.37	Metabolite levels;	chr10:98388896	chr10:98395271~98395292:-
THCA	cis	rs1712517	0.836	rs11191649	MIMAT0022727	hsa-miR-1307-5p	-8.7	5.53e-17	-0.28	-0.37	Migraine;	chr10:103307280	chr10:103394341~103394361:-
THCA	cis	rs7072216	0.881	rs2182168	MIMAT0005878	hsa-miR-1287-5p	8.67	7.23e-17	0.31	0.37	Metabolite levels;	chr10:98388596	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.881	rs2182169	MIMAT0005878	hsa-miR-1287-5p	8.66	7.61e-17	0.31	0.37	Metabolite levels;	chr10:98388247	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.65	rs10883089	MIMAT0026738	hsa-miR-1287-3p	8.65	8.26e-17	0.28	0.37	Metabolite levels;	chr10:98403363	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.881	rs4345897	MIMAT0005878	hsa-miR-1287-5p	8.63	9.52e-17	0.31	0.37	Metabolite levels;	chr10:98387303	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.881	rs2147895	MIMAT0005878	hsa-miR-1287-5p	8.62	9.91e-17	0.31	0.37	Metabolite levels;	chr10:98388551	chr10:98395271~98395292:-
THCA	cis	rs8064299	0.967	rs878906	MIMAT0017994	hsa-miR-3615	-8.62	9.94e-17	-0.39	-0.37	Monocyte count;	chr17:74773195	chr17:74748663~74748683:+
THCA	cis	rs8064299	0.967	rs878907	MIMAT0017994	hsa-miR-3615	-8.62	9.98e-17	-0.39	-0.37	Monocyte count;	chr17:74773555	chr17:74748663~74748683:+
THCA	cis	rs4713675	0.565	rs60704560	MIMAT0022975	hsa-miR-3934-3p	-8.62	1.04e-16	-0.42	-0.37	Plateletcrit;	chr6:33745523	chr6:33698191~33698212:+
THCA	cis	rs6841433	0.607	rs34695716	MIMAT0003242	hsa-miR-577	-8.61	1.06e-16	-0.44	-0.37	Hemoglobin concentration;	chr4:114658285	chr4:114656774~114656794:+
THCA	cis	rs1712517	0.904	rs4918007	MIMAT0022727	hsa-miR-1307-5p	8.61	1.14e-16	0.28	0.37	Migraine;	chr10:103347713	chr10:103394341~103394361:-
THCA	cis	rs7072216	0.881	rs11189591	MIMAT0005878	hsa-miR-1287-5p	8.58	1.33e-16	0.31	0.37	Metabolite levels;	chr10:98395539	chr10:98395271~98395292:-
THCA	cis	rs4713675	0.584	rs509539	MIMAT0022975	hsa-miR-3934-3p	8.58	1.35e-16	0.42	0.37	Plateletcrit;	chr6:33740413	chr6:33698191~33698212:+
THCA	cis	rs8064299	0.967	rs878905	MIMAT0017994	hsa-miR-3615	-8.55	1.67e-16	-0.39	-0.37	Monocyte count;	chr17:74773272	chr17:74748663~74748683:+
THCA	cis	rs6841433	0.718	rs7656139	MIMAT0003242	hsa-miR-577	-8.55	1.68e-16	-0.44	-0.37	Hemoglobin concentration;	chr4:114672622	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.75	rs6857337	MIMAT0003242	hsa-miR-577	8.54	1.91e-16	0.44	0.37	Hemoglobin concentration;	chr4:114667805	chr4:114656774~114656794:+
THCA	cis	rs7894407	0.504	rs7089271	MIMAT0022727	hsa-miR-1307-5p	-8.54	1.91e-16	-0.28	-0.37	White matter hyperintensity burden;	chr10:103417157	chr10:103394341~103394361:-
THCA	cis	rs4711336	1	rs3818523	MIMAT0022975	hsa-miR-3934-3p	-8.53	1.97e-16	-0.41	-0.37	Height;	chr6:33692594	chr6:33698191~33698212:+
THCA	cis	rs4711336	0.967	rs4711338	MIMAT0022975	hsa-miR-3934-3p	-8.53	2e-16	-0.41	-0.37	Height;	chr6:33692411	chr6:33698191~33698212:+
THCA	cis	rs7072216	0.655	rs3830025	MIMAT0026738	hsa-miR-1287-3p	8.51	2.27e-16	0.28	0.36	Metabolite levels;	chr10:98416347	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.655	rs3830024	MIMAT0026738	hsa-miR-1287-3p	8.51	2.27e-16	0.28	0.36	Metabolite levels;	chr10:98416349	chr10:98395232~98395253:-
THCA	cis	rs6584202	0.589	rs10883094	MIMAT0005878	hsa-miR-1287-5p	8.51	2.29e-16	0.34	0.36	Obesity-related traits;	chr10:98428349	chr10:98395271~98395292:-
THCA	cis	rs1712517	0.904	rs6584547	MIMAT0022727	hsa-miR-1307-5p	-8.51	2.39e-16	-0.28	-0.36	Migraine;	chr10:103305652	chr10:103394341~103394361:-
THCA	cis	rs8064299	0.967	rs880827	MIMAT0017994	hsa-miR-3615	8.49	2.77e-16	0.38	0.36	Monocyte count;	chr17:74771296	chr17:74748663~74748683:+
THCA	cis	rs74233809	1	rs11191519	MIMAT0005951	hsa-miR-1307-3p	-8.48	2.88e-16	-0.4	-0.36	Birth weight;	chr10:103025161	chr10:103394301~103394322:-
THCA	cis	rs4711336	0.712	rs942641	MIMAT0022975	hsa-miR-3934-3p	-8.48	2.92e-16	-0.4	-0.36	Height;	chr6:33719230	chr6:33698191~33698212:+
THCA	cis	rs4711336	0.935	rs3818525	MIMAT0022975	hsa-miR-3934-3p	-8.41	4.82e-16	-0.41	-0.36	Height;	chr6:33693002	chr6:33698191~33698212:+
THCA	cis	rs7072216	0.922	rs2296438	MIMAT0005878	hsa-miR-1287-5p	8.41	4.94e-16	0.31	0.36	Metabolite levels;	chr10:98387138	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.652	rs11189600	MIMAT0005878	hsa-miR-1287-5p	-8.39	5.81e-16	-0.32	-0.36	Metabolite levels;	chr10:98419517	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.616	rs701801	MIMAT0005878	hsa-miR-1287-5p	8.38	6.17e-16	0.32	0.36	Metabolite levels;	chr10:98417112	chr10:98395271~98395292:-
THCA	cis	rs6841433	0.687	rs12640227	MIMAT0003242	hsa-miR-577	-8.37	6.5e-16	-0.43	-0.36	Hemoglobin concentration;	chr4:114700788	chr4:114656774~114656794:+
THCA	cis	rs74233809	1	rs11191514	MIMAT0005951	hsa-miR-1307-3p	-8.35	7.49e-16	-0.39	-0.36	Birth weight;	chr10:103013607	chr10:103394301~103394322:-
THCA	cis	rs4713675	0.505	rs753890	MIMAT0022975	hsa-miR-3934-3p	-8.35	7.53e-16	-0.42	-0.36	Plateletcrit;	chr6:33685103	chr6:33698191~33698212:+
THCA	cis	rs74233809	1	rs77787671	MIMAT0005951	hsa-miR-1307-3p	-8.35	7.74e-16	-0.39	-0.36	Birth weight;	chr10:103016448	chr10:103394301~103394322:-
THCA	cis	rs7072216	0.881	rs2147897	MIMAT0005878	hsa-miR-1287-5p	-8.35	7.83e-16	-0.31	-0.36	Metabolite levels;	chr10:98388056	chr10:98395271~98395292:-
THCA	cis	rs4711336	0.967	rs4713658	MIMAT0022975	hsa-miR-3934-3p	-8.34	8.34e-16	-0.41	-0.36	Height;	chr6:33699340	chr6:33698191~33698212:+
THCA	cis	rs4711336	0.935	rs754404	MIMAT0022975	hsa-miR-3934-3p	-8.33	8.67e-16	-0.4	-0.36	Height;	chr6:33696953	chr6:33698191~33698212:+
THCA	cis	rs74233809	1	rs11191580	MIMAT0005951	hsa-miR-1307-3p	8.33	9.03e-16	0.4	0.36	Birth weight;	chr10:103146454	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs11191499	MIMAT0005951	hsa-miR-1307-3p	-8.32	9.21e-16	-0.39	-0.36	Birth weight;	chr10:103004514	chr10:103394301~103394322:-
THCA	cis	rs1712517	0.904	rs10883863	MIMAT0022727	hsa-miR-1307-5p	8.32	9.62e-16	0.27	0.36	Migraine;	chr10:103402122	chr10:103394341~103394361:-
THCA	cis	rs4711336	0.935	rs3818529	MIMAT0022975	hsa-miR-3934-3p	-8.32	9.66e-16	-0.4	-0.36	Height;	chr6:33693329	chr6:33698191~33698212:+
THCA	cis	rs74233809	1	rs11191472	MIMAT0005951	hsa-miR-1307-3p	-8.29	1.17e-15	-0.4	-0.36	Birth weight;	chr10:102947259	chr10:103394301~103394322:-
THCA	cis	rs4711336	1	rs2296740	MIMAT0022975	hsa-miR-3934-3p	-8.29	1.22e-15	-0.41	-0.36	Height;	chr6:33691759	chr6:33698191~33698212:+
THCA	cis	rs4711336	0.527	rs28651968	MIMAT0022975	hsa-miR-3934-3p	-8.28	1.26e-15	-0.41	-0.36	Height;	chr6:33749647	chr6:33698191~33698212:+
THCA	cis	rs75358501	0.901	rs16838691	MIMAT0014995	hsa-miR-3130-5p	-8.27	1.33e-15	-0.56	-0.36	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206718128	chr2:206783276~206783296:-
THCA	cis	rs75358501	0.901	rs16838691	MIMAT0014995_1	hsa-miR-3130-5p	-8.27	1.33e-15	-0.56	-0.36	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206718128	chr2:206783246~206783266:+
THCA	cis	rs74233809	1	rs12411886	MIMAT0005951	hsa-miR-1307-3p	-8.27	1.36e-15	-0.39	-0.36	Birth weight;	chr10:102925542	chr10:103394301~103394322:-
THCA	cis	rs4713675	0.584	rs7770465	MIMAT0018349	hsa-miR-3934-5p	-8.27	1.4e-15	-0.42	-0.36	Plateletcrit;	chr6:33706379	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.584	rs4713661	MIMAT0018349	hsa-miR-3934-5p	-8.27	1.4e-15	-0.42	-0.36	Plateletcrit;	chr6:33706397	chr6:33698152~33698173:+
THCA	cis	rs4711336	0.664	rs4713662	MIMAT0018349	hsa-miR-3934-5p	-8.27	1.4e-15	-0.42	-0.36	Height;	chr6:33706411	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.546	rs10947435	MIMAT0022975	hsa-miR-3934-3p	-8.27	1.41e-15	-0.41	-0.36	Plateletcrit;	chr6:33750298	chr6:33698191~33698212:+
THCA	cis	rs74233809	1	rs12221193	MIMAT0005951	hsa-miR-1307-3p	-8.26	1.5e-15	-0.39	-0.36	Birth weight;	chr10:102905510	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs77180047	MIMAT0005951	hsa-miR-1307-3p	-8.26	1.5e-15	-0.39	-0.36	Birth weight;	chr10:102907000	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs5011520	MIMAT0005951	hsa-miR-1307-3p	-8.25	1.55e-15	-0.39	-0.36	Birth weight;	chr10:102937759	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs10883808	MIMAT0005951	hsa-miR-1307-3p	-8.25	1.55e-15	-0.39	-0.36	Birth weight;	chr10:102961369	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs11191479	MIMAT0005951	hsa-miR-1307-3p	-8.25	1.55e-15	-0.39	-0.36	Birth weight;	chr10:102963863	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs10883815	MIMAT0005951	hsa-miR-1307-3p	-8.25	1.55e-15	-0.39	-0.36	Birth weight;	chr10:102979422	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs112390216	MIMAT0005951	hsa-miR-1307-3p	-8.25	1.55e-15	-0.39	-0.36	Birth weight;	chr10:102981274	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs11191502	MIMAT0005951	hsa-miR-1307-3p	-8.25	1.55e-15	-0.39	-0.36	Birth weight;	chr10:103005737	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs74444347	MIMAT0005951	hsa-miR-1307-3p	-8.25	1.55e-15	-0.39	-0.36	Birth weight;	chr10:103009518	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs12221335	MIMAT0005951	hsa-miR-1307-3p	-8.25	1.55e-15	-0.39	-0.36	Birth weight;	chr10:103009635	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs11191515	MIMAT0005951	hsa-miR-1307-3p	-8.25	1.57e-15	-0.39	-0.36	Birth weight;	chr10:103016770	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs77860422	MIMAT0005951	hsa-miR-1307-3p	-8.24	1.72e-15	-0.39	-0.35	Birth weight;	chr10:102988252	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs75970938	MIMAT0005951	hsa-miR-1307-3p	-8.24	1.77e-15	-0.4	-0.35	Birth weight;	chr10:103033891	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs79668541	MIMAT0005951	hsa-miR-1307-3p	-8.24	1.77e-15	-0.4	-0.35	Birth weight;	chr10:103034147	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs3781285	MIMAT0005951	hsa-miR-1307-3p	-8.24	1.77e-15	-0.4	-0.35	Birth weight;	chr10:103065908	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs12221064	MIMAT0005951	hsa-miR-1307-3p	-8.23	1.78e-15	-0.39	-0.35	Birth weight;	chr10:102917369	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs77602510	MIMAT0005951	hsa-miR-1307-3p	-8.23	1.78e-15	-0.39	-0.35	Birth weight;	chr10:102922845	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs78821730	MIMAT0005951	hsa-miR-1307-3p	-8.23	1.78e-15	-0.39	-0.35	Birth weight;	chr10:102924787	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs10509759	MIMAT0005951	hsa-miR-1307-3p	-8.23	1.83e-15	-0.39	-0.35	Birth weight;	chr10:102929908	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs10883806	MIMAT0005951	hsa-miR-1307-3p	-8.23	1.83e-15	-0.39	-0.35	Birth weight;	chr10:102953319	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs78260931	MIMAT0005951	hsa-miR-1307-3p	-8.23	1.83e-15	-0.39	-0.35	Birth weight;	chr10:102962205	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs11191505	MIMAT0005951	hsa-miR-1307-3p	-8.23	1.83e-15	-0.39	-0.35	Birth weight;	chr10:103007134	chr10:103394301~103394322:-
THCA	cis	rs4711336	0.638	rs4713664	MIMAT0018349	hsa-miR-3934-5p	-8.22	1.92e-15	-0.41	-0.35	Height;	chr6:33706421	chr6:33698152~33698173:+
THCA	cis	rs74233809	1	rs17115213	MIMAT0005951	hsa-miR-1307-3p	-8.21	2.12e-15	-0.39	-0.35	Birth weight;	chr10:102921386	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs11191543	MIMAT0005951	hsa-miR-1307-3p	-8.2	2.22e-15	-0.39	-0.35	Birth weight;	chr10:103064630	chr10:103394301~103394322:-
THCA	cis	rs4713675	0.584	rs4711339	MIMAT0018349	hsa-miR-3934-5p	-8.2	2.29e-15	-0.41	-0.35	Plateletcrit;	chr6:33699422	chr6:33698152~33698173:+
THCA	cis	rs74233809	1	rs76752100	MIMAT0005951	hsa-miR-1307-3p	-8.19	2.39e-15	-0.39	-0.35	Birth weight;	chr10:103034329	chr10:103394301~103394322:-
THCA	cis	rs4713675	0.565	rs942640	MIMAT0018349	hsa-miR-3934-5p	-8.19	2.43e-15	-0.41	-0.35	Plateletcrit;	chr6:33718665	chr6:33698152~33698173:+
THCA	cis	rs74233809	1	rs12219027	MIMAT0005951	hsa-miR-1307-3p	-8.19	2.43e-15	-0.39	-0.35	Birth weight;	chr10:103051446	chr10:103394301~103394322:-
THCA	cis	rs4713675	0.584	rs9380375	MIMAT0018349	hsa-miR-3934-5p	-8.19	2.51e-15	-0.41	-0.35	Plateletcrit;	chr6:33714614	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.584	rs4713667	MIMAT0018349	hsa-miR-3934-5p	-8.19	2.55e-15	-0.41	-0.35	Plateletcrit;	chr6:33712239	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.51	rs1014933	MIMAT0018349	hsa-miR-3934-5p	-8.18	2.63e-15	-0.41	-0.35	Plateletcrit;	chr6:33709458	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.565	rs1555965	MIMAT0018349	hsa-miR-3934-5p	-8.18	2.63e-15	-0.41	-0.35	Plateletcrit;	chr6:33709623	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.584	rs6916949	MIMAT0018349	hsa-miR-3934-5p	-8.18	2.63e-15	-0.41	-0.35	Plateletcrit;	chr6:33710513	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.584	rs6917140	MIMAT0018349	hsa-miR-3934-5p	-8.18	2.63e-15	-0.41	-0.35	Plateletcrit;	chr6:33710617	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.584	rs4713666	MIMAT0018349	hsa-miR-3934-5p	-8.18	2.71e-15	-0.41	-0.35	Plateletcrit;	chr6:33711284	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.565	rs2274458	MIMAT0018349	hsa-miR-3934-5p	-8.18	2.71e-15	-0.41	-0.35	Plateletcrit;	chr6:33711819	chr6:33698152~33698173:+
THCA	cis	rs74233809	1	rs11191531	MIMAT0005951	hsa-miR-1307-3p	-8.17	2.79e-15	-0.39	-0.35	Birth weight;	chr10:103047141	chr10:103394301~103394322:-
THCA	cis	rs4713675	0.584	rs2966	MIMAT0018349	hsa-miR-3934-5p	-8.16	3.11e-15	-0.41	-0.35	Plateletcrit;	chr6:33721743	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.565	rs4711341	MIMAT0018349	hsa-miR-3934-5p	-8.16	3.11e-15	-0.41	-0.35	Plateletcrit;	chr6:33723020	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.584	rs7759668	MIMAT0018349	hsa-miR-3934-5p	8.16	3.13e-15	0.41	0.35	Plateletcrit;	chr6:33702629	chr6:33698152~33698173:+
THCA	cis	rs74233809	1	rs11191454	MIMAT0005951	hsa-miR-1307-3p	-8.15	3.24e-15	-0.39	-0.35	Birth weight;	chr10:102900247	chr10:103394301~103394322:-
THCA	cis	rs4713675	0.584	rs3227	MIMAT0018349	hsa-miR-3934-5p	-8.15	3.34e-15	-0.41	-0.35	Plateletcrit;	chr6:33694518	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.584	rs749847	MIMAT0018349	hsa-miR-3934-5p	-8.15	3.34e-15	-0.41	-0.35	Plateletcrit;	chr6:33697224	chr6:33698152~33698173:+
THCA	cis	rs74233809	1	rs12219901	MIMAT0005951	hsa-miR-1307-3p	-8.14	3.6e-15	-0.39	-0.35	Birth weight;	chr10:103081210	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs10458729	MIMAT0005951	hsa-miR-1307-3p	-8.14	3.6e-15	-0.39	-0.35	Birth weight;	chr10:103081722	chr10:103394301~103394322:-
THCA	cis	rs4713675	0.584	rs6457739	MIMAT0018349	hsa-miR-3934-5p	-8.14	3.63e-15	-0.41	-0.35	Plateletcrit;	chr6:33706054	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.565	rs4713665	MIMAT0018349	hsa-miR-3934-5p	-8.14	3.63e-15	-0.41	-0.35	Plateletcrit;	chr6:33706642	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.565	rs9366828	MIMAT0018349	hsa-miR-3934-5p	-8.14	3.65e-15	-0.41	-0.35	Plateletcrit;	chr6:33705021	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.525	rs622917	MIMAT0022975	hsa-miR-3934-3p	8.14	3.66e-15	0.39	0.35	Plateletcrit;	chr6:33735092	chr6:33698191~33698212:+
THCA	cis	rs7072216	0.666	rs11598689	MIMAT0005878	hsa-miR-1287-5p	8.13	3.86e-15	0.34	0.35	Metabolite levels;	chr10:98396270	chr10:98395271~98395292:-
THCA	cis	rs4713675	0.565	rs4713670	MIMAT0018349	hsa-miR-3934-5p	8.11	4.31e-15	0.41	0.35	Plateletcrit;	chr6:33732105	chr6:33698152~33698173:+
THCA	cis	rs1018697	1	rs7088711	MIMAT0005951	hsa-miR-1307-3p	-8.11	4.52e-15	-0.24	-0.35	Colorectal adenoma (advanced);	chr10:102799509	chr10:103394301~103394322:-
THCA	cis	rs4713675	0.584	rs3818527	MIMAT0018349	hsa-miR-3934-5p	8.1	4.84e-15	0.41	0.35	Plateletcrit;	chr6:33693258	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.584	rs6938056	MIMAT0018349	hsa-miR-3934-5p	-8.08	5.32e-15	-0.41	-0.35	Plateletcrit;	chr6:33701800	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.565	rs9394161	MIMAT0018349	hsa-miR-3934-5p	-8.08	5.32e-15	-0.41	-0.35	Plateletcrit;	chr6:33702016	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.584	rs7739505	MIMAT0018349	hsa-miR-3934-5p	-8.08	5.32e-15	-0.41	-0.35	Plateletcrit;	chr6:33702593	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.565	rs4711340	MIMAT0018349	hsa-miR-3934-5p	-8.08	5.5e-15	-0.4	-0.35	Plateletcrit;	chr6:33713354	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.565	rs9368773	MIMAT0018349	hsa-miR-3934-5p	-8.08	5.5e-15	-0.4	-0.35	Plateletcrit;	chr6:33714764	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.565	rs2281829	MIMAT0018349	hsa-miR-3934-5p	-8.07	5.68e-15	-0.41	-0.35	Plateletcrit;	chr6:33707865	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.565	rs6904816	MIMAT0018349	hsa-miR-3934-5p	-8.07	5.68e-15	-0.41	-0.35	Plateletcrit;	chr6:33708379	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.565	rs6928010	MIMAT0018349	hsa-miR-3934-5p	-8.07	5.68e-15	-0.41	-0.35	Plateletcrit;	chr6:33708813	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.584	rs9394163	MIMAT0018349	hsa-miR-3934-5p	-8.07	6.07e-15	-0.4	-0.35	Plateletcrit;	chr6:33714637	chr6:33698152~33698173:+
THCA	cis	rs74233809	0.892	rs11191447	MIMAT0005951	hsa-miR-1307-3p	-8.06	6.12e-15	-0.38	-0.35	Birth weight;	chr10:102892566	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs35125602	MIMAT0005951	hsa-miR-1307-3p	-8.06	6.39e-15	-0.38	-0.35	Birth weight;	chr10:102896282	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs11191453	MIMAT0005951	hsa-miR-1307-3p	-8.06	6.39e-15	-0.38	-0.35	Birth weight;	chr10:102900095	chr10:103394301~103394322:-
THCA	cis	rs1018697	1	rs7092051	MIMAT0005951	hsa-miR-1307-3p	8.06	6.53e-15	0.24	0.35	Colorectal adenoma (advanced);	chr10:102799720	chr10:103394301~103394322:-
THCA	cis	rs4713675	0.546	rs10947434	MIMAT0018349	hsa-miR-3934-5p	-8.05	6.81e-15	-0.4	-0.35	Plateletcrit;	chr6:33723724	chr6:33698152~33698173:+
THCA	cis	rs7072216	0.77	rs942810	MIMAT0026738	hsa-miR-1287-3p	8.05	6.87e-15	0.25	0.35	Metabolite levels;	chr10:98408103	chr10:98395232~98395253:-
THCA	cis	rs74233809	1	rs74233296	MIMAT0005951	hsa-miR-1307-3p	-8.04	7.13e-15	-0.38	-0.35	Birth weight;	chr10:102895593	chr10:103394301~103394322:-
THCA	cis	rs7072216	0.666	rs11189592	MIMAT0005878	hsa-miR-1287-5p	8.04	7.25e-15	0.33	0.35	Metabolite levels;	chr10:98395885	chr10:98395271~98395292:-
THCA	cis	rs4713675	0.565	rs4713659	MIMAT0018349	hsa-miR-3934-5p	-8.04	7.43e-15	-0.41	-0.35	Plateletcrit;	chr6:33700062	chr6:33698152~33698173:+
THCA	cis	rs74233809	1	rs12413409	MIMAT0005951	hsa-miR-1307-3p	-8.04	7.52e-15	-0.38	-0.35	Birth weight;	chr10:102959339	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs943037	MIMAT0005951	hsa-miR-1307-3p	-8.04	7.55e-15	-0.39	-0.35	Birth weight;	chr10:103076162	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs9633712	MIMAT0005951	hsa-miR-1307-3p	-8.03	7.67e-15	-0.38	-0.35	Birth weight;	chr10:103114004	chr10:103394301~103394322:-
THCA	cis	rs74233809	0.786	rs11191564	MIMAT0005951	hsa-miR-1307-3p	-8.03	7.67e-15	-0.38	-0.35	Birth weight;	chr10:103118786	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs1060240	MIMAT0005951	hsa-miR-1307-3p	-8.03	7.67e-15	-0.38	-0.35	Birth weight;	chr10:103123580	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs10883835	MIMAT0005951	hsa-miR-1307-3p	-8.03	7.67e-15	-0.38	-0.35	Birth weight;	chr10:103124451	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs11191575	MIMAT0005951	hsa-miR-1307-3p	-8.03	7.67e-15	-0.38	-0.35	Birth weight;	chr10:103138580	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs79993475	MIMAT0005951	hsa-miR-1307-3p	-8.03	7.67e-15	-0.38	-0.35	Birth weight;	chr10:103141274	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs732998	MIMAT0005951	hsa-miR-1307-3p	8.03	7.67e-15	0.38	0.35	Birth weight;	chr10:103138144	chr10:103394301~103394322:-
THCA	cis	rs1018697	1	rs7086400	MIMAT0005951	hsa-miR-1307-3p	8.03	7.76e-15	0.24	0.35	Colorectal adenoma (advanced);	chr10:102802340	chr10:103394301~103394322:-
THCA	cis	rs4713675	0.565	rs9469566	MIMAT0018349	hsa-miR-3934-5p	-8.02	8.14e-15	-0.41	-0.35	Plateletcrit;	chr6:33699828	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.565	rs4713671	MIMAT0018349	hsa-miR-3934-5p	-8.02	8.67e-15	-0.4	-0.35	Plateletcrit;	chr6:33732122	chr6:33698152~33698173:+
THCA	cis	rs74233809	1	rs11191560	MIMAT0005951	hsa-miR-1307-3p	-8.01	8.74e-15	-0.38	-0.35	Birth weight;	chr10:103109281	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs12413046	MIMAT0005951	hsa-miR-1307-3p	-8.01	8.74e-15	-0.38	-0.35	Birth weight;	chr10:103111447	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs10883832	MIMAT0005951	hsa-miR-1307-3p	-8.01	8.74e-15	-0.38	-0.35	Birth weight;	chr10:103111522	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs79082900	MIMAT0005951	hsa-miR-1307-3p	-8.01	8.74e-15	-0.38	-0.35	Birth weight;	chr10:103117545	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs12220375	MIMAT0005951	hsa-miR-1307-3p	-8.01	8.74e-15	-0.38	-0.35	Birth weight;	chr10:103141734	chr10:103394301~103394322:-
THCA	cis	rs1018697	1	rs4919677	MIMAT0005951	hsa-miR-1307-3p	8.01	9.27e-15	0.24	0.35	Colorectal adenoma (advanced);	chr10:102794547	chr10:103394301~103394322:-
THCA	cis	rs4713675	0.565	rs3818530	MIMAT0018349	hsa-miR-3934-5p	-8	1e-14	-0.4	-0.35	Plateletcrit;	chr6:33693445	chr6:33698152~33698173:+
THCA	cis	rs1018697	0.897	rs2150929	MIMAT0005951	hsa-miR-1307-3p	7.99	1.04e-14	0.24	0.35	Colorectal adenoma (advanced);	chr10:102791180	chr10:103394301~103394322:-
THCA	cis	rs1018697	1	rs7911528	MIMAT0005951	hsa-miR-1307-3p	7.99	1.04e-14	0.24	0.35	Colorectal adenoma (advanced);	chr10:102791810	chr10:103394301~103394322:-
THCA	cis	rs1018697	1	rs7073114	MIMAT0005951	hsa-miR-1307-3p	7.98	1.14e-14	0.24	0.34	Colorectal adenoma (advanced);	chr10:102795894	chr10:103394301~103394322:-
THCA	cis	rs1018697	1	rs7092346	MIMAT0005951	hsa-miR-1307-3p	7.98	1.15e-14	0.24	0.34	Colorectal adenoma (advanced);	chr10:102800007	chr10:103394301~103394322:-
THCA	cis	rs1018697	0.966	rs1475643	MIMAT0005951	hsa-miR-1307-3p	7.97	1.21e-14	0.24	0.34	Colorectal adenoma (advanced);	chr10:102786710	chr10:103394301~103394322:-
THCA	cis	rs1018697	1	rs11191397	MIMAT0005951	hsa-miR-1307-3p	7.97	1.24e-14	0.24	0.34	Colorectal adenoma (advanced);	chr10:102798517	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs11191555	MIMAT0005951	hsa-miR-1307-3p	-7.97	1.25e-14	-0.38	-0.34	Birth weight;	chr10:103097766	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs11191557	MIMAT0005951	hsa-miR-1307-3p	-7.97	1.25e-14	-0.38	-0.34	Birth weight;	chr10:103104857	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs11191558	MIMAT0005951	hsa-miR-1307-3p	-7.97	1.25e-14	-0.38	-0.34	Birth weight;	chr10:103104921	chr10:103394301~103394322:-
THCA	cis	rs1018697	0.966	rs10748832	MIMAT0005951	hsa-miR-1307-3p	7.96	1.28e-14	0.24	0.34	Colorectal adenoma (advanced);	chr10:102808723	chr10:103394301~103394322:-
THCA	cis	rs4713675	0.584	rs9368776	MIMAT0018349	hsa-miR-3934-5p	-7.96	1.3e-14	-0.4	-0.34	Plateletcrit;	chr6:33728628	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.565	rs4713668	MIMAT0018349	hsa-miR-3934-5p	-7.95	1.36e-14	-0.4	-0.34	Plateletcrit;	chr6:33723019	chr6:33698152~33698173:+
THCA	cis	rs1018697	1	rs10748830	MIMAT0005951	hsa-miR-1307-3p	7.95	1.36e-14	0.24	0.34	Colorectal adenoma (advanced);	chr10:102788625	chr10:103394301~103394322:-
THCA	cis	rs1018697	1	rs10786710	MIMAT0005951	hsa-miR-1307-3p	7.95	1.36e-14	0.24	0.34	Colorectal adenoma (advanced);	chr10:102788982	chr10:103394301~103394322:-
THCA	cis	rs4711336	0.809	rs749338	MIMAT0022975	hsa-miR-3934-3p	7.95	1.39e-14	0.4	0.34	Height;	chr6:33685671	chr6:33698191~33698212:+
THCA	cis	rs74233809	1	rs34747231	MIMAT0005951	hsa-miR-1307-3p	-7.95	1.42e-14	-0.39	-0.34	Birth weight;	chr10:103182487	chr10:103394301~103394322:-
THCA	cis	rs4713675	0.584	rs942643	MIMAT0018349	hsa-miR-3934-5p	-7.94	1.46e-14	-0.4	-0.34	Plateletcrit;	chr6:33700593	chr6:33698152~33698173:+
THCA	cis	rs1018697	0.966	rs11191396	MIMAT0005951	hsa-miR-1307-3p	7.94	1.51e-14	0.24	0.34	Colorectal adenoma (advanced);	chr10:102793108	chr10:103394301~103394322:-
THCA	cis	rs1018697	1	rs4919678	MIMAT0005951	hsa-miR-1307-3p	7.94	1.51e-14	0.24	0.34	Colorectal adenoma (advanced);	chr10:102794606	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs3740390	MIMAT0005951	hsa-miR-1307-3p	-7.93	1.65e-14	-0.36	-0.34	Birth weight;	chr10:102878723	chr10:103394301~103394322:-
THCA	cis	rs1018697	1	rs2150928	MIMAT0005951	hsa-miR-1307-3p	7.92	1.7e-14	0.24	0.34	Colorectal adenoma (advanced);	chr10:102791228	chr10:103394301~103394322:-
THCA	cis	rs1018697	1	rs6584525	MIMAT0005951	hsa-miR-1307-3p	7.92	1.7e-14	0.24	0.34	Colorectal adenoma (advanced);	chr10:102792224	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs12412038	MIMAT0005951	hsa-miR-1307-3p	-7.92	1.72e-14	-0.38	-0.34	Birth weight;	chr10:103096405	chr10:103394301~103394322:-
THCA	cis	rs1018697	1	rs1018696	MIMAT0005951	hsa-miR-1307-3p	7.91	1.82e-14	0.24	0.34	Colorectal adenoma (advanced);	chr10:102789309	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs11191587	MIMAT0005951	hsa-miR-1307-3p	-7.91	1.85e-14	-0.38	-0.34	Birth weight;	chr10:103169959	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs11191593	MIMAT0005951	hsa-miR-1307-3p	-7.91	1.85e-14	-0.38	-0.34	Birth weight;	chr10:103179458	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs11191582	MIMAT0005951	hsa-miR-1307-3p	-7.9	1.99e-14	-0.39	-0.34	Birth weight;	chr10:103153896	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs11191551	MIMAT0005951	hsa-miR-1307-3p	-7.89	2.12e-14	-0.37	-0.34	Birth weight;	chr10:103091078	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs17094683	MIMAT0005951	hsa-miR-1307-3p	-7.89	2.12e-14	-0.37	-0.34	Birth weight;	chr10:103091544	chr10:103394301~103394322:-
THCA	cis	rs4711336	0.664	rs4713663	MIMAT0018349	hsa-miR-3934-5p	-7.89	2.12e-14	-0.4	-0.34	Height;	chr6:33706420	chr6:33698152~33698173:+
THCA	cis	rs74233809	0.901	rs12416331	MIMAT0005951	hsa-miR-1307-3p	-7.89	2.13e-14	-0.38	-0.34	Birth weight;	chr10:103169157	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs79237883	MIMAT0005951	hsa-miR-1307-3p	-7.89	2.13e-14	-0.38	-0.34	Birth weight;	chr10:103181189	chr10:103394301~103394322:-
THCA	cis	rs7072216	0.77	rs7909131	MIMAT0026738	hsa-miR-1287-3p	7.88	2.3e-14	0.25	0.34	Metabolite levels;	chr10:98411714	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.77	rs7897357	MIMAT0026738	hsa-miR-1287-3p	7.85	2.85e-14	0.25	0.34	Metabolite levels;	chr10:98403840	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.77	rs1737	MIMAT0026738	hsa-miR-1287-3p	7.85	2.91e-14	0.25	0.34	Metabolite levels;	chr10:98416609	chr10:98395232~98395253:-
THCA	cis	rs1018697	0.966	rs10748831	MIMAT0005951	hsa-miR-1307-3p	7.83	3.17e-14	0.23	0.34	Colorectal adenoma (advanced);	chr10:102798986	chr10:103394301~103394322:-
THCA	cis	rs1018697	0.966	rs1953930	MIMAT0005951	hsa-miR-1307-3p	7.83	3.35e-14	0.24	0.34	Colorectal adenoma (advanced);	chr10:102789704	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs77420391	MIMAT0005951	hsa-miR-1307-3p	-7.82	3.47e-14	-0.38	-0.34	Birth weight;	chr10:103186066	chr10:103394301~103394322:-
THCA	cis	rs1163656	0.502	rs17007711	MIMAT0003287	hsa-miR-618	7.8	4.12e-14	0.53	0.34	Dental caries;	chr12:80934305	chr12:80935796~80935818:-
THCA	cis	rs74233809	1	rs74233809	MIMAT0005951	hsa-miR-1307-3p	-7.78	4.74e-14	-0.37	-0.34	Birth weight;	chr10:103154183	chr10:103394301~103394322:-
THCA	cis	rs7072216	0.77	rs1739	MIMAT0026738	hsa-miR-1287-3p	7.77	5.06e-14	0.25	0.34	Metabolite levels;	chr10:98416582	chr10:98395232~98395253:-
THCA	cis	rs1018697	1	rs7909612	MIMAT0005951	hsa-miR-1307-3p	7.75	5.87e-14	0.23	0.34	Colorectal adenoma (advanced);	chr10:102801699	chr10:103394301~103394322:-
THCA	cis	rs4713675	0.565	rs3818524	MIMAT0018349	hsa-miR-3934-5p	-7.74	5.93e-14	-0.39	-0.34	Plateletcrit;	chr6:33692918	chr6:33698152~33698173:+
THCA	cis	rs7502590	1	rs72854146	MIMAT0015378	hsa-miR-3065-3p	-7.74	6.26e-14	-0.56	-0.34	Neuroticism;	chr17:81104810	chr17:81125926~81125948:+
THCA	cis	rs74233809	1	rs12219304	MIMAT0005951	hsa-miR-1307-3p	-7.73	6.36e-14	-0.37	-0.34	Birth weight;	chr10:103171827	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs12220743	MIMAT0005951	hsa-miR-1307-3p	-7.73	6.5e-14	-0.37	-0.34	Birth weight;	chr10:103092155	chr10:103394301~103394322:-
THCA	cis	rs7502590	0.92	rs56084168	MIMAT0015378	hsa-miR-3065-3p	-7.73	6.58e-14	-0.56	-0.34	Neuroticism;	chr17:81110774	chr17:81125926~81125948:+
THCA	cis	rs74233809	1	rs12217501	MIMAT0005951	hsa-miR-1307-3p	-7.71	7.65e-14	-0.37	-0.33	Birth weight;	chr10:103092132	chr10:103394301~103394322:-
THCA	cis	rs4713675	0.546	rs2296739	MIMAT0018349	hsa-miR-3934-5p	-7.7	7.85e-14	-0.39	-0.33	Plateletcrit;	chr6:33689192	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.546	rs3818521	MIMAT0018349	hsa-miR-3934-5p	-7.7	7.85e-14	-0.39	-0.33	Plateletcrit;	chr6:33689469	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.546	rs10947430	MIMAT0018349	hsa-miR-3934-5p	-7.7	7.85e-14	-0.39	-0.33	Plateletcrit;	chr6:33690757	chr6:33698152~33698173:+
THCA	cis	rs7072216	0.77	rs3830020	MIMAT0026738	hsa-miR-1287-3p	-7.69	8.92e-14	-0.25	-0.33	Metabolite levels;	chr10:98416858	chr10:98395232~98395253:-
THCA	cis	rs1163656	0.502	rs17007704	MIMAT0003287	hsa-miR-618	-7.62	1.36e-13	-0.53	-0.33	Dental caries;	chr12:80932218	chr12:80935796~80935818:-
THCA	cis	rs7072216	0.587	rs3814141	MIMAT0026738	hsa-miR-1287-3p	7.6	1.59e-13	0.26	0.33	Metabolite levels;	chr10:98411271	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.77	rs1061115	MIMAT0026738	hsa-miR-1287-3p	7.59	1.74e-13	0.24	0.33	Metabolite levels;	chr10:98417292	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.621	rs3750605	MIMAT0026738	hsa-miR-1287-3p	7.58	1.89e-13	0.26	0.33	Metabolite levels;	chr10:98415897	chr10:98395232~98395253:-
THCA	cis	rs9663711	1	rs9663711	MIMAT0005951	hsa-miR-1307-3p	7.58	1.9e-13	0.23	0.33	Carotid plaque burden;	chr10:102787871	chr10:103394301~103394322:-
THCA	cis	rs7072216	0.77	rs7896828	MIMAT0026738	hsa-miR-1287-3p	7.56	2.06e-13	0.24	0.33	Metabolite levels;	chr10:98410750	chr10:98395232~98395253:-
THCA	cis	rs4713675	0.604	rs791902	MIMAT0018349	hsa-miR-3934-5p	7.55	2.2e-13	0.39	0.33	Plateletcrit;	chr6:33734840	chr6:33698152~33698173:+
THCA	cis	rs74233809	0.748	rs10786736	MIMAT0022727	hsa-miR-1307-5p	-7.55	2.28e-13	-0.38	-0.33	Birth weight;	chr10:103089359	chr10:103394341~103394361:-
THCA	cis	rs1018697	1	rs7896903	MIMAT0005951	hsa-miR-1307-3p	7.54	2.4e-13	0.23	0.33	Colorectal adenoma (advanced);	chr10:102806660	chr10:103394301~103394322:-
THCA	cis	rs4711336	0.967	rs4713658	MIMAT0018349	hsa-miR-3934-5p	-7.54	2.42e-13	-0.38	-0.33	Height;	chr6:33699340	chr6:33698152~33698173:+
THCA	cis	rs1018697	1	rs7080587	MIMAT0005951	hsa-miR-1307-3p	7.52	2.79e-13	0.23	0.33	Colorectal adenoma (advanced);	chr10:102785517	chr10:103394301~103394322:-
THCA	cis	rs1163656	0.502	rs11114658	MIMAT0003287	hsa-miR-618	-7.51	3e-13	-0.52	-0.33	Dental caries;	chr12:80933378	chr12:80935796~80935818:-
THCA	cis	rs4713675	0.524	rs4713672	MIMAT0018349	hsa-miR-3934-5p	-7.5	3.13e-13	-0.38	-0.33	Plateletcrit;	chr6:33737289	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.565	rs9348924	MIMAT0018349	hsa-miR-3934-5p	-7.5	3.13e-13	-0.38	-0.33	Plateletcrit;	chr6:33737659	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.546	rs791903	MIMAT0018349	hsa-miR-3934-5p	7.5	3.2e-13	0.39	0.33	Plateletcrit;	chr6:33734868	chr6:33698152~33698173:+
THCA	cis	rs1018697	0.966	rs6584526	MIMAT0005951	hsa-miR-1307-3p	7.5	3.28e-13	0.23	0.33	Colorectal adenoma (advanced);	chr10:102806484	chr10:103394301~103394322:-
THCA	cis	rs4711336	1	rs4711336	MIMAT0018349	hsa-miR-3934-5p	7.49	3.47e-13	0.39	0.33	Height;	chr6:33691269	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.565	rs4711343	MIMAT0018349	hsa-miR-3934-5p	-7.49	3.53e-13	-0.38	-0.33	Plateletcrit;	chr6:33746771	chr6:33698152~33698173:+
THCA	cis	rs1163656	0.502	rs10862209	MIMAT0003287	hsa-miR-618	-7.48	3.57e-13	-0.52	-0.33	Dental caries;	chr12:80933176	chr12:80935796~80935818:-
THCA	cis	rs4711336	1	rs2296741	MIMAT0018349	hsa-miR-3934-5p	-7.48	3.62e-13	-0.39	-0.33	Height;	chr6:33691780	chr6:33698152~33698173:+
THCA	cis	rs7072216	0.853	rs6584194	MIMAT0026738	hsa-miR-1287-3p	7.48	3.74e-13	0.23	0.33	Metabolite levels;	chr10:98400642	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.621	rs11189595	MIMAT0026738	hsa-miR-1287-3p	7.47	3.82e-13	0.26	0.33	Metabolite levels;	chr10:98407565	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.621	rs3750604	MIMAT0026738	hsa-miR-1287-3p	7.45	4.56e-13	0.27	0.32	Metabolite levels;	chr10:98415824	chr10:98395232~98395253:-
THCA	cis	rs4713675	0.505	rs2395450	MIMAT0018349	hsa-miR-3934-5p	-7.42	5.39e-13	-0.39	-0.32	Plateletcrit;	chr6:33686811	chr6:33698152~33698173:+
THCA	cis	rs7072216	0.77	rs1061123	MIMAT0026738	hsa-miR-1287-3p	7.42	5.58e-13	0.24	0.32	Metabolite levels;	chr10:98417240	chr10:98395232~98395253:-
THCA	cis	rs4713675	0.565	rs60704560	MIMAT0018349	hsa-miR-3934-5p	-7.41	5.71e-13	-0.38	-0.32	Plateletcrit;	chr6:33745523	chr6:33698152~33698173:+
THCA	cis	rs4711336	1	rs11759396	MIMAT0018349	hsa-miR-3934-5p	-7.41	5.72e-13	-0.39	-0.32	Height;	chr6:33688877	chr6:33698152~33698173:+
THCA	cis	rs4713675	0.546	rs9348925	MIMAT0018349	hsa-miR-3934-5p	-7.41	5.99e-13	-0.38	-0.32	Plateletcrit;	chr6:33742919	chr6:33698152~33698173:+
THCA	cis	rs7072216	0.666	rs2274248	MIMAT0005878	hsa-miR-1287-5p	7.39	6.71e-13	0.3	0.32	Metabolite levels;	chr10:98388785	chr10:98395271~98395292:-
THCA	cis	rs4713675	0.565	rs4713674	MIMAT0018349	hsa-miR-3934-5p	7.38	7.14e-13	0.38	0.32	Plateletcrit;	chr6:33740392	chr6:33698152~33698173:+
THCA	cis	rs4711336	0.935	rs754404	MIMAT0018349	hsa-miR-3934-5p	-7.38	7.32e-13	-0.37	-0.32	Height;	chr6:33696953	chr6:33698152~33698173:+
THCA	cis	rs74233809	1	rs11191607	MIMAT0005951	hsa-miR-1307-3p	-7.35	8.64e-13	-0.35	-0.32	Birth weight;	chr10:103199431	chr10:103394301~103394322:-
THCA	cis	rs1163656	0.559	rs17007699	MIMAT0003287	hsa-miR-618	-7.35	8.73e-13	-0.62	-0.32	Dental caries;	chr12:80930007	chr12:80935796~80935818:-
THCA	cis	rs7072216	0.687	rs7097625	MIMAT0005878	hsa-miR-1287-5p	7.35	9.05e-13	0.28	0.32	Metabolite levels;	chr10:98399165	chr10:98395271~98395292:-
THCA	cis	rs4711336	1	rs764752	MIMAT0018349	hsa-miR-3934-5p	-7.34	9.15e-13	-0.38	-0.32	Height;	chr6:33690289	chr6:33698152~33698173:+
THCA	cis	rs4711336	1	rs764754	MIMAT0018349	hsa-miR-3934-5p	-7.34	9.15e-13	-0.38	-0.32	Height;	chr6:33690533	chr6:33698152~33698173:+
THCA	cis	rs74233809	1	rs11191548	MIMAT0005951	hsa-miR-1307-3p	7.33	1.03e-12	0.35	0.32	Birth weight;	chr10:103086421	chr10:103394301~103394322:-
THCA	cis	rs4711336	1	rs2296738	MIMAT0018349	hsa-miR-3934-5p	-7.31	1.17e-12	-0.38	-0.32	Height;	chr6:33689073	chr6:33698152~33698173:+
THCA	cis	rs7072216	0.922	rs4488133	MIMAT0026738	hsa-miR-1287-3p	-7.31	1.18e-12	-0.23	-0.32	Metabolite levels;	chr10:98399379	chr10:98395232~98395253:-
THCA	cis	rs4711336	0.935	rs3818529	MIMAT0018349	hsa-miR-3934-5p	-7.3	1.27e-12	-0.37	-0.32	Height;	chr6:33693329	chr6:33698152~33698173:+
THCA	cis	rs7072216	0.843	rs4400721	MIMAT0026738	hsa-miR-1287-3p	7.28	1.41e-12	0.24	0.32	Metabolite levels;	chr10:98387340	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.691	rs10786419	MIMAT0026738	hsa-miR-1287-3p	7.25	1.77e-12	0.23	0.32	Metabolite levels;	chr10:98421183	chr10:98395232~98395253:-
THCA	cis	rs74233809	1	rs12411886	MIMAT0022727	hsa-miR-1307-5p	-7.24	1.88e-12	-0.41	-0.32	Birth weight;	chr10:102925542	chr10:103394341~103394361:-
THCA	cis	rs4711336	1	rs2296736	MIMAT0018349	hsa-miR-3934-5p	-7.23	1.92e-12	-0.38	-0.32	Height;	chr6:33688473	chr6:33698152~33698173:+
THCA	cis	rs74233809	1	rs11191472	MIMAT0022727	hsa-miR-1307-5p	-7.23	1.96e-12	-0.41	-0.32	Birth weight;	chr10:102947259	chr10:103394341~103394361:-
THCA	cis	rs1163656	0.502	rs7310000	MIMAT0003287	hsa-miR-618	-7.22	2.06e-12	-0.5	-0.32	Dental caries;	chr12:80933498	chr12:80935796~80935818:-
THCA	cis	rs7072216	0.587	rs2296435	MIMAT0026738	hsa-miR-1287-3p	-7.22	2.07e-12	-0.25	-0.32	Metabolite levels;	chr10:98422528	chr10:98395232~98395253:-
THCA	cis	rs6584202	0.589	rs10883094	MIMAT0026738	hsa-miR-1287-3p	7.22	2.15e-12	0.24	0.32	Obesity-related traits;	chr10:98428349	chr10:98395232~98395253:-
THCA	cis	rs1163656	0.559	rs17007693	MIMAT0003287	hsa-miR-618	-7.21	2.17e-12	-0.61	-0.32	Dental caries;	chr12:80925305	chr12:80935796~80935818:-
THCA	cis	rs4711336	0.935	rs3818525	MIMAT0018349	hsa-miR-3934-5p	-7.21	2.22e-12	-0.37	-0.32	Height;	chr6:33693002	chr6:33698152~33698173:+
THCA	cis	rs7502590	1	rs72854146	MIMAT0015066	hsa-miR-3065-5p	-7.21	2.26e-12	-0.51	-0.31	Neuroticism;	chr17:81104810	chr17:81125886~81125908:+
THCA	cis	rs74233809	1	rs17115213	MIMAT0022727	hsa-miR-1307-5p	-7.2	2.38e-12	-0.41	-0.31	Birth weight;	chr10:102921386	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs10509759	MIMAT0022727	hsa-miR-1307-5p	-7.19	2.49e-12	-0.41	-0.31	Birth weight;	chr10:102929908	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs10883806	MIMAT0022727	hsa-miR-1307-5p	-7.19	2.49e-12	-0.41	-0.31	Birth weight;	chr10:102953319	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs78260931	MIMAT0022727	hsa-miR-1307-5p	-7.19	2.49e-12	-0.41	-0.31	Birth weight;	chr10:102962205	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs11191505	MIMAT0022727	hsa-miR-1307-5p	-7.19	2.49e-12	-0.41	-0.31	Birth weight;	chr10:103007134	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs11191514	MIMAT0022727	hsa-miR-1307-5p	-7.19	2.61e-12	-0.4	-0.31	Birth weight;	chr10:103013607	chr10:103394341~103394361:-
THCA	cis	rs7894407	0.623	rs10883846	MIMAT0005951	hsa-miR-1307-3p	7.18	2.72e-12	0.24	0.31	White matter hyperintensity burden;	chr10:103198487	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs77860422	MIMAT0022727	hsa-miR-1307-5p	-7.17	2.85e-12	-0.4	-0.31	Birth weight;	chr10:102988252	chr10:103394341~103394361:-
THCA	cis	rs9527	0.622	rs12779263	MIMAT0005951	hsa-miR-1307-3p	7.16	3.1e-12	0.24	0.31	Arsenic metabolism;	chr10:103126776	chr10:103394301~103394322:-
THCA	cis	rs7502590	0.92	rs56084168	MIMAT0015066	hsa-miR-3065-5p	-7.16	3.16e-12	-0.5	-0.31	Neuroticism;	chr17:81110774	chr17:81125886~81125908:+
THCA	cis	rs7894407	0.594	rs1163238	MIMAT0005951	hsa-miR-1307-3p	7.16	3.16e-12	0.24	0.31	White matter hyperintensity burden;	chr10:103184236	chr10:103394301~103394322:-
THCA	cis	rs7072216	0.555	rs2296433	MIMAT0026738	hsa-miR-1287-3p	7.15	3.23e-12	0.26	0.31	Metabolite levels;	chr10:98424305	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.555	rs2296432	MIMAT0026738	hsa-miR-1287-3p	7.15	3.23e-12	0.26	0.31	Metabolite levels;	chr10:98424306	chr10:98395232~98395253:-
THCA	cis	rs7072216	1	rs7072216	MIMAT0026738	hsa-miR-1287-3p	7.15	3.27e-12	0.22	0.31	Metabolite levels;	chr10:98397096	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.615	rs6584195	MIMAT0005878	hsa-miR-1287-5p	7.15	3.33e-12	0.28	0.31	Metabolite levels;	chr10:98400990	chr10:98395271~98395292:-
THCA	cis	rs74233809	1	rs12221064	MIMAT0022727	hsa-miR-1307-5p	-7.14	3.58e-12	-0.4	-0.31	Birth weight;	chr10:102917369	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs77602510	MIMAT0022727	hsa-miR-1307-5p	-7.14	3.58e-12	-0.4	-0.31	Birth weight;	chr10:102922845	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs78821730	MIMAT0022727	hsa-miR-1307-5p	-7.14	3.58e-12	-0.4	-0.31	Birth weight;	chr10:102924787	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs5011520	MIMAT0022727	hsa-miR-1307-5p	-7.13	3.77e-12	-0.4	-0.31	Birth weight;	chr10:102937759	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs10883808	MIMAT0022727	hsa-miR-1307-5p	-7.13	3.77e-12	-0.4	-0.31	Birth weight;	chr10:102961369	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs11191479	MIMAT0022727	hsa-miR-1307-5p	-7.13	3.77e-12	-0.4	-0.31	Birth weight;	chr10:102963863	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs10883815	MIMAT0022727	hsa-miR-1307-5p	-7.13	3.77e-12	-0.4	-0.31	Birth weight;	chr10:102979422	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs112390216	MIMAT0022727	hsa-miR-1307-5p	-7.13	3.77e-12	-0.4	-0.31	Birth weight;	chr10:102981274	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs11191502	MIMAT0022727	hsa-miR-1307-5p	-7.13	3.77e-12	-0.4	-0.31	Birth weight;	chr10:103005737	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs74444347	MIMAT0022727	hsa-miR-1307-5p	-7.13	3.77e-12	-0.4	-0.31	Birth weight;	chr10:103009518	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs12221335	MIMAT0022727	hsa-miR-1307-5p	-7.13	3.77e-12	-0.4	-0.31	Birth weight;	chr10:103009635	chr10:103394341~103394361:-
THCA	cis	rs4711336	1	rs2229642	MIMAT0018349	hsa-miR-3934-5p	-7.12	4.15e-12	-0.36	-0.31	Height;	chr6:33691695	chr6:33698152~33698173:+
THCA	cis	rs4711336	1	rs2296742	MIMAT0018349	hsa-miR-3934-5p	-7.12	4.15e-12	-0.36	-0.31	Height;	chr6:33692016	chr6:33698152~33698173:+
THCA	cis	rs4711336	1	rs4711337	MIMAT0018349	hsa-miR-3934-5p	-7.12	4.15e-12	-0.36	-0.31	Height;	chr6:33692210	chr6:33698152~33698173:+
THCA	cis	rs4711336	1	rs3818523	MIMAT0018349	hsa-miR-3934-5p	-7.09	4.87e-12	-0.36	-0.31	Height;	chr6:33692594	chr6:33698152~33698173:+
THCA	cis	rs4711336	0.967	rs4711338	MIMAT0018349	hsa-miR-3934-5p	-7.09	4.89e-12	-0.36	-0.31	Height;	chr6:33692411	chr6:33698152~33698173:+
THCA	cis	rs74233809	1	rs11191519	MIMAT0022727	hsa-miR-1307-5p	-7.08	5.27e-12	-0.4	-0.31	Birth weight;	chr10:103025161	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs12221193	MIMAT0022727	hsa-miR-1307-5p	-7.08	5.38e-12	-0.4	-0.31	Birth weight;	chr10:102905510	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs77180047	MIMAT0022727	hsa-miR-1307-5p	-7.08	5.38e-12	-0.4	-0.31	Birth weight;	chr10:102907000	chr10:103394341~103394361:-
THCA	cis	rs4713675	0.584	rs560111	MIMAT0018349	hsa-miR-3934-5p	-7.07	5.7e-12	-0.36	-0.31	Plateletcrit;	chr6:33738500	chr6:33698152~33698173:+
THCA	cis	rs74233809	1	rs77787671	MIMAT0022727	hsa-miR-1307-5p	-7.05	6.58e-12	-0.4	-0.31	Birth weight;	chr10:103016448	chr10:103394341~103394361:-
THCA	cis	rs7072216	0.922	rs10786415	MIMAT0026738	hsa-miR-1287-3p	7.04	7.02e-12	0.22	0.31	Metabolite levels;	chr10:98391509	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.922	rs942814	MIMAT0026738	hsa-miR-1287-3p	7.04	7.02e-12	0.22	0.31	Metabolite levels;	chr10:98391548	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.922	rs6584191	MIMAT0026738	hsa-miR-1287-3p	7.04	7.02e-12	0.22	0.31	Metabolite levels;	chr10:98392298	chr10:98395232~98395253:-
THCA	cis	rs74233809	0.901	rs17878846	MIMAT0005951	hsa-miR-1307-3p	-7.03	7.18e-12	-0.33	-0.31	Birth weight;	chr10:102870655	chr10:103394301~103394322:-
THCA	cis	rs7894407	0.629	rs11598702	MIMAT0005951	hsa-miR-1307-3p	7.02	7.81e-12	0.23	0.31	White matter hyperintensity burden;	chr10:103138228	chr10:103394301~103394322:-
THCA	cis	rs4713675	0.584	rs509539	MIMAT0018349	hsa-miR-3934-5p	7.01	8.04e-12	0.36	0.31	Plateletcrit;	chr6:33740413	chr6:33698152~33698173:+
THCA	cis	rs7072216	0.922	rs4539242	MIMAT0026738	hsa-miR-1287-3p	7	8.66e-12	0.22	0.31	Metabolite levels;	chr10:98388301	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.881	rs2147896	MIMAT0026738	hsa-miR-1287-3p	7	8.66e-12	0.22	0.31	Metabolite levels;	chr10:98388419	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.652	rs11189600	MIMAT0026738	hsa-miR-1287-3p	-7	8.9e-12	-0.23	-0.31	Metabolite levels;	chr10:98419517	chr10:98395232~98395253:-
THCA	cis	rs74233809	1	rs943037	MIMAT0022727	hsa-miR-1307-5p	-6.99	9.47e-12	-0.4	-0.31	Birth weight;	chr10:103076162	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs35125602	MIMAT0022727	hsa-miR-1307-5p	-6.97	1.04e-11	-0.39	-0.31	Birth weight;	chr10:102896282	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs11191453	MIMAT0022727	hsa-miR-1307-5p	-6.97	1.04e-11	-0.39	-0.31	Birth weight;	chr10:102900095	chr10:103394341~103394361:-
THCA	cis	rs4713675	0.505	rs753890	MIMAT0018349	hsa-miR-3934-5p	-6.96	1.11e-11	-0.37	-0.31	Plateletcrit;	chr6:33685103	chr6:33698152~33698173:+
THCA	cis	rs4711336	0.527	rs28651968	MIMAT0018349	hsa-miR-3934-5p	-6.96	1.14e-11	-0.36	-0.31	Height;	chr6:33749647	chr6:33698152~33698173:+
THCA	cis	rs74233809	1	rs74233296	MIMAT0022727	hsa-miR-1307-5p	-6.95	1.25e-11	-0.39	-0.3	Birth weight;	chr10:102895593	chr10:103394341~103394361:-
THCA	cis	rs74233809	0.901	rs11191425	MIMAT0005951	hsa-miR-1307-3p	-6.93	1.4e-11	-0.32	-0.3	Birth weight;	chr10:102866213	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs12219901	MIMAT0022727	hsa-miR-1307-5p	-6.93	1.4e-11	-0.4	-0.3	Birth weight;	chr10:103081210	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs10458729	MIMAT0022727	hsa-miR-1307-5p	-6.93	1.4e-11	-0.4	-0.3	Birth weight;	chr10:103081722	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs75970938	MIMAT0022727	hsa-miR-1307-5p	-6.93	1.43e-11	-0.4	-0.3	Birth weight;	chr10:103033891	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs79668541	MIMAT0022727	hsa-miR-1307-5p	-6.93	1.43e-11	-0.4	-0.3	Birth weight;	chr10:103034147	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs3781285	MIMAT0022727	hsa-miR-1307-5p	-6.93	1.43e-11	-0.4	-0.3	Birth weight;	chr10:103065908	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs74233809	MIMAT0022727	hsa-miR-1307-5p	-6.92	1.45e-11	-0.39	-0.3	Birth weight;	chr10:103154183	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs34747231	MIMAT0022727	hsa-miR-1307-5p	-6.92	1.46e-11	-0.4	-0.3	Birth weight;	chr10:103182487	chr10:103394341~103394361:-
THCA	cis	rs4713675	0.546	rs10947435	MIMAT0018349	hsa-miR-3934-5p	-6.91	1.56e-11	-0.36	-0.3	Plateletcrit;	chr6:33750298	chr6:33698152~33698173:+
THCA	cis	rs74233809	0.892	rs11191447	MIMAT0022727	hsa-miR-1307-5p	-6.9	1.71e-11	-0.39	-0.3	Birth weight;	chr10:102892566	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs11191531	MIMAT0022727	hsa-miR-1307-5p	-6.89	1.79e-11	-0.4	-0.3	Birth weight;	chr10:103047141	chr10:103394341~103394361:-
THCA	cis	rs74233809	0.901	rs12416331	MIMAT0022727	hsa-miR-1307-5p	-6.89	1.79e-11	-0.39	-0.3	Birth weight;	chr10:103169157	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs79237883	MIMAT0022727	hsa-miR-1307-5p	-6.89	1.79e-11	-0.39	-0.3	Birth weight;	chr10:103181189	chr10:103394341~103394361:-
THCA	cis	rs9527	0.615	rs4919685	MIMAT0005951	hsa-miR-1307-3p	6.89	1.8e-11	0.24	0.3	Arsenic metabolism;	chr10:102827605	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs12412038	MIMAT0022727	hsa-miR-1307-5p	-6.89	1.83e-11	-0.39	-0.3	Birth weight;	chr10:103096405	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs11191551	MIMAT0022727	hsa-miR-1307-5p	-6.89	1.84e-11	-0.39	-0.3	Birth weight;	chr10:103091078	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs17094683	MIMAT0022727	hsa-miR-1307-5p	-6.89	1.84e-11	-0.39	-0.3	Birth weight;	chr10:103091544	chr10:103394341~103394361:-
THCA	cis	rs9527	0.641	rs4919684	MIMAT0005951	hsa-miR-1307-3p	6.88	1.92e-11	0.24	0.3	Arsenic metabolism;	chr10:102827267	chr10:103394301~103394322:-
THCA	cis	rs9527	0.662	rs10883783	MIMAT0005951	hsa-miR-1307-3p	6.88	1.95e-11	0.24	0.3	Arsenic metabolism;	chr10:102831395	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs12217501	MIMAT0022727	hsa-miR-1307-5p	-6.86	2.12e-11	-0.39	-0.3	Birth weight;	chr10:103092132	chr10:103394341~103394361:-
THCA	cis	rs4711336	0.712	rs942641	MIMAT0018349	hsa-miR-3934-5p	-6.86	2.13e-11	-0.34	-0.3	Height;	chr6:33719230	chr6:33698152~33698173:+
THCA	cis	rs74233809	1	rs11191454	MIMAT0022727	hsa-miR-1307-5p	-6.86	2.14e-11	-0.39	-0.3	Birth weight;	chr10:102900247	chr10:103394341~103394361:-
THCA	cis	rs1163656	0.527	rs1402347	MIMAT0003287	hsa-miR-618	6.85	2.37e-11	0.56	0.3	Dental caries;	chr12:80913217	chr12:80935796~80935818:-
THCA	cis	rs7072216	0.687	rs10883085	MIMAT0005878	hsa-miR-1287-5p	6.84	2.4e-11	0.26	0.3	Metabolite levels;	chr10:98395856	chr10:98395271~98395292:-
THCA	cis	rs74233809	1	rs11191499	MIMAT0022727	hsa-miR-1307-5p	-6.84	2.52e-11	-0.38	-0.3	Birth weight;	chr10:103004514	chr10:103394341~103394361:-
THCA	cis	rs7072216	0.922	rs942813	MIMAT0026738	hsa-miR-1287-3p	6.83	2.58e-11	0.22	0.3	Metabolite levels;	chr10:98393851	chr10:98395232~98395253:-
THCA	cis	rs74233809	1	rs12219027	MIMAT0022727	hsa-miR-1307-5p	-6.83	2.68e-11	-0.39	-0.3	Birth weight;	chr10:103051446	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs11191555	MIMAT0022727	hsa-miR-1307-5p	-6.83	2.69e-11	-0.39	-0.3	Birth weight;	chr10:103097766	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs11191557	MIMAT0022727	hsa-miR-1307-5p	-6.83	2.69e-11	-0.39	-0.3	Birth weight;	chr10:103104857	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs11191558	MIMAT0022727	hsa-miR-1307-5p	-6.83	2.69e-11	-0.39	-0.3	Birth weight;	chr10:103104921	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs11191587	MIMAT0022727	hsa-miR-1307-5p	-6.82	2.71e-11	-0.39	-0.3	Birth weight;	chr10:103169959	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs11191593	MIMAT0022727	hsa-miR-1307-5p	-6.82	2.71e-11	-0.39	-0.3	Birth weight;	chr10:103179458	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs11191543	MIMAT0022727	hsa-miR-1307-5p	-6.82	2.86e-11	-0.39	-0.3	Birth weight;	chr10:103064630	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs11191515	MIMAT0022727	hsa-miR-1307-5p	-6.81	3e-11	-0.39	-0.3	Birth weight;	chr10:103016770	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs76752100	MIMAT0022727	hsa-miR-1307-5p	-6.81	3.03e-11	-0.39	-0.3	Birth weight;	chr10:103034329	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs12220743	MIMAT0022727	hsa-miR-1307-5p	-6.8	3.15e-11	-0.38	-0.3	Birth weight;	chr10:103092155	chr10:103394341~103394361:-
THCA	cis	rs74233809	0.901	rs4409766	MIMAT0005951	hsa-miR-1307-3p	-6.8	3.17e-11	-0.3	-0.3	Birth weight;	chr10:102856906	chr10:103394301~103394322:-
THCA	cis	rs7072216	0.922	rs59667296	MIMAT0026738	hsa-miR-1287-3p	6.79	3.35e-11	0.21	0.3	Metabolite levels;	chr10:98386556	chr10:98395232~98395253:-
THCA	cis	rs4711336	0.633	rs9469583	MIMAT0022975	hsa-miR-3934-3p	-6.79	3.44e-11	-0.35	-0.3	Height;	chr6:33749993	chr6:33698191~33698212:+
THCA	cis	rs9527	0.545	rs35756290	MIMAT0005951	hsa-miR-1307-3p	6.78	3.62e-11	0.24	0.3	Arsenic metabolism;	chr10:102825815	chr10:103394301~103394322:-
THCA	cis	rs7072216	0.687	rs7924209	MIMAT0005878	hsa-miR-1287-5p	6.77	3.89e-11	0.26	0.3	Metabolite levels;	chr10:98396170	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.687	rs7908310	MIMAT0005878	hsa-miR-1287-5p	6.77	3.89e-11	0.26	0.3	Metabolite levels;	chr10:98396470	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.687	rs10883087	MIMAT0005878	hsa-miR-1287-5p	6.77	3.89e-11	0.26	0.3	Metabolite levels;	chr10:98397233	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.687	rs7924303	MIMAT0005878	hsa-miR-1287-5p	-6.77	3.9e-11	-0.26	-0.3	Metabolite levels;	chr10:98396206	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.687	rs7907555	MIMAT0005878	hsa-miR-1287-5p	-6.76	4.18e-11	-0.26	-0.3	Metabolite levels;	chr10:98396053	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.687	rs10786418	MIMAT0005878	hsa-miR-1287-5p	6.75	4.31e-11	0.26	0.3	Metabolite levels;	chr10:98397611	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.687	rs11189587	MIMAT0005878	hsa-miR-1287-5p	6.75	4.39e-11	0.26	0.3	Metabolite levels;	chr10:98394788	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.687	rs11189588	MIMAT0005878	hsa-miR-1287-5p	6.75	4.39e-11	0.26	0.3	Metabolite levels;	chr10:98394794	chr10:98395271~98395292:-
THCA	cis	rs6841433	0.706	rs13147491	MIMAT0003242	hsa-miR-577	6.75	4.41e-11	0.5	0.3	Hemoglobin concentration;	chr4:114696462	chr4:114656774~114656794:+
THCA	cis	rs4711336	1	rs2296740	MIMAT0018349	hsa-miR-3934-5p	-6.75	4.42e-11	-0.35	-0.3	Height;	chr6:33691759	chr6:33698152~33698173:+
THCA	cis	rs7072216	0.687	rs11189590	MIMAT0005878	hsa-miR-1287-5p	6.75	4.44e-11	0.26	0.3	Metabolite levels;	chr10:98394848	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.687	rs4551689	MIMAT0005878	hsa-miR-1287-5p	-6.74	4.51e-11	-0.26	-0.3	Metabolite levels;	chr10:98397836	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.881	rs11189591	MIMAT0026738	hsa-miR-1287-3p	6.74	4.59e-11	0.21	0.3	Metabolite levels;	chr10:98395539	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.687	rs10883086	MIMAT0005878	hsa-miR-1287-5p	6.74	4.65e-11	0.26	0.3	Metabolite levels;	chr10:98395986	chr10:98395271~98395292:-
THCA	cis	rs74233809	0.901	rs7098825	MIMAT0005951	hsa-miR-1307-3p	-6.73	4.95e-11	-0.31	-0.3	Birth weight;	chr10:102868477	chr10:103394301~103394322:-
THCA	cis	rs7072216	0.687	rs11189589	MIMAT0005878	hsa-miR-1287-5p	6.71	5.68e-11	0.26	0.29	Metabolite levels;	chr10:98394808	chr10:98395271~98395292:-
THCA	cis	rs9527	0.59	rs1541213	MIMAT0005951	hsa-miR-1307-3p	6.7	5.84e-11	0.22	0.29	Arsenic metabolism;	chr10:103125573	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs10883836	MIMAT0005951	hsa-miR-1307-3p	6.7	5.84e-11	0.22	0.29	Arsenic metabolism;	chr10:103131441	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs11191572	MIMAT0005951	hsa-miR-1307-3p	6.7	5.84e-11	0.22	0.29	Arsenic metabolism;	chr10:103133380	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs12415199	MIMAT0005951	hsa-miR-1307-3p	6.7	5.84e-11	0.22	0.29	Arsenic metabolism;	chr10:103135779	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs34104646	MIMAT0005951	hsa-miR-1307-3p	6.7	5.84e-11	0.22	0.29	Arsenic metabolism;	chr10:103136321	chr10:103394301~103394322:-
THCA	cis	rs9527	0.567	rs11191573	MIMAT0005951	hsa-miR-1307-3p	6.7	5.84e-11	0.22	0.29	Arsenic metabolism;	chr10:103137059	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs11191578	MIMAT0005951	hsa-miR-1307-3p	6.7	5.84e-11	0.22	0.29	Arsenic metabolism;	chr10:103142580	chr10:103394301~103394322:-
THCA	cis	rs9527	0.641	rs34130454	MIMAT0005951	hsa-miR-1307-3p	6.7	5.84e-11	0.22	0.29	Arsenic metabolism;	chr10:103143881	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs7897663	MIMAT0005951	hsa-miR-1307-3p	6.7	5.84e-11	0.22	0.29	Arsenic metabolism;	chr10:103145847	chr10:103394301~103394322:-
THCA	cis	rs6543140	0.964	rs2141781	MIMAT0019927	hsa-miR-4772-3p	-6.69	6.23e-11	-0.29	-0.29	Blood protein levels;	chr2:102466446	chr2:102432336~102432357:+
THCA	cis	rs6543140	0.964	rs11903551	MIMAT0019927	hsa-miR-4772-3p	-6.69	6.23e-11	-0.29	-0.29	Blood protein levels;	chr2:102467721	chr2:102432336~102432357:+
THCA	cis	rs6543140	0.964	rs6543143	MIMAT0019927	hsa-miR-4772-3p	-6.69	6.23e-11	-0.29	-0.29	Blood protein levels;	chr2:102468960	chr2:102432336~102432357:+
THCA	cis	rs6543140	0.964	rs13383602	MIMAT0019927	hsa-miR-4772-3p	-6.69	6.23e-11	-0.29	-0.29	Blood protein levels;	chr2:102469502	chr2:102432336~102432357:+
THCA	cis	rs6543140	0.964	rs10193485	MIMAT0019927	hsa-miR-4772-3p	-6.69	6.29e-11	-0.29	-0.29	Blood protein levels;	chr2:102473114	chr2:102432336~102432357:+
THCA	cis	rs6543140	0.964	rs10196334	MIMAT0019927	hsa-miR-4772-3p	-6.69	6.29e-11	-0.29	-0.29	Blood protein levels;	chr2:102473582	chr2:102432336~102432357:+
THCA	cis	rs6543140	0.964	rs10200081	MIMAT0019927	hsa-miR-4772-3p	-6.69	6.29e-11	-0.29	-0.29	Blood protein levels;	chr2:102475097	chr2:102432336~102432357:+
THCA	cis	rs6543140	0.964	rs4851592	MIMAT0019927	hsa-miR-4772-3p	-6.68	6.68e-11	-0.29	-0.29	Blood protein levels;	chr2:102471181	chr2:102432336~102432357:+
THCA	cis	rs9527	0.59	rs10786738	MIMAT0005951	hsa-miR-1307-3p	6.68	6.76e-11	0.22	0.29	Arsenic metabolism;	chr10:103109694	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs1807298	MIMAT0005951	hsa-miR-1307-3p	6.68	6.76e-11	0.22	0.29	Arsenic metabolism;	chr10:103110461	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs2182348	MIMAT0005951	hsa-miR-1307-3p	6.68	6.76e-11	0.22	0.29	Arsenic metabolism;	chr10:103112927	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs10509766	MIMAT0005951	hsa-miR-1307-3p	6.68	6.89e-11	0.22	0.29	Arsenic metabolism;	chr10:103166577	chr10:103394301~103394322:-
THCA	cis	rs9527	0.64	rs35195396	MIMAT0005951	hsa-miR-1307-3p	6.68	6.89e-11	0.22	0.29	Arsenic metabolism;	chr10:103169013	chr10:103394301~103394322:-
THCA	cis	rs9527	0.614	rs11191589	MIMAT0005951	hsa-miR-1307-3p	6.68	6.89e-11	0.22	0.29	Arsenic metabolism;	chr10:103170625	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs3740386	MIMAT0005951	hsa-miR-1307-3p	6.68	6.89e-11	0.22	0.29	Arsenic metabolism;	chr10:103171294	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs10786741	MIMAT0005951	hsa-miR-1307-3p	6.68	6.89e-11	0.22	0.29	Arsenic metabolism;	chr10:103179425	chr10:103394301~103394322:-
THCA	cis	rs7072216	0.687	rs10786417	MIMAT0005878	hsa-miR-1287-5p	6.68	6.89e-11	0.26	0.29	Metabolite levels;	chr10:98394147	chr10:98395271~98395292:-
THCA	cis	rs9527	0.59	rs12775302	MIMAT0005951	hsa-miR-1307-3p	6.67	7.2e-11	0.22	0.29	Arsenic metabolism;	chr10:103151599	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs12414232	MIMAT0005951	hsa-miR-1307-3p	6.67	7.2e-11	0.22	0.29	Arsenic metabolism;	chr10:103154734	chr10:103394301~103394322:-
THCA	cis	rs1163656	0.559	rs12228291	MIMAT0003287	hsa-miR-618	-6.67	7.32e-11	-0.58	-0.29	Dental caries;	chr12:80918034	chr12:80935796~80935818:-
THCA	cis	rs9527	0.662	rs4919686	MIMAT0005951	hsa-miR-1307-3p	6.66	7.54e-11	0.23	0.29	Arsenic metabolism;	chr10:102832492	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs3861984	MIMAT0005951	hsa-miR-1307-3p	6.66	7.59e-11	0.22	0.29	Arsenic metabolism;	chr10:103157223	chr10:103394301~103394322:-
THCA	cis	rs1163656	0.559	rs7136415	MIMAT0003287	hsa-miR-618	-6.66	7.66e-11	-0.58	-0.29	Dental caries;	chr12:80915511	chr12:80935796~80935818:-
THCA	cis	rs9527	0.544	rs3781280	MIMAT0005951	hsa-miR-1307-3p	6.65	8.08e-11	0.22	0.29	Arsenic metabolism;	chr10:103104086	chr10:103394301~103394322:-
THCA	cis	rs6543140	0.964	rs6543142	MIMAT0019927	hsa-miR-4772-3p	-6.64	8.61e-11	-0.29	-0.29	Blood protein levels;	chr2:102465546	chr2:102432336~102432357:+
THCA	cis	rs6543140	0.929	rs6742530	MIMAT0019927	hsa-miR-4772-3p	-6.64	8.61e-11	-0.29	-0.29	Blood protein levels;	chr2:102465820	chr2:102432336~102432357:+
THCA	cis	rs9527	0.59	rs2281877	MIMAT0005951	hsa-miR-1307-3p	6.64	8.69e-11	0.22	0.29	Arsenic metabolism;	chr10:103106305	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs1926037	MIMAT0005951	hsa-miR-1307-3p	6.64	8.69e-11	0.22	0.29	Arsenic metabolism;	chr10:103118253	chr10:103394301~103394322:-
THCA	cis	rs9527	0.567	rs6584539	MIMAT0005951	hsa-miR-1307-3p	6.64	8.69e-11	0.22	0.29	Arsenic metabolism;	chr10:103119645	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs2148200	MIMAT0005951	hsa-miR-1307-3p	6.64	8.69e-11	0.22	0.29	Arsenic metabolism;	chr10:103120090	chr10:103394301~103394322:-
THCA	cis	rs9527	0.614	rs2153774	MIMAT0005951	hsa-miR-1307-3p	6.64	8.69e-11	0.22	0.29	Arsenic metabolism;	chr10:103121278	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs10883834	MIMAT0005951	hsa-miR-1307-3p	6.64	8.69e-11	0.22	0.29	Arsenic metabolism;	chr10:103121645	chr10:103394301~103394322:-
THCA	cis	rs9527	0.545	rs7915816	MIMAT0005951	hsa-miR-1307-3p	6.64	8.69e-11	0.22	0.29	Arsenic metabolism;	chr10:103121993	chr10:103394301~103394322:-
THCA	cis	rs9527	0.568	rs1926036	MIMAT0005951	hsa-miR-1307-3p	6.64	8.73e-11	0.22	0.29	Arsenic metabolism;	chr10:103124055	chr10:103394301~103394322:-
THCA	cis	rs6543140	0.964	rs10169192	MIMAT0019927	hsa-miR-4772-3p	-6.63	9.02e-11	-0.29	-0.29	Blood protein levels;	chr2:102455751	chr2:102432336~102432357:+
THCA	cis	rs6543140	0.964	rs11886793	MIMAT0019927	hsa-miR-4772-3p	-6.63	9.02e-11	-0.29	-0.29	Blood protein levels;	chr2:102455760	chr2:102432336~102432357:+
THCA	cis	rs6543140	0.964	rs2310301	MIMAT0019927	hsa-miR-4772-3p	-6.63	9.02e-11	-0.29	-0.29	Blood protein levels;	chr2:102456475	chr2:102432336~102432357:+
THCA	cis	rs6543140	1	rs6543140	MIMAT0019927	hsa-miR-4772-3p	-6.63	9.02e-11	-0.29	-0.29	Blood protein levels;	chr2:102457814	chr2:102432336~102432357:+
THCA	cis	rs6543140	0.964	rs13390895	MIMAT0019927	hsa-miR-4772-3p	-6.63	9.02e-11	-0.29	-0.29	Blood protein levels;	chr2:102459039	chr2:102432336~102432357:+
THCA	cis	rs6543140	0.855	rs4851591	MIMAT0019927	hsa-miR-4772-3p	-6.63	9.02e-11	-0.29	-0.29	Blood protein levels;	chr2:102460963	chr2:102432336~102432357:+
THCA	cis	rs6543140	0.964	rs7561351	MIMAT0019927	hsa-miR-4772-3p	-6.63	9.02e-11	-0.29	-0.29	Blood protein levels;	chr2:102461320	chr2:102432336~102432357:+
THCA	cis	rs6543140	0.964	rs13393175	MIMAT0019927	hsa-miR-4772-3p	-6.63	9.02e-11	-0.29	-0.29	Blood protein levels;	chr2:102462389	chr2:102432336~102432357:+
THCA	cis	rs6543140	0.865	rs6760275	MIMAT0019927	hsa-miR-4772-3p	-6.63	9.02e-11	-0.29	-0.29	Blood protein levels;	chr2:102463147	chr2:102432336~102432357:+
THCA	cis	rs6543140	0.964	rs6734203	MIMAT0019927	hsa-miR-4772-3p	-6.63	9.02e-11	-0.29	-0.29	Blood protein levels;	chr2:102463606	chr2:102432336~102432357:+
THCA	cis	rs9527	0.615	rs11191485	MIMAT0005951	hsa-miR-1307-3p	6.63	9.15e-11	0.22	0.29	Arsenic metabolism;	chr10:102970059	chr10:103394301~103394322:-
THCA	cis	rs7072216	0.616	rs701801	MIMAT0026738	hsa-miR-1287-3p	6.62	9.63e-11	0.22	0.29	Metabolite levels;	chr10:98417112	chr10:98395232~98395253:-
THCA	cis	rs9527	0.59	rs7067663	MIMAT0005951	hsa-miR-1307-3p	6.62	9.67e-11	0.22	0.29	Arsenic metabolism;	chr10:103123893	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs12355120	MIMAT0005951	hsa-miR-1307-3p	6.61	1.05e-10	0.22	0.29	Arsenic metabolism;	chr10:103092409	chr10:103394301~103394322:-
THCA	cis	rs7072216	0.687	rs11597425	MIMAT0005878	hsa-miR-1287-5p	6.61	1.07e-10	0.26	0.29	Metabolite levels;	chr10:98394445	chr10:98395271~98395292:-
THCA	cis	rs7072216	0.687	rs11597428	MIMAT0005878	hsa-miR-1287-5p	6.61	1.07e-10	0.26	0.29	Metabolite levels;	chr10:98394490	chr10:98395271~98395292:-
THCA	cis	rs9527	0.615	rs7096452	MIMAT0005951	hsa-miR-1307-3p	6.6	1.08e-10	0.22	0.29	Arsenic metabolism;	chr10:102976806	chr10:103394301~103394322:-
THCA	cis	rs9527	0.615	rs7080462	MIMAT0005951	hsa-miR-1307-3p	6.6	1.08e-10	0.22	0.29	Arsenic metabolism;	chr10:102976942	chr10:103394301~103394322:-
THCA	cis	rs9527	0.615	rs11191489	MIMAT0005951	hsa-miR-1307-3p	6.6	1.08e-10	0.22	0.29	Arsenic metabolism;	chr10:102980811	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs11191560	MIMAT0022727	hsa-miR-1307-5p	-6.59	1.16e-10	-0.38	-0.29	Birth weight;	chr10:103109281	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs12413046	MIMAT0022727	hsa-miR-1307-5p	-6.59	1.16e-10	-0.38	-0.29	Birth weight;	chr10:103111447	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs10883832	MIMAT0022727	hsa-miR-1307-5p	-6.59	1.16e-10	-0.38	-0.29	Birth weight;	chr10:103111522	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs79082900	MIMAT0022727	hsa-miR-1307-5p	-6.59	1.16e-10	-0.38	-0.29	Birth weight;	chr10:103117545	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs12220375	MIMAT0022727	hsa-miR-1307-5p	-6.59	1.16e-10	-0.38	-0.29	Birth weight;	chr10:103141734	chr10:103394341~103394361:-
THCA	cis	rs9527	0.662	rs743575	MIMAT0005951	hsa-miR-1307-3p	6.59	1.21e-10	0.23	0.29	Arsenic metabolism;	chr10:102835149	chr10:103394301~103394322:-
THCA	cis	rs7072216	0.687	rs11189586	MIMAT0005878	hsa-miR-1287-5p	6.58	1.22e-10	0.26	0.29	Metabolite levels;	chr10:98394339	chr10:98395271~98395292:-
THCA	cis	rs9527	0.59	rs2148198	MIMAT0005951	hsa-miR-1307-3p	-6.58	1.24e-10	-0.23	-0.29	Arsenic metabolism;	chr10:103155553	chr10:103394301~103394322:-
THCA	cis	rs9527	0.544	rs1572578	MIMAT0005951	hsa-miR-1307-3p	6.58	1.27e-10	0.22	0.29	Arsenic metabolism;	chr10:103062674	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs11191540	MIMAT0005951	hsa-miR-1307-3p	6.58	1.27e-10	0.22	0.29	Arsenic metabolism;	chr10:103063052	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs7092029	MIMAT0005951	hsa-miR-1307-3p	6.58	1.27e-10	0.22	0.29	Arsenic metabolism;	chr10:103064152	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs943039	MIMAT0005951	hsa-miR-1307-3p	6.58	1.27e-10	0.22	0.29	Arsenic metabolism;	chr10:103065375	chr10:103394301~103394322:-
THCA	cis	rs6543140	0.964	rs1523206	MIMAT0019927	hsa-miR-4772-3p	-6.57	1.3e-10	-0.29	-0.29	Blood protein levels;	chr2:102453715	chr2:102432336~102432357:+
THCA	cis	rs6543140	0.964	rs1523205	MIMAT0019927	hsa-miR-4772-3p	-6.57	1.3e-10	-0.29	-0.29	Blood protein levels;	chr2:102453716	chr2:102432336~102432357:+
THCA	cis	rs9527	0.535	rs4917999	MIMAT0005951	hsa-miR-1307-3p	-6.57	1.3e-10	-0.23	-0.29	Arsenic metabolism;	chr10:103203294	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs11191548	MIMAT0022727	hsa-miR-1307-5p	6.57	1.37e-10	0.38	0.29	Birth weight;	chr10:103086421	chr10:103394341~103394361:-
THCA	cis	rs9527	0.59	rs11191544	MIMAT0005951	hsa-miR-1307-3p	6.56	1.38e-10	0.22	0.29	Arsenic metabolism;	chr10:103067441	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs7910900	MIMAT0005951	hsa-miR-1307-3p	6.56	1.38e-10	0.22	0.29	Arsenic metabolism;	chr10:103070141	chr10:103394301~103394322:-
THCA	cis	rs1163656	0.534	rs17007709	MIMAT0003287	hsa-miR-618	-6.56	1.38e-10	-0.39	-0.29	Dental caries;	chr12:80934267	chr12:80935796~80935818:-
THCA	cis	rs9527	0.59	rs7073323	MIMAT0005951	hsa-miR-1307-3p	6.56	1.39e-10	0.23	0.29	Arsenic metabolism;	chr10:103037666	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs11191582	MIMAT0022727	hsa-miR-1307-5p	-6.55	1.47e-10	-0.38	-0.29	Birth weight;	chr10:103153896	chr10:103394341~103394361:-
THCA	cis	rs1867631	1	rs11208927	MIMAT0014979	hsa-miR-3117-3p	-6.55	1.52e-10	-0.34	-0.29	Menopause (age at onset);	chr1:66623878	chr1:66628485~66628505:+
THCA	cis	rs6841433	0.632	rs7679995	MIMAT0003242	hsa-miR-577	-6.54	1.58e-10	-0.31	-0.29	Hemoglobin concentration;	chr4:114665137	chr4:114656774~114656794:+
THCA	cis	rs9527	0.59	rs4917992	MIMAT0005951	hsa-miR-1307-3p	6.54	1.58e-10	0.22	0.29	Arsenic metabolism;	chr10:103026556	chr10:103394301~103394322:-
THCA	cis	rs9527	0.615	rs12248123	MIMAT0005951	hsa-miR-1307-3p	6.54	1.61e-10	0.22	0.29	Arsenic metabolism;	chr10:102975609	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs12415388	MIMAT0005951	hsa-miR-1307-3p	6.53	1.66e-10	0.22	0.29	Arsenic metabolism;	chr10:103036588	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs9633712	MIMAT0022727	hsa-miR-1307-5p	-6.53	1.7e-10	-0.37	-0.29	Birth weight;	chr10:103114004	chr10:103394341~103394361:-
THCA	cis	rs74233809	0.786	rs11191564	MIMAT0022727	hsa-miR-1307-5p	-6.53	1.7e-10	-0.37	-0.29	Birth weight;	chr10:103118786	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs1060240	MIMAT0022727	hsa-miR-1307-5p	-6.53	1.7e-10	-0.37	-0.29	Birth weight;	chr10:103123580	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs10883835	MIMAT0022727	hsa-miR-1307-5p	-6.53	1.7e-10	-0.37	-0.29	Birth weight;	chr10:103124451	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs732998	MIMAT0022727	hsa-miR-1307-5p	6.53	1.7e-10	0.37	0.29	Birth weight;	chr10:103138144	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs11191575	MIMAT0022727	hsa-miR-1307-5p	-6.53	1.7e-10	-0.37	-0.29	Birth weight;	chr10:103138580	chr10:103394341~103394361:-
THCA	cis	rs74233809	1	rs79993475	MIMAT0022727	hsa-miR-1307-5p	-6.53	1.7e-10	-0.37	-0.29	Birth weight;	chr10:103141274	chr10:103394341~103394361:-
THCA	cis	rs9527	0.662	rs4919687	MIMAT0005951	hsa-miR-1307-3p	6.52	1.78e-10	0.22	0.29	Arsenic metabolism;	chr10:102835491	chr10:103394301~103394322:-
THCA	cis	rs6543140	0.601	rs7558013	MIMAT0019927	hsa-miR-4772-3p	-6.52	1.8e-10	-0.33	-0.29	Blood protein levels;	chr2:102376346	chr2:102432336~102432357:+
THCA	cis	rs9527	0.59	rs7898770	MIMAT0005951	hsa-miR-1307-3p	-6.52	1.81e-10	-0.22	-0.29	Arsenic metabolism;	chr10:102996879	chr10:103394301~103394322:-
THCA	cis	rs74233809	0.901	rs3824754	MIMAT0005951	hsa-miR-1307-3p	-6.52	1.86e-10	-0.31	-0.29	Birth weight;	chr10:102854593	chr10:103394301~103394322:-
THCA	cis	rs1867631	0.958	rs7536188	MIMAT0014979	hsa-miR-3117-3p	6.51	1.88e-10	0.33	0.29	Menopause (age at onset);	chr1:66622243	chr1:66628485~66628505:+
THCA	cis	rs1867631	1	rs10889636	MIMAT0014979	hsa-miR-3117-3p	6.51	1.88e-10	0.33	0.29	Menopause (age at onset);	chr1:66624241	chr1:66628485~66628505:+
THCA	cis	rs9527	0.545	rs10218853	MIMAT0005951	hsa-miR-1307-3p	6.51	1.89e-10	0.22	0.29	Arsenic metabolism;	chr10:103037030	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs7087040	MIMAT0005951	hsa-miR-1307-3p	6.51	1.89e-10	0.22	0.29	Arsenic metabolism;	chr10:103039911	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs7089680	MIMAT0005951	hsa-miR-1307-3p	-6.51	1.89e-10	-0.22	-0.29	Arsenic metabolism;	chr10:103042314	chr10:103394301~103394322:-
THCA	cis	rs9527	0.615	rs10883810	MIMAT0005951	hsa-miR-1307-3p	6.51	1.96e-10	0.22	0.29	Arsenic metabolism;	chr10:102967467	chr10:103394301~103394322:-
THCA	cis	rs9527	0.615	rs10883811	MIMAT0005951	hsa-miR-1307-3p	6.51	1.96e-10	0.22	0.29	Arsenic metabolism;	chr10:102967522	chr10:103394301~103394322:-
THCA	cis	rs9527	0.615	rs1556960	MIMAT0005951	hsa-miR-1307-3p	6.51	1.96e-10	0.22	0.29	Arsenic metabolism;	chr10:102966916	chr10:103394301~103394322:-
THCA	cis	rs9527	0.662	rs10786714	MIMAT0005951	hsa-miR-1307-3p	6.51	1.98e-10	0.22	0.29	Arsenic metabolism;	chr10:102838849	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs11191580	MIMAT0022727	hsa-miR-1307-5p	6.5	1.99e-10	0.37	0.29	Birth weight;	chr10:103146454	chr10:103394341~103394361:-
THCA	cis	rs74233809	0.901	rs17878846	MIMAT0022727	hsa-miR-1307-5p	-6.5	2.07e-10	-0.36	-0.29	Birth weight;	chr10:102870655	chr10:103394341~103394361:-
THCA	cis	rs74233809	0.901	rs11191425	MIMAT0022727	hsa-miR-1307-5p	-6.5	2.08e-10	-0.36	-0.29	Birth weight;	chr10:102866213	chr10:103394341~103394361:-
THCA	cis	rs9527	0.59	rs3781281	MIMAT0005951	hsa-miR-1307-3p	-6.5	2.09e-10	-0.22	-0.29	Arsenic metabolism;	chr10:103092891	chr10:103394301~103394322:-
THCA	cis	rs6841433	0.561	rs13148598	MIMAT0003242	hsa-miR-577	-6.49	2.16e-10	-0.31	-0.29	Hemoglobin concentration;	chr4:114676939	chr4:114656774~114656794:+
THCA	cis	rs7072216	0.687	rs10786416	MIMAT0005878	hsa-miR-1287-5p	6.49	2.2e-10	0.26	0.29	Metabolite levels;	chr10:98393843	chr10:98395271~98395292:-
THCA	cis	rs9527	0.59	rs726010	MIMAT0005951	hsa-miR-1307-3p	6.49	2.21e-10	0.22	0.29	Arsenic metabolism;	chr10:103082220	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs77420391	MIMAT0022727	hsa-miR-1307-5p	-6.48	2.25e-10	-0.37	-0.29	Birth weight;	chr10:103186066	chr10:103394341~103394361:-
THCA	cis	rs9394169	0.592	rs4304152	MIMAT0022975	hsa-miR-3934-3p	-6.48	2.27e-10	-0.33	-0.29	Essential tremor;	chr6:33755513	chr6:33698191~33698212:+
THCA	cis	rs74233809	1	rs12219304	MIMAT0022727	hsa-miR-1307-5p	-6.48	2.34e-10	-0.37	-0.29	Birth weight;	chr10:103171827	chr10:103394341~103394361:-
THCA	cis	rs7072216	0.881	rs7082192	MIMAT0026738	hsa-miR-1287-3p	6.48	2.36e-10	0.21	0.29	Metabolite levels;	chr10:98392087	chr10:98395232~98395253:-
THCA	cis	rs950880	0.71	rs1474309	MIMAT0019926	hsa-miR-4772-5p	6.47	2.44e-10	0.6	0.29	Serum protein levels (sST2);	chr2:102474542	chr2:102432300~102432321:+
THCA	cis	rs9527	1	rs12416687	MIMAT0005951	hsa-miR-1307-3p	6.47	2.52e-10	0.24	0.29	Arsenic metabolism;	chr10:102869254	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs7920868	MIMAT0005951	hsa-miR-1307-3p	6.46	2.53e-10	0.22	0.29	Arsenic metabolism;	chr10:103035652	chr10:103394301~103394322:-
THCA	cis	rs1867631	1	rs11208928	MIMAT0014979	hsa-miR-3117-3p	-6.46	2.54e-10	-0.34	-0.29	Menopause (age at onset);	chr1:66623879	chr1:66628485~66628505:+
THCA	cis	rs6841433	0.699	rs12643031	MIMAT0003242	hsa-miR-577	6.46	2.56e-10	0.36	0.29	Hemoglobin concentration;	chr4:114541449	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.706	rs13134858	MIMAT0003242	hsa-miR-577	6.46	2.57e-10	0.47	0.29	Hemoglobin concentration;	chr4:114601150	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.706	rs35571359	MIMAT0003242	hsa-miR-577	6.46	2.57e-10	0.47	0.29	Hemoglobin concentration;	chr4:114606130	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.706	rs35759252	MIMAT0003242	hsa-miR-577	6.46	2.57e-10	0.47	0.29	Hemoglobin concentration;	chr4:114608520	chr4:114656774~114656794:+
THCA	cis	rs6543140	0.601	rs78178597	MIMAT0019927	hsa-miR-4772-3p	-6.46	2.59e-10	-0.33	-0.29	Blood protein levels;	chr2:102407136	chr2:102432336~102432357:+
THCA	cis	rs9527	0.64	rs6584541	MIMAT0005951	hsa-miR-1307-3p	6.45	2.71e-10	0.22	0.28	Arsenic metabolism;	chr10:103169367	chr10:103394301~103394322:-
THCA	cis	rs4713675	0.525	rs622917	MIMAT0018349	hsa-miR-3934-5p	6.45	2.79e-10	0.33	0.28	Plateletcrit;	chr6:33735092	chr6:33698152~33698173:+
THCA	cis	rs9527	0.59	rs7087459	MIMAT0005951	hsa-miR-1307-3p	6.45	2.85e-10	0.21	0.28	Arsenic metabolism;	chr10:103031242	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs7088200	MIMAT0005951	hsa-miR-1307-3p	6.45	2.85e-10	0.21	0.28	Arsenic metabolism;	chr10:103033478	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs11191547	MIMAT0005951	hsa-miR-1307-3p	6.44	2.87e-10	0.22	0.28	Arsenic metabolism;	chr10:103083391	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs7917650	MIMAT0005951	hsa-miR-1307-3p	6.44	2.91e-10	0.22	0.28	Arsenic metabolism;	chr10:103177343	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs10786744	MIMAT0005951	hsa-miR-1307-3p	-6.44	2.91e-10	-0.22	-0.28	Arsenic metabolism;	chr10:103185271	chr10:103394301~103394322:-
THCA	cis	rs9527	0.569	rs78193706	MIMAT0005951	hsa-miR-1307-3p	6.44	2.94e-10	0.21	0.28	Arsenic metabolism;	chr10:103020807	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs7906754	MIMAT0005951	hsa-miR-1307-3p	6.44	2.94e-10	0.21	0.28	Arsenic metabolism;	chr10:103022800	chr10:103394301~103394322:-
THCA	cis	rs9527	0.615	rs4917991	MIMAT0005951	hsa-miR-1307-3p	6.44	2.94e-10	0.21	0.28	Arsenic metabolism;	chr10:103024076	chr10:103394301~103394322:-
THCA	cis	rs7072216	0.881	rs7916469	MIMAT0026738	hsa-miR-1287-3p	6.43	3.04e-10	0.2	0.28	Metabolite levels;	chr10:98388896	chr10:98395232~98395253:-
THCA	cis	rs9527	0.59	rs7901197	MIMAT0005951	hsa-miR-1307-3p	6.43	3.06e-10	0.22	0.28	Arsenic metabolism;	chr10:103080676	chr10:103394301~103394322:-
THCA	cis	rs75358501	0.688	rs2287629	MIMAT0014994	hsa-miR-3130-3p	-6.43	3.08e-10	-0.4	-0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783245~206783265:-
THCA	cis	rs75358501	0.688	rs2287629	MIMAT0014994_1	hsa-miR-3130-3p	-6.43	3.08e-10	-0.4	-0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783277~206783297:+
THCA	cis	rs75358501	0.636	rs13427002	MIMAT0014994	hsa-miR-3130-3p	6.43	3.08e-10	0.4	0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783245~206783265:-
THCA	cis	rs75358501	0.636	rs13427002	MIMAT0014994_1	hsa-miR-3130-3p	6.43	3.08e-10	0.4	0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783277~206783297:+
THCA	cis	rs74233809	0.901	rs17115100	MIMAT0005951	hsa-miR-1307-3p	-6.43	3.1e-10	-0.3	-0.28	Birth weight;	chr10:102831636	chr10:103394301~103394322:-
THCA	cis	rs6543140	0.964	rs918000	MIMAT0019927	hsa-miR-4772-3p	-6.43	3.1e-10	-0.28	-0.28	Blood protein levels;	chr2:102451402	chr2:102432336~102432357:+
THCA	cis	rs6543140	0.927	rs917999	MIMAT0019927	hsa-miR-4772-3p	-6.43	3.1e-10	-0.28	-0.28	Blood protein levels;	chr2:102451409	chr2:102432336~102432357:+
THCA	cis	rs74233809	0.901	rs11191416	MIMAT0005951	hsa-miR-1307-3p	6.43	3.16e-10	0.3	0.28	Birth weight;	chr10:102845159	chr10:103394301~103394322:-
THCA	cis	rs9527	0.615	rs10883800	MIMAT0005951	hsa-miR-1307-3p	6.43	3.16e-10	0.21	0.28	Arsenic metabolism;	chr10:102911455	chr10:103394301~103394322:-
THCA	cis	rs9527	0.615	rs7073295	MIMAT0005951	hsa-miR-1307-3p	6.43	3.16e-10	0.21	0.28	Arsenic metabolism;	chr10:102912476	chr10:103394301~103394322:-
THCA	cis	rs9527	0.569	rs10883801	MIMAT0005951	hsa-miR-1307-3p	6.43	3.16e-10	0.21	0.28	Arsenic metabolism;	chr10:102918130	chr10:103394301~103394322:-
THCA	cis	rs9527	0.615	rs17725614	MIMAT0005951	hsa-miR-1307-3p	6.43	3.16e-10	0.21	0.28	Arsenic metabolism;	chr10:102925736	chr10:103394301~103394322:-
THCA	cis	rs7072216	0.881	rs10883084	MIMAT0026738	hsa-miR-1287-3p	6.43	3.16e-10	0.2	0.28	Metabolite levels;	chr10:98391432	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.922	rs7097824	MIMAT0026738	hsa-miR-1287-3p	6.43	3.16e-10	0.2	0.28	Metabolite levels;	chr10:98392042	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.881	rs6584192	MIMAT0026738	hsa-miR-1287-3p	6.43	3.16e-10	0.2	0.28	Metabolite levels;	chr10:98392616	chr10:98395232~98395253:-
THCA	cis	rs6543140	0.964	rs4851010	MIMAT0019927	hsa-miR-4772-3p	6.42	3.28e-10	0.28	0.28	Blood protein levels;	chr2:102439667	chr2:102432336~102432357:+
THCA	cis	rs6543140	0.964	rs6543136	MIMAT0019927	hsa-miR-4772-3p	-6.42	3.31e-10	-0.28	-0.28	Blood protein levels;	chr2:102449087	chr2:102432336~102432357:+
THCA	cis	rs7072216	0.881	rs2182168	MIMAT0026738	hsa-miR-1287-3p	6.42	3.33e-10	0.2	0.28	Metabolite levels;	chr10:98388596	chr10:98395232~98395253:-
THCA	cis	rs1163656	0.534	rs11114656	MIMAT0003287	hsa-miR-618	-6.42	3.38e-10	-0.39	-0.28	Dental caries;	chr12:80925906	chr12:80935796~80935818:-
THCA	cis	rs6543140	0.964	rs4851593	MIMAT0019927	hsa-miR-4772-3p	6.42	3.41e-10	0.28	0.28	Blood protein levels;	chr2:102472767	chr2:102432336~102432357:+
THCA	cis	rs6543140	0.89	rs61122764	MIMAT0019927	hsa-miR-4772-3p	-6.41	3.43e-10	-0.28	-0.28	Blood protein levels;	chr2:102383060	chr2:102432336~102432357:+
THCA	cis	rs9527	0.59	rs7912517	MIMAT0005951	hsa-miR-1307-3p	6.41	3.5e-10	0.21	0.28	Arsenic metabolism;	chr10:103145772	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs2066322	MIMAT0005951	hsa-miR-1307-3p	6.41	3.5e-10	0.21	0.28	Arsenic metabolism;	chr10:103149582	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs12785223	MIMAT0005951	hsa-miR-1307-3p	-6.41	3.54e-10	-0.22	-0.28	Arsenic metabolism;	chr10:103084254	chr10:103394301~103394322:-
THCA	cis	rs7072216	0.881	rs2274247	MIMAT0026738	hsa-miR-1287-3p	6.41	3.59e-10	0.2	0.28	Metabolite levels;	chr10:98390391	chr10:98395232~98395253:-
THCA	cis	rs9527	0.59	rs11191513	MIMAT0005951	hsa-miR-1307-3p	6.4	3.77e-10	0.21	0.28	Arsenic metabolism;	chr10:103013227	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs10509764	MIMAT0005951	hsa-miR-1307-3p	6.4	3.77e-10	0.21	0.28	Arsenic metabolism;	chr10:103016718	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs6584537	MIMAT0005951	hsa-miR-1307-3p	6.4	3.77e-10	0.21	0.28	Arsenic metabolism;	chr10:103018510	chr10:103394301~103394322:-
THCA	cis	rs74233809	0.901	rs3824755	MIMAT0005951	hsa-miR-1307-3p	-6.4	3.8e-10	-0.29	-0.28	Birth weight;	chr10:102836092	chr10:103394301~103394322:-
THCA	cis	rs9527	0.615	rs7917295	MIMAT0005951	hsa-miR-1307-3p	6.4	3.81e-10	0.21	0.28	Arsenic metabolism;	chr10:102941430	chr10:103394301~103394322:-
THCA	cis	rs75358501	0.636	rs888621	MIMAT0014994	hsa-miR-3130-3p	-6.4	3.82e-10	-0.4	-0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783245~206783265:-
THCA	cis	rs75358501	0.636	rs888621	MIMAT0014994_1	hsa-miR-3130-3p	-6.4	3.82e-10	-0.4	-0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783277~206783297:+
THCA	cis	rs7072216	0.881	rs2182169	MIMAT0026738	hsa-miR-1287-3p	6.39	3.99e-10	0.2	0.28	Metabolite levels;	chr10:98388247	chr10:98395232~98395253:-
THCA	cis	rs9527	0.59	rs10883843	MIMAT0005951	hsa-miR-1307-3p	6.39	3.99e-10	0.21	0.28	Arsenic metabolism;	chr10:103187736	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs1935323	MIMAT0005951	hsa-miR-1307-3p	6.39	4.03e-10	0.21	0.28	Arsenic metabolism;	chr10:103117278	chr10:103394301~103394322:-
THCA	cis	rs6543140	0.964	rs6543138	MIMAT0019927	hsa-miR-4772-3p	-6.38	4.11e-10	-0.28	-0.28	Blood protein levels;	chr2:102449672	chr2:102432336~102432357:+
THCA	cis	rs9527	0.59	rs1926029	MIMAT0005951	hsa-miR-1307-3p	6.38	4.14e-10	0.21	0.28	Arsenic metabolism;	chr10:103095913	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs7074395	MIMAT0005951	hsa-miR-1307-3p	-6.38	4.21e-10	-0.22	-0.28	Arsenic metabolism;	chr10:103085171	chr10:103394301~103394322:-
THCA	cis	rs6543140	0.964	rs6736135	MIMAT0019927	hsa-miR-4772-3p	-6.38	4.32e-10	-0.28	-0.28	Blood protein levels;	chr2:102448464	chr2:102432336~102432357:+
THCA	cis	rs6543140	0.964	rs6543144	MIMAT0019927	hsa-miR-4772-3p	-6.38	4.34e-10	-0.29	-0.28	Blood protein levels;	chr2:102476116	chr2:102432336~102432357:+
THCA	cis	rs7072216	0.666	rs11598689	MIMAT0026738	hsa-miR-1287-3p	6.37	4.4e-10	0.23	0.28	Metabolite levels;	chr10:98396270	chr10:98395232~98395253:-
THCA	cis	rs7894407	0.76	rs1163072	MIMAT0022727	hsa-miR-1307-5p	6.37	4.42e-10	0.23	0.28	White matter hyperintensity burden;	chr10:103264621	chr10:103394341~103394361:-
THCA	cis	rs9527	0.59	rs10883829	MIMAT0005951	hsa-miR-1307-3p	6.37	4.55e-10	0.21	0.28	Arsenic metabolism;	chr10:103080878	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs763914	MIMAT0005951	hsa-miR-1307-3p	6.37	4.55e-10	0.21	0.28	Arsenic metabolism;	chr10:103081830	chr10:103394301~103394322:-
THCA	cis	rs6841433	0.632	rs4834428	MIMAT0003242	hsa-miR-577	-6.36	4.64e-10	-0.31	-0.28	Hemoglobin concentration;	chr4:114683908	chr4:114656774~114656794:+
THCA	cis	rs9527	0.615	rs10883781	MIMAT0005951	hsa-miR-1307-3p	6.36	4.71e-10	0.22	0.28	Arsenic metabolism;	chr10:102821373	chr10:103394301~103394322:-
THCA	cis	rs1867631	0.876	rs10889637	MIMAT0014979	hsa-miR-3117-3p	-6.36	4.79e-10	-0.33	-0.28	Menopause (age at onset);	chr1:66631782	chr1:66628485~66628505:+
THCA	cis	rs9527	0.59	rs3781282	MIMAT0005951	hsa-miR-1307-3p	-6.36	4.88e-10	-0.21	-0.28	Arsenic metabolism;	chr10:103092662	chr10:103394301~103394322:-
THCA	cis	rs75358501	0.636	rs7576591	MIMAT0014994	hsa-miR-3130-3p	6.36	4.89e-10	0.4	0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783245~206783265:-
THCA	cis	rs75358501	0.636	rs7576591	MIMAT0014994_1	hsa-miR-3130-3p	6.36	4.89e-10	0.4	0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783277~206783297:+
THCA	cis	rs75358501	0.636	rs2287628	MIMAT0014994	hsa-miR-3130-3p	6.36	4.89e-10	0.4	0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783245~206783265:-
THCA	cis	rs75358501	0.636	rs2287628	MIMAT0014994_1	hsa-miR-3130-3p	6.36	4.89e-10	0.4	0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783277~206783297:+
THCA	cis	rs9527	0.59	rs2274339	MIMAT0005951	hsa-miR-1307-3p	6.35	5.03e-10	0.21	0.28	Arsenic metabolism;	chr10:103100296	chr10:103394301~103394322:-
THCA	cis	rs7072216	0.881	rs2147895	MIMAT0026738	hsa-miR-1287-3p	6.34	5.27e-10	0.2	0.28	Metabolite levels;	chr10:98388551	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.881	rs4345897	MIMAT0026738	hsa-miR-1287-3p	6.34	5.38e-10	0.2	0.28	Metabolite levels;	chr10:98387303	chr10:98395232~98395253:-
THCA	cis	rs9527	0.64	rs7089061	MIMAT0005951	hsa-miR-1307-3p	6.34	5.54e-10	0.21	0.28	Arsenic metabolism;	chr10:102963258	chr10:103394301~103394322:-
THCA	cis	rs9527	0.615	rs7089065	MIMAT0005951	hsa-miR-1307-3p	6.34	5.54e-10	0.21	0.28	Arsenic metabolism;	chr10:102963265	chr10:103394301~103394322:-
THCA	cis	rs9527	0.569	rs10786730	MIMAT0005951	hsa-miR-1307-3p	6.34	5.54e-10	0.21	0.28	Arsenic metabolism;	chr10:102964443	chr10:103394301~103394322:-
THCA	cis	rs9527	0.615	rs7899622	MIMAT0005951	hsa-miR-1307-3p	6.33	5.57e-10	0.21	0.28	Arsenic metabolism;	chr10:102967576	chr10:103394301~103394322:-
THCA	cis	rs6543140	0.964	rs4851589	MIMAT0019927	hsa-miR-4772-3p	-6.33	5.7e-10	-0.28	-0.28	Blood protein levels;	chr2:102460685	chr2:102432336~102432357:+
THCA	cis	rs9527	0.59	rs10883820	MIMAT0005951	hsa-miR-1307-3p	-6.33	5.73e-10	-0.21	-0.28	Arsenic metabolism;	chr10:103004904	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs10883818	MIMAT0005951	hsa-miR-1307-3p	6.33	5.73e-10	0.21	0.28	Arsenic metabolism;	chr10:102999829	chr10:103394301~103394322:-
THCA	cis	rs9527	0.641	rs10786732	MIMAT0005951	hsa-miR-1307-3p	6.33	5.73e-10	0.21	0.28	Arsenic metabolism;	chr10:103002778	chr10:103394301~103394322:-
THCA	cis	rs7072216	0.881	rs755126	MIMAT0026738	hsa-miR-1287-3p	6.33	5.86e-10	0.2	0.28	Metabolite levels;	chr10:98389194	chr10:98395232~98395253:-
THCA	cis	rs74233809	0.901	rs7098825	MIMAT0022727	hsa-miR-1307-5p	-6.32	6.01e-10	-0.35	-0.28	Birth weight;	chr10:102868477	chr10:103394341~103394361:-
THCA	cis	rs7072216	0.881	rs1079179	MIMAT0026738	hsa-miR-1287-3p	6.32	6.23e-10	0.2	0.28	Metabolite levels;	chr10:98389589	chr10:98395232~98395253:-
THCA	cis	rs9394169	0.533	rs4713675	MIMAT0022975	hsa-miR-3934-3p	-6.31	6.43e-10	-0.32	-0.28	Essential tremor;	chr6:33750641	chr6:33698191~33698212:+
THCA	cis	rs6543140	0.601	rs6543135	MIMAT0019927	hsa-miR-4772-3p	-6.3	6.71e-10	-0.32	-0.28	Blood protein levels;	chr2:102445946	chr2:102432336~102432357:+
THCA	cis	rs75358501	0.636	rs725980	MIMAT0014994	hsa-miR-3130-3p	6.3	6.73e-10	0.39	0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783245~206783265:-
THCA	cis	rs75358501	0.636	rs725980	MIMAT0014994_1	hsa-miR-3130-3p	6.3	6.73e-10	0.39	0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783277~206783297:+
THCA	cis	rs75358501	0.636	rs10199766	MIMAT0014994	hsa-miR-3130-3p	6.3	6.73e-10	0.39	0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783245~206783265:-
THCA	cis	rs75358501	0.636	rs10199766	MIMAT0014994_1	hsa-miR-3130-3p	6.3	6.73e-10	0.39	0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783277~206783297:+
THCA	cis	rs9527	0.615	rs10883804	MIMAT0005951	hsa-miR-1307-3p	6.3	6.77e-10	0.21	0.28	Arsenic metabolism;	chr10:102946763	chr10:103394301~103394322:-
THCA	cis	rs9527	0.544	rs11191549	MIMAT0005951	hsa-miR-1307-3p	6.3	6.9e-10	0.21	0.28	Arsenic metabolism;	chr10:103087040	chr10:103394301~103394322:-
THCA	cis	rs9527	0.545	rs12247514	MIMAT0005951	hsa-miR-1307-3p	6.28	7.51e-10	0.21	0.28	Arsenic metabolism;	chr10:103198309	chr10:103394301~103394322:-
THCA	cis	rs74233809	1	rs11191607	MIMAT0022727	hsa-miR-1307-5p	-6.28	7.71e-10	-0.35	-0.28	Birth weight;	chr10:103199431	chr10:103394341~103394361:-
THCA	cis	rs74233809	0.901	rs3824754	MIMAT0022727	hsa-miR-1307-5p	-6.27	8.08e-10	-0.35	-0.28	Birth weight;	chr10:102854593	chr10:103394341~103394361:-
THCA	cis	rs9527	0.59	rs10883839	MIMAT0005951	hsa-miR-1307-3p	6.27	8.11e-10	0.22	0.28	Arsenic metabolism;	chr10:103160584	chr10:103394301~103394322:-
THCA	cis	rs9394169	0.592	rs4304152	MIMAT0018349	hsa-miR-3934-5p	-6.27	8.19e-10	-0.33	-0.28	Essential tremor;	chr6:33755513	chr6:33698152~33698173:+
THCA	cis	rs6543140	0.964	rs1035126	MIMAT0019927	hsa-miR-4772-3p	-6.27	8.32e-10	-0.27	-0.28	Blood protein levels;	chr2:102403521	chr2:102432336~102432357:+
THCA	cis	rs75358501	0.636	rs7580138	MIMAT0014994	hsa-miR-3130-3p	6.26	8.49e-10	0.4	0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783245~206783265:-
THCA	cis	rs75358501	0.636	rs7580138	MIMAT0014994_1	hsa-miR-3130-3p	6.26	8.49e-10	0.4	0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783277~206783297:+
THCA	cis	rs9527	0.59	rs10883830	MIMAT0005951	hsa-miR-1307-3p	6.26	8.64e-10	0.21	0.28	Arsenic metabolism;	chr10:103091528	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs11191553	MIMAT0005951	hsa-miR-1307-3p	6.26	8.64e-10	0.21	0.28	Arsenic metabolism;	chr10:103091639	chr10:103394301~103394322:-
THCA	cis	rs6841433	0.632	rs13152031	MIMAT0003242	hsa-miR-577	-6.26	8.91e-10	-0.3	-0.28	Hemoglobin concentration;	chr4:114644503	chr4:114656774~114656794:+
THCA	cis	rs9527	0.615	rs9733635	MIMAT0005951	hsa-miR-1307-3p	6.25	8.95e-10	0.21	0.28	Arsenic metabolism;	chr10:102952183	chr10:103394301~103394322:-
THCA	cis	rs6543140	0.929	rs11465700	MIMAT0019927	hsa-miR-4772-3p	-6.25	9.12e-10	-0.28	-0.28	Blood protein levels;	chr2:102441208	chr2:102432336~102432357:+
THCA	cis	rs6841433	0.632	rs6533807	MIMAT0003242	hsa-miR-577	-6.25	9.35e-10	-0.3	-0.28	Hemoglobin concentration;	chr4:114699454	chr4:114656774~114656794:+
THCA	cis	rs1867631	1	rs10889640	MIMAT0014979	hsa-miR-3117-3p	-6.24	9.53e-10	-0.33	-0.28	Menopause (age at onset);	chr1:66662168	chr1:66628485~66628505:+
THCA	cis	rs1867631	1	rs10789212	MIMAT0014979	hsa-miR-3117-3p	-6.24	9.53e-10	-0.33	-0.28	Menopause (age at onset);	chr1:66662472	chr1:66628485~66628505:+
THCA	cis	rs1867631	1	rs10789213	MIMAT0014979	hsa-miR-3117-3p	-6.24	9.53e-10	-0.33	-0.28	Menopause (age at onset);	chr1:66662518	chr1:66628485~66628505:+
THCA	cis	rs74233809	1	rs12413409	MIMAT0022727	hsa-miR-1307-5p	-6.23	1.01e-09	-0.35	-0.28	Birth weight;	chr10:102959339	chr10:103394341~103394361:-
THCA	cis	rs6543140	0.572	rs17027173	MIMAT0019927	hsa-miR-4772-3p	-6.23	1.01e-09	-0.32	-0.28	Blood protein levels;	chr2:102440583	chr2:102432336~102432357:+
THCA	cis	rs9527	0.521	rs12259163	MIMAT0005951	hsa-miR-1307-3p	6.23	1.03e-09	0.21	0.28	Arsenic metabolism;	chr10:103201720	chr10:103394301~103394322:-
THCA	cis	rs9527	0.615	rs11191401	MIMAT0005951	hsa-miR-1307-3p	6.23	1.04e-09	0.21	0.28	Arsenic metabolism;	chr10:102813646	chr10:103394301~103394322:-
THCA	cis	rs9527	0.615	rs2152915	MIMAT0005951	hsa-miR-1307-3p	6.23	1.05e-09	0.21	0.28	Arsenic metabolism;	chr10:102931975	chr10:103394301~103394322:-
THCA	cis	rs9527	0.615	rs3897401	MIMAT0005951	hsa-miR-1307-3p	6.23	1.05e-09	0.21	0.28	Arsenic metabolism;	chr10:102936622	chr10:103394301~103394322:-
THCA	cis	rs9527	0.615	rs36045108	MIMAT0005951	hsa-miR-1307-3p	6.23	1.05e-09	0.21	0.28	Arsenic metabolism;	chr10:102938172	chr10:103394301~103394322:-
THCA	cis	rs9527	0.568	rs12772775	MIMAT0005951	hsa-miR-1307-3p	6.23	1.05e-09	0.21	0.28	Arsenic metabolism;	chr10:102943242	chr10:103394301~103394322:-
THCA	cis	rs9527	0.59	rs1046411	MIMAT0005951	hsa-miR-1307-3p	6.23	1.06e-09	0.21	0.28	Arsenic metabolism;	chr10:103078059	chr10:103394301~103394322:-
THCA	cis	rs6543140	0.964	rs6748390	MIMAT0019927	hsa-miR-4772-3p	-6.22	1.07e-09	-0.28	-0.28	Blood protein levels;	chr2:102445715	chr2:102432336~102432357:+
THCA	cis	rs74233809	0.901	rs1004467	MIMAT0005951	hsa-miR-1307-3p	-6.22	1.08e-09	-0.28	-0.28	Birth weight;	chr10:102834750	chr10:103394301~103394322:-
THCA	cis	rs9527	1	rs9527	MIMAT0005951	hsa-miR-1307-3p	6.22	1.09e-09	0.23	0.28	Arsenic metabolism;	chr10:102863821	chr10:103394301~103394322:-
THCA	cis	rs7894407	0.76	rs4917386	MIMAT0022727	hsa-miR-1307-5p	6.22	1.09e-09	0.22	0.28	White matter hyperintensity burden;	chr10:103247771	chr10:103394341~103394361:-
THCA	cis	rs7894407	0.856	rs7093667	MIMAT0022727	hsa-miR-1307-5p	-6.22	1.11e-09	-0.22	-0.28	White matter hyperintensity burden;	chr10:103320818	chr10:103394341~103394361:-
THCA	cis	rs6543140	0.964	rs62154972	MIMAT0019927	hsa-miR-4772-3p	-6.21	1.15e-09	-0.27	-0.27	Blood protein levels;	chr2:102432278	chr2:102432336~102432357:+
THCA	cis	rs9527	0.545	rs11191602	MIMAT0005951	hsa-miR-1307-3p	6.21	1.2e-09	0.21	0.27	Arsenic metabolism;	chr10:103194462	chr10:103394301~103394322:-
THCA	cis	rs9527	0.545	rs7095304	MIMAT0005951	hsa-miR-1307-3p	6.21	1.2e-09	0.21	0.27	Arsenic metabolism;	chr10:103195038	chr10:103394301~103394322:-
THCA	cis	rs9527	0.545	rs7100369	MIMAT0005951	hsa-miR-1307-3p	6.21	1.2e-09	0.21	0.27	Arsenic metabolism;	chr10:103196461	chr10:103394301~103394322:-
THCA	cis	rs9527	0.545	rs12784384	MIMAT0005951	hsa-miR-1307-3p	6.21	1.2e-09	0.21	0.27	Arsenic metabolism;	chr10:103197837	chr10:103394301~103394322:-
THCA	cis	rs9527	0.545	rs10883847	MIMAT0005951	hsa-miR-1307-3p	6.21	1.2e-09	0.21	0.27	Arsenic metabolism;	chr10:103198527	chr10:103394301~103394322:-
THCA	cis	rs6543140	0.964	rs6761350	MIMAT0019927	hsa-miR-4772-3p	-6.2	1.2e-09	-0.27	-0.27	Blood protein levels;	chr2:102414316	chr2:102432336~102432357:+
THCA	cis	rs6543140	0.929	rs7602207	MIMAT0019927	hsa-miR-4772-3p	-6.2	1.2e-09	-0.27	-0.27	Blood protein levels;	chr2:102415906	chr2:102432336~102432357:+
THCA	cis	rs6543140	0.964	rs2160200	MIMAT0019927	hsa-miR-4772-3p	-6.2	1.2e-09	-0.27	-0.27	Blood protein levels;	chr2:102417503	chr2:102432336~102432357:+
THCA	cis	rs6120849	0.707	rs3746444	MIMAT0004772	hsa-miR-499a-3p	-6.19	1.31e-09	-0.4	-0.27	Protein C levels;	chr20:34990448	chr20:34990445~34990466:+
THCA	cis	rs9527	0.668	rs7092815	MIMAT0005951	hsa-miR-1307-3p	6.18	1.36e-09	0.21	0.27	Arsenic metabolism;	chr10:102976588	chr10:103394301~103394322:-
THCA	cis	rs7072216	0.666	rs11189592	MIMAT0026738	hsa-miR-1287-3p	6.18	1.37e-09	0.22	0.27	Metabolite levels;	chr10:98395885	chr10:98395232~98395253:-
THCA	cis	rs74233809	1	rs3740390	MIMAT0022727	hsa-miR-1307-5p	-6.18	1.38e-09	-0.34	-0.27	Birth weight;	chr10:102878723	chr10:103394341~103394361:-
THCA	cis	rs6841433	0.632	rs4585328	MIMAT0003242	hsa-miR-577	-6.16	1.54e-09	-0.3	-0.27	Hemoglobin concentration;	chr4:114613660	chr4:114656774~114656794:+
THCA	cis	rs7894407	0.856	rs10883855	MIMAT0022727	hsa-miR-1307-5p	-6.16	1.56e-09	-0.22	-0.27	White matter hyperintensity burden;	chr10:103332690	chr10:103394341~103394361:-
THCA	cis	rs6543140	0.964	rs4851578	MIMAT0019927	hsa-miR-4772-3p	-6.16	1.56e-09	-0.27	-0.27	Blood protein levels;	chr2:102412491	chr2:102432336~102432357:+
THCA	cis	rs7072216	0.922	rs2296438	MIMAT0026738	hsa-miR-1287-3p	6.14	1.73e-09	0.2	0.27	Metabolite levels;	chr10:98387138	chr10:98395232~98395253:-
THCA	cis	rs7894407	0.76	rs1163085	MIMAT0022727	hsa-miR-1307-5p	-6.14	1.73e-09	-0.22	-0.27	White matter hyperintensity burden;	chr10:103279484	chr10:103394341~103394361:-
THCA	cis	rs1867631	0.958	rs7520226	MIMAT0014979	hsa-miR-3117-3p	-6.14	1.73e-09	-0.32	-0.27	Menopause (age at onset);	chr1:66615312	chr1:66628485~66628505:+
THCA	cis	rs1867631	1	rs7546090	MIMAT0014979	hsa-miR-3117-3p	-6.14	1.74e-09	-0.32	-0.27	Menopause (age at onset);	chr1:66618298	chr1:66628485~66628505:+
THCA	cis	rs6841433	0.632	rs35717197	MIMAT0003242	hsa-miR-577	-6.13	1.83e-09	-0.3	-0.27	Hemoglobin concentration;	chr4:114639584	chr4:114656774~114656794:+
THCA	cis	rs75358501	0.636	rs1862089	MIMAT0014994	hsa-miR-3130-3p	6.13	1.84e-09	0.4	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783245~206783265:-
THCA	cis	rs75358501	0.636	rs1862089	MIMAT0014994_1	hsa-miR-3130-3p	6.13	1.84e-09	0.4	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783277~206783297:+
THCA	cis	rs6841433	0.632	rs7699896	MIMAT0003242	hsa-miR-577	6.13	1.86e-09	0.3	0.27	Hemoglobin concentration;	chr4:114617357	chr4:114656774~114656794:+
THCA	cis	rs75358501	0.636	rs16838834	MIMAT0014994	hsa-miR-3130-3p	6.12	1.94e-09	0.38	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783245~206783265:-
THCA	cis	rs75358501	0.636	rs16838834	MIMAT0014994_1	hsa-miR-3130-3p	6.12	1.94e-09	0.38	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783277~206783297:+
THCA	cis	rs75358501	0.636	rs10932164	MIMAT0014994	hsa-miR-3130-3p	6.12	1.95e-09	0.39	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783245~206783265:-
THCA	cis	rs75358501	0.636	rs10932164	MIMAT0014994_1	hsa-miR-3130-3p	6.12	1.95e-09	0.39	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783277~206783297:+
THCA	cis	rs6841433	0.632	rs10034697	MIMAT0003242	hsa-miR-577	-6.12	1.97e-09	-0.3	-0.27	Hemoglobin concentration;	chr4:114614102	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.632	rs13106767	MIMAT0003242	hsa-miR-577	-6.12	1.98e-09	-0.3	-0.27	Hemoglobin concentration;	chr4:114635719	chr4:114656774~114656794:+
THCA	cis	rs75358501	0.584	rs11894165	MIMAT0014994	hsa-miR-3130-3p	6.11	2.06e-09	0.39	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783245~206783265:-
THCA	cis	rs75358501	0.584	rs11894165	MIMAT0014994_1	hsa-miR-3130-3p	6.11	2.06e-09	0.39	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783277~206783297:+
THCA	cis	rs75358501	0.688	rs1862087	MIMAT0014994	hsa-miR-3130-3p	6.11	2.06e-09	0.39	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783245~206783265:-
THCA	cis	rs75358501	0.688	rs1862087	MIMAT0014994_1	hsa-miR-3130-3p	6.11	2.06e-09	0.39	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783277~206783297:+
THCA	cis	rs6841433	0.632	rs7685523	MIMAT0003242	hsa-miR-577	-6.11	2.13e-09	-0.3	-0.27	Hemoglobin concentration;	chr4:114621913	chr4:114656774~114656794:+
THCA	cis	rs6543140	0.964	rs2080288	MIMAT0019927	hsa-miR-4772-3p	-6.11	2.14e-09	-0.27	-0.27	Blood protein levels;	chr2:102405706	chr2:102432336~102432357:+
THCA	cis	rs75358501	0.636	rs3815686	MIMAT0014994	hsa-miR-3130-3p	6.1	2.16e-09	0.38	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783245~206783265:-
THCA	cis	rs75358501	0.636	rs3815686	MIMAT0014994_1	hsa-miR-3130-3p	6.1	2.16e-09	0.38	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783277~206783297:+
THCA	cis	rs4713675	0.709	rs542441	MIMAT0022975	hsa-miR-3934-3p	6.09	2.35e-09	0.31	0.27	Plateletcrit;	chr6:33708074	chr6:33698191~33698212:+
THCA	cis	rs1163656	0.536	rs7306751	MIMAT0003287	hsa-miR-618	-6.07	2.68e-09	-0.41	-0.27	Dental caries;	chr12:80922459	chr12:80935796~80935818:-
THCA	cis	rs75358501	0.636	rs2241347	MIMAT0014994	hsa-miR-3130-3p	6.06	2.71e-09	0.38	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783245~206783265:-
THCA	cis	rs75358501	0.636	rs2241347	MIMAT0014994_1	hsa-miR-3130-3p	6.06	2.71e-09	0.38	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783277~206783297:+
THCA	cis	rs1867631	1	rs6665859	MIMAT0014979	hsa-miR-3117-3p	-6.06	2.8e-09	-0.31	-0.27	Menopause (age at onset);	chr1:66611872	chr1:66628485~66628505:+
THCA	cis	rs74233809	0.901	rs17115100	MIMAT0022727	hsa-miR-1307-5p	-6.04	3.11e-09	-0.33	-0.27	Birth weight;	chr10:102831636	chr10:103394341~103394361:-
THCA	cis	rs1163656	0.536	rs4261347	MIMAT0003287	hsa-miR-618	-6.04	3.13e-09	-0.4	-0.27	Dental caries;	chr12:80921546	chr12:80935796~80935818:-
THCA	cis	rs75358501	0.636	rs12471008	MIMAT0014994	hsa-miR-3130-3p	6.03	3.26e-09	0.37	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783245~206783265:-
THCA	cis	rs75358501	0.636	rs12471008	MIMAT0014994_1	hsa-miR-3130-3p	6.03	3.26e-09	0.37	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783277~206783297:+
THCA	cis	rs75358501	0.636	rs768533	MIMAT0014994	hsa-miR-3130-3p	6.03	3.26e-09	0.37	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783245~206783265:-
THCA	cis	rs75358501	0.636	rs768533	MIMAT0014994_1	hsa-miR-3130-3p	6.03	3.26e-09	0.37	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783277~206783297:+
THCA	cis	rs8064299	0.655	rs12797	MIMAT0017994	hsa-miR-3615	-6.02	3.43e-09	-0.29	-0.27	Monocyte count;	chr17:74770854	chr17:74748663~74748683:+
THCA	cis	rs9527	0.545	rs7894588	MIMAT0005951	hsa-miR-1307-3p	6	4.02e-09	0.2	0.27	Arsenic metabolism;	chr10:102996273	chr10:103394301~103394322:-
THCA	cis	rs7072216	0.881	rs2147897	MIMAT0026738	hsa-miR-1287-3p	-5.99	4.18e-09	-0.19	-0.27	Metabolite levels;	chr10:98388056	chr10:98395232~98395253:-
THCA	cis	rs4713675	0.709	rs626156	MIMAT0022975	hsa-miR-3934-3p	5.98	4.53e-09	0.3	0.27	Plateletcrit;	chr6:33702705	chr6:33698191~33698212:+
THCA	cis	rs6120849	0.754	rs1885116	MIMAT0004772	hsa-miR-499a-3p	-5.95	5.33e-09	-0.38	-0.26	Protein C levels;	chr20:35012757	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.754	rs1885117	MIMAT0004772	hsa-miR-499a-3p	-5.95	5.33e-09	-0.38	-0.26	Protein C levels;	chr20:35012937	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.754	rs3818253	MIMAT0004772	hsa-miR-499a-3p	-5.94	5.59e-09	-0.38	-0.26	Protein C levels;	chr20:35009073	chr20:34990445~34990466:+
THCA	cis	rs9527	1	rs4919690	MIMAT0005951	hsa-miR-1307-3p	-5.93	5.76e-09	-0.22	-0.26	Arsenic metabolism;	chr10:102856743	chr10:103394301~103394322:-
THCA	cis	rs74233809	0.901	rs11191416	MIMAT0022727	hsa-miR-1307-5p	5.93	5.9e-09	0.33	0.26	Birth weight;	chr10:102845159	chr10:103394341~103394361:-
THCA	cis	rs9527	0.59	rs12246739	MIMAT0005951	hsa-miR-1307-3p	-5.93	5.93e-09	-0.2	-0.26	Arsenic metabolism;	chr10:103027262	chr10:103394301~103394322:-
THCA	cis	rs9527	0.83	rs12249194	MIMAT0005951	hsa-miR-1307-3p	5.92	6.11e-09	0.21	0.26	Arsenic metabolism;	chr10:102883941	chr10:103394301~103394322:-
THCA	cis	rs9527	0.83	rs11191442	MIMAT0005951	hsa-miR-1307-3p	5.92	6.22e-09	0.21	0.26	Arsenic metabolism;	chr10:102883839	chr10:103394301~103394322:-
THCA	cis	rs74233809	0.901	rs4409766	MIMAT0022727	hsa-miR-1307-5p	-5.92	6.23e-09	-0.31	-0.26	Birth weight;	chr10:102856906	chr10:103394341~103394361:-
THCA	cis	rs75358501	0.636	rs11895370	MIMAT0014994	hsa-miR-3130-3p	5.9	6.83e-09	0.37	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783245~206783265:-
THCA	cis	rs75358501	0.636	rs11895370	MIMAT0014994_1	hsa-miR-3130-3p	5.9	6.83e-09	0.37	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783277~206783297:+
THCA	cis	rs6120849	0.754	rs7268266	MIMAT0004772	hsa-miR-499a-3p	-5.9	6.96e-09	-0.38	-0.26	Protein C levels;	chr20:34994086	chr20:34990445~34990466:+
THCA	cis	rs9527	0.83	rs10883790	MIMAT0005951	hsa-miR-1307-3p	5.89	7.32e-09	0.21	0.26	Arsenic metabolism;	chr10:102881198	chr10:103394301~103394322:-
THCA	cis	rs9527	0.83	rs11191440	MIMAT0005951	hsa-miR-1307-3p	5.89	7.32e-09	0.21	0.26	Arsenic metabolism;	chr10:102881754	chr10:103394301~103394322:-
THCA	cis	rs8064299	0.632	rs750018	MIMAT0017994	hsa-miR-3615	-5.89	7.52e-09	-0.29	-0.26	Monocyte count;	chr17:74775498	chr17:74748663~74748683:+
THCA	cis	rs7894407	1	rs7894407	MIMAT0022727	hsa-miR-1307-5p	5.88	7.61e-09	0.22	0.26	White matter hyperintensity burden;	chr10:103416422	chr10:103394341~103394361:-
THCA	cis	rs74233809	0.551	rs3740393	MIMAT0005951	hsa-miR-1307-3p	-5.87	8.35e-09	-0.25	-0.26	Birth weight;	chr10:102876898	chr10:103394301~103394322:-
THCA	cis	rs6120849	0.754	rs6120793	MIMAT0004772	hsa-miR-499a-3p	-5.86	8.9e-09	-0.38	-0.26	Protein C levels;	chr20:35016604	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.754	rs6120797	MIMAT0004772	hsa-miR-499a-3p	-5.86	8.9e-09	-0.38	-0.26	Protein C levels;	chr20:35018199	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.754	rs6119560	MIMAT0004772	hsa-miR-499a-3p	-5.86	8.9e-09	-0.38	-0.26	Protein C levels;	chr20:35019174	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.707	rs6120798	MIMAT0004772	hsa-miR-499a-3p	-5.86	8.9e-09	-0.38	-0.26	Protein C levels;	chr20:35023019	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.708	rs6087659	MIMAT0004772	hsa-miR-499a-3p	-5.85	9.07e-09	-0.38	-0.26	Protein C levels;	chr20:35018580	chr20:34990445~34990466:+
THCA	cis	rs9394169	0.533	rs4713675	MIMAT0018349	hsa-miR-3934-5p	-5.85	9.12e-09	-0.31	-0.26	Essential tremor;	chr6:33750641	chr6:33698152~33698173:+
THCA	cis	rs55833108	1	rs55833108	MIMAT0005951	hsa-miR-1307-3p	5.85	9.39e-09	0.27	0.26	Schizophrenia;	chr10:102981826	chr10:103394301~103394322:-
THCA	cis	rs6120849	0.754	rs36003887	MIMAT0004772	hsa-miR-499a-3p	-5.84	9.68e-09	-0.38	-0.26	Protein C levels;	chr20:35001304	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.754	rs8501	MIMAT0004772	hsa-miR-499a-3p	-5.84	9.68e-09	-0.38	-0.26	Protein C levels;	chr20:35002781	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.707	rs752075	MIMAT0004772	hsa-miR-499a-3p	-5.84	9.68e-09	-0.38	-0.26	Protein C levels;	chr20:35003788	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.754	rs752448	MIMAT0004772	hsa-miR-499a-3p	-5.84	9.68e-09	-0.38	-0.26	Protein C levels;	chr20:35004445	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.615	rs11167248	MIMAT0004772	hsa-miR-499a-3p	-5.84	9.94e-09	-0.37	-0.26	Protein C levels;	chr20:34950918	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.586	rs2025096	MIMAT0004772	hsa-miR-499a-3p	-5.84	9.94e-09	-0.37	-0.26	Protein C levels;	chr20:34952197	chr20:34990445~34990466:+
THCA	cis	rs7894407	0.892	rs10883859	MIMAT0022727	hsa-miR-1307-5p	5.82	1.07e-08	0.22	0.26	White matter hyperintensity burden;	chr10:103368377	chr10:103394341~103394361:-
THCA	cis	rs8064299	0.655	rs11655219	MIMAT0017994	hsa-miR-3615	-5.82	1.1e-08	-0.28	-0.26	Monocyte count;	chr17:74775154	chr17:74748663~74748683:+
THCA	cis	rs74233809	0.515	rs72841270	MIMAT0005951	hsa-miR-1307-3p	-5.81	1.15e-08	-0.24	-0.26	Birth weight;	chr10:102882480	chr10:103394301~103394322:-
THCA	cis	rs75358501	0.688	rs28365797	MIMAT0014994	hsa-miR-3130-3p	5.81	1.15e-08	0.36	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783245~206783265:-
THCA	cis	rs75358501	0.688	rs28365797	MIMAT0014994_1	hsa-miR-3130-3p	5.81	1.15e-08	0.36	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783277~206783297:+
THCA	cis	rs6120849	0.754	rs3746446	MIMAT0004772	hsa-miR-499a-3p	-5.8	1.18e-08	-0.38	-0.26	Protein C levels;	chr20:34986962	chr20:34990445~34990466:+
THCA	cis	rs3227	0.55	rs545787	MIMAT0022975	hsa-miR-3934-3p	5.8	1.19e-08	0.3	0.26	Educational attainment;	chr6:33735453	chr6:33698191~33698212:+
THCA	cis	rs6120849	0.754	rs6120790	MIMAT0004772	hsa-miR-499a-3p	-5.8	1.22e-08	-0.37	-0.26	Protein C levels;	chr20:35011287	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.754	rs11167253	MIMAT0004772	hsa-miR-499a-3p	-5.8	1.23e-08	-0.37	-0.26	Protein C levels;	chr20:35026646	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.707	rs6120799	MIMAT0004772	hsa-miR-499a-3p	-5.8	1.23e-08	-0.37	-0.26	Protein C levels;	chr20:35027152	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.754	rs13433216	MIMAT0004772	hsa-miR-499a-3p	-5.8	1.23e-08	-0.37	-0.26	Protein C levels;	chr20:35028498	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.754	rs6088686	MIMAT0004772	hsa-miR-499a-3p	-5.8	1.23e-08	-0.37	-0.26	Protein C levels;	chr20:35035634	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.754	rs6120804	MIMAT0004772	hsa-miR-499a-3p	-5.8	1.23e-08	-0.37	-0.26	Protein C levels;	chr20:35035898	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.754	rs6120812	MIMAT0004772	hsa-miR-499a-3p	-5.8	1.23e-08	-0.37	-0.26	Protein C levels;	chr20:35041624	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.707	rs6088690	MIMAT0004772	hsa-miR-499a-3p	-5.8	1.23e-08	-0.37	-0.26	Protein C levels;	chr20:35045523	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.754	rs6088691	MIMAT0004772	hsa-miR-499a-3p	-5.8	1.23e-08	-0.37	-0.26	Protein C levels;	chr20:35045955	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.518	rs11696652	MIMAT0004772	hsa-miR-499a-3p	-5.8	1.23e-08	-0.37	-0.26	Protein C levels;	chr20:35049257	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.663	rs13041792	MIMAT0004772	hsa-miR-499a-3p	-5.8	1.25e-08	-0.37	-0.26	Protein C levels;	chr20:34957252	chr20:34990445~34990466:+
THCA	cis	rs6543140	0.693	rs7579737	MIMAT0019927	hsa-miR-4772-3p	-5.79	1.31e-08	-0.25	-0.26	Blood protein levels;	chr2:102370901	chr2:102432336~102432357:+
THCA	cis	rs7894407	0.634	rs755577	MIMAT0005951	hsa-miR-1307-3p	5.79	1.31e-08	0.2	0.26	White matter hyperintensity burden;	chr10:103464309	chr10:103394301~103394322:-
THCA	cis	rs8064299	0.655	rs734232	MIMAT0017994	hsa-miR-3615	-5.78	1.32e-08	-0.28	-0.26	Monocyte count;	chr17:74769592	chr17:74748663~74748683:+
THCA	cis	rs6120849	0.754	rs6088682	MIMAT0004772	hsa-miR-499a-3p	-5.78	1.33e-08	-0.37	-0.26	Protein C levels;	chr20:35027899	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.663	rs11698868	MIMAT0004772	hsa-miR-499a-3p	-5.77	1.46e-08	-0.36	-0.26	Protein C levels;	chr20:34962143	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.663	rs6119548	MIMAT0004772	hsa-miR-499a-3p	-5.77	1.46e-08	-0.36	-0.26	Protein C levels;	chr20:34964809	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.754	rs6120788	MIMAT0004772	hsa-miR-499a-3p	-5.76	1.48e-08	-0.37	-0.26	Protein C levels;	chr20:34995913	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.754	rs3746436	MIMAT0004772	hsa-miR-499a-3p	-5.76	1.48e-08	-0.37	-0.26	Protein C levels;	chr20:34998390	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.754	rs3746435	MIMAT0004772	hsa-miR-499a-3p	-5.76	1.48e-08	-0.37	-0.26	Protein C levels;	chr20:34999395	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.707	rs6088703	MIMAT0004772	hsa-miR-499a-3p	-5.76	1.55e-08	-0.38	-0.26	Protein C levels;	chr20:35088246	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.754	rs6087666	MIMAT0004772	hsa-miR-499a-3p	-5.75	1.6e-08	-0.37	-0.26	Protein C levels;	chr20:35052439	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.754	rs6088678	MIMAT0004772	hsa-miR-499a-3p	5.75	1.65e-08	0.37	0.26	Protein C levels;	chr20:35019748	chr20:34990445~34990466:+
THCA	cis	rs3227	0.626	rs3818528	MIMAT0022975	hsa-miR-3934-3p	-5.73	1.78e-08	-0.29	-0.26	Educational attainment;	chr6:33693314	chr6:33698191~33698212:+
THCA	cis	rs6841433	0.503	rs4425400	MIMAT0003242	hsa-miR-577	-5.73	1.8e-08	-0.29	-0.25	Hemoglobin concentration;	chr4:114613788	chr4:114656774~114656794:+
THCA	cis	rs9527	0.59	rs7894959	MIMAT0005951	hsa-miR-1307-3p	5.73	1.81e-08	0.19	0.25	Arsenic metabolism;	chr10:102996425	chr10:103394301~103394322:-
THCA	cis	rs6120849	0.754	rs6120813	MIMAT0004772	hsa-miR-499a-3p	-5.71	1.96e-08	-0.37	-0.25	Protein C levels;	chr20:35054309	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.754	rs17319032	MIMAT0004772	hsa-miR-499a-3p	-5.71	1.96e-08	-0.37	-0.25	Protein C levels;	chr20:35055493	chr20:34990445~34990466:+
THCA	cis	rs1867631	1	rs1867631	MIMAT0014979	hsa-miR-3117-3p	-5.71	2.01e-08	-0.3	-0.25	Menopause (age at onset);	chr1:66580443	chr1:66628485~66628505:+
THCA	cis	rs74233809	0.901	rs3824755	MIMAT0022727	hsa-miR-1307-5p	-5.71	2.05e-08	-0.3	-0.25	Birth weight;	chr10:102836092	chr10:103394341~103394361:-
THCA	cis	rs6120849	0.754	rs6088667	MIMAT0004772	hsa-miR-499a-3p	-5.7	2.08e-08	-0.36	-0.25	Protein C levels;	chr20:34978919	chr20:34990445~34990466:+
THCA	cis	rs4711336	0.809	rs749338	MIMAT0018349	hsa-miR-3934-5p	5.7	2.1e-08	0.3	0.25	Height;	chr6:33685671	chr6:33698152~33698173:+
THCA	cis	rs6681460	0.625	rs2872079	MIMAT0014979	hsa-miR-3117-3p	-5.68	2.32e-08	-0.29	-0.25	Presence of antiphospholipid antibodies;	chr1:66664388	chr1:66628485~66628505:+
THCA	cis	rs6120849	0.663	rs6088662	MIMAT0004772	hsa-miR-499a-3p	-5.67	2.44e-08	-0.36	-0.25	Protein C levels;	chr20:34959830	chr20:34990445~34990466:+
THCA	cis	rs7894407	0.594	rs1163238	MIMAT0022727	hsa-miR-1307-5p	5.67	2.55e-08	0.22	0.25	White matter hyperintensity burden;	chr10:103184236	chr10:103394341~103394361:-
THCA	cis	rs74233809	0.901	rs1004467	MIMAT0022727	hsa-miR-1307-5p	-5.66	2.65e-08	-0.3	-0.25	Birth weight;	chr10:102834750	chr10:103394341~103394361:-
THCA	cis	rs1867631	0.959	rs11208914	MIMAT0014979	hsa-miR-3117-3p	-5.64	2.93e-08	-0.29	-0.25	Menopause (age at onset);	chr1:66584045	chr1:66628485~66628505:+
THCA	cis	rs6120849	0.707	rs6120826	MIMAT0004772	hsa-miR-499a-3p	-5.63	3.03e-08	-0.37	-0.25	Protein C levels;	chr20:35084028	chr20:34990445~34990466:+
THCA	cis	rs9527	0.59	rs1475642	MIMAT0005951	hsa-miR-1307-3p	-5.63	3.07e-08	-0.2	-0.25	Arsenic metabolism;	chr10:102786426	chr10:103394301~103394322:-
THCA	cis	rs8064299	0.655	rs895691	MIMAT0017994	hsa-miR-3615	-5.61	3.44e-08	-0.27	-0.25	Monocyte count;	chr17:74770161	chr17:74748663~74748683:+
THCA	cis	rs7894407	0.623	rs10883846	MIMAT0022727	hsa-miR-1307-5p	5.61	3.51e-08	0.22	0.25	White matter hyperintensity burden;	chr10:103198487	chr10:103394341~103394361:-
THCA	cis	rs7894407	0.522	rs116821290	MIMAT0005951	hsa-miR-1307-3p	5.61	3.51e-08	0.23	0.25	White matter hyperintensity burden;	chr10:103183633	chr10:103394301~103394322:-
THCA	cis	rs2277912	0.865	rs111954117	MIMAT0014995	hsa-miR-3130-5p	5.61	3.53e-08	0.31	0.25	Height;	chr2:206793017	chr2:206783276~206783296:-
THCA	cis	rs2277912	0.865	rs111954117	MIMAT0014995_1	hsa-miR-3130-5p	5.61	3.53e-08	0.31	0.25	Height;	chr2:206793017	chr2:206783246~206783266:+
THCA	cis	rs6120849	0.707	rs6088694	MIMAT0004772	hsa-miR-499a-3p	-5.6	3.72e-08	-0.36	-0.25	Protein C levels;	chr20:35064568	chr20:34990445~34990466:+
THCA	cis	rs7072216	0.666	rs2274248	MIMAT0026738	hsa-miR-1287-3p	5.6	3.73e-08	0.2	0.25	Metabolite levels;	chr10:98388785	chr10:98395232~98395253:-
THCA	cis	rs6120849	0.617	rs12480442	MIMAT0004772	hsa-miR-499a-3p	-5.59	3.91e-08	-0.36	-0.25	Protein C levels;	chr20:35060585	chr20:34990445~34990466:+
THCA	cis	rs8064299	0.597	rs2053748	MIMAT0017994	hsa-miR-3615	5.59	3.94e-08	0.27	0.25	Monocyte count;	chr17:74779772	chr17:74748663~74748683:+
THCA	cis	rs6120849	0.754	rs6087667	MIMAT0004772	hsa-miR-499a-3p	-5.57	4.18e-08	-0.36	-0.25	Protein C levels;	chr20:35064084	chr20:34990445~34990466:+
THCA	cis	rs9527	0.83	rs3740392	MIMAT0005951	hsa-miR-1307-3p	5.57	4.34e-08	0.2	0.25	Arsenic metabolism;	chr10:102877098	chr10:103394301~103394322:-
THCA	cis	rs74233809	0.901	rs77335224	MIMAT0022727	hsa-miR-1307-5p	-5.54	4.95e-08	-0.33	-0.25	Birth weight;	chr10:102876519	chr10:103394341~103394361:-
THCA	cis	rs6120849	0.754	rs6120819	MIMAT0004772	hsa-miR-499a-3p	-5.54	5.08e-08	-0.36	-0.25	Protein C levels;	chr20:35065235	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.754	rs6120828	MIMAT0004772	hsa-miR-499a-3p	-5.5	6.13e-08	-0.36	-0.25	Protein C levels;	chr20:35086657	chr20:34990445~34990466:+
THCA	cis	rs74233809	0.901	rs77335224	MIMAT0005951	hsa-miR-1307-3p	-5.5	6.39e-08	-0.28	-0.25	Birth weight;	chr10:102876519	chr10:103394301~103394322:-
THCA	cis	rs8064299	0.655	rs2305214	MIMAT0017994	hsa-miR-3615	-5.48	6.88e-08	-0.27	-0.24	Monocyte count;	chr17:74772831	chr17:74748663~74748683:+
THCA	cis	rs8064299	0.597	rs6501736	MIMAT0017994	hsa-miR-3615	-5.47	7.43e-08	-0.26	-0.24	Monocyte count;	chr17:74779219	chr17:74748663~74748683:+
THCA	cis	rs9394169	0.613	rs7774682	MIMAT0022975	hsa-miR-3934-3p	-5.45	8.19e-08	-0.29	-0.24	Essential tremor;	chr6:33754867	chr6:33698191~33698212:+
THCA	cis	rs7894407	0.629	rs11598702	MIMAT0022727	hsa-miR-1307-5p	5.43	9.24e-08	0.21	0.24	White matter hyperintensity burden;	chr10:103138228	chr10:103394341~103394361:-
THCA	cis	rs4711336	0.633	rs9469583	MIMAT0018349	hsa-miR-3934-5p	-5.41	9.87e-08	-0.29	-0.24	Height;	chr6:33749993	chr6:33698152~33698173:+
THCA	cis	rs1867631	0.585	rs12062570	MIMAT0014979	hsa-miR-3117-3p	-5.39	1.14e-07	-0.29	-0.24	Menopause (age at onset);	chr1:66620602	chr1:66628485~66628505:+
THCA	cis	rs1018697	0.966	rs1953930	MIMAT0022727	hsa-miR-1307-5p	5.38	1.18e-07	0.2	0.24	Colorectal adenoma (advanced);	chr10:102789704	chr10:103394341~103394361:-
THCA	cis	rs7072216	0.687	rs4551689	MIMAT0026738	hsa-miR-1287-3p	-5.36	1.34e-07	-0.17	-0.24	Metabolite levels;	chr10:98397836	chr10:98395232~98395253:-
THCA	cis	rs8064299	0.597	rs3785539	MIMAT0017994	hsa-miR-3615	-5.35	1.37e-07	-0.26	-0.24	Monocyte count;	chr17:74778960	chr17:74748663~74748683:+
THCA	cis	rs79387448	0.701	rs10515921	MIMAT0019927	hsa-miR-4772-3p	-5.35	1.39e-07	-0.35	-0.24	Gut microbiota (bacterial taxa);	chr2:102364558	chr2:102432336~102432357:+
THCA	cis	rs79387448	0.701	rs76943877	MIMAT0019927	hsa-miR-4772-3p	-5.34	1.42e-07	-0.35	-0.24	Gut microbiota (bacterial taxa);	chr2:102354217	chr2:102432336~102432357:+
THCA	cis	rs79387448	0.576	rs11902044	MIMAT0019927	hsa-miR-4772-3p	-5.34	1.42e-07	-0.35	-0.24	Gut microbiota (bacterial taxa);	chr2:102356074	chr2:102432336~102432357:+
THCA	cis	rs7072216	0.687	rs10883085	MIMAT0026738	hsa-miR-1287-3p	5.33	1.49e-07	0.18	0.24	Metabolite levels;	chr10:98395856	chr10:98395232~98395253:-
THCA	cis	rs1163656	0.572	rs7303026	MIMAT0003287	hsa-miR-618	-5.32	1.63e-07	-0.32	-0.24	Dental caries;	chr12:80921967	chr12:80935796~80935818:-
THCA	cis	rs1163656	0.572	rs7134652	MIMAT0003287	hsa-miR-618	-5.32	1.63e-07	-0.32	-0.24	Dental caries;	chr12:80922054	chr12:80935796~80935818:-
THCA	cis	rs1163656	0.572	rs7134827	MIMAT0003287	hsa-miR-618	-5.32	1.63e-07	-0.32	-0.24	Dental caries;	chr12:80922229	chr12:80935796~80935818:-
THCA	cis	rs1867631	0.585	rs5008753	MIMAT0014979	hsa-miR-3117-3p	-5.32	1.64e-07	-0.28	-0.24	Menopause (age at onset);	chr1:66626565	chr1:66628485~66628505:+
THCA	cis	rs8064299	0.597	rs4789097	MIMAT0017994	hsa-miR-3615	5.31	1.67e-07	0.25	0.24	Monocyte count;	chr17:74785069	chr17:74748663~74748683:+
THCA	cis	rs6681460	0.584	rs7528182	MIMAT0014979	hsa-miR-3117-3p	-5.31	1.73e-07	-0.26	-0.24	Presence of antiphospholipid antibodies;	chr1:66601686	chr1:66628485~66628505:+
THCA	cis	rs1163656	0.605	rs7487519	MIMAT0003287	hsa-miR-618	-5.3	1.74e-07	-0.31	-0.24	Dental caries;	chr12:80921469	chr12:80935796~80935818:-
THCA	cis	rs6681460	0.625	rs4488004	MIMAT0014979	hsa-miR-3117-3p	-5.3	1.76e-07	-0.26	-0.24	Presence of antiphospholipid antibodies;	chr1:66607631	chr1:66628485~66628505:+
THCA	cis	rs1018697	0.966	rs1475643	MIMAT0022727	hsa-miR-1307-5p	5.29	1.84e-07	0.2	0.24	Colorectal adenoma (advanced);	chr10:102786710	chr10:103394341~103394361:-
THCA	cis	rs75358501	0.636	rs12473690	MIMAT0014995	hsa-miR-3130-5p	5.29	1.84e-07	0.3	0.24	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206734939	chr2:206783276~206783296:-
THCA	cis	rs75358501	0.636	rs12473690	MIMAT0014995_1	hsa-miR-3130-5p	5.29	1.84e-07	0.3	0.24	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206734939	chr2:206783246~206783266:+
THCA	cis	rs1163656	0.572	rs1402349	MIMAT0003287	hsa-miR-618	-5.29	1.88e-07	-0.32	-0.24	Dental caries;	chr12:80919985	chr12:80935796~80935818:-
THCA	cis	rs1867631	0.585	rs4655639	MIMAT0014979	hsa-miR-3117-3p	-5.29	1.91e-07	-0.28	-0.24	Menopause (age at onset);	chr1:66623407	chr1:66628485~66628505:+
THCA	cis	rs6681460	0.966	rs10889642	MIMAT0014979	hsa-miR-3117-3p	-5.28	1.95e-07	-0.3	-0.24	Presence of antiphospholipid antibodies;	chr1:66677651	chr1:66628485~66628505:+
THCA	cis	rs6681460	0.565	rs6689755	MIMAT0014979	hsa-miR-3117-3p	-5.27	2.05e-07	-0.28	-0.24	Presence of antiphospholipid antibodies;	chr1:66647367	chr1:66628485~66628505:+
THCA	cis	rs6681460	1	rs10889641	MIMAT0014979	hsa-miR-3117-3p	-5.26	2.22e-07	-0.3	-0.24	Presence of antiphospholipid antibodies;	chr1:66672684	chr1:66628485~66628505:+
THCA	cis	rs1163656	0.534	rs12311427	MIMAT0003287	hsa-miR-618	-5.26	2.23e-07	-0.31	-0.24	Dental caries;	chr12:80934053	chr12:80935796~80935818:-
THCA	cis	rs330071	0.686	rs10087406	MIMAT0019728	hsa-miR-4660	-5.26	2.23e-07	-0.31	-0.24	Acne (severe);	chr8:9389088	chr8:9048453~9048475:+
THCA	cis	rs7072216	0.687	rs11189589	MIMAT0026738	hsa-miR-1287-3p	5.26	2.24e-07	0.17	0.24	Metabolite levels;	chr10:98394808	chr10:98395232~98395253:-
THCA	cis	rs8064299	0.597	rs2166703	MIMAT0017994	hsa-miR-3615	-5.25	2.27e-07	-0.25	-0.23	Monocyte count;	chr17:74785673	chr17:74748663~74748683:+
THCA	cis	rs7072216	0.687	rs11189587	MIMAT0026738	hsa-miR-1287-3p	5.25	2.33e-07	0.17	0.23	Metabolite levels;	chr10:98394788	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.687	rs11189588	MIMAT0026738	hsa-miR-1287-3p	5.25	2.33e-07	0.17	0.23	Metabolite levels;	chr10:98394794	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.687	rs10786418	MIMAT0026738	hsa-miR-1287-3p	5.24	2.4e-07	0.17	0.23	Metabolite levels;	chr10:98397611	chr10:98395232~98395253:-
THCA	cis	rs8064299	0.536	rs2290038	MIMAT0017994	hsa-miR-3615	5.24	2.42e-07	0.25	0.23	Monocyte count;	chr17:74790472	chr17:74748663~74748683:+
THCA	cis	rs1018697	0.897	rs2150929	MIMAT0022727	hsa-miR-1307-5p	5.24	2.43e-07	0.19	0.23	Colorectal adenoma (advanced);	chr10:102791180	chr10:103394341~103394361:-
THCA	cis	rs1018697	1	rs7911528	MIMAT0022727	hsa-miR-1307-5p	5.24	2.43e-07	0.19	0.23	Colorectal adenoma (advanced);	chr10:102791810	chr10:103394341~103394361:-
THCA	cis	rs7477	0.557	rs3785626	MIMAT0005942	hsa-miR-1288-3p	-5.24	2.44e-07	-0.29	-0.23	Amyotrophic lateral sclerosis;	chr17:16281934	chr17:16282058~16282078:+
THCA	cis	rs7072216	0.687	rs11189590	MIMAT0026738	hsa-miR-1287-3p	5.24	2.46e-07	0.17	0.23	Metabolite levels;	chr10:98394848	chr10:98395232~98395253:-
THCA	cis	rs6681460	0.604	rs11208920	MIMAT0014979	hsa-miR-3117-3p	-5.23	2.49e-07	-0.26	-0.23	Presence of antiphospholipid antibodies;	chr1:66609629	chr1:66628485~66628505:+
THCA	cis	rs9663711	1	rs9663711	MIMAT0022727	hsa-miR-1307-5p	5.23	2.57e-07	0.19	0.23	Carotid plaque burden;	chr10:102787871	chr10:103394341~103394361:-
THCA	cis	rs9394169	0.613	rs7774682	MIMAT0018349	hsa-miR-3934-5p	-5.22	2.62e-07	-0.29	-0.23	Essential tremor;	chr6:33754867	chr6:33698152~33698173:+
THCA	cis	rs7477	0.557	rs6502498	MIMAT0005942	hsa-miR-1288-3p	5.22	2.65e-07	0.29	0.23	Amyotrophic lateral sclerosis;	chr17:16295661	chr17:16282058~16282078:+
THCA	cis	rs7072216	0.687	rs11189586	MIMAT0026738	hsa-miR-1287-3p	5.22	2.65e-07	0.17	0.23	Metabolite levels;	chr10:98394339	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.687	rs10883086	MIMAT0026738	hsa-miR-1287-3p	5.22	2.68e-07	0.17	0.23	Metabolite levels;	chr10:98395986	chr10:98395232~98395253:-
THCA	cis	rs1018697	1	rs4919677	MIMAT0022727	hsa-miR-1307-5p	5.22	2.74e-07	0.19	0.23	Colorectal adenoma (advanced);	chr10:102794547	chr10:103394341~103394361:-
THCA	cis	rs1018697	1	rs10748830	MIMAT0022727	hsa-miR-1307-5p	5.22	2.74e-07	0.19	0.23	Colorectal adenoma (advanced);	chr10:102788625	chr10:103394341~103394361:-
THCA	cis	rs1018697	1	rs10786710	MIMAT0022727	hsa-miR-1307-5p	5.22	2.74e-07	0.19	0.23	Colorectal adenoma (advanced);	chr10:102788982	chr10:103394341~103394361:-
THCA	cis	rs1018697	1	rs7088711	MIMAT0022727	hsa-miR-1307-5p	-5.21	2.8e-07	-0.19	-0.23	Colorectal adenoma (advanced);	chr10:102799509	chr10:103394341~103394361:-
THCA	cis	rs1163656	0.572	rs1402348	MIMAT0003287	hsa-miR-618	-5.21	2.82e-07	-0.31	-0.23	Dental caries;	chr12:80919695	chr12:80935796~80935818:-
THCA	cis	rs1018697	1	rs2150928	MIMAT0022727	hsa-miR-1307-5p	5.21	2.88e-07	0.19	0.23	Colorectal adenoma (advanced);	chr10:102791228	chr10:103394341~103394361:-
THCA	cis	rs1018697	1	rs6584525	MIMAT0022727	hsa-miR-1307-5p	5.21	2.88e-07	0.19	0.23	Colorectal adenoma (advanced);	chr10:102792224	chr10:103394341~103394361:-
THCA	cis	rs7072216	0.687	rs7924209	MIMAT0026738	hsa-miR-1287-3p	5.21	2.9e-07	0.17	0.23	Metabolite levels;	chr10:98396170	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.687	rs7908310	MIMAT0026738	hsa-miR-1287-3p	5.21	2.9e-07	0.17	0.23	Metabolite levels;	chr10:98396470	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.687	rs10883087	MIMAT0026738	hsa-miR-1287-3p	5.21	2.9e-07	0.17	0.23	Metabolite levels;	chr10:98397233	chr10:98395232~98395253:-
THCA	cis	rs7477	0.557	rs4792731	MIMAT0005942	hsa-miR-1288-3p	5.2	2.94e-07	0.29	0.23	Amyotrophic lateral sclerosis;	chr17:16298627	chr17:16282058~16282078:+
THCA	cis	rs7072216	0.615	rs6584195	MIMAT0026738	hsa-miR-1287-3p	5.2	2.96e-07	0.17	0.23	Metabolite levels;	chr10:98400990	chr10:98395232~98395253:-
THCA	cis	rs1018697	1	rs7080587	MIMAT0022727	hsa-miR-1307-5p	5.2	3.02e-07	0.19	0.23	Colorectal adenoma (advanced);	chr10:102785517	chr10:103394341~103394361:-
THCA	cis	rs7477	0.557	rs9944524	MIMAT0005942	hsa-miR-1288-3p	5.2	3.05e-07	0.29	0.23	Amyotrophic lateral sclerosis;	chr17:16309336	chr17:16282058~16282078:+
THCA	cis	rs7072216	0.687	rs11597425	MIMAT0026738	hsa-miR-1287-3p	5.19	3.12e-07	0.17	0.23	Metabolite levels;	chr10:98394445	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.687	rs11597428	MIMAT0026738	hsa-miR-1287-3p	5.19	3.12e-07	0.17	0.23	Metabolite levels;	chr10:98394490	chr10:98395232~98395253:-
THCA	cis	rs7072216	0.687	rs10786417	MIMAT0026738	hsa-miR-1287-3p	5.19	3.19e-07	0.17	0.23	Metabolite levels;	chr10:98394147	chr10:98395232~98395253:-
THCA	cis	rs1018697	1	rs7092051	MIMAT0022727	hsa-miR-1307-5p	5.18	3.23e-07	0.19	0.23	Colorectal adenoma (advanced);	chr10:102799720	chr10:103394341~103394361:-
THCA	cis	rs1018697	0.966	rs11191396	MIMAT0022727	hsa-miR-1307-5p	5.18	3.25e-07	0.19	0.23	Colorectal adenoma (advanced);	chr10:102793108	chr10:103394341~103394361:-
THCA	cis	rs1018697	1	rs4919678	MIMAT0022727	hsa-miR-1307-5p	5.18	3.25e-07	0.19	0.23	Colorectal adenoma (advanced);	chr10:102794606	chr10:103394341~103394361:-
THCA	cis	rs6681460	0.625	rs12138066	MIMAT0014979	hsa-miR-3117-3p	-5.18	3.36e-07	-0.26	-0.23	Presence of antiphospholipid antibodies;	chr1:66638133	chr1:66628485~66628505:+
THCA	cis	rs8064299	0.597	rs9944506	MIMAT0017994	hsa-miR-3615	-5.18	3.36e-07	-0.25	-0.23	Monocyte count;	chr17:74786587	chr17:74748663~74748683:+
THCA	cis	rs4919694	0.536	rs12414777	MIMAT0022727	hsa-miR-1307-5p	-5.17	3.38e-07	-0.23	-0.23	Arsenic metabolism;	chr10:102938024	chr10:103394341~103394361:-
THCA	cis	rs1018697	1	rs7086400	MIMAT0022727	hsa-miR-1307-5p	5.17	3.4e-07	0.19	0.23	Colorectal adenoma (advanced);	chr10:102802340	chr10:103394341~103394361:-
THCA	cis	rs6681460	1	rs2147777	MIMAT0014979	hsa-miR-3117-3p	-5.17	3.47e-07	-0.29	-0.23	Presence of antiphospholipid antibodies;	chr1:66663571	chr1:66628485~66628505:+
THCA	cis	rs6681460	1	rs6680876	MIMAT0014979	hsa-miR-3117-3p	-5.17	3.47e-07	-0.29	-0.23	Presence of antiphospholipid antibodies;	chr1:66663799	chr1:66628485~66628505:+
THCA	cis	rs1964356	0.967	rs2953802	MIMAT0019728	hsa-miR-4660	5.17	3.48e-07	0.3	0.23	Mean corpuscular volume;	chr8:8994371	chr8:9048453~9048475:+
THCA	cis	rs1018697	1	rs7092346	MIMAT0022727	hsa-miR-1307-5p	5.16	3.56e-07	0.19	0.23	Colorectal adenoma (advanced);	chr10:102800007	chr10:103394341~103394361:-
THCA	cis	rs1018697	1	rs1018696	MIMAT0022727	hsa-miR-1307-5p	5.16	3.57e-07	0.19	0.23	Colorectal adenoma (advanced);	chr10:102789309	chr10:103394341~103394361:-
THCA	cis	rs7477	0.557	rs4792728	MIMAT0005942	hsa-miR-1288-3p	5.16	3.62e-07	0.29	0.23	Amyotrophic lateral sclerosis;	chr17:16283501	chr17:16282058~16282078:+
THCA	cis	rs7477	0.56	rs11651578	MIMAT0005942	hsa-miR-1288-3p	5.16	3.65e-07	0.29	0.23	Amyotrophic lateral sclerosis;	chr17:16284278	chr17:16282058~16282078:+
THCA	cis	rs7477	0.557	rs4792729	MIMAT0005942	hsa-miR-1288-3p	5.16	3.65e-07	0.29	0.23	Amyotrophic lateral sclerosis;	chr17:16285105	chr17:16282058~16282078:+
THCA	cis	rs7477	0.557	rs3785625	MIMAT0005942	hsa-miR-1288-3p	5.16	3.65e-07	0.29	0.23	Amyotrophic lateral sclerosis;	chr17:16287104	chr17:16282058~16282078:+
THCA	cis	rs10021731	0.577	rs34941812	MIMAT0003242	hsa-miR-577	-5.16	3.69e-07	-0.25	-0.23	Optic disc area;	chr4:114673260	chr4:114656774~114656794:+
THCA	cis	rs8064299	0.597	rs4789098	MIMAT0017994	hsa-miR-3615	-5.15	3.77e-07	-0.24	-0.23	Monocyte count;	chr17:74785153	chr17:74748663~74748683:+
THCA	cis	rs6681460	0.966	rs6588215	MIMAT0014979	hsa-miR-3117-3p	-5.15	3.8e-07	-0.29	-0.23	Presence of antiphospholipid antibodies;	chr1:66676266	chr1:66628485~66628505:+
THCA	cis	rs6681460	1	rs6670378	MIMAT0014979	hsa-miR-3117-3p	-5.15	3.91e-07	-0.29	-0.23	Presence of antiphospholipid antibodies;	chr1:66660902	chr1:66628485~66628505:+
THCA	cis	rs6681460	0.565	rs2147776	MIMAT0014979	hsa-miR-3117-3p	-5.14	3.99e-07	-0.27	-0.23	Presence of antiphospholipid antibodies;	chr1:66641720	chr1:66628485~66628505:+
THCA	cis	rs7477	0.557	rs2109262	MIMAT0005942	hsa-miR-1288-3p	5.14	4.02e-07	0.29	0.23	Amyotrophic lateral sclerosis;	chr17:16281315	chr17:16282058~16282078:+
THCA	cis	rs1867631	0.585	rs6670827	MIMAT0014979	hsa-miR-3117-3p	-5.14	4.06e-07	-0.28	-0.23	Menopause (age at onset);	chr1:66661323	chr1:66628485~66628505:+
THCA	cis	rs6681460	0.966	rs1325261	MIMAT0014979	hsa-miR-3117-3p	-5.14	4.07e-07	-0.29	-0.23	Presence of antiphospholipid antibodies;	chr1:66644833	chr1:66628485~66628505:+
THCA	cis	rs1867631	0.585	rs4655642	MIMAT0014979	hsa-miR-3117-3p	-5.13	4.28e-07	-0.27	-0.23	Menopause (age at onset);	chr1:66624400	chr1:66628485~66628505:+
THCA	cis	rs1163656	0.592	rs1795514	MIMAT0003287	hsa-miR-618	5.13	4.28e-07	0.39	0.23	Dental caries;	chr12:80939088	chr12:80935796~80935818:-
THCA	cis	rs6681460	0.625	rs6680364	MIMAT0014979	hsa-miR-3117-3p	-5.13	4.28e-07	-0.26	-0.23	Presence of antiphospholipid antibodies;	chr1:66639151	chr1:66628485~66628505:+
THCA	cis	rs7477	0.557	rs12938878	MIMAT0005942	hsa-miR-1288-3p	5.12	4.38e-07	0.29	0.23	Amyotrophic lateral sclerosis;	chr17:16313291	chr17:16282058~16282078:+
THCA	cis	rs79387448	0.701	rs11465584	MIMAT0019927	hsa-miR-4772-3p	-5.12	4.47e-07	-0.34	-0.23	Gut microbiota (bacterial taxa);	chr2:102366169	chr2:102432336~102432357:+
THCA	cis	rs6681460	1	rs6680944	MIMAT0014979	hsa-miR-3117-3p	-5.12	4.47e-07	-0.29	-0.23	Presence of antiphospholipid antibodies;	chr1:66656882	chr1:66628485~66628505:+
THCA	cis	rs1867631	0.585	rs6694782	MIMAT0014979	hsa-miR-3117-3p	5.12	4.49e-07	0.27	0.23	Menopause (age at onset);	chr1:66661079	chr1:66628485~66628505:+
THCA	cis	rs7477	0.557	rs11654658	MIMAT0005942	hsa-miR-1288-3p	-5.12	4.54e-07	-0.29	-0.23	Amyotrophic lateral sclerosis;	chr17:16304141	chr17:16282058~16282078:+
THCA	cis	rs1018697	1	rs11191397	MIMAT0022727	hsa-miR-1307-5p	5.12	4.56e-07	0.19	0.23	Colorectal adenoma (advanced);	chr10:102798517	chr10:103394341~103394361:-
THCA	cis	rs6681460	1	rs6681460	MIMAT0014979	hsa-miR-3117-3p	5.12	4.57e-07	0.29	0.23	Presence of antiphospholipid antibodies;	chr1:66657374	chr1:66628485~66628505:+
THCA	cis	rs7477	0.557	rs11868284	MIMAT0005942	hsa-miR-1288-3p	5.11	4.62e-07	0.29	0.23	Amyotrophic lateral sclerosis;	chr17:16292961	chr17:16282058~16282078:+
THCA	cis	rs6681460	1	rs1536115	MIMAT0014979	hsa-miR-3117-3p	-5.11	4.67e-07	-0.29	-0.23	Presence of antiphospholipid antibodies;	chr1:66655318	chr1:66628485~66628505:+
THCA	cis	rs79387448	0.638	rs6759588	MIMAT0019927	hsa-miR-4772-3p	-5.11	4.71e-07	-0.34	-0.23	Gut microbiota (bacterial taxa);	chr2:102423699	chr2:102432336~102432357:+
THCA	cis	rs6681460	1	rs1329978	MIMAT0014979	hsa-miR-3117-3p	-5.11	4.72e-07	-0.29	-0.23	Presence of antiphospholipid antibodies;	chr1:66650548	chr1:66628485~66628505:+
THCA	cis	rs1018697	0.966	rs6584526	MIMAT0022727	hsa-miR-1307-5p	5.1	4.84e-07	0.19	0.23	Colorectal adenoma (advanced);	chr10:102806484	chr10:103394341~103394361:-
THCA	cis	rs6681460	0.625	rs6696812	MIMAT0014979	hsa-miR-3117-3p	-5.1	4.86e-07	-0.26	-0.23	Presence of antiphospholipid antibodies;	chr1:66634626	chr1:66628485~66628505:+
THCA	cis	rs74233809	0.515	rs72841270	MIMAT0022727	hsa-miR-1307-5p	-5.1	4.86e-07	-0.25	-0.23	Birth weight;	chr10:102882480	chr10:103394341~103394361:-
THCA	cis	rs6555855	0.514	rs4868478	MIMAT0026618	hsa-miR-585-5p	5.1	4.88e-07	0.27	0.23	Menarche (age at onset);	chr5:169291036	chr5:169263649~169263670:-
THCA	cis	rs2277912	1	rs2277912	MIMAT0014995	hsa-miR-3130-5p	5.1	4.95e-07	0.3	0.23	Height;	chr2:206769512	chr2:206783276~206783296:-
THCA	cis	rs2277912	1	rs2277912	MIMAT0014995_1	hsa-miR-3130-5p	5.1	4.95e-07	0.3	0.23	Height;	chr2:206769512	chr2:206783246~206783266:+
THCA	cis	rs2277912	1	rs56243714	MIMAT0014995	hsa-miR-3130-5p	5.09	5.07e-07	0.3	0.23	Height;	chr2:206776345	chr2:206783276~206783296:-
THCA	cis	rs2277912	1	rs56243714	MIMAT0014995_1	hsa-miR-3130-5p	5.09	5.07e-07	0.3	0.23	Height;	chr2:206776345	chr2:206783246~206783266:+
THCA	cis	rs6681460	1	rs6659968	MIMAT0014979	hsa-miR-3117-3p	-5.09	5.16e-07	-0.29	-0.23	Presence of antiphospholipid antibodies;	chr1:66657776	chr1:66628485~66628505:+
THCA	cis	rs6681460	1	rs2031478	MIMAT0014979	hsa-miR-3117-3p	-5.09	5.16e-07	-0.29	-0.23	Presence of antiphospholipid antibodies;	chr1:66658059	chr1:66628485~66628505:+
THCA	cis	rs6120849	0.951	rs6120848	MIMAT0004772	hsa-miR-499a-3p	-5.09	5.29e-07	-0.33	-0.23	Protein C levels;	chr20:35140875	chr20:34990445~34990466:+
THCA	cis	rs6681460	1	rs4655648	MIMAT0014979	hsa-miR-3117-3p	-5.09	5.3e-07	-0.29	-0.23	Presence of antiphospholipid antibodies;	chr1:66648626	chr1:66628485~66628505:+
THCA	cis	rs6681460	1	rs9662962	MIMAT0014979	hsa-miR-3117-3p	-5.09	5.31e-07	-0.29	-0.23	Presence of antiphospholipid antibodies;	chr1:66655681	chr1:66628485~66628505:+
THCA	cis	rs6681460	0.966	rs9659879	MIMAT0014979	hsa-miR-3117-3p	-5.09	5.31e-07	-0.29	-0.23	Presence of antiphospholipid antibodies;	chr1:66655751	chr1:66628485~66628505:+
THCA	cis	rs6681460	1	rs7521111	MIMAT0014979	hsa-miR-3117-3p	-5.09	5.31e-07	-0.29	-0.23	Presence of antiphospholipid antibodies;	chr1:66655951	chr1:66628485~66628505:+
THCA	cis	rs6681460	1	rs7521123	MIMAT0014979	hsa-miR-3117-3p	-5.09	5.31e-07	-0.29	-0.23	Presence of antiphospholipid antibodies;	chr1:66655980	chr1:66628485~66628505:+
THCA	cis	rs7477	0.557	rs9914734	MIMAT0005942	hsa-miR-1288-3p	5.08	5.41e-07	0.29	0.23	Amyotrophic lateral sclerosis;	chr17:16278700	chr17:16282058~16282078:+
THCA	cis	rs453301	0.653	rs1045529	MIMAT0019728	hsa-miR-4660	-5.08	5.46e-07	-0.29	-0.23	Joint mobility (Beighton score);	chr8:9032588	chr8:9048453~9048475:+
THCA	cis	rs7072216	0.687	rs7097625	MIMAT0026738	hsa-miR-1287-3p	5.08	5.53e-07	0.17	0.23	Metabolite levels;	chr10:98399165	chr10:98395232~98395253:-
THCA	cis	rs79387448	0.626	rs80277428	MIMAT0019927	hsa-miR-4772-3p	-5.07	5.61e-07	-0.35	-0.23	Gut microbiota (bacterial taxa);	chr2:102463596	chr2:102432336~102432357:+
THCA	cis	rs453301	0.653	rs11784393	MIMAT0019728	hsa-miR-4660	5.07	5.63e-07	0.28	0.23	Joint mobility (Beighton score);	chr8:9045624	chr8:9048453~9048475:+
THCA	cis	rs6681460	0.966	rs7519747	MIMAT0014979	hsa-miR-3117-3p	-5.07	5.67e-07	-0.29	-0.23	Presence of antiphospholipid antibodies;	chr1:66675040	chr1:66628485~66628505:+
THCA	cis	rs1018697	0.966	rs10748831	MIMAT0022727	hsa-miR-1307-5p	5.07	5.68e-07	0.18	0.23	Colorectal adenoma (advanced);	chr10:102798986	chr10:103394341~103394361:-
THCA	cis	rs6681460	0.604	rs7546825	MIMAT0014979	hsa-miR-3117-3p	-5.07	5.77e-07	-0.26	-0.23	Presence of antiphospholipid antibodies;	chr1:66636119	chr1:66628485~66628505:+
THCA	cis	rs6681460	0.625	rs12127199	MIMAT0014979	hsa-miR-3117-3p	-5.07	5.77e-07	-0.26	-0.23	Presence of antiphospholipid antibodies;	chr1:66638059	chr1:66628485~66628505:+
THCA	cis	rs7894407	0.522	rs2274341	MIMAT0005951	hsa-miR-1307-3p	5.07	5.81e-07	0.21	0.23	White matter hyperintensity burden;	chr10:103093746	chr10:103394301~103394322:-
THCA	cis	rs6681460	1	rs6656550	MIMAT0014979	hsa-miR-3117-3p	-5.06	5.92e-07	-0.29	-0.23	Presence of antiphospholipid antibodies;	chr1:66656869	chr1:66628485~66628505:+
THCA	cis	rs7072216	0.687	rs7924303	MIMAT0026738	hsa-miR-1287-3p	-5.06	6.02e-07	-0.17	-0.23	Metabolite levels;	chr10:98396206	chr10:98395232~98395253:-
THCA	cis	rs6681460	0.546	rs1998716	MIMAT0014979	hsa-miR-3117-3p	-5.06	6.04e-07	-0.27	-0.23	Presence of antiphospholipid antibodies;	chr1:66651423	chr1:66628485~66628505:+
THCA	cis	rs1018697	1	rs7073114	MIMAT0022727	hsa-miR-1307-5p	5.06	6.09e-07	0.19	0.23	Colorectal adenoma (advanced);	chr10:102795894	chr10:103394341~103394361:-
THCA	cis	rs8064299	0.565	rs12453550	MIMAT0017994	hsa-miR-3615	-5.06	6.16e-07	-0.24	-0.23	Monocyte count;	chr17:74789947	chr17:74748663~74748683:+
THCA	cis	rs12712135	0.709	rs10201184	MIMAT0019927	hsa-miR-4772-3p	-5.05	6.24e-07	-0.2	-0.23	Blood protein levels;	chr2:102472618	chr2:102432336~102432357:+
THCA	cis	rs12712135	0.709	rs12463588	MIMAT0019927	hsa-miR-4772-3p	5.05	6.27e-07	0.2	0.23	Blood protein levels;	chr2:102468797	chr2:102432336~102432357:+
THCA	cis	rs12712135	0.709	rs2310302	MIMAT0019927	hsa-miR-4772-3p	5.05	6.27e-07	0.2	0.23	Blood protein levels;	chr2:102469589	chr2:102432336~102432357:+
THCA	cis	rs12712135	0.709	rs12469887	MIMAT0019927	hsa-miR-4772-3p	5.05	6.27e-07	0.2	0.23	Blood protein levels;	chr2:102470298	chr2:102432336~102432357:+
THCA	cis	rs12712135	0.709	rs10195075	MIMAT0019927	hsa-miR-4772-3p	5.05	6.27e-07	0.2	0.23	Blood protein levels;	chr2:102471192	chr2:102432336~102432357:+
THCA	cis	rs12712135	0.709	rs1403553	MIMAT0019927	hsa-miR-4772-3p	5.05	6.27e-07	0.2	0.23	Blood protein levels;	chr2:102471202	chr2:102432336~102432357:+
THCA	cis	rs17109512	1	rs942812	MIMAT0005878	hsa-miR-1287-5p	5.05	6.37e-07	0.36	0.23	Aspartate aminotransferase levels;	chr10:98393907	chr10:98395271~98395292:-
THCA	cis	rs17109512	1	rs7073497	MIMAT0005878	hsa-miR-1287-5p	5.05	6.37e-07	0.36	0.23	Aspartate aminotransferase levels;	chr10:98393931	chr10:98395271~98395292:-
THCA	cis	rs12712135	0.677	rs6705385	MIMAT0019927	hsa-miR-4772-3p	5.05	6.42e-07	0.2	0.23	Blood protein levels;	chr2:102460109	chr2:102432336~102432357:+
THCA	cis	rs1867631	0.585	rs12094526	MIMAT0014979	hsa-miR-3117-3p	-5.05	6.42e-07	-0.27	-0.23	Menopause (age at onset);	chr1:66660431	chr1:66628485~66628505:+
THCA	cis	rs6681460	1	rs1325263	MIMAT0014979	hsa-miR-3117-3p	-5.05	6.43e-07	-0.29	-0.23	Presence of antiphospholipid antibodies;	chr1:66664108	chr1:66628485~66628505:+
THCA	cis	rs8064299	0.597	rs7210318	MIMAT0017994	hsa-miR-3615	-5.04	6.54e-07	-0.24	-0.23	Monocyte count;	chr17:74787246	chr17:74748663~74748683:+
THCA	cis	rs12712135	0.652	rs11465727	MIMAT0019927	hsa-miR-4772-3p	5.04	6.57e-07	0.2	0.23	Blood protein levels;	chr2:102448043	chr2:102432336~102432357:+
THCA	cis	rs12712135	0.709	rs11465729	MIMAT0019927	hsa-miR-4772-3p	5.04	6.57e-07	0.2	0.23	Blood protein levels;	chr2:102448052	chr2:102432336~102432357:+
THCA	cis	rs6681460	0.966	rs10789214	MIMAT0014979	hsa-miR-3117-3p	-5.04	6.57e-07	-0.29	-0.23	Presence of antiphospholipid antibodies;	chr1:66681134	chr1:66628485~66628505:+
THCA	cis	rs2277912	1	rs72957112	MIMAT0014995	hsa-miR-3130-5p	5.04	6.63e-07	0.3	0.23	Height;	chr2:206830729	chr2:206783276~206783296:-
THCA	cis	rs2277912	1	rs72957112	MIMAT0014995_1	hsa-miR-3130-5p	5.04	6.63e-07	0.3	0.23	Height;	chr2:206830729	chr2:206783246~206783266:+
THCA	cis	rs1018697	0.966	rs10748832	MIMAT0022727	hsa-miR-1307-5p	5.04	6.63e-07	0.19	0.23	Colorectal adenoma (advanced);	chr10:102808723	chr10:103394341~103394361:-
THCA	cis	rs4713675	0.709	rs542441	MIMAT0018349	hsa-miR-3934-5p	5.04	6.73e-07	0.27	0.23	Plateletcrit;	chr6:33708074	chr6:33698152~33698173:+
THCA	cis	rs330071	0.686	rs4841139	MIMAT0019728	hsa-miR-4660	5.04	6.73e-07	0.29	0.23	Acne (severe);	chr8:9391700	chr8:9048453~9048475:+
THCA	cis	rs4713675	0.709	rs626156	MIMAT0018349	hsa-miR-3934-5p	5.04	6.75e-07	0.27	0.23	Plateletcrit;	chr6:33702705	chr6:33698152~33698173:+
THCA	cis	rs12712135	0.709	rs11465730	MIMAT0019927	hsa-miR-4772-3p	5.03	6.84e-07	0.2	0.23	Blood protein levels;	chr2:102450398	chr2:102432336~102432357:+
THCA	cis	rs7917772	0.715	rs7077678	MIMAT0005951	hsa-miR-1307-3p	-5.03	6.85e-07	-0.16	-0.23	Waist-to-hip ratio adjusted for body mass index;White blood cell count;Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);	chr10:102678808	chr10:103394301~103394322:-
THCA	cis	rs1867631	0.585	rs9787219	MIMAT0014979	hsa-miR-3117-3p	-5.03	6.86e-07	-0.27	-0.23	Menopause (age at onset);	chr1:66614476	chr1:66628485~66628505:+
THCA	cis	rs1867631	0.585	rs11208922	MIMAT0014979	hsa-miR-3117-3p	-5.03	6.86e-07	-0.27	-0.23	Menopause (age at onset);	chr1:66614543	chr1:66628485~66628505:+
THCA	cis	rs1018697	1	rs7909612	MIMAT0022727	hsa-miR-1307-5p	5.03	6.97e-07	0.18	0.23	Colorectal adenoma (advanced);	chr10:102801699	chr10:103394341~103394361:-
THCA	cis	rs7917772	0.69	rs11191369	MIMAT0005951	hsa-miR-1307-3p	-5.03	6.97e-07	-0.16	-0.23	Waist-to-hip ratio adjusted for body mass index;White blood cell count;Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);	chr10:102697699	chr10:103394301~103394322:-
THCA	cis	rs1018697	1	rs7896903	MIMAT0022727	hsa-miR-1307-5p	5.03	7.06e-07	0.18	0.23	Colorectal adenoma (advanced);	chr10:102806660	chr10:103394341~103394361:-
THCA	cis	rs453301	0.653	rs1562211	MIMAT0019728	hsa-miR-4660	-5.03	7.14e-07	-0.28	-0.23	Joint mobility (Beighton score);	chr8:9044914	chr8:9048453~9048475:+
THCA	cis	rs953492	1	rs2783971	MIMAT0019761	hsa-miR-4677-3p	-5.02	7.32e-07	-0.24	-0.23	Diastolic blood pressure;	chr1:243311234	chr1:243346225~243346246:+
THCA	cis	rs2277912	1	rs17214385	MIMAT0014995	hsa-miR-3130-5p	5.02	7.35e-07	0.3	0.23	Height;	chr2:206816879	chr2:206783276~206783296:-
THCA	cis	rs2277912	1	rs17214385	MIMAT0014995_1	hsa-miR-3130-5p	5.02	7.35e-07	0.3	0.23	Height;	chr2:206816879	chr2:206783246~206783266:+
THCA	cis	rs8064299	0.597	rs2016126	MIMAT0017994	hsa-miR-3615	-5.02	7.39e-07	-0.24	-0.23	Monocyte count;	chr17:74788793	chr17:74748663~74748683:+
THCA	cis	rs12712135	0.709	rs11465728	MIMAT0019927	hsa-miR-4772-3p	5.02	7.52e-07	0.2	0.22	Blood protein levels;	chr2:102448051	chr2:102432336~102432357:+
THCA	cis	rs8064299	0.597	rs6501737	MIMAT0017994	hsa-miR-3615	5.01	7.54e-07	0.24	0.22	Monocyte count;	chr17:74784691	chr17:74748663~74748683:+
THCA	cis	rs6681460	1	rs4655647	MIMAT0014979	hsa-miR-3117-3p	-5.01	7.64e-07	-0.28	-0.22	Presence of antiphospholipid antibodies;	chr1:66640394	chr1:66628485~66628505:+
THCA	cis	rs6120849	0.707	rs3746448	MIMAT0004772	hsa-miR-499a-3p	-5.01	7.69e-07	-0.34	-0.22	Protein C levels;	chr20:34985176	chr20:34990445~34990466:+
THCA	cis	rs6681460	0.966	rs10889643	MIMAT0014979	hsa-miR-3117-3p	-5.01	7.69e-07	-0.29	-0.22	Presence of antiphospholipid antibodies;	chr1:66677685	chr1:66628485~66628505:+
THCA	cis	rs7477	0.557	rs12939078	MIMAT0005942	hsa-miR-1288-3p	5.01	7.72e-07	0.29	0.22	Amyotrophic lateral sclerosis;	chr17:16313152	chr17:16282058~16282078:+
THCA	cis	rs8064299	0.56	rs11077763	MIMAT0017994	hsa-miR-3615	-5.01	7.75e-07	-0.24	-0.22	Monocyte count;	chr17:74789890	chr17:74748663~74748683:+
THCA	cis	rs12712135	0.709	rs4140786	MIMAT0019927	hsa-miR-4772-3p	5.01	7.8e-07	0.2	0.22	Blood protein levels;	chr2:102471716	chr2:102432336~102432357:+
THCA	cis	rs453301	0.624	rs2979265	MIMAT0019728	hsa-miR-4660	5.01	7.83e-07	0.29	0.22	Joint mobility (Beighton score);	chr8:9001207	chr8:9048453~9048475:+
THCA	cis	rs12712135	0.709	rs11676236	MIMAT0019927	hsa-miR-4772-3p	5.01	7.84e-07	0.2	0.22	Blood protein levels;	chr2:102465235	chr2:102432336~102432357:+
THCA	cis	rs12712135	0.677	rs11687013	MIMAT0019927	hsa-miR-4772-3p	5.01	7.84e-07	0.2	0.22	Blood protein levels;	chr2:102465261	chr2:102432336~102432357:+
THCA	cis	rs6681460	0.966	rs11208932	MIMAT0014979	hsa-miR-3117-3p	-5.01	7.85e-07	-0.28	-0.22	Presence of antiphospholipid antibodies;	chr1:66632170	chr1:66628485~66628505:+
THCA	cis	rs1964356	0.967	rs17701675	MIMAT0019728	hsa-miR-4660	-5.01	7.86e-07	-0.29	-0.22	Mean corpuscular volume;	chr8:8993123	chr8:9048453~9048475:+
THCA	cis	rs17604090	0.938	rs73088374	MIMAT0004800	hsa-miR-550a-5p	5	7.95e-07	0.35	0.22	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29615203	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.938	rs73088374	MIMAT0004800_1	hsa-miR-550a-5p	5	7.95e-07	0.35	0.22	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29615203	chr7:32733002~32733024:+
THCA	cis	rs12712135	0.677	rs11678721	MIMAT0019927	hsa-miR-4772-3p	5	8.01e-07	0.2	0.22	Blood protein levels;	chr2:102456778	chr2:102432336~102432357:+
THCA	cis	rs12712135	0.709	rs11677555	MIMAT0019927	hsa-miR-4772-3p	5	8.01e-07	0.2	0.22	Blood protein levels;	chr2:102456833	chr2:102432336~102432357:+
THCA	cis	rs12712135	0.651	rs12712150	MIMAT0019927	hsa-miR-4772-3p	5	8.01e-07	0.2	0.22	Blood protein levels;	chr2:102458353	chr2:102432336~102432357:+
THCA	cis	rs12712135	0.709	rs6705498	MIMAT0019927	hsa-miR-4772-3p	5	8.01e-07	0.2	0.22	Blood protein levels;	chr2:102460210	chr2:102432336~102432357:+
THCA	cis	rs12712135	0.709	rs6719196	MIMAT0019927	hsa-miR-4772-3p	5	8.01e-07	0.2	0.22	Blood protein levels;	chr2:102460428	chr2:102432336~102432357:+
THCA	cis	rs7072216	0.687	rs7907555	MIMAT0026738	hsa-miR-1287-3p	-5	8.22e-07	-0.17	-0.22	Metabolite levels;	chr10:98396053	chr10:98395232~98395253:-
THCA	cis	rs9527	0.518	rs4633383	MIMAT0005951	hsa-miR-1307-3p	4.99	8.35e-07	0.23	0.22	Arsenic metabolism;	chr10:103035966	chr10:103394301~103394322:-
THCA	cis	rs1867631	0.585	rs11208940	MIMAT0014979	hsa-miR-3117-3p	4.99	8.38e-07	0.27	0.22	Menopause (age at onset);	chr1:66661559	chr1:66628485~66628505:+
THCA	cis	rs6681460	0.625	rs6679568	MIMAT0014979	hsa-miR-3117-3p	-4.99	8.6e-07	-0.25	-0.22	Presence of antiphospholipid antibodies;	chr1:66608494	chr1:66628485~66628505:+
THCA	cis	rs6555855	0.715	rs11134568	MIMAT0026618	hsa-miR-585-5p	-4.99	8.65e-07	-0.36	-0.22	Menarche (age at onset);	chr5:169280558	chr5:169263649~169263670:-
THCA	cis	rs1018697	0.518	rs284843	MIMAT0005951	hsa-miR-1307-3p	-4.98	8.9e-07	-0.18	-0.22	Colorectal adenoma (advanced);	chr10:102793809	chr10:103394301~103394322:-
THCA	cis	rs1018697	0.518	rs284846	MIMAT0005951	hsa-miR-1307-3p	-4.98	8.9e-07	-0.18	-0.22	Colorectal adenoma (advanced);	chr10:102797533	chr10:103394301~103394322:-
THCA	cis	rs12712135	0.709	rs55664618	MIMAT0019927	hsa-miR-4772-3p	4.98	9.02e-07	0.2	0.22	Blood protein levels;	chr2:102399756	chr2:102432336~102432357:+
THCA	cis	rs17109512	1	rs7915455	MIMAT0005878	hsa-miR-1287-5p	4.97	9.48e-07	0.38	0.22	Aspartate aminotransferase levels;	chr10:98364062	chr10:98395271~98395292:-
THCA	cis	rs953492	1	rs953492	MIMAT0019761	hsa-miR-4677-3p	-4.96	9.69e-07	-0.24	-0.22	Diastolic blood pressure;	chr1:243307890	chr1:243346225~243346246:+
THCA	cis	rs8064299	0.584	rs2384957	MIMAT0017994	hsa-miR-3615	-4.95	1.02e-06	-0.24	-0.22	Monocyte count;	chr17:74788491	chr17:74748663~74748683:+
THCA	cis	rs17604090	0.938	rs10276157	MIMAT0004800	hsa-miR-550a-5p	4.94	1.07e-06	0.34	0.22	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29625400	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.938	rs10276157	MIMAT0004800_1	hsa-miR-550a-5p	4.94	1.07e-06	0.34	0.22	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29625400	chr7:32733002~32733024:+
THCA	cis	rs17109512	1	rs17109512	MIMAT0005878	hsa-miR-1287-5p	4.94	1.07e-06	0.36	0.22	Aspartate aminotransferase levels;	chr10:98367794	chr10:98395271~98395292:-
THCA	cis	rs453301	0.653	rs7005133	MIMAT0019728	hsa-miR-4660	4.94	1.08e-06	0.28	0.22	Joint mobility (Beighton score);	chr8:9043712	chr8:9048453~9048475:+
THCA	cis	rs1163656	0.559	rs1163657	MIMAT0003287	hsa-miR-618	4.93	1.14e-06	0.37	0.22	Dental caries;	chr12:80943890	chr12:80935796~80935818:-
THCA	cis	rs6681460	0.966	rs4655650	MIMAT0014979	hsa-miR-3117-3p	-4.92	1.19e-06	-0.28	-0.22	Presence of antiphospholipid antibodies;	chr1:66676603	chr1:66628485~66628505:+
THCA	cis	rs6681460	0.966	rs10889644	MIMAT0014979	hsa-miR-3117-3p	-4.92	1.2e-06	-0.28	-0.22	Presence of antiphospholipid antibodies;	chr1:66679639	chr1:66628485~66628505:+
THCA	cis	rs4711336	0.509	rs764753	MIMAT0022975	hsa-miR-3934-3p	-4.92	1.2e-06	-0.26	-0.22	Height;	chr6:33690332	chr6:33698191~33698212:+
THCA	cis	rs79387448	0.592	rs6728945	MIMAT0019927	hsa-miR-4772-3p	-4.91	1.24e-06	-0.32	-0.22	Gut microbiota (bacterial taxa);	chr2:102370011	chr2:102432336~102432357:+
THCA	cis	rs2268667	0.597	rs1403954	MIMAT0019232	hsa-miR-4423-5p	-4.91	1.25e-06	-0.28	-0.22	Asymmetrical dimethylarginine levels;	chr1:85474474	chr1:85133806~85133827:+
THCA	cis	rs2277912	1	rs12620432	MIMAT0014995	hsa-miR-3130-5p	4.91	1.25e-06	0.29	0.22	Height;	chr2:206771794	chr2:206783276~206783296:-
THCA	cis	rs2277912	1	rs12620432	MIMAT0014995_1	hsa-miR-3130-5p	4.91	1.25e-06	0.29	0.22	Height;	chr2:206771794	chr2:206783246~206783266:+
THCA	cis	rs17604090	1	rs67970052	MIMAT0004800	hsa-miR-550a-5p	4.91	1.27e-06	0.34	0.22	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29615422	chr7:30289815~30289837:+
THCA	cis	rs17604090	1	rs67970052	MIMAT0004800_1	hsa-miR-550a-5p	4.91	1.27e-06	0.34	0.22	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29615422	chr7:32733002~32733024:+
THCA	cis	rs6681460	0.901	rs1570815	MIMAT0014979	hsa-miR-3117-3p	-4.91	1.27e-06	-0.28	-0.22	Presence of antiphospholipid antibodies;	chr1:66673984	chr1:66628485~66628505:+
THCA	cis	rs6555855	0.673	rs4643976	MIMAT0026618	hsa-miR-585-5p	4.9	1.31e-06	0.36	0.22	Menarche (age at onset);	chr5:169273399	chr5:169263649~169263670:-
THCA	cis	rs7072216	0.687	rs10786416	MIMAT0026738	hsa-miR-1287-3p	4.89	1.38e-06	0.17	0.22	Metabolite levels;	chr10:98393843	chr10:98395232~98395253:-
THCA	cis	rs453301	0.653	rs7016139	MIMAT0019728	hsa-miR-4660	-4.89	1.38e-06	-0.27	-0.22	Joint mobility (Beighton score);	chr8:9037960	chr8:9048453~9048475:+
THCA	cis	rs6555855	0.514	rs2338526	MIMAT0026618	hsa-miR-585-5p	4.89	1.39e-06	0.26	0.22	Menarche (age at onset);	chr5:169298244	chr5:169263649~169263670:-
THCA	cis	rs6555855	0.514	rs6882648	MIMAT0026618	hsa-miR-585-5p	4.89	1.39e-06	0.26	0.22	Menarche (age at onset);	chr5:169290358	chr5:169263649~169263670:-
THCA	cis	rs1163656	0.559	rs1183656	MIMAT0003287	hsa-miR-618	4.89	1.4e-06	0.37	0.22	Dental caries;	chr12:80944131	chr12:80935796~80935818:-
THCA	cis	rs79387448	0.638	rs13405222	MIMAT0019927	hsa-miR-4772-3p	-4.88	1.42e-06	-0.31	-0.22	Gut microbiota (bacterial taxa);	chr2:102365431	chr2:102432336~102432357:+
THCA	cis	rs1870653	0.588	rs922196	MIMAT0003242	hsa-miR-577	-4.88	1.44e-06	-0.49	-0.22	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);	chr4:114476138	chr4:114656774~114656794:+
THCA	cis	rs999943	0.774	rs12205634	MIMAT0022975	hsa-miR-3934-3p	-4.88	1.46e-06	-0.29	-0.22	Obesity (extreme);	chr6:33643890	chr6:33698191~33698212:+
THCA	cis	rs79387448	0.655	rs3771167	MIMAT0019927	hsa-miR-4772-3p	-4.87	1.5e-06	-0.31	-0.22	Gut microbiota (bacterial taxa);	chr2:102369728	chr2:102432336~102432357:+
THCA	cis	rs79387448	0.626	rs80256362	MIMAT0019927	hsa-miR-4772-3p	-4.87	1.51e-06	-0.32	-0.22	Gut microbiota (bacterial taxa);	chr2:102409041	chr2:102432336~102432357:+
THCA	cis	rs72848980	0.516	rs2296569	MIMAT0005951	hsa-miR-1307-3p	4.87	1.52e-06	0.24	0.22	White matter hyperintensity burden;	chr10:103076754	chr10:103394301~103394322:-
THCA	cis	rs6681460	0.966	rs7524851	MIMAT0014979	hsa-miR-3117-3p	-4.87	1.53e-06	-0.28	-0.22	Presence of antiphospholipid antibodies;	chr1:66627335	chr1:66628485~66628505:+
THCA	cis	rs6681460	0.966	rs4655646	MIMAT0014979	hsa-miR-3117-3p	-4.87	1.53e-06	-0.28	-0.22	Presence of antiphospholipid antibodies;	chr1:66628653	chr1:66628485~66628505:+
THCA	cis	rs7477	0.529	rs11656811	MIMAT0005942	hsa-miR-1288-3p	4.86	1.58e-06	0.28	0.22	Amyotrophic lateral sclerosis;	chr17:16310940	chr17:16282058~16282078:+
THCA	cis	rs453301	0.598	rs2921383	MIMAT0019728	hsa-miR-4660	4.86	1.58e-06	0.27	0.22	Joint mobility (Beighton score);	chr8:9034711	chr8:9048453~9048475:+
THCA	cis	rs6681460	1	rs2872078	MIMAT0014979	hsa-miR-3117-3p	-4.85	1.65e-06	-0.28	-0.22	Presence of antiphospholipid antibodies;	chr1:66661684	chr1:66628485~66628505:+
THCA	cis	rs6120849	1	rs6120849	MIMAT0004772	hsa-miR-499a-3p	-4.85	1.69e-06	-0.31	-0.22	Protein C levels;	chr20:35142584	chr20:34990445~34990466:+
THCA	cis	rs7477	0.619	rs3785622	MIMAT0005942	hsa-miR-1288-3p	4.85	1.69e-06	0.28	0.22	Amyotrophic lateral sclerosis;	chr17:16315372	chr17:16282058~16282078:+
THCA	cis	rs79387448	0.701	rs11465586	MIMAT0019927	hsa-miR-4772-3p	-4.85	1.7e-06	-0.31	-0.22	Gut microbiota (bacterial taxa);	chr2:102366249	chr2:102432336~102432357:+
THCA	cis	rs1018697	0.518	rs2250301	MIMAT0005951	hsa-miR-1307-3p	-4.85	1.7e-06	-0.18	-0.22	Colorectal adenoma (advanced);	chr10:102788636	chr10:103394301~103394322:-
THCA	cis	rs6681460	0.932	rs4655640	MIMAT0014979	hsa-miR-3117-3p	-4.84	1.73e-06	-0.28	-0.22	Presence of antiphospholipid antibodies;	chr1:66623537	chr1:66628485~66628505:+
THCA	cis	rs1163656	0.605	rs10778771	MIMAT0003287	hsa-miR-618	-4.84	1.78e-06	-0.33	-0.22	Dental caries;	chr12:80924235	chr12:80935796~80935818:-
THCA	cis	rs6681460	0.565	rs1536112	MIMAT0014979	hsa-miR-3117-3p	4.84	1.8e-06	0.26	0.22	Presence of antiphospholipid antibodies;	chr1:66641542	chr1:66628485~66628505:+
THCA	cis	rs453301	0.522	rs1964356	MIMAT0019728	hsa-miR-4660	4.84	1.8e-06	0.28	0.22	Joint mobility (Beighton score);	chr8:8995760	chr8:9048453~9048475:+
THCA	cis	rs79387448	0.701	rs3752659	MIMAT0019927	hsa-miR-4772-3p	-4.83	1.82e-06	-0.3	-0.22	Gut microbiota (bacterial taxa);	chr2:102385138	chr2:102432336~102432357:+
THCA	cis	rs453301	0.653	rs7853	MIMAT0019728	hsa-miR-4660	4.83	1.86e-06	0.27	0.22	Joint mobility (Beighton score);	chr8:9033304	chr8:9048453~9048475:+
THCA	cis	rs10021731	0.597	rs12508215	MIMAT0003242	hsa-miR-577	-4.83	1.88e-06	-0.23	-0.22	Optic disc area;	chr4:114699103	chr4:114656774~114656794:+
THCA	cis	rs6555855	0.514	rs888783	MIMAT0026618	hsa-miR-585-5p	4.83	1.89e-06	0.25	0.22	Menarche (age at onset);	chr5:169295655	chr5:169263649~169263670:-
THCA	cis	rs2277912	1	rs3762567	MIMAT0014995	hsa-miR-3130-5p	4.82	1.91e-06	0.29	0.22	Height;	chr2:206765614	chr2:206783276~206783296:-
THCA	cis	rs2277912	1	rs3762567	MIMAT0014995_1	hsa-miR-3130-5p	4.82	1.91e-06	0.29	0.22	Height;	chr2:206765614	chr2:206783246~206783266:+
THCA	cis	rs453301	0.592	rs4841084	MIMAT0019728	hsa-miR-4660	4.82	1.92e-06	0.27	0.22	Joint mobility (Beighton score);	chr8:9026395	chr8:9048453~9048475:+
THCA	cis	rs453301	0.653	rs2956244	MIMAT0019728	hsa-miR-4660	4.82	1.92e-06	0.27	0.22	Joint mobility (Beighton score);	chr8:9027656	chr8:9048453~9048475:+
THCA	cis	rs6555855	0.514	rs4339366	MIMAT0026618	hsa-miR-585-5p	-4.82	1.98e-06	-0.26	-0.22	Menarche (age at onset);	chr5:169288938	chr5:169263649~169263670:-
THCA	cis	rs10021731	0.597	rs11098263	MIMAT0003242	hsa-miR-577	-4.81	2e-06	-0.23	-0.22	Optic disc area;	chr4:114686481	chr4:114656774~114656794:+
THCA	cis	rs6681460	0.625	rs2312154	MIMAT0014979	hsa-miR-3117-3p	4.81	2.06e-06	0.24	0.22	Presence of antiphospholipid antibodies;	chr1:66607293	chr1:66628485~66628505:+
THCA	cis	rs453301	0.598	rs10104303	MIMAT0019728	hsa-miR-4660	4.81	2.08e-06	0.27	0.22	Joint mobility (Beighton score);	chr8:8977018	chr8:9048453~9048475:+
THCA	cis	rs453301	0.624	rs2288673	MIMAT0019728	hsa-miR-4660	4.8	2.1e-06	0.28	0.22	Joint mobility (Beighton score);	chr8:9002766	chr8:9048453~9048475:+
THCA	cis	rs79387448	0.655	rs17639215	MIMAT0019927	hsa-miR-4772-3p	-4.8	2.11e-06	-0.32	-0.22	Gut microbiota (bacterial taxa);	chr2:102336984	chr2:102432336~102432357:+
THCA	cis	rs8064299	0.597	rs9893035	MIMAT0017994	hsa-miR-3615	-4.8	2.15e-06	-0.23	-0.22	Monocyte count;	chr17:74787659	chr17:74748663~74748683:+
THCA	cis	rs4800353	0.81	rs7229928	MIMAT0000427	hsa-miR-133a-3p	-4.79	2.2e-06	-0.28	-0.22	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22034167	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.81	rs7229928	MIMAT0000427_1	hsa-miR-133a-3p	-4.79	2.2e-06	-0.28	-0.22	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22034167	chr20:62564970~62564991:+
THCA	cis	rs4800353	0.714	rs11877885	MIMAT0000427	hsa-miR-133a-3p	-4.79	2.2e-06	-0.28	-0.22	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22033191	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.714	rs11877885	MIMAT0000427_1	hsa-miR-133a-3p	-4.79	2.2e-06	-0.28	-0.22	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22033191	chr20:62564970~62564991:+
THCA	cis	rs17604090	0.756	rs10249388	MIMAT0004800	hsa-miR-550a-5p	4.79	2.21e-06	0.31	0.22	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29689519	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.756	rs10249388	MIMAT0004800_1	hsa-miR-550a-5p	4.79	2.21e-06	0.31	0.22	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29689519	chr7:32733002~32733024:+
THCA	cis	rs79387448	0.701	rs11465596	MIMAT0019927	hsa-miR-4772-3p	-4.79	2.24e-06	-0.33	-0.22	Gut microbiota (bacterial taxa);	chr2:102370633	chr2:102432336~102432357:+
THCA	cis	rs4800353	0.673	rs1383039	MIMAT0000427	hsa-miR-133a-3p	-4.79	2.26e-06	-0.28	-0.22	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22034021	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.673	rs1383039	MIMAT0000427_1	hsa-miR-133a-3p	-4.79	2.26e-06	-0.28	-0.22	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22034021	chr20:62564970~62564991:+
THCA	cis	rs4711336	0.583	rs10672	MIMAT0022975	hsa-miR-3934-3p	-4.79	2.28e-06	-0.25	-0.22	Height;	chr6:33694488	chr6:33698191~33698212:+
THCA	cis	rs453301	0.624	rs6987558	MIMAT0019728	hsa-miR-4660	4.78	2.29e-06	0.27	0.22	Joint mobility (Beighton score);	chr8:9005011	chr8:9048453~9048475:+
THCA	cis	rs17604090	0.878	rs4000284	MIMAT0004800	hsa-miR-550a-5p	4.78	2.31e-06	0.31	0.22	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29687301	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.878	rs4000284	MIMAT0004800_1	hsa-miR-550a-5p	4.78	2.31e-06	0.31	0.22	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29687301	chr7:32733002~32733024:+
THCA	cis	rs1018697	0.518	rs2482506	MIMAT0005951	hsa-miR-1307-3p	-4.78	2.35e-06	-0.18	-0.21	Colorectal adenoma (advanced);	chr10:102803986	chr10:103394301~103394322:-
THCA	cis	rs7477	0.586	rs12948905	MIMAT0005942	hsa-miR-1288-3p	4.77	2.49e-06	0.28	0.21	Amyotrophic lateral sclerosis;	chr17:16321561	chr17:16282058~16282078:+
THCA	cis	rs75358501	0.551	rs79761690	MIMAT0014995	hsa-miR-3130-5p	-4.76	2.61e-06	-0.27	-0.21	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206717731	chr2:206783276~206783296:-
THCA	cis	rs75358501	0.551	rs79761690	MIMAT0014995_1	hsa-miR-3130-5p	-4.76	2.61e-06	-0.27	-0.21	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206717731	chr2:206783246~206783266:+
THCA	cis	rs75358501	0.551	rs28619220	MIMAT0014995	hsa-miR-3130-5p	-4.76	2.61e-06	-0.27	-0.21	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206720891	chr2:206783276~206783296:-
THCA	cis	rs75358501	0.551	rs28619220	MIMAT0014995_1	hsa-miR-3130-5p	-4.76	2.61e-06	-0.27	-0.21	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206720891	chr2:206783246~206783266:+
THCA	cis	rs953492	0.871	rs2484640	MIMAT0019761	hsa-miR-4677-3p	-4.76	2.63e-06	-0.23	-0.21	Diastolic blood pressure;	chr1:243299115	chr1:243346225~243346246:+
THCA	cis	rs999943	0.739	rs62407633	MIMAT0022975	hsa-miR-3934-3p	-4.75	2.66e-06	-0.29	-0.21	Obesity (extreme);	chr6:33641467	chr6:33698191~33698212:+
THCA	cis	rs4800353	0.714	rs4392158	MIMAT0000427	hsa-miR-133a-3p	4.74	2.78e-06	0.28	0.21	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22031132	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.714	rs4392158	MIMAT0000427_1	hsa-miR-133a-3p	4.74	2.78e-06	0.28	0.21	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22031132	chr20:62564970~62564991:+
THCA	cis	rs2274459	0.778	rs2281917	MIMAT0022975	hsa-miR-3934-3p	4.74	2.84e-06	0.3	0.21	Obesity (extreme);	chr6:33687951	chr6:33698191~33698212:+
THCA	cis	rs6681460	1	rs6689864	MIMAT0014979	hsa-miR-3117-3p	-4.74	2.86e-06	-0.27	-0.21	Presence of antiphospholipid antibodies;	chr1:66602429	chr1:66628485~66628505:+
THCA	cis	rs4800353	0.673	rs9963751	MIMAT0000427	hsa-miR-133a-3p	-4.73	2.93e-06	-0.27	-0.21	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22022608	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.673	rs9963751	MIMAT0000427_1	hsa-miR-133a-3p	-4.73	2.93e-06	-0.27	-0.21	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22022608	chr20:62564970~62564991:+
THCA	cis	rs9527	0.518	rs11191487	MIMAT0005951	hsa-miR-1307-3p	4.73	2.93e-06	0.22	0.21	Arsenic metabolism;	chr10:102974866	chr10:103394301~103394322:-
THCA	cis	rs17604090	0.816	rs10248839	MIMAT0004800	hsa-miR-550a-5p	4.72	3.06e-06	0.32	0.21	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29657637	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.816	rs10248839	MIMAT0004800_1	hsa-miR-550a-5p	4.72	3.06e-06	0.32	0.21	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29657637	chr7:32733002~32733024:+
THCA	cis	rs6681460	0.932	rs603750	MIMAT0014979	hsa-miR-3117-3p	-4.72	3.07e-06	-0.26	-0.21	Presence of antiphospholipid antibodies;	chr1:66711805	chr1:66628485~66628505:+
THCA	cis	rs17604090	0.823	rs28415620	MIMAT0004800	hsa-miR-550a-5p	4.72	3.1e-06	0.32	0.21	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29661488	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.823	rs28415620	MIMAT0004800_1	hsa-miR-550a-5p	4.72	3.1e-06	0.32	0.21	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29661488	chr7:32733002~32733024:+
THCA	cis	rs17604090	0.878	rs4457221	MIMAT0004800	hsa-miR-550a-5p	4.72	3.1e-06	0.32	0.21	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29662158	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.878	rs4457221	MIMAT0004800_1	hsa-miR-550a-5p	4.72	3.1e-06	0.32	0.21	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29662158	chr7:32733002~32733024:+
THCA	cis	rs17604090	0.878	rs10262227	MIMAT0004800	hsa-miR-550a-5p	4.72	3.1e-06	0.32	0.21	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29664457	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.878	rs10262227	MIMAT0004800_1	hsa-miR-550a-5p	4.72	3.1e-06	0.32	0.21	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29664457	chr7:32733002~32733024:+
THCA	cis	rs9527	0.518	rs11191530	MIMAT0005951	hsa-miR-1307-3p	-4.72	3.1e-06	-0.21	-0.21	Arsenic metabolism;	chr10:103040287	chr10:103394301~103394322:-
THCA	cis	rs75358501	0.551	rs12471939	MIMAT0014995	hsa-miR-3130-5p	-4.72	3.11e-06	-0.27	-0.21	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206723545	chr2:206783276~206783296:-
THCA	cis	rs75358501	0.551	rs12471939	MIMAT0014995_1	hsa-miR-3130-5p	-4.72	3.11e-06	-0.27	-0.21	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206723545	chr2:206783246~206783266:+
THCA	cis	rs2274459	0.673	rs35328423	MIMAT0022975	hsa-miR-3934-3p	4.72	3.15e-06	0.28	0.21	Obesity (extreme);	chr6:33763815	chr6:33698191~33698212:+
THCA	cis	rs6681460	0.966	rs2025595	MIMAT0014979	hsa-miR-3117-3p	-4.72	3.15e-06	-0.27	-0.21	Presence of antiphospholipid antibodies;	chr1:66686816	chr1:66628485~66628505:+
THCA	cis	rs79387448	0.638	rs76255660	MIMAT0019927	hsa-miR-4772-3p	-4.69	3.56e-06	-0.31	-0.21	Gut microbiota (bacterial taxa);	chr2:102474569	chr2:102432336~102432357:+
THCA	cis	rs3227	0.626	rs3818528	MIMAT0018349	hsa-miR-3934-5p	-4.68	3.69e-06	-0.24	-0.21	Educational attainment;	chr6:33693314	chr6:33698152~33698173:+
THCA	cis	rs1018697	0.518	rs2790914	MIMAT0005951	hsa-miR-1307-3p	-4.68	3.7e-06	-0.17	-0.21	Colorectal adenoma (advanced);	chr10:102808261	chr10:103394301~103394322:-
THCA	cis	rs6681460	1	rs6696927	MIMAT0014979	hsa-miR-3117-3p	-4.68	3.75e-06	-0.26	-0.21	Presence of antiphospholipid antibodies;	chr1:66604698	chr1:66628485~66628505:+
THCA	cis	rs2274459	0.722	rs9461896	MIMAT0022975	hsa-miR-3934-3p	4.68	3.76e-06	0.27	0.21	Obesity (extreme);	chr6:33681920	chr6:33698191~33698212:+
THCA	cis	rs6681460	0.966	rs10789215	MIMAT0014979	hsa-miR-3117-3p	4.68	3.76e-06	0.27	0.21	Presence of antiphospholipid antibodies;	chr1:66685502	chr1:66628485~66628505:+
THCA	cis	rs999943	0.81	rs62407648	MIMAT0022975	hsa-miR-3934-3p	-4.66	4.07e-06	-0.28	-0.21	Obesity (extreme);	chr6:33654659	chr6:33698191~33698212:+
THCA	cis	rs3227	0.55	rs545787	MIMAT0018349	hsa-miR-3934-5p	4.66	4.19e-06	0.25	0.21	Educational attainment;	chr6:33735453	chr6:33698152~33698173:+
THCA	cis	rs9527	0.518	rs12776863	MIMAT0005951	hsa-miR-1307-3p	4.65	4.29e-06	0.21	0.21	Arsenic metabolism;	chr10:102881922	chr10:103394301~103394322:-
THCA	cis	rs59372292	0.619	rs12609437	MIMAT0021017	hsa-miR-4999-5p	4.65	4.34e-06	0.32	0.21	Coronary artery disease;	chr19:8489903	chr19:8389340~8389360:-
THCA	cis	rs12145833	0.85	rs2490392	MIMAT0019761	hsa-miR-4677-3p	-4.64	4.45e-06	-0.29	-0.21	Obesity (early onset extreme);	chr1:243299221	chr1:243346225~243346246:+
THCA	cis	rs7477	0.616	rs15739	MIMAT0005942	hsa-miR-1288-3p	4.64	4.51e-06	0.27	0.21	Amyotrophic lateral sclerosis;	chr17:16325918	chr17:16282058~16282078:+
THCA	cis	rs6681460	1	rs9662943	MIMAT0014979	hsa-miR-3117-3p	4.64	4.55e-06	0.27	0.21	Presence of antiphospholipid antibodies;	chr1:66655449	chr1:66628485~66628505:+
THCA	cis	rs6993244	1	rs6993244	MIMAT0019728	hsa-miR-4660	4.63	4.81e-06	0.26	0.21	Mean corpuscular hemoglobin;	chr8:9005549	chr8:9048453~9048475:+
THCA	cis	rs74233809	0.551	rs3740393	MIMAT0022727	hsa-miR-1307-5p	-4.62	5.04e-06	-0.23	-0.21	Birth weight;	chr10:102876898	chr10:103394341~103394361:-
THCA	cis	rs9527	0.518	rs12771834	MIMAT0005951	hsa-miR-1307-3p	4.6	5.36e-06	0.21	0.21	Arsenic metabolism;	chr10:102895662	chr10:103394301~103394322:-
THCA	cis	rs17027258	0.609	rs4851005	MIMAT0019926	hsa-miR-4772-5p	4.6	5.54e-06	0.24	0.21	White blood cell types;	chr2:102395092	chr2:102432300~102432321:+
THCA	cis	rs2274459	0.722	rs2296328	MIMAT0022975	hsa-miR-3934-3p	4.59	5.64e-06	0.27	0.21	Obesity (extreme);	chr6:33683500	chr6:33698191~33698212:+
THCA	cis	rs17604090	0.756	rs113829432	MIMAT0004800	hsa-miR-550a-5p	4.59	5.71e-06	0.3	0.21	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29685453	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.756	rs113829432	MIMAT0004800_1	hsa-miR-550a-5p	4.59	5.71e-06	0.3	0.21	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29685453	chr7:32733002~32733024:+
THCA	cis	rs453301	0.598	rs1025395	MIMAT0019728	hsa-miR-4660	4.58	5.87e-06	0.26	0.21	Joint mobility (Beighton score);	chr8:8979093	chr8:9048453~9048475:+
THCA	cis	rs453301	0.624	rs2288671	MIMAT0019728	hsa-miR-4660	4.58	5.87e-06	0.26	0.21	Joint mobility (Beighton score);	chr8:9003384	chr8:9048453~9048475:+
THCA	cis	rs2274459	0.778	rs2296737	MIMAT0022975	hsa-miR-3934-3p	4.58	5.88e-06	0.29	0.21	Obesity (extreme);	chr6:33688639	chr6:33698191~33698212:+
THCA	cis	rs2268667	0.597	rs1403955	MIMAT0019232	hsa-miR-4423-5p	4.58	5.92e-06	0.26	0.21	Asymmetrical dimethylarginine levels;	chr1:85474422	chr1:85133806~85133827:+
THCA	cis	rs6681460	0.966	rs7542924	MIMAT0014979	hsa-miR-3117-3p	-4.57	6.25e-06	-0.26	-0.21	Presence of antiphospholipid antibodies;	chr1:66677372	chr1:66628485~66628505:+
THCA	cis	rs453301	0.624	rs4841083	MIMAT0019728	hsa-miR-4660	4.56	6.58e-06	0.26	0.21	Joint mobility (Beighton score);	chr8:9012918	chr8:9048453~9048475:+
THCA	cis	rs6120849	0.573	rs3746429	MIMAT0004772	hsa-miR-499a-3p	4.55	6.69e-06	0.33	0.21	Protein C levels;	chr20:35115804	chr20:34990445~34990466:+
THCA	cis	rs79387448	0.564	rs77375846	MIMAT0019927	hsa-miR-4772-3p	-4.55	6.8e-06	-0.31	-0.21	Gut microbiota (bacterial taxa);	chr2:102538616	chr2:102432336~102432357:+
THCA	cis	rs7477	0.616	rs56326304	MIMAT0005942	hsa-miR-1288-3p	4.55	6.82e-06	0.27	0.2	Amyotrophic lateral sclerosis;	chr17:16320021	chr17:16282058~16282078:+
THCA	cis	rs6681460	0.899	rs502690	MIMAT0014979	hsa-miR-3117-3p	-4.55	6.84e-06	-0.25	-0.2	Presence of antiphospholipid antibodies;	chr1:66716720	chr1:66628485~66628505:+
THCA	cis	rs17604090	1	rs10272065	MIMAT0004800	hsa-miR-550a-5p	4.55	6.87e-06	0.31	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29654620	chr7:30289815~30289837:+
THCA	cis	rs17604090	1	rs10272065	MIMAT0004800_1	hsa-miR-550a-5p	4.55	6.87e-06	0.31	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29654620	chr7:32733002~32733024:+
THCA	cis	rs2274459	0.63	rs9461906	MIMAT0018349	hsa-miR-3934-5p	4.55	6.88e-06	0.26	0.2	Obesity (extreme);	chr6:33757410	chr6:33698152~33698173:+
THCA	cis	rs453301	0.624	rs2979256	MIMAT0019728	hsa-miR-4660	4.55	6.93e-06	0.26	0.2	Joint mobility (Beighton score);	chr8:9014200	chr8:9048453~9048475:+
THCA	cis	rs2274459	0.722	rs67854583	MIMAT0022975	hsa-miR-3934-3p	4.54	7.19e-06	0.27	0.2	Obesity (extreme);	chr6:33681871	chr6:33698191~33698212:+
THCA	cis	rs6681460	1	rs1562217	MIMAT0014979	hsa-miR-3117-3p	4.54	7.28e-06	0.25	0.2	Presence of antiphospholipid antibodies;	chr1:66607883	chr1:66628485~66628505:+
THCA	cis	rs6681460	1	rs4655636	MIMAT0014979	hsa-miR-3117-3p	-4.54	7.28e-06	-0.25	-0.2	Presence of antiphospholipid antibodies;	chr1:66602854	chr1:66628485~66628505:+
THCA	cis	rs6681460	1	rs7524818	MIMAT0014979	hsa-miR-3117-3p	-4.54	7.28e-06	-0.25	-0.2	Presence of antiphospholipid antibodies;	chr1:66606348	chr1:66628485~66628505:+
THCA	cis	rs75358501	0.551	rs13394079	MIMAT0014995	hsa-miR-3130-5p	-4.54	7.29e-06	-0.26	-0.2	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206729470	chr2:206783276~206783296:-
THCA	cis	rs75358501	0.551	rs13394079	MIMAT0014995_1	hsa-miR-3130-5p	-4.54	7.29e-06	-0.26	-0.2	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206729470	chr2:206783246~206783266:+
THCA	cis	rs79387448	0.592	rs76362690	MIMAT0019927	hsa-miR-4772-3p	-4.53	7.42e-06	-0.31	-0.2	Gut microbiota (bacterial taxa);	chr2:102335017	chr2:102432336~102432357:+
THCA	cis	rs79387448	0.655	rs11891827	MIMAT0019927	hsa-miR-4772-3p	-4.53	7.55e-06	-0.31	-0.2	Gut microbiota (bacterial taxa);	chr2:102334722	chr2:102432336~102432357:+
THCA	cis	rs74233809	0.71	rs4147157	MIMAT0022727	hsa-miR-1307-5p	-4.53	7.63e-06	-0.26	-0.2	Birth weight;	chr10:102776603	chr10:103394341~103394361:-
THCA	cis	rs6681460	1	rs10889634	MIMAT0014979	hsa-miR-3117-3p	4.52	7.69e-06	0.25	0.2	Presence of antiphospholipid antibodies;	chr1:66600228	chr1:66628485~66628505:+
THCA	cis	rs17604090	0.646	rs10258473	MIMAT0004800	hsa-miR-550a-5p	4.52	7.84e-06	0.29	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29650823	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.646	rs10258473	MIMAT0004800_1	hsa-miR-550a-5p	4.52	7.84e-06	0.29	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29650823	chr7:32733002~32733024:+
THCA	cis	rs6681460	1	rs6588207	MIMAT0014979	hsa-miR-3117-3p	-4.52	7.9e-06	-0.25	-0.2	Presence of antiphospholipid antibodies;	chr1:66600872	chr1:66628485~66628505:+
THCA	cis	rs6681460	1	rs7532173	MIMAT0014979	hsa-miR-3117-3p	-4.51	8.27e-06	-0.25	-0.2	Presence of antiphospholipid antibodies;	chr1:66620428	chr1:66628485~66628505:+
THCA	cis	rs79387448	0.638	rs116055209	MIMAT0019927	hsa-miR-4772-3p	-4.51	8.34e-06	-0.29	-0.2	Gut microbiota (bacterial taxa);	chr2:102415729	chr2:102432336~102432357:+
THCA	cis	rs999943	0.774	rs12212284	MIMAT0022975	hsa-miR-3934-3p	-4.5	8.44e-06	-0.28	-0.2	Obesity (extreme);	chr6:33673097	chr6:33698191~33698212:+
THCA	cis	rs950880	0.71	rs1474309	MIMAT0019927	hsa-miR-4772-3p	-4.5	8.49e-06	-0.37	-0.2	Serum protein levels (sST2);	chr2:102474542	chr2:102432336~102432357:+
THCA	cis	rs6120849	0.901	rs6058193	MIMAT0004772	hsa-miR-499a-3p	-4.5	8.59e-06	-0.29	-0.2	Protein C levels;	chr20:35146661	chr20:34990445~34990466:+
THCA	cis	rs6681460	1	rs964574	MIMAT0014979	hsa-miR-3117-3p	-4.5	8.64e-06	-0.25	-0.2	Presence of antiphospholipid antibodies;	chr1:66597202	chr1:66628485~66628505:+
THCA	cis	rs2274459	0.722	rs2296328	MIMAT0018349	hsa-miR-3934-5p	4.5	8.73e-06	0.27	0.2	Obesity (extreme);	chr6:33683500	chr6:33698152~33698173:+
THCA	cis	rs6681460	0.932	rs2044399	MIMAT0014979	hsa-miR-3117-3p	-4.49	8.81e-06	-0.26	-0.2	Presence of antiphospholipid antibodies;	chr1:66588397	chr1:66628485~66628505:+
THCA	cis	rs6681460	0.932	rs2044400	MIMAT0014979	hsa-miR-3117-3p	-4.49	8.81e-06	-0.26	-0.2	Presence of antiphospholipid antibodies;	chr1:66588398	chr1:66628485~66628505:+
THCA	cis	rs79387448	0.638	rs11465698	MIMAT0019927	hsa-miR-4772-3p	-4.49	8.87e-06	-0.29	-0.2	Gut microbiota (bacterial taxa);	chr2:102438117	chr2:102432336~102432357:+
THCA	cis	rs6681460	0.932	rs602513	MIMAT0014979	hsa-miR-3117-3p	-4.49	8.88e-06	-0.25	-0.2	Presence of antiphospholipid antibodies;	chr1:66711587	chr1:66628485~66628505:+
THCA	cis	rs1163656	0.819	rs1185534	MIMAT0003287	hsa-miR-618	4.49	8.94e-06	0.26	0.2	Dental caries;	chr12:80944374	chr12:80935796~80935818:-
THCA	cis	rs6681460	0.966	rs10749763	MIMAT0014979	hsa-miR-3117-3p	-4.49	9.04e-06	-0.26	-0.2	Presence of antiphospholipid antibodies;	chr1:66596443	chr1:66628485~66628505:+
THCA	cis	rs6681460	0.932	rs523188	MIMAT0014979	hsa-miR-3117-3p	-4.49	9.14e-06	-0.25	-0.2	Presence of antiphospholipid antibodies;	chr1:66708739	chr1:66628485~66628505:+
THCA	cis	rs6555855	0.514	rs4868478	MIMAT0003250	hsa-miR-585-3p	4.48	9.17e-06	0.24	0.2	Menarche (age at onset);	chr5:169291036	chr5:169263616~169263634:-
THCA	cis	rs2274459	0.722	rs9461896	MIMAT0018349	hsa-miR-3934-5p	4.48	9.3e-06	0.27	0.2	Obesity (extreme);	chr6:33681920	chr6:33698152~33698173:+
THCA	cis	rs7477	0.616	rs11651955	MIMAT0005942	hsa-miR-1288-3p	4.48	9.32e-06	0.26	0.2	Amyotrophic lateral sclerosis;	chr17:16332148	chr17:16282058~16282078:+
THCA	cis	rs17604090	0.648	rs823384	MIMAT0004800	hsa-miR-550a-5p	4.48	9.39e-06	0.26	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29617999	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.648	rs823384	MIMAT0004800_1	hsa-miR-550a-5p	4.48	9.39e-06	0.26	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29617999	chr7:32733002~32733024:+
THCA	cis	rs10947428	0.522	rs2967	MIMAT0022975	hsa-miR-3934-3p	4.48	9.57e-06	0.24	0.2	Allergic disease (asthma, hay fever or eczema);	chr6:33721757	chr6:33698191~33698212:+
THCA	cis	rs6681460	1	rs10789210	MIMAT0014979	hsa-miR-3117-3p	-4.48	9.57e-06	-0.25	-0.2	Presence of antiphospholipid antibodies;	chr1:66600347	chr1:66628485~66628505:+
THCA	cis	rs9527	0.518	rs7899608	MIMAT0005951	hsa-miR-1307-3p	4.47	9.66e-06	0.2	0.2	Arsenic metabolism;	chr10:102967547	chr10:103394301~103394322:-
THCA	cis	rs6681460	0.934	rs4655635	MIMAT0014979	hsa-miR-3117-3p	-4.47	9.82e-06	-0.25	-0.2	Presence of antiphospholipid antibodies;	chr1:66602557	chr1:66628485~66628505:+
THCA	cis	rs17604090	0.775	rs76480599	MIMAT0004800	hsa-miR-550a-5p	4.47	9.83e-06	0.28	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29649564	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.775	rs76480599	MIMAT0004800_1	hsa-miR-550a-5p	4.47	9.83e-06	0.28	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29649564	chr7:32733002~32733024:+
THCA	cis	rs2980439	0.517	rs17594065	MIMAT0019728	hsa-miR-4660	-4.47	9.97e-06	-0.27	-0.2	Neuroticism;	chr8:8247883	chr8:9048453~9048475:+
THCA	cis	rs6120849	0.901	rs6060266	MIMAT0004772	hsa-miR-499a-3p	-4.46	1.03e-05	-0.28	-0.2	Protein C levels;	chr20:35145275	chr20:34990445~34990466:+
THCA	cis	rs330071	0.5	rs17662123	MIMAT0019728	hsa-miR-4660	4.46	1.03e-05	0.26	0.2	Acne (severe);	chr8:9389327	chr8:9048453~9048475:+
THCA	cis	rs977145	0.721	rs6682125	MIMAT0000456	hsa-miR-186-5p	4.46	1.03e-05	0.13	0.2	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71361839	chr1:71067681~71067702:-
THCA	cis	rs17604090	0.938	rs850027	MIMAT0004800	hsa-miR-550a-5p	4.45	1.05e-05	0.27	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29636176	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.938	rs850027	MIMAT0004800_1	hsa-miR-550a-5p	4.45	1.05e-05	0.27	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29636176	chr7:32733002~32733024:+
THCA	cis	rs6841433	0.516	rs11098259	MIMAT0003242	hsa-miR-577	-4.45	1.05e-05	-0.28	-0.2	Hemoglobin concentration;	chr4:114598669	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs6849357	MIMAT0003242	hsa-miR-577	-4.45	1.07e-05	-0.28	-0.2	Hemoglobin concentration;	chr4:114598115	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs13112553	MIMAT0003242	hsa-miR-577	-4.45	1.07e-05	-0.28	-0.2	Hemoglobin concentration;	chr4:114598194	chr4:114656774~114656794:+
THCA	cis	rs10256972	0.605	rs10251094	MIMAT0004702	hsa-miR-339-3p	-4.44	1.1e-05	-0.3	-0.2	Endometriosis;Longevity;	chr7:977447	chr7:1022955~1022977:-
THCA	cis	rs953492	0.83	rs2451669	MIMAT0019761	hsa-miR-4677-3p	-4.44	1.14e-05	-0.21	-0.2	Diastolic blood pressure;	chr1:243329822	chr1:243346225~243346246:+
THCA	cis	rs977145	0.951	rs12123319	MIMAT0000456	hsa-miR-186-5p	-4.44	1.14e-05	-0.13	-0.2	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71447229	chr1:71067681~71067702:-
THCA	cis	rs7477	0.647	rs3785623	MIMAT0005942	hsa-miR-1288-3p	4.44	1.14e-05	0.25	0.2	Amyotrophic lateral sclerosis;	chr17:16297846	chr17:16282058~16282078:+
THCA	cis	rs17604090	0.818	rs28390296	MIMAT0004800	hsa-miR-550a-5p	4.43	1.15e-05	0.29	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29647475	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.818	rs28390296	MIMAT0004800_1	hsa-miR-550a-5p	4.43	1.15e-05	0.29	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29647475	chr7:32733002~32733024:+
THCA	cis	rs7477	0.708	rs4792730	MIMAT0005942	hsa-miR-1288-3p	4.43	1.17e-05	0.25	0.2	Amyotrophic lateral sclerosis;	chr17:16285262	chr17:16282058~16282078:+
THCA	cis	rs6681460	0.899	rs499263	MIMAT0014979	hsa-miR-3117-3p	-4.43	1.17e-05	-0.25	-0.2	Presence of antiphospholipid antibodies;	chr1:66714254	chr1:66628485~66628505:+
THCA	cis	rs6841433	0.56	rs11098260	MIMAT0003242	hsa-miR-577	-4.43	1.17e-05	-0.28	-0.2	Hemoglobin concentration;	chr4:114598670	chr4:114656774~114656794:+
THCA	cis	rs7477	0.616	rs35762856	MIMAT0005942	hsa-miR-1288-3p	4.43	1.18e-05	0.26	0.2	Amyotrophic lateral sclerosis;	chr17:16334921	chr17:16282058~16282078:+
THCA	cis	rs9394169	0.875	rs1547669	MIMAT0018349	hsa-miR-3934-5p	-4.43	1.18e-05	-0.23	-0.2	Essential tremor;	chr6:33807864	chr6:33698152~33698173:+
THCA	cis	rs9394169	0.875	rs1547670	MIMAT0018349	hsa-miR-3934-5p	-4.43	1.18e-05	-0.23	-0.2	Essential tremor;	chr6:33808091	chr6:33698152~33698173:+
THCA	cis	rs7477	0.587	rs7225920	MIMAT0005942	hsa-miR-1288-3p	4.43	1.19e-05	0.25	0.2	Amyotrophic lateral sclerosis;	chr17:16275432	chr17:16282058~16282078:+
THCA	cis	rs7477	0.528	rs12948244	MIMAT0005942	hsa-miR-1288-3p	4.42	1.21e-05	0.24	0.2	Amyotrophic lateral sclerosis;	chr17:16274786	chr17:16282058~16282078:+
THCA	cis	rs79387448	0.655	rs79144324	MIMAT0019927	hsa-miR-4772-3p	-4.42	1.21e-05	-0.3	-0.2	Gut microbiota (bacterial taxa);	chr2:102316354	chr2:102432336~102432357:+
THCA	cis	rs6681460	0.934	rs10889635	MIMAT0014979	hsa-miR-3117-3p	-4.42	1.22e-05	-0.25	-0.2	Presence of antiphospholipid antibodies;	chr1:66609892	chr1:66628485~66628505:+
THCA	cis	rs6681460	0.932	rs2483705	MIMAT0014979	hsa-miR-3117-3p	4.42	1.22e-05	0.25	0.2	Presence of antiphospholipid antibodies;	chr1:66725497	chr1:66628485~66628505:+
THCA	cis	rs2274459	0.63	rs9461906	MIMAT0022975	hsa-miR-3934-3p	4.42	1.23e-05	0.24	0.2	Obesity (extreme);	chr6:33757410	chr6:33698191~33698212:+
THCA	cis	rs17604090	0.938	rs68158127	MIMAT0004800	hsa-miR-550a-5p	4.42	1.24e-05	0.28	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29645082	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.938	rs68158127	MIMAT0004800_1	hsa-miR-550a-5p	4.42	1.24e-05	0.28	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29645082	chr7:32733002~32733024:+
THCA	cis	rs17604090	0.756	rs4000290	MIMAT0004800	hsa-miR-550a-5p	-4.42	1.24e-05	-0.28	-0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29667871	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.756	rs4000290	MIMAT0004800_1	hsa-miR-550a-5p	-4.42	1.24e-05	-0.28	-0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29667871	chr7:32733002~32733024:+
THCA	cis	rs6120849	0.901	rs6060270	MIMAT0004772	hsa-miR-499a-3p	-4.41	1.25e-05	-0.28	-0.2	Protein C levels;	chr20:35149011	chr20:34990445~34990466:+
THCA	cis	rs1163656	0.819	rs1795515	MIMAT0003287	hsa-miR-618	4.41	1.26e-05	0.25	0.2	Dental caries;	chr12:80941888	chr12:80935796~80935818:-
THCA	cis	rs6681460	1	rs1445575	MIMAT0014979	hsa-miR-3117-3p	-4.41	1.26e-05	-0.25	-0.2	Presence of antiphospholipid antibodies;	chr1:66586481	chr1:66628485~66628505:+
THCA	cis	rs6681460	0.934	rs4655628	MIMAT0014979	hsa-miR-3117-3p	-4.41	1.26e-05	-0.25	-0.2	Presence of antiphospholipid antibodies;	chr1:66586926	chr1:66628485~66628505:+
THCA	cis	rs9394169	0.818	rs1547671	MIMAT0018349	hsa-miR-3934-5p	-4.41	1.27e-05	-0.23	-0.2	Essential tremor;	chr6:33809483	chr6:33698152~33698173:+
THCA	cis	rs7477	0.677	rs28516015	MIMAT0005942	hsa-miR-1288-3p	-4.41	1.28e-05	-0.24	-0.2	Amyotrophic lateral sclerosis;	chr17:16306241	chr17:16282058~16282078:+
THCA	cis	rs999943	0.846	rs2274200	MIMAT0022975	hsa-miR-3934-3p	-4.41	1.28e-05	-0.25	-0.2	Obesity (extreme);	chr6:33657919	chr6:33698191~33698212:+
THCA	cis	rs2274459	0.841	rs34778247	MIMAT0022975	hsa-miR-3934-3p	4.41	1.28e-05	0.29	0.2	Obesity (extreme);	chr6:33690775	chr6:33698191~33698212:+
THCA	cis	rs977145	0.721	rs12026468	MIMAT0000456	hsa-miR-186-5p	-4.41	1.28e-05	-0.13	-0.2	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71362349	chr1:71067681~71067702:-
THCA	cis	rs6681460	0.932	rs523132	MIMAT0014979	hsa-miR-3117-3p	4.41	1.29e-05	0.24	0.2	Presence of antiphospholipid antibodies;	chr1:66708757	chr1:66628485~66628505:+
THCA	cis	rs7477	0.647	rs4791665	MIMAT0005942	hsa-miR-1288-3p	4.41	1.29e-05	0.24	0.2	Amyotrophic lateral sclerosis;	chr17:16292742	chr17:16282058~16282078:+
THCA	cis	rs1163656	0.819	rs1716537	MIMAT0003287	hsa-miR-618	4.41	1.3e-05	0.25	0.2	Dental caries;	chr12:80940959	chr12:80935796~80935818:-
THCA	cis	rs7477	0.647	rs3112513	MIMAT0005942	hsa-miR-1288-3p	-4.41	1.31e-05	-0.24	-0.2	Amyotrophic lateral sclerosis;	chr17:16305498	chr17:16282058~16282078:+
THCA	cis	rs4919694	1	rs79254677	MIMAT0005951	hsa-miR-1307-3p	4.41	1.31e-05	0.24	0.2	Arsenic metabolism;	chr10:102931810	chr10:103394301~103394322:-
THCA	cis	rs977145	0.721	rs1517753	MIMAT0000456	hsa-miR-186-5p	4.4	1.32e-05	0.13	0.2	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71372815	chr1:71067681~71067702:-
THCA	cis	rs9394169	0.514	rs1886355	MIMAT0018349	hsa-miR-3934-5p	-4.4	1.32e-05	-0.22	-0.2	Essential tremor;	chr6:33809100	chr6:33698152~33698173:+
THCA	cis	rs9394169	0.818	rs1547671	MIMAT0022975	hsa-miR-3934-3p	-4.4	1.32e-05	-0.22	-0.2	Essential tremor;	chr6:33809483	chr6:33698191~33698212:+
THCA	cis	rs4800353	0.714	rs4800103	MIMAT0000427	hsa-miR-133a-3p	-4.4	1.35e-05	-0.25	-0.2	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22019781	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.714	rs4800103	MIMAT0000427_1	hsa-miR-133a-3p	-4.4	1.35e-05	-0.25	-0.2	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22019781	chr20:62564970~62564991:+
THCA	cis	rs2274459	0.722	rs67854583	MIMAT0018349	hsa-miR-3934-5p	4.4	1.35e-05	0.27	0.2	Obesity (extreme);	chr6:33681871	chr6:33698152~33698173:+
THCA	cis	rs9527	0.518	rs10883802	MIMAT0005951	hsa-miR-1307-3p	-4.4	1.35e-05	-0.19	-0.2	Arsenic metabolism;	chr10:102920605	chr10:103394301~103394322:-
THCA	cis	rs17604090	0.793	rs10241305	MIMAT0004800	hsa-miR-550a-5p	4.4	1.36e-05	0.27	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29650313	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.793	rs10241305	MIMAT0004800_1	hsa-miR-550a-5p	4.4	1.36e-05	0.27	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29650313	chr7:32733002~32733024:+
THCA	cis	rs12145833	0.538	rs12042959	MIMAT0019761	hsa-miR-4677-3p	4.39	1.39e-05	0.31	0.2	Obesity (early onset extreme);	chr1:243369971	chr1:243346225~243346246:+
THCA	cis	rs6755560	1	rs35311487	MIMAT0014995	hsa-miR-3130-5p	4.39	1.4e-05	0.21	0.2	QT interval (drug interaction);	chr2:206848647	chr2:206783276~206783296:-
THCA	cis	rs6755560	1	rs35311487	MIMAT0014995_1	hsa-miR-3130-5p	4.39	1.4e-05	0.21	0.2	QT interval (drug interaction);	chr2:206848647	chr2:206783246~206783266:+
THCA	cis	rs17604090	0.761	rs115923387	MIMAT0004800	hsa-miR-550a-5p	4.39	1.42e-05	0.3	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29681086	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.761	rs115923387	MIMAT0004800_1	hsa-miR-550a-5p	4.39	1.42e-05	0.3	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29681086	chr7:32733002~32733024:+
THCA	cis	rs17604090	0.877	rs68169519	MIMAT0004800	hsa-miR-550a-5p	4.39	1.42e-05	0.28	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29645542	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.877	rs68169519	MIMAT0004800_1	hsa-miR-550a-5p	4.39	1.42e-05	0.28	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29645542	chr7:32733002~32733024:+
THCA	cis	rs6120849	0.901	rs6058194	MIMAT0004772	hsa-miR-499a-3p	-4.38	1.47e-05	-0.28	-0.2	Protein C levels;	chr20:35152028	chr20:34990445~34990466:+
THCA	cis	rs6555855	0.514	rs2338526	MIMAT0003250	hsa-miR-585-3p	4.38	1.49e-05	0.23	0.2	Menarche (age at onset);	chr5:169298244	chr5:169263616~169263634:-
THCA	cis	rs6681460	0.932	rs492109	MIMAT0014979	hsa-miR-3117-3p	4.37	1.5e-05	0.24	0.2	Presence of antiphospholipid antibodies;	chr1:66721450	chr1:66628485~66628505:+
THCA	cis	rs7477	0.586	rs12945877	MIMAT0005942	hsa-miR-1288-3p	4.37	1.51e-05	0.26	0.2	Amyotrophic lateral sclerosis;	chr17:16334889	chr17:16282058~16282078:+
THCA	cis	rs17604090	0.878	rs4000281	MIMAT0004800	hsa-miR-550a-5p	4.37	1.52e-05	0.3	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29686671	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.878	rs4000281	MIMAT0004800_1	hsa-miR-550a-5p	4.37	1.52e-05	0.3	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29686671	chr7:32733002~32733024:+
THCA	cis	rs55833108	1	rs55833108	MIMAT0022727	hsa-miR-1307-5p	4.37	1.52e-05	0.24	0.2	Schizophrenia;	chr10:102981826	chr10:103394341~103394361:-
THCA	cis	rs17604090	0.938	rs10241566	MIMAT0004800	hsa-miR-550a-5p	4.37	1.53e-05	0.28	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29650563	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.938	rs10241566	MIMAT0004800_1	hsa-miR-550a-5p	4.37	1.53e-05	0.28	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29650563	chr7:32733002~32733024:+
THCA	cis	rs7477	0.619	rs12938397	MIMAT0005942	hsa-miR-1288-3p	-4.37	1.54e-05	-0.25	-0.2	Amyotrophic lateral sclerosis;	chr17:16282786	chr17:16282058~16282078:+
THCA	cis	rs7477	0.647	rs3112511	MIMAT0005942	hsa-miR-1288-3p	-4.37	1.54e-05	-0.24	-0.2	Amyotrophic lateral sclerosis;	chr17:16304212	chr17:16282058~16282078:+
THCA	cis	rs7829975	0.777	rs560544	MIMAT0019728	hsa-miR-4660	-4.37	1.56e-05	-0.25	-0.2	Mood instability;	chr8:8779919	chr8:9048453~9048475:+
THCA	cis	rs6681460	0.932	rs524114	MIMAT0014979	hsa-miR-3117-3p	4.36	1.57e-05	0.24	0.2	Presence of antiphospholipid antibodies;	chr1:66722652	chr1:66628485~66628505:+
THCA	cis	rs6681460	0.932	rs536410	MIMAT0014979	hsa-miR-3117-3p	-4.36	1.58e-05	-0.24	-0.2	Presence of antiphospholipid antibodies;	chr1:66725401	chr1:66628485~66628505:+
THCA	cis	rs59372292	0.618	rs1055554	MIMAT0021017	hsa-miR-4999-5p	4.36	1.58e-05	0.31	0.2	Coronary artery disease;	chr19:8438737	chr19:8389340~8389360:-
THCA	cis	rs6681460	0.933	rs7554101	MIMAT0014979	hsa-miR-3117-3p	4.36	1.58e-05	0.24	0.2	Presence of antiphospholipid antibodies;	chr1:66690789	chr1:66628485~66628505:+
THCA	cis	rs17604090	0.701	rs60930239	MIMAT0004800	hsa-miR-550a-5p	4.36	1.6e-05	0.27	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29648928	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.701	rs60930239	MIMAT0004800_1	hsa-miR-550a-5p	4.36	1.6e-05	0.27	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29648928	chr7:32733002~32733024:+
THCA	cis	rs17604090	0.793	rs66956566	MIMAT0004800	hsa-miR-550a-5p	4.36	1.6e-05	0.27	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29649086	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.793	rs66956566	MIMAT0004800_1	hsa-miR-550a-5p	4.36	1.6e-05	0.27	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29649086	chr7:32733002~32733024:+
THCA	cis	rs17604090	0.793	rs73687726	MIMAT0004800	hsa-miR-550a-5p	4.36	1.6e-05	0.27	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29649157	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.793	rs73687726	MIMAT0004800_1	hsa-miR-550a-5p	4.36	1.6e-05	0.27	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29649157	chr7:32733002~32733024:+
THCA	cis	rs17604090	0.793	rs17150665	MIMAT0004800	hsa-miR-550a-5p	4.36	1.6e-05	0.27	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29649244	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.793	rs17150665	MIMAT0004800_1	hsa-miR-550a-5p	4.36	1.6e-05	0.27	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29649244	chr7:32733002~32733024:+
THCA	cis	rs17604090	0.793	rs17136535	MIMAT0004800	hsa-miR-550a-5p	4.36	1.6e-05	0.27	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29649542	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.793	rs17136535	MIMAT0004800_1	hsa-miR-550a-5p	4.36	1.6e-05	0.27	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29649542	chr7:32733002~32733024:+
THCA	cis	rs17604090	0.793	rs17150667	MIMAT0004800	hsa-miR-550a-5p	4.36	1.6e-05	0.27	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29649722	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.793	rs17150667	MIMAT0004800_1	hsa-miR-550a-5p	4.36	1.6e-05	0.27	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29649722	chr7:32733002~32733024:+
THCA	cis	rs17604090	0.775	rs10225523	MIMAT0004800	hsa-miR-550a-5p	4.36	1.6e-05	0.27	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29650119	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.775	rs10225523	MIMAT0004800_1	hsa-miR-550a-5p	4.36	1.6e-05	0.27	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29650119	chr7:32733002~32733024:+
THCA	cis	rs2980439	0.517	rs712253	MIMAT0019728	hsa-miR-4660	-4.36	1.61e-05	-0.26	-0.2	Neuroticism;	chr8:8246260	chr8:9048453~9048475:+
THCA	cis	rs6681460	0.932	rs618093	MIMAT0014979	hsa-miR-3117-3p	-4.36	1.62e-05	-0.24	-0.2	Presence of antiphospholipid antibodies;	chr1:66712745	chr1:66628485~66628505:+
THCA	cis	rs17604090	0.526	rs10260080	MIMAT0004800	hsa-miR-550a-5p	4.36	1.63e-05	0.34	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29718325	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.526	rs10260080	MIMAT0004800_1	hsa-miR-550a-5p	4.36	1.63e-05	0.34	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29718325	chr7:32733002~32733024:+
THCA	cis	rs7829975	0.593	rs2979241	MIMAT0019728	hsa-miR-4660	4.35	1.65e-05	0.25	0.2	Mood instability;	chr8:8445843	chr8:9048453~9048475:+
THCA	cis	rs12145833	0.79	rs74666281	MIMAT0019761	hsa-miR-4677-3p	4.35	1.67e-05	0.3	0.2	Obesity (early onset extreme);	chr1:243352678	chr1:243346225~243346246:+
THCA	cis	rs977145	0.951	rs1983122	MIMAT0000456	hsa-miR-186-5p	-4.35	1.69e-05	-0.13	-0.2	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71445309	chr1:71067681~71067702:-
THCA	cis	rs9394169	1	rs9394169	MIMAT0022975	hsa-miR-3934-3p	-4.35	1.7e-05	-0.22	-0.2	Essential tremor;	chr6:33811187	chr6:33698191~33698212:+
THCA	cis	rs977145	0.953	rs10889918	MIMAT0000456	hsa-miR-186-5p	-4.34	1.71e-05	-0.12	-0.2	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71466036	chr1:71067681~71067702:-
THCA	cis	rs977145	1	rs2421926	MIMAT0000456	hsa-miR-186-5p	-4.34	1.71e-05	-0.12	-0.2	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71471417	chr1:71067681~71067702:-
THCA	cis	rs12145833	1	rs10926986	MIMAT0019761	hsa-miR-4677-3p	-4.34	1.72e-05	-0.3	-0.2	Obesity (early onset extreme);	chr1:243304309	chr1:243346225~243346246:+
THCA	cis	rs79387448	0.614	rs6719130	MIMAT0019927	hsa-miR-4772-3p	-4.34	1.74e-05	-0.28	-0.2	Gut microbiota (bacterial taxa);	chr2:102341776	chr2:102432336~102432357:+
THCA	cis	rs950880	0.56	rs1362349	MIMAT0019927	hsa-miR-4772-3p	4.34	1.75e-05	0.17	0.2	Serum protein levels (sST2);	chr2:102335512	chr2:102432336~102432357:+
THCA	cis	rs79387448	0.614	rs985523	MIMAT0019927	hsa-miR-4772-3p	-4.34	1.77e-05	-0.28	-0.2	Gut microbiota (bacterial taxa);	chr2:102337916	chr2:102432336~102432357:+
THCA	cis	rs977145	0.951	rs4649938	MIMAT0000456	hsa-miR-186-5p	-4.34	1.77e-05	-0.12	-0.2	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71440768	chr1:71067681~71067702:-
THCA	cis	rs6681460	0.899	rs1280280	MIMAT0014979	hsa-miR-3117-3p	-4.34	1.78e-05	-0.24	-0.2	Presence of antiphospholipid antibodies;	chr1:66708220	chr1:66628485~66628505:+
THCA	cis	rs6981523	0.553	rs2409730	MIMAT0003266	hsa-miR-598-3p	4.33	1.79e-05	0.18	0.2	Neuroticism;	chr8:11203129	chr8:11035221~11035242:-
THCA	cis	rs7477	0.647	rs7219687	MIMAT0005942	hsa-miR-1288-3p	-4.33	1.79e-05	-0.24	-0.2	Amyotrophic lateral sclerosis;	chr17:16274073	chr17:16282058~16282078:+
THCA	cis	rs2229637	1	rs2229637	MIMAT0018349	hsa-miR-3934-5p	-4.33	1.79e-05	-0.25	-0.2	Venous thromboembolism adjusted for sickle cell variant rs77121243-T;	chr6:33675781	chr6:33698152~33698173:+
THCA	cis	rs59372292	0.667	rs34445564	MIMAT0021017	hsa-miR-4999-5p	4.33	1.8e-05	0.29	0.2	Coronary artery disease;	chr19:8468214	chr19:8389340~8389360:-
THCA	cis	rs59372292	0.667	rs17159302	MIMAT0021017	hsa-miR-4999-5p	4.33	1.8e-05	0.29	0.2	Coronary artery disease;	chr19:8469632	chr19:8389340~8389360:-
THCA	cis	rs59372292	0.667	rs17159303	MIMAT0021017	hsa-miR-4999-5p	4.33	1.8e-05	0.29	0.2	Coronary artery disease;	chr19:8469677	chr19:8389340~8389360:-
THCA	cis	rs59372292	0.572	rs35279560	MIMAT0021017	hsa-miR-4999-5p	4.33	1.8e-05	0.29	0.2	Coronary artery disease;	chr19:8472212	chr19:8389340~8389360:-
THCA	cis	rs17604090	1	rs73297441	MIMAT0004800	hsa-miR-550a-5p	4.33	1.81e-05	0.28	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29644747	chr7:30289815~30289837:+
THCA	cis	rs17604090	1	rs73297441	MIMAT0004800_1	hsa-miR-550a-5p	4.33	1.81e-05	0.28	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29644747	chr7:32733002~32733024:+
THCA	cis	rs17604090	0.877	rs28516764	MIMAT0004800	hsa-miR-550a-5p	4.33	1.81e-05	0.28	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29645629	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.877	rs28516764	MIMAT0004800_1	hsa-miR-550a-5p	4.33	1.81e-05	0.28	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29645629	chr7:32733002~32733024:+
THCA	cis	rs17604090	0.938	rs28664977	MIMAT0004800	hsa-miR-550a-5p	4.33	1.81e-05	0.28	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29645753	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.938	rs28664977	MIMAT0004800_1	hsa-miR-550a-5p	4.33	1.81e-05	0.28	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29645753	chr7:32733002~32733024:+
THCA	cis	rs17604090	0.536	rs112165062	MIMAT0004800	hsa-miR-550a-5p	4.33	1.81e-05	0.28	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29647976	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.536	rs112165062	MIMAT0004800_1	hsa-miR-550a-5p	4.33	1.81e-05	0.28	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29647976	chr7:32733002~32733024:+
THCA	cis	rs59372292	0.667	rs34244685	MIMAT0021017	hsa-miR-4999-5p	4.33	1.81e-05	0.29	0.2	Coronary artery disease;	chr19:8458122	chr19:8389340~8389360:-
THCA	cis	rs59372292	0.667	rs3764570	MIMAT0021017	hsa-miR-4999-5p	4.33	1.81e-05	0.29	0.2	Coronary artery disease;	chr19:8463393	chr19:8389340~8389360:-
THCA	cis	rs59372292	0.667	rs3794997	MIMAT0021017	hsa-miR-4999-5p	4.33	1.81e-05	0.29	0.2	Coronary artery disease;	chr19:8465003	chr19:8389340~8389360:-
THCA	cis	rs17604090	0.938	rs68072609	MIMAT0004800	hsa-miR-550a-5p	4.33	1.82e-05	0.28	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29642851	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.938	rs68072609	MIMAT0004800_1	hsa-miR-550a-5p	4.33	1.82e-05	0.28	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29642851	chr7:32733002~32733024:+
THCA	cis	rs7897654	0.61	rs12570528	MIMAT0005951	hsa-miR-1307-3p	4.33	1.83e-05	0.16	0.2	Schizophrenia;	chr10:103070453	chr10:103394301~103394322:-
THCA	cis	rs59372292	0.667	rs17160520	MIMAT0021017	hsa-miR-4999-5p	-4.33	1.83e-05	-0.29	-0.2	Coronary artery disease;	chr19:8483705	chr19:8389340~8389360:-
THCA	cis	rs3227	0.509	rs942642	MIMAT0022975	hsa-miR-3934-3p	-4.33	1.83e-05	-0.23	-0.2	Educational attainment;	chr6:33687120	chr6:33698191~33698212:+
THCA	cis	rs6755560	1	rs4283403	MIMAT0014995	hsa-miR-3130-5p	4.33	1.85e-05	0.21	0.2	QT interval (drug interaction);	chr2:206829091	chr2:206783276~206783296:-
THCA	cis	rs6755560	1	rs4283403	MIMAT0014995_1	hsa-miR-3130-5p	4.33	1.85e-05	0.21	0.2	QT interval (drug interaction);	chr2:206829091	chr2:206783246~206783266:+
THCA	cis	rs2980439	0.517	rs793753	MIMAT0019728	hsa-miR-4660	-4.33	1.86e-05	-0.26	-0.2	Neuroticism;	chr8:8247837	chr8:9048453~9048475:+
THCA	cis	rs17604090	1	rs28420551	MIMAT0004800	hsa-miR-550a-5p	4.32	1.87e-05	0.28	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29645737	chr7:30289815~30289837:+
THCA	cis	rs17604090	1	rs28420551	MIMAT0004800_1	hsa-miR-550a-5p	4.32	1.87e-05	0.28	0.2	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29645737	chr7:32733002~32733024:+
THCA	cis	rs6555855	0.514	rs888783	MIMAT0003250	hsa-miR-585-3p	4.32	1.87e-05	0.23	0.2	Menarche (age at onset);	chr5:169295655	chr5:169263616~169263634:-
THCA	cis	rs977145	1	rs2222177	MIMAT0000456	hsa-miR-186-5p	-4.32	1.9e-05	-0.13	-0.2	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71464948	chr1:71067681~71067702:-
THCA	cis	rs977145	0.953	rs6668512	MIMAT0000456	hsa-miR-186-5p	-4.32	1.9e-05	-0.13	-0.2	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71470641	chr1:71067681~71067702:-
THCA	cis	rs6681460	0.837	rs6669023	MIMAT0014979	hsa-miR-3117-3p	-4.32	1.9e-05	-0.24	-0.2	Presence of antiphospholipid antibodies;	chr1:66706185	chr1:66628485~66628505:+
THCA	cis	rs7897654	0.61	rs7916476	MIMAT0005951	hsa-miR-1307-3p	4.32	1.91e-05	0.17	0.2	Schizophrenia;	chr10:103055511	chr10:103394301~103394322:-
THCA	cis	rs7477	0.647	rs3095171	MIMAT0005942	hsa-miR-1288-3p	-4.32	1.91e-05	-0.24	-0.2	Amyotrophic lateral sclerosis;	chr17:16304152	chr17:16282058~16282078:+
THCA	cis	rs6681460	0.934	rs4655631	MIMAT0014979	hsa-miR-3117-3p	-4.32	1.91e-05	-0.24	-0.19	Presence of antiphospholipid antibodies;	chr1:66589224	chr1:66628485~66628505:+
THCA	cis	rs6981523	0.5	rs4412337	MIMAT0003266	hsa-miR-598-3p	-4.31	1.96e-05	-0.18	-0.19	Neuroticism;	chr8:11214511	chr8:11035221~11035242:-
THCA	cis	rs7897654	0.548	rs7917547	MIMAT0005951	hsa-miR-1307-3p	4.31	1.96e-05	0.16	0.19	Schizophrenia;	chr10:103052295	chr10:103394301~103394322:-
THCA	cis	rs79387448	0.638	rs74731686	MIMAT0019927	hsa-miR-4772-3p	-4.31	1.97e-05	-0.27	-0.19	Gut microbiota (bacterial taxa);	chr2:102427521	chr2:102432336~102432357:+
THCA	cis	rs977145	1	rs977145	MIMAT0000456	hsa-miR-186-5p	-4.31	1.99e-05	-0.13	-0.19	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71463606	chr1:71067681~71067702:-
THCA	cis	rs9394169	1	rs9394169	MIMAT0018349	hsa-miR-3934-5p	-4.31	2e-05	-0.22	-0.19	Essential tremor;	chr6:33811187	chr6:33698152~33698173:+
THCA	cis	rs17604090	0.877	rs57253003	MIMAT0004800	hsa-miR-550a-5p	4.31	2.02e-05	0.28	0.19	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29646940	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.877	rs57253003	MIMAT0004800_1	hsa-miR-550a-5p	4.31	2.02e-05	0.28	0.19	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29646940	chr7:32733002~32733024:+
THCA	cis	rs4800353	0.673	rs8094271	MIMAT0000427	hsa-miR-133a-3p	4.31	2.02e-05	0.26	0.19	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22020499	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.673	rs8094271	MIMAT0000427_1	hsa-miR-133a-3p	4.31	2.02e-05	0.26	0.19	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22020499	chr20:62564970~62564991:+
THCA	cis	rs12145833	1	rs76473275	MIMAT0019761	hsa-miR-4677-3p	4.3	2.07e-05	0.3	0.19	Obesity (early onset extreme);	chr1:243297253	chr1:243346225~243346246:+
THCA	cis	rs7477	0.647	rs3785621	MIMAT0005942	hsa-miR-1288-3p	4.3	2.1e-05	0.24	0.19	Amyotrophic lateral sclerosis;	chr17:16315532	chr17:16282058~16282078:+
THCA	cis	rs12145833	0.92	rs12354170	MIMAT0019761	hsa-miR-4677-3p	4.3	2.11e-05	0.3	0.19	Obesity (early onset extreme);	chr1:243294474	chr1:243346225~243346246:+
THCA	cis	rs17604090	0.938	rs115369413	MIMAT0004800	hsa-miR-550a-5p	4.29	2.17e-05	0.28	0.19	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29645424	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.938	rs115369413	MIMAT0004800_1	hsa-miR-550a-5p	4.29	2.17e-05	0.28	0.19	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29645424	chr7:32733002~32733024:+
THCA	cis	rs6681460	0.966	rs10749765	MIMAT0014979	hsa-miR-3117-3p	-4.29	2.18e-05	-0.25	-0.19	Presence of antiphospholipid antibodies;	chr1:66684597	chr1:66628485~66628505:+
THCA	cis	rs17604090	0.938	rs850029	MIMAT0004800	hsa-miR-550a-5p	4.29	2.19e-05	0.28	0.19	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29638471	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.938	rs850029	MIMAT0004800_1	hsa-miR-550a-5p	4.29	2.19e-05	0.28	0.19	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29638471	chr7:32733002~32733024:+
THCA	cis	rs2274459	0.841	rs12205398	MIMAT0022975	hsa-miR-3934-3p	4.29	2.2e-05	0.28	0.19	Obesity (extreme);	chr6:33733766	chr6:33698191~33698212:+
THCA	cis	rs17604090	1	rs17603986	MIMAT0004800	hsa-miR-550a-5p	4.29	2.2e-05	0.29	0.19	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29650873	chr7:30289815~30289837:+
THCA	cis	rs17604090	1	rs17603986	MIMAT0004800_1	hsa-miR-550a-5p	4.29	2.2e-05	0.29	0.19	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29650873	chr7:32733002~32733024:+
THCA	cis	rs6120849	0.951	rs55670307	MIMAT0004772	hsa-miR-499a-3p	-4.29	2.21e-05	-0.27	-0.19	Protein C levels;	chr20:35132691	chr20:34990445~34990466:+
THCA	cis	rs59372292	0.597	rs11259985	MIMAT0021017	hsa-miR-4999-5p	4.29	2.21e-05	0.29	0.19	Coronary artery disease;	chr19:8451793	chr19:8389340~8389360:-
THCA	cis	rs6681460	0.932	rs665319	MIMAT0014979	hsa-miR-3117-3p	-4.28	2.22e-05	-0.24	-0.19	Presence of antiphospholipid antibodies;	chr1:66709805	chr1:66628485~66628505:+
THCA	cis	rs977145	1	rs7552024	MIMAT0000456	hsa-miR-186-5p	-4.28	2.24e-05	-0.12	-0.19	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71463173	chr1:71067681~71067702:-
THCA	cis	rs977145	1	rs6703162	MIMAT0000456	hsa-miR-186-5p	-4.28	2.24e-05	-0.12	-0.19	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71464285	chr1:71067681~71067702:-
THCA	cis	rs977145	1	rs12135145	MIMAT0000456	hsa-miR-186-5p	-4.28	2.24e-05	-0.12	-0.19	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71468546	chr1:71067681~71067702:-
THCA	cis	rs977145	0.953	rs908686	MIMAT0000456	hsa-miR-186-5p	-4.28	2.24e-05	-0.12	-0.19	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71471875	chr1:71067681~71067702:-
THCA	cis	rs12145833	1	rs61833916	MIMAT0019761	hsa-miR-4677-3p	4.28	2.25e-05	0.3	0.19	Obesity (early onset extreme);	chr1:243306644	chr1:243346225~243346246:+
THCA	cis	rs953492	0.863	rs2802722	MIMAT0019761	hsa-miR-4677-3p	-4.28	2.25e-05	-0.21	-0.19	Diastolic blood pressure;	chr1:243335231	chr1:243346225~243346246:+
THCA	cis	rs977145	0.721	rs6697634	MIMAT0000456	hsa-miR-186-5p	4.28	2.27e-05	0.13	0.19	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71386486	chr1:71067681~71067702:-
THCA	cis	rs7894407	0.522	rs116821290	MIMAT0022727	hsa-miR-1307-5p	4.28	2.31e-05	0.21	0.19	White matter hyperintensity burden;	chr10:103183633	chr10:103394341~103394361:-
THCA	cis	rs17604090	0.646	rs75322793	MIMAT0004800	hsa-miR-550a-5p	4.27	2.33e-05	0.29	0.19	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29643560	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.646	rs75322793	MIMAT0004800_1	hsa-miR-550a-5p	4.27	2.33e-05	0.29	0.19	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29643560	chr7:32733002~32733024:+
THCA	cis	rs10947428	0.522	rs6457740	MIMAT0022975	hsa-miR-3934-3p	-4.27	2.37e-05	-0.23	-0.19	Allergic disease (asthma, hay fever or eczema);	chr6:33729348	chr6:33698191~33698212:+
THCA	cis	rs6981523	0.553	rs11989369	MIMAT0003266	hsa-miR-598-3p	-4.27	2.37e-05	-0.18	-0.19	Neuroticism;	chr8:11197876	chr8:11035221~11035242:-
THCA	cis	rs12145833	1	rs10926984	MIMAT0019761	hsa-miR-4677-3p	4.27	2.41e-05	0.3	0.19	Obesity (early onset extreme);	chr1:243298851	chr1:243346225~243346246:+
THCA	cis	rs999943	0.846	rs1570760	MIMAT0022975	hsa-miR-3934-3p	-4.26	2.42e-05	-0.24	-0.19	Obesity (extreme);	chr6:33655156	chr6:33698191~33698212:+
THCA	cis	rs977145	0.855	rs11209780	MIMAT0000456	hsa-miR-186-5p	-4.26	2.42e-05	-0.13	-0.19	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71410969	chr1:71067681~71067702:-
THCA	cis	rs2967605	1	rs2967605	MIMAT0021017	hsa-miR-4999-5p	-4.26	2.43e-05	-0.32	-0.19	HDL cholesterol;	chr19:8404854	chr19:8389340~8389360:-
THCA	cis	rs4713675	0.649	rs568901	MIMAT0022975	hsa-miR-3934-3p	4.26	2.48e-05	0.23	0.19	Plateletcrit;	chr6:33742261	chr6:33698191~33698212:+
THCA	cis	rs999943	0.774	rs12205634	MIMAT0018349	hsa-miR-3934-5p	-4.26	2.49e-05	-0.26	-0.19	Obesity (extreme);	chr6:33643890	chr6:33698152~33698173:+
THCA	cis	rs59372292	0.597	rs34337793	MIMAT0021017	hsa-miR-4999-5p	4.25	2.53e-05	0.29	0.19	Coronary artery disease;	chr19:8454339	chr19:8389340~8389360:-
THCA	cis	rs7897654	0.61	rs10883822	MIMAT0005951	hsa-miR-1307-3p	4.25	2.54e-05	0.16	0.19	Schizophrenia;	chr10:103036895	chr10:103394301~103394322:-
THCA	cis	rs10256972	0.678	rs6962989	MIMAT0004702	hsa-miR-339-3p	-4.25	2.56e-05	-0.28	-0.19	Endometriosis;Longevity;	chr7:977876	chr7:1022955~1022977:-
THCA	cis	rs999943	0.846	rs1570760	MIMAT0018349	hsa-miR-3934-5p	-4.25	2.57e-05	-0.25	-0.19	Obesity (extreme);	chr6:33655156	chr6:33698152~33698173:+
THCA	cis	rs6555855	0.514	rs6882648	MIMAT0003250	hsa-miR-585-3p	4.25	2.6e-05	0.23	0.19	Menarche (age at onset);	chr5:169290358	chr5:169263616~169263634:-
THCA	cis	rs2274459	0.556	rs35250767	MIMAT0018349	hsa-miR-3934-5p	4.25	2.6e-05	0.25	0.19	Obesity (extreme);	chr6:33718063	chr6:33698152~33698173:+
THCA	cis	rs10216189	0.785	rs4352753	MIMAT0004799	hsa-miR-589-5p	-4.25	2.63e-05	-0.19	-0.19	Relative hand skill in reading disability;	chr7:5487592	chr7:5495873~5495894:-
THCA	cis	rs10216189	0.785	rs4623325	MIMAT0004799	hsa-miR-589-5p	4.25	2.63e-05	0.19	0.19	Relative hand skill in reading disability;	chr7:5487176	chr7:5495873~5495894:-
THCA	cis	rs6120849	0.901	rs11696967	MIMAT0004772	hsa-miR-499a-3p	-4.24	2.64e-05	-0.27	-0.19	Protein C levels;	chr20:35155806	chr20:34990445~34990466:+
THCA	cis	rs977145	0.721	rs11209773	MIMAT0000456	hsa-miR-186-5p	4.24	2.67e-05	0.13	0.19	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71358257	chr1:71067681~71067702:-
THCA	cis	rs6681460	0.932	rs659291	MIMAT0014979	hsa-miR-3117-3p	-4.23	2.76e-05	-0.23	-0.19	Presence of antiphospholipid antibodies;	chr1:66715063	chr1:66628485~66628505:+
THCA	cis	rs17604090	1	rs114892953	MIMAT0004800	hsa-miR-550a-5p	4.23	2.78e-05	0.29	0.19	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29636682	chr7:30289815~30289837:+
THCA	cis	rs17604090	1	rs114892953	MIMAT0004800_1	hsa-miR-550a-5p	4.23	2.78e-05	0.29	0.19	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29636682	chr7:32733002~32733024:+
THCA	cis	rs17604090	0.941	rs114036198	MIMAT0004800	hsa-miR-550a-5p	4.23	2.78e-05	0.29	0.19	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29636684	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.941	rs114036198	MIMAT0004800_1	hsa-miR-550a-5p	4.23	2.78e-05	0.29	0.19	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29636684	chr7:32733002~32733024:+
THCA	cis	rs2274459	0.556	rs35250767	MIMAT0022975	hsa-miR-3934-3p	4.23	2.8e-05	0.24	0.19	Obesity (extreme);	chr6:33718063	chr6:33698191~33698212:+
THCA	cis	rs79387448	0.81	rs76229479	MIMAT0019927	hsa-miR-4772-3p	-4.23	2.83e-05	-0.27	-0.19	Gut microbiota (bacterial taxa);	chr2:102507453	chr2:102432336~102432357:+
THCA	cis	rs6755560	0.963	rs1862090	MIMAT0014995	hsa-miR-3130-5p	4.23	2.85e-05	0.21	0.19	QT interval (drug interaction);	chr2:206828016	chr2:206783276~206783296:-
THCA	cis	rs6755560	0.963	rs1862090	MIMAT0014995_1	hsa-miR-3130-5p	4.23	2.85e-05	0.21	0.19	QT interval (drug interaction);	chr2:206828016	chr2:206783246~206783266:+
THCA	cis	rs977145	1	rs10889916	MIMAT0000456	hsa-miR-186-5p	-4.23	2.85e-05	-0.12	-0.19	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71457421	chr1:71067681~71067702:-
THCA	cis	rs6555855	0.521	rs10866633	MIMAT0026618	hsa-miR-585-5p	4.23	2.87e-05	0.26	0.19	Menarche (age at onset);	chr5:169285741	chr5:169263649~169263670:-
THCA	cis	rs6681460	0.932	rs523956	MIMAT0014979	hsa-miR-3117-3p	4.22	2.88e-05	0.23	0.19	Presence of antiphospholipid antibodies;	chr1:66722593	chr1:66628485~66628505:+
THCA	cis	rs17109512	1	rs7915455	MIMAT0026738	hsa-miR-1287-3p	4.22	2.88e-05	0.27	0.19	Aspartate aminotransferase levels;	chr10:98364062	chr10:98395232~98395253:-
THCA	cis	rs2594714	0.515	rs10411270	MIMAT0000084	hsa-miR-27a-3p	-4.22	2.89e-05	-0.1	-0.19	Breast cancer;	chr19:13830024	chr19:13836447~13836467:-
THCA	cis	rs953492	0.932	rs2490391	MIMAT0019761	hsa-miR-4677-3p	-4.22	2.91e-05	-0.21	-0.19	Diastolic blood pressure;	chr1:243306367	chr1:243346225~243346246:+
THCA	cis	rs4713675	0.553	rs943465	MIMAT0022975	hsa-miR-3934-3p	-4.22	2.95e-05	-0.25	-0.19	Plateletcrit;	chr6:33763886	chr6:33698191~33698212:+
THCA	cis	rs999943	0.846	rs999942	MIMAT0022975	hsa-miR-3934-3p	-4.22	2.97e-05	-0.24	-0.19	Obesity (extreme);	chr6:33657125	chr6:33698191~33698212:+
THCA	cis	rs6681460	0.932	rs2146904	MIMAT0014979	hsa-miR-3117-3p	4.22	2.98e-05	0.24	0.19	Presence of antiphospholipid antibodies;	chr1:66694653	chr1:66628485~66628505:+
THCA	cis	rs453301	0.624	rs2915251	MIMAT0019728	hsa-miR-4660	4.22	2.99e-05	0.24	0.19	Joint mobility (Beighton score);	chr8:9009901	chr8:9048453~9048475:+
THCA	cis	rs59372292	0.597	rs17160495	MIMAT0021017	hsa-miR-4999-5p	-4.21	3.05e-05	-0.28	-0.19	Coronary artery disease;	chr19:8451394	chr19:8389340~8389360:-
THCA	cis	rs953492	0.731	rs10803133	MIMAT0019761	hsa-miR-4677-3p	4.21	3.08e-05	0.21	0.19	Diastolic blood pressure;	chr1:243290712	chr1:243346225~243346246:+
THCA	cis	rs79387448	0.745	rs78136548	MIMAT0019927	hsa-miR-4772-3p	-4.21	3.12e-05	-0.29	-0.19	Gut microbiota (bacterial taxa);	chr2:102487281	chr2:102432336~102432357:+
THCA	cis	rs953492	0.932	rs2636323	MIMAT0019761	hsa-miR-4677-3p	-4.21	3.12e-05	-0.21	-0.19	Diastolic blood pressure;	chr1:243318254	chr1:243346225~243346246:+
THCA	cis	rs330071	0.622	rs898797	MIMAT0019728	hsa-miR-4660	4.2	3.18e-05	0.26	0.19	Acne (severe);	chr8:9372179	chr8:9048453~9048475:+
THCA	cis	rs6120849	0.662	rs6060300	MIMAT0004772	hsa-miR-499a-3p	-4.2	3.2e-05	-0.27	-0.19	Protein C levels;	chr20:35193167	chr20:34990445~34990466:+
THCA	cis	rs7477	0.647	rs2014604	MIMAT0005942	hsa-miR-1288-3p	-4.2	3.2e-05	-0.23	-0.19	Amyotrophic lateral sclerosis;	chr17:16273569	chr17:16282058~16282078:+
THCA	cis	rs330071	0.515	rs12545193	MIMAT0019728	hsa-miR-4660	4.2	3.23e-05	0.24	0.19	Acne (severe);	chr8:9394370	chr8:9048453~9048475:+
THCA	cis	rs977145	0.721	rs6703087	MIMAT0000456	hsa-miR-186-5p	4.2	3.25e-05	0.13	0.19	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71385838	chr1:71067681~71067702:-
THCA	cis	rs17604090	1	rs28591682	MIMAT0004800	hsa-miR-550a-5p	4.2	3.26e-05	0.28	0.19	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29651195	chr7:30289815~30289837:+
THCA	cis	rs17604090	1	rs28591682	MIMAT0004800_1	hsa-miR-550a-5p	4.2	3.26e-05	0.28	0.19	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29651195	chr7:32733002~32733024:+
THCA	cis	rs953492	0.932	rs2932634	MIMAT0019761	hsa-miR-4677-3p	-4.19	3.27e-05	-0.21	-0.19	Diastolic blood pressure;	chr1:243307151	chr1:243346225~243346246:+
THCA	cis	rs4800353	0.714	rs9958479	MIMAT0000427	hsa-miR-133a-3p	-4.18	3.41e-05	-0.24	-0.19	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22000325	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.714	rs9958479	MIMAT0000427_1	hsa-miR-133a-3p	-4.18	3.41e-05	-0.24	-0.19	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22000325	chr20:62564970~62564991:+
THCA	cis	rs12145833	0.619	rs10927006	MIMAT0019761	hsa-miR-4677-3p	4.18	3.41e-05	0.3	0.19	Obesity (early onset extreme);	chr1:243394357	chr1:243346225~243346246:+
THCA	cis	rs12145833	0.679	rs12029086	MIMAT0019761	hsa-miR-4677-3p	4.18	3.41e-05	0.3	0.19	Obesity (early onset extreme);	chr1:243401420	chr1:243346225~243346246:+
THCA	cis	rs950880	0.542	rs12712135	MIMAT0019927	hsa-miR-4772-3p	4.18	3.43e-05	0.17	0.19	Serum protein levels (sST2);	chr2:102314488	chr2:102432336~102432357:+
THCA	cis	rs7897654	0.61	rs12780440	MIMAT0005951	hsa-miR-1307-3p	4.18	3.49e-05	0.16	0.19	Schizophrenia;	chr10:103032491	chr10:103394301~103394322:-
THCA	cis	rs7897654	0.61	rs7091889	MIMAT0005951	hsa-miR-1307-3p	4.18	3.49e-05	0.16	0.19	Schizophrenia;	chr10:103033966	chr10:103394301~103394322:-
THCA	cis	rs999943	0.846	rs999942	MIMAT0018349	hsa-miR-3934-5p	-4.18	3.49e-05	-0.25	-0.19	Obesity (extreme);	chr6:33657125	chr6:33698152~33698173:+
THCA	cis	rs4800353	0.6	rs8084283	MIMAT0000427	hsa-miR-133a-3p	-4.18	3.49e-05	-0.25	-0.19	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:21988185	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.6	rs8084283	MIMAT0000427_1	hsa-miR-133a-3p	-4.18	3.49e-05	-0.25	-0.19	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:21988185	chr20:62564970~62564991:+
THCA	cis	rs953492	0.831	rs2802723	MIMAT0019761	hsa-miR-4677-3p	-4.18	3.52e-05	-0.2	-0.19	Diastolic blood pressure;	chr1:243335010	chr1:243346225~243346246:+
THCA	cis	rs4919694	0.572	rs7080935	MIMAT0005951	hsa-miR-1307-3p	4.18	3.52e-05	0.19	0.19	Arsenic metabolism;	chr10:103169356	chr10:103394301~103394322:-
THCA	cis	rs4919694	0.572	rs12261294	MIMAT0005951	hsa-miR-1307-3p	4.18	3.52e-05	0.19	0.19	Arsenic metabolism;	chr10:103175195	chr10:103394301~103394322:-
THCA	cis	rs4919694	0.572	rs12240508	MIMAT0005951	hsa-miR-1307-3p	4.18	3.52e-05	0.19	0.19	Arsenic metabolism;	chr10:103179475	chr10:103394301~103394322:-
THCA	cis	rs6695223	1	rs4907132	MIMAT0019232	hsa-miR-4423-5p	-4.18	3.52e-05	-0.32	-0.19	Venous thromboembolism (SNP x SNP interaction);	chr1:85071839	chr1:85133806~85133827:+
THCA	cis	rs79387448	0.655	rs75579337	MIMAT0019927	hsa-miR-4772-3p	-4.18	3.53e-05	-0.3	-0.19	Gut microbiota (bacterial taxa);	chr2:102300842	chr2:102432336~102432357:+
THCA	cis	rs12145833	0.679	rs12048498	MIMAT0019761	hsa-miR-4677-3p	4.17	3.55e-05	0.3	0.19	Obesity (early onset extreme);	chr1:243387345	chr1:243346225~243346246:+
THCA	cis	rs4919694	0.572	rs12262258	MIMAT0005951	hsa-miR-1307-3p	4.17	3.56e-05	0.19	0.19	Arsenic metabolism;	chr10:103140515	chr10:103394301~103394322:-
THCA	cis	rs4919694	0.572	rs12243903	MIMAT0005951	hsa-miR-1307-3p	4.17	3.56e-05	0.19	0.19	Arsenic metabolism;	chr10:103147235	chr10:103394301~103394322:-
THCA	cis	rs999943	0.846	rs2274200	MIMAT0018349	hsa-miR-3934-5p	-4.17	3.56e-05	-0.25	-0.19	Obesity (extreme);	chr6:33657919	chr6:33698152~33698173:+
THCA	cis	rs999943	0.81	rs62407648	MIMAT0018349	hsa-miR-3934-5p	-4.17	3.61e-05	-0.26	-0.19	Obesity (extreme);	chr6:33654659	chr6:33698152~33698173:+
THCA	cis	rs17604090	1	rs17661938	MIMAT0004800	hsa-miR-550a-5p	4.17	3.62e-05	0.28	0.19	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29653762	chr7:30289815~30289837:+
THCA	cis	rs17604090	1	rs17661938	MIMAT0004800_1	hsa-miR-550a-5p	4.17	3.62e-05	0.28	0.19	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29653762	chr7:32733002~32733024:+
THCA	cis	rs977145	0.721	rs12411099	MIMAT0000456	hsa-miR-186-5p	-4.17	3.63e-05	-0.11	-0.19	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71359153	chr1:71067681~71067702:-
THCA	cis	rs79387448	0.655	rs79091585	MIMAT0019927	hsa-miR-4772-3p	-4.17	3.64e-05	-0.3	-0.19	Gut microbiota (bacterial taxa);	chr2:102300783	chr2:102432336~102432357:+
THCA	cis	rs4711336	0.583	rs10672	MIMAT0018349	hsa-miR-3934-5p	-4.17	3.65e-05	-0.22	-0.19	Height;	chr6:33694488	chr6:33698152~33698173:+
THCA	cis	rs7897654	0.61	rs34060850	MIMAT0005951	hsa-miR-1307-3p	4.17	3.67e-05	0.16	0.19	Schizophrenia;	chr10:103004308	chr10:103394301~103394322:-
THCA	cis	rs79387448	0.638	rs11465670	MIMAT0019927	hsa-miR-4772-3p	-4.17	3.68e-05	-0.26	-0.19	Gut microbiota (bacterial taxa);	chr2:102417980	chr2:102432336~102432357:+
THCA	cis	rs17604090	0.55	rs111649163	MIMAT0004800	hsa-miR-550a-5p	4.17	3.68e-05	0.27	0.19	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29649560	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.55	rs111649163	MIMAT0004800_1	hsa-miR-550a-5p	4.17	3.68e-05	0.27	0.19	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29649560	chr7:32733002~32733024:+
THCA	cis	rs950880	0.542	rs10179654	MIMAT0019927	hsa-miR-4772-3p	4.16	3.72e-05	0.17	0.19	Serum protein levels (sST2);	chr2:102305323	chr2:102432336~102432357:+
THCA	cis	rs950880	0.542	rs7568913	MIMAT0019927	hsa-miR-4772-3p	4.16	3.74e-05	0.17	0.19	Serum protein levels (sST2);	chr2:102303577	chr2:102432336~102432357:+
THCA	cis	rs7897654	0.651	rs11191457	MIMAT0005951	hsa-miR-1307-3p	4.16	3.74e-05	0.16	0.19	Schizophrenia;	chr10:102901951	chr10:103394301~103394322:-
THCA	cis	rs953492	0.932	rs2783972	MIMAT0019761	hsa-miR-4677-3p	-4.16	3.76e-05	-0.21	-0.19	Diastolic blood pressure;	chr1:243318129	chr1:243346225~243346246:+
THCA	cis	rs4919694	0.572	rs12255989	MIMAT0005951	hsa-miR-1307-3p	4.16	3.78e-05	0.19	0.19	Arsenic metabolism;	chr10:103107449	chr10:103394301~103394322:-
THCA	cis	rs4919694	0.572	rs72846714	MIMAT0005951	hsa-miR-1307-3p	4.16	3.78e-05	0.19	0.19	Arsenic metabolism;	chr10:103118697	chr10:103394301~103394322:-
THCA	cis	rs950880	0.56	rs12712141	MIMAT0019927	hsa-miR-4772-3p	4.16	3.85e-05	0.17	0.19	Serum protein levels (sST2);	chr2:102336607	chr2:102432336~102432357:+
THCA	cis	rs2274459	0.841	rs13214874	MIMAT0022975	hsa-miR-3934-3p	4.16	3.86e-05	0.27	0.19	Obesity (extreme);	chr6:33718591	chr6:33698191~33698212:+
THCA	cis	rs4919694	1	rs4917988	MIMAT0005951	hsa-miR-1307-3p	4.16	3.86e-05	0.23	0.19	Arsenic metabolism;	chr10:102993073	chr10:103394301~103394322:-
THCA	cis	rs4919694	1	rs4917379	MIMAT0005951	hsa-miR-1307-3p	4.16	3.86e-05	0.23	0.19	Arsenic metabolism;	chr10:102993074	chr10:103394301~103394322:-
THCA	cis	rs4919694	1	rs12254254	MIMAT0005951	hsa-miR-1307-3p	4.16	3.86e-05	0.23	0.19	Arsenic metabolism;	chr10:103005848	chr10:103394301~103394322:-
THCA	cis	rs4919694	1	rs12258551	MIMAT0005951	hsa-miR-1307-3p	4.16	3.86e-05	0.23	0.19	Arsenic metabolism;	chr10:103008135	chr10:103394301~103394322:-
THCA	cis	rs4919694	1	rs7100592	MIMAT0005951	hsa-miR-1307-3p	4.16	3.86e-05	0.23	0.19	Arsenic metabolism;	chr10:103009341	chr10:103394301~103394322:-
THCA	cis	rs4919694	1	rs7083328	MIMAT0005951	hsa-miR-1307-3p	4.16	3.86e-05	0.23	0.19	Arsenic metabolism;	chr10:103009511	chr10:103394301~103394322:-
THCA	cis	rs4919694	1	rs12245343	MIMAT0005951	hsa-miR-1307-3p	4.16	3.86e-05	0.23	0.19	Arsenic metabolism;	chr10:103014293	chr10:103394301~103394322:-
THCA	cis	rs4919694	0.901	rs10509763	MIMAT0005951	hsa-miR-1307-3p	4.16	3.86e-05	0.23	0.19	Arsenic metabolism;	chr10:103016634	chr10:103394301~103394322:-
THCA	cis	rs4800353	0.673	rs899642	MIMAT0000427	hsa-miR-133a-3p	-4.16	3.86e-05	-0.24	-0.19	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22005712	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.673	rs899642	MIMAT0000427_1	hsa-miR-133a-3p	-4.16	3.86e-05	-0.24	-0.19	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22005712	chr20:62564970~62564991:+
THCA	cis	rs7829975	0.742	rs7832968	MIMAT0019728	hsa-miR-4660	4.15	3.88e-05	0.24	0.19	Mood instability;	chr8:8795379	chr8:9048453~9048475:+
THCA	cis	rs977145	0.721	rs11209775	MIMAT0000456	hsa-miR-186-5p	4.15	3.91e-05	0.13	0.19	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71385685	chr1:71067681~71067702:-
THCA	cis	rs59372292	0.597	rs2081197	MIMAT0021017	hsa-miR-4999-5p	4.15	3.91e-05	0.28	0.19	Coronary artery disease;	chr19:8448452	chr19:8389340~8389360:-
THCA	cis	rs59372292	0.597	rs11666117	MIMAT0021017	hsa-miR-4999-5p	4.15	3.91e-05	0.28	0.19	Coronary artery disease;	chr19:8449010	chr19:8389340~8389360:-
THCA	cis	rs59372292	0.619	rs11259983	MIMAT0021017	hsa-miR-4999-5p	4.15	3.91e-05	0.28	0.19	Coronary artery disease;	chr19:8450491	chr19:8389340~8389360:-
THCA	cis	rs6695223	1	rs4243775	MIMAT0019232	hsa-miR-4423-5p	-4.15	3.91e-05	-0.32	-0.19	Venous thromboembolism (SNP x SNP interaction);	chr1:85071598	chr1:85133806~85133827:+
THCA	cis	rs4800353	0.714	rs9947423	MIMAT0000427	hsa-miR-133a-3p	-4.15	4.01e-05	-0.24	-0.19	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22002012	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.714	rs9947423	MIMAT0000427_1	hsa-miR-133a-3p	-4.15	4.01e-05	-0.24	-0.19	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22002012	chr20:62564970~62564991:+
THCA	cis	rs7819412	0.502	rs11777918	MIMAT0003266	hsa-miR-598-3p	-4.14	4.04e-05	-0.17	-0.19	Triglycerides;	chr8:11179410	chr8:11035221~11035242:-
THCA	cis	rs2274459	0.841	rs12203688	MIMAT0022975	hsa-miR-3934-3p	-4.14	4.06e-05	-0.27	-0.19	Obesity (extreme);	chr6:33725847	chr6:33698191~33698212:+
THCA	cis	rs4919694	1	rs12268849	MIMAT0005951	hsa-miR-1307-3p	4.14	4.06e-05	0.22	0.19	Arsenic metabolism;	chr10:102977925	chr10:103394301~103394322:-
THCA	cis	rs4919694	1	rs12241091	MIMAT0005951	hsa-miR-1307-3p	4.14	4.07e-05	0.23	0.19	Arsenic metabolism;	chr10:103049240	chr10:103394301~103394322:-
THCA	cis	rs953492	0.591	rs10803123	MIMAT0019761	hsa-miR-4677-3p	-4.14	4.1e-05	-0.2	-0.19	Diastolic blood pressure;	chr1:243214590	chr1:243346225~243346246:+
THCA	cis	rs977145	0.721	rs10889914	MIMAT0000456	hsa-miR-186-5p	4.14	4.11e-05	0.12	0.19	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71371041	chr1:71067681~71067702:-
THCA	cis	rs17604090	0.938	rs28457783	MIMAT0004800	hsa-miR-550a-5p	4.14	4.12e-05	0.28	0.19	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29647442	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.938	rs28457783	MIMAT0004800_1	hsa-miR-550a-5p	4.14	4.12e-05	0.28	0.19	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29647442	chr7:32733002~32733024:+
THCA	cis	rs17604090	0.818	rs73090342	MIMAT0004800	hsa-miR-550a-5p	4.14	4.12e-05	0.28	0.19	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29647924	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.818	rs73090342	MIMAT0004800_1	hsa-miR-550a-5p	4.14	4.12e-05	0.28	0.19	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29647924	chr7:32733002~32733024:+
THCA	cis	rs6841433	0.615	rs12511581	MIMAT0003242	hsa-miR-577	-4.14	4.18e-05	-0.26	-0.19	Hemoglobin concentration;	chr4:114598400	chr4:114656774~114656794:+
THCA	cis	rs950880	0.542	rs6543118	MIMAT0019927	hsa-miR-4772-3p	4.13	4.2e-05	0.16	0.19	Serum protein levels (sST2);	chr2:102313009	chr2:102432336~102432357:+
THCA	cis	rs977145	0.951	rs7516999	MIMAT0000456	hsa-miR-186-5p	-4.13	4.28e-05	-0.12	-0.19	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71436587	chr1:71067681~71067702:-
THCA	cis	rs2274459	0.841	rs3818526	MIMAT0022975	hsa-miR-3934-3p	4.13	4.33e-05	0.26	0.19	Obesity (extreme);	chr6:33693196	chr6:33698191~33698212:+
THCA	cis	rs7897654	0.651	rs12780134	MIMAT0005951	hsa-miR-1307-3p	4.12	4.39e-05	0.15	0.19	Schizophrenia;	chr10:102886686	chr10:103394301~103394322:-
THCA	cis	rs7897654	0.61	rs11191512	MIMAT0005951	hsa-miR-1307-3p	4.12	4.44e-05	0.16	0.19	Schizophrenia;	chr10:103012942	chr10:103394301~103394322:-
THCA	cis	rs7897654	0.61	rs11191516	MIMAT0005951	hsa-miR-1307-3p	4.12	4.44e-05	0.16	0.19	Schizophrenia;	chr10:103018115	chr10:103394301~103394322:-
THCA	cis	rs4919694	0.611	rs7091462	MIMAT0005951	hsa-miR-1307-3p	4.12	4.44e-05	0.19	0.19	Arsenic metabolism;	chr10:103188858	chr10:103394301~103394322:-
THCA	cis	rs6555855	0.521	rs888777	MIMAT0026618	hsa-miR-585-5p	4.12	4.45e-05	0.25	0.19	Menarche (age at onset);	chr5:169285452	chr5:169263649~169263670:-
THCA	cis	rs6555855	0.521	rs6555854	MIMAT0026618	hsa-miR-585-5p	4.12	4.45e-05	0.25	0.19	Menarche (age at onset);	chr5:169285510	chr5:169263649~169263670:-
THCA	cis	rs7829975	0.564	rs2921060	MIMAT0019728	hsa-miR-4660	-4.12	4.53e-05	-0.24	-0.19	Mood instability;	chr8:8460307	chr8:9048453~9048475:+
THCA	cis	rs4800353	0.516	rs12456978	MIMAT0000427	hsa-miR-133a-3p	-4.12	4.53e-05	-0.27	-0.19	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:21955653	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.516	rs12456978	MIMAT0000427_1	hsa-miR-133a-3p	-4.12	4.53e-05	-0.27	-0.19	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:21955653	chr20:62564970~62564991:+
THCA	cis	rs6555855	0.521	rs751346	MIMAT0026618	hsa-miR-585-5p	4.12	4.54e-05	0.25	0.19	Menarche (age at onset);	chr5:169283363	chr5:169263649~169263670:-
THCA	cis	rs950880	0.56	rs59247511	MIMAT0019927	hsa-miR-4772-3p	4.12	4.54e-05	0.16	0.19	Serum protein levels (sST2);	chr2:102337730	chr2:102432336~102432357:+
THCA	cis	rs953492	0.765	rs2171975	MIMAT0019761	hsa-miR-4677-3p	4.12	4.57e-05	0.2	0.19	Diastolic blood pressure;	chr1:243283692	chr1:243346225~243346246:+
THCA	cis	rs79387448	0.655	rs76930359	MIMAT0019927	hsa-miR-4772-3p	-4.11	4.59e-05	-0.29	-0.19	Gut microbiota (bacterial taxa);	chr2:102308224	chr2:102432336~102432357:+
THCA	cis	rs977145	1	rs1517760	MIMAT0000456	hsa-miR-186-5p	4.11	4.61e-05	0.12	0.19	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71472011	chr1:71067681~71067702:-
THCA	cis	rs4919694	1	rs12242000	MIMAT0005951	hsa-miR-1307-3p	4.11	4.61e-05	0.23	0.19	Arsenic metabolism;	chr10:102942656	chr10:103394301~103394322:-
THCA	cis	rs4919694	1	rs11191473	MIMAT0005951	hsa-miR-1307-3p	4.11	4.61e-05	0.23	0.19	Arsenic metabolism;	chr10:102950953	chr10:103394301~103394322:-
THCA	cis	rs4919694	0.901	rs113541728	MIMAT0005951	hsa-miR-1307-3p	4.11	4.61e-05	0.23	0.19	Arsenic metabolism;	chr10:102957014	chr10:103394301~103394322:-
THCA	cis	rs977145	1	rs10889917	MIMAT0000456	hsa-miR-186-5p	-4.11	4.61e-05	-0.12	-0.19	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71457461	chr1:71067681~71067702:-
THCA	cis	rs79387448	0.638	rs78123896	MIMAT0019927	hsa-miR-4772-3p	-4.11	4.63e-05	-0.26	-0.19	Gut microbiota (bacterial taxa);	chr2:102458957	chr2:102432336~102432357:+
THCA	cis	rs7897654	0.651	rs7085854	MIMAT0005951	hsa-miR-1307-3p	4.11	4.64e-05	0.15	0.19	Schizophrenia;	chr10:102890494	chr10:103394301~103394322:-
THCA	cis	rs6755560	1	rs6755560	MIMAT0014995	hsa-miR-3130-5p	4.11	4.65e-05	0.2	0.19	QT interval (drug interaction);	chr2:206853059	chr2:206783276~206783296:-
THCA	cis	rs6755560	1	rs6755560	MIMAT0014995_1	hsa-miR-3130-5p	4.11	4.65e-05	0.2	0.19	QT interval (drug interaction);	chr2:206853059	chr2:206783246~206783266:+
THCA	cis	rs4919694	1	rs11191490	MIMAT0005951	hsa-miR-1307-3p	4.11	4.67e-05	0.23	0.19	Arsenic metabolism;	chr10:102985417	chr10:103394301~103394322:-
THCA	cis	rs2274459	0.841	rs10456075	MIMAT0022975	hsa-miR-3934-3p	4.11	4.73e-05	0.26	0.19	Obesity (extreme);	chr6:33713826	chr6:33698191~33698212:+
THCA	cis	rs6755560	0.889	rs7597011	MIMAT0014995	hsa-miR-3130-5p	4.11	4.74e-05	0.2	0.19	QT interval (drug interaction);	chr2:206855115	chr2:206783276~206783296:-
THCA	cis	rs6755560	0.889	rs7597011	MIMAT0014995_1	hsa-miR-3130-5p	4.11	4.74e-05	0.2	0.19	QT interval (drug interaction);	chr2:206855115	chr2:206783246~206783266:+
THCA	cis	rs12145833	1	rs2802727	MIMAT0019761	hsa-miR-4677-3p	-4.11	4.76e-05	-0.27	-0.19	Obesity (early onset extreme);	chr1:243320024	chr1:243346225~243346246:+
THCA	cis	rs953492	0.644	rs4634890	MIMAT0019761	hsa-miR-4677-3p	-4.1	4.78e-05	-0.2	-0.19	Diastolic blood pressure;	chr1:243227523	chr1:243346225~243346246:+
THCA	cis	rs59372292	0.597	rs17160491	MIMAT0021017	hsa-miR-4999-5p	4.1	4.81e-05	0.28	0.19	Coronary artery disease;	chr19:8448056	chr19:8389340~8389360:-
THCA	cis	rs953492	0.591	rs10803128	MIMAT0019761	hsa-miR-4677-3p	-4.1	4.89e-05	-0.2	-0.19	Diastolic blood pressure;	chr1:243230540	chr1:243346225~243346246:+
THCA	cis	rs953492	0.831	rs2783964	MIMAT0019761	hsa-miR-4677-3p	-4.1	4.89e-05	-0.2	-0.19	Diastolic blood pressure;	chr1:243337362	chr1:243346225~243346246:+
THCA	cis	rs950880	0.56	rs10178436	MIMAT0019927	hsa-miR-4772-3p	4.1	4.94e-05	0.16	0.19	Serum protein levels (sST2);	chr2:102310051	chr2:102432336~102432357:+
THCA	cis	rs953492	0.644	rs10926974	MIMAT0019761	hsa-miR-4677-3p	-4.1	4.94e-05	-0.2	-0.19	Diastolic blood pressure;	chr1:243233024	chr1:243346225~243346246:+
THCA	cis	rs7897654	0.61	rs12569364	MIMAT0005951	hsa-miR-1307-3p	4.1	4.95e-05	0.15	0.19	Schizophrenia;	chr10:102993750	chr10:103394301~103394322:-
THCA	cis	rs2274459	0.778	rs9296097	MIMAT0022975	hsa-miR-3934-3p	4.1	4.96e-05	0.26	0.19	Obesity (extreme);	chr6:33692366	chr6:33698191~33698212:+
THCA	cis	rs6537837	0.793	rs1434285	MIMAT0000227	hsa-miR-197-3p	-4.09	5.04e-05	-0.17	-0.19	Major depressive disorder;	chr1:109538187	chr1:109598940~109598961:+
THCA	cis	rs4919694	1	rs4919694	MIMAT0005951	hsa-miR-1307-3p	4.09	5.05e-05	0.21	0.19	Arsenic metabolism;	chr10:102939221	chr10:103394301~103394322:-
THCA	cis	rs953492	0.831	rs2783965	MIMAT0019761	hsa-miR-4677-3p	-4.09	5.15e-05	-0.2	-0.18	Diastolic blood pressure;	chr1:243337095	chr1:243346225~243346246:+
THCA	cis	rs4919694	1	rs10509758	MIMAT0005951	hsa-miR-1307-3p	4.08	5.2e-05	0.21	0.18	Arsenic metabolism;	chr10:102921953	chr10:103394301~103394322:-
THCA	cis	rs10851411	0.567	rs62022301	MIMAT0026623	hsa-miR-627-3p	-4.08	5.22e-05	-0.34	-0.18	Glucose homeostasis traits;	chr15:42419087	chr15:42199593~42199612:-
THCA	cis	rs4919694	1	rs112809537	MIMAT0005951	hsa-miR-1307-3p	4.08	5.22e-05	0.23	0.18	Arsenic metabolism;	chr10:102910589	chr10:103394301~103394322:-
THCA	cis	rs4919694	0.901	rs12251035	MIMAT0005951	hsa-miR-1307-3p	4.08	5.22e-05	0.23	0.18	Arsenic metabolism;	chr10:102911702	chr10:103394301~103394322:-
THCA	cis	rs6681460	1	rs6697088	MIMAT0014979	hsa-miR-3117-3p	4.08	5.23e-05	0.24	0.18	Presence of antiphospholipid antibodies;	chr1:66579041	chr1:66628485~66628505:+
THCA	cis	rs950880	0.56	rs12712140	MIMAT0019927	hsa-miR-4772-3p	4.08	5.25e-05	0.16	0.18	Serum protein levels (sST2);	chr2:102334602	chr2:102432336~102432357:+
THCA	cis	rs950880	0.58	rs1997467	MIMAT0019927	hsa-miR-4772-3p	4.08	5.25e-05	0.16	0.18	Serum protein levels (sST2);	chr2:102334613	chr2:102432336~102432357:+
THCA	cis	rs10216189	0.967	rs4724700	MIMAT0004799	hsa-miR-589-5p	-4.08	5.26e-05	-0.18	-0.18	Relative hand skill in reading disability;	chr7:5487158	chr7:5495873~5495894:-
THCA	cis	rs4919694	0.611	rs77328741	MIMAT0005951	hsa-miR-1307-3p	4.08	5.29e-05	0.19	0.18	Arsenic metabolism;	chr10:103306557	chr10:103394301~103394322:-
THCA	cis	rs4919694	0.611	rs76695159	MIMAT0005951	hsa-miR-1307-3p	4.08	5.29e-05	0.19	0.18	Arsenic metabolism;	chr10:103311080	chr10:103394301~103394322:-
THCA	cis	rs4919687	0.514	rs3850699	MIMAT0005951	hsa-miR-1307-3p	4.08	5.35e-05	0.14	0.18	Colorectal cancer;	chr10:102654464	chr10:103394301~103394322:-
THCA	cis	rs6555855	0.521	rs10061289	MIMAT0026618	hsa-miR-585-5p	4.08	5.38e-05	0.24	0.18	Menarche (age at onset);	chr5:169291336	chr5:169263649~169263670:-
THCA	cis	rs7477	0.647	rs56269147	MIMAT0005942	hsa-miR-1288-3p	-4.08	5.4e-05	-0.23	-0.18	Amyotrophic lateral sclerosis;	chr17:16271972	chr17:16282058~16282078:+
THCA	cis	rs2274459	0.841	rs10947432	MIMAT0022975	hsa-miR-3934-3p	-4.07	5.42e-05	-0.26	-0.18	Obesity (extreme);	chr6:33708779	chr6:33698191~33698212:+
THCA	cis	rs953492	0.765	rs3818802	MIMAT0019761	hsa-miR-4677-3p	-4.07	5.42e-05	-0.2	-0.18	Diastolic blood pressure;	chr1:243286579	chr1:243346225~243346246:+
THCA	cis	rs953492	0.765	rs10926982	MIMAT0019761	hsa-miR-4677-3p	-4.07	5.42e-05	-0.2	-0.18	Diastolic blood pressure;	chr1:243289562	chr1:243346225~243346246:+
THCA	cis	rs4711336	0.509	rs764753	MIMAT0018349	hsa-miR-3934-5p	-4.07	5.43e-05	-0.22	-0.18	Height;	chr6:33690332	chr6:33698152~33698173:+
THCA	cis	rs79387448	0.638	rs6741230	MIMAT0019927	hsa-miR-4772-3p	-4.07	5.5e-05	-0.26	-0.18	Gut microbiota (bacterial taxa);	chr2:102453171	chr2:102432336~102432357:+
THCA	cis	rs75358501	0.551	rs16838710	MIMAT0014995	hsa-miR-3130-5p	4.07	5.5e-05	0.22	0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206724196	chr2:206783276~206783296:-
THCA	cis	rs75358501	0.551	rs16838710	MIMAT0014995_1	hsa-miR-3130-5p	4.07	5.5e-05	0.22	0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206724196	chr2:206783246~206783266:+
THCA	cis	rs59372292	0.667	rs12975669	MIMAT0021017	hsa-miR-4999-5p	4.07	5.53e-05	0.28	0.18	Coronary artery disease;	chr19:8435935	chr19:8389340~8389360:-
THCA	cis	rs999943	0.846	rs10947420	MIMAT0018349	hsa-miR-3934-5p	-4.07	5.59e-05	-0.23	-0.18	Obesity (extreme);	chr6:33643284	chr6:33698152~33698173:+
THCA	cis	rs17639215	0.55	rs9679297	MIMAT0019927	hsa-miR-4772-3p	-4.07	5.59e-05	-0.19	-0.18	Serum protein levels (sST2);	chr2:102298109	chr2:102432336~102432357:+
THCA	cis	rs4919694	1	rs12253284	MIMAT0005951	hsa-miR-1307-3p	4.07	5.61e-05	0.21	0.18	Arsenic metabolism;	chr10:102905388	chr10:103394301~103394322:-
THCA	cis	rs4919694	1	rs12261040	MIMAT0005951	hsa-miR-1307-3p	4.07	5.61e-05	0.21	0.18	Arsenic metabolism;	chr10:102905640	chr10:103394301~103394322:-
THCA	cis	rs7897654	0.651	rs12778673	MIMAT0005951	hsa-miR-1307-3p	4.06	5.65e-05	0.15	0.18	Schizophrenia;	chr10:102965413	chr10:103394301~103394322:-
THCA	cis	rs7897654	0.61	rs10786731	MIMAT0005951	hsa-miR-1307-3p	4.06	5.65e-05	0.15	0.18	Schizophrenia;	chr10:102992024	chr10:103394301~103394322:-
THCA	cis	rs79387448	0.655	rs77763678	MIMAT0019927	hsa-miR-4772-3p	-4.06	5.69e-05	-0.29	-0.18	Gut microbiota (bacterial taxa);	chr2:102300289	chr2:102432336~102432357:+
THCA	cis	rs7914558	0.505	rs12260436	MIMAT0022727	hsa-miR-1307-5p	-4.06	5.74e-05	-0.16	-0.18	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);Schizophrenia;	chr10:102981357	chr10:103394341~103394361:-
THCA	cis	rs7897654	0.59	rs7093470	MIMAT0005951	hsa-miR-1307-3p	4.06	5.77e-05	0.15	0.18	Schizophrenia;	chr10:102911111	chr10:103394301~103394322:-
THCA	cis	rs7897654	0.651	rs7924072	MIMAT0005951	hsa-miR-1307-3p	4.06	5.77e-05	0.15	0.18	Schizophrenia;	chr10:102914601	chr10:103394301~103394322:-
THCA	cis	rs7897654	0.651	rs6584532	MIMAT0005951	hsa-miR-1307-3p	4.06	5.77e-05	0.15	0.18	Schizophrenia;	chr10:102914759	chr10:103394301~103394322:-
THCA	cis	rs950880	0.542	rs953934	MIMAT0019927	hsa-miR-4772-3p	4.06	5.8e-05	0.16	0.18	Serum protein levels (sST2);	chr2:102315833	chr2:102432336~102432357:+
THCA	cis	rs953492	0.583	rs10803125	MIMAT0019761	hsa-miR-4677-3p	-4.06	5.81e-05	-0.2	-0.18	Diastolic blood pressure;	chr1:243217074	chr1:243346225~243346246:+
THCA	cis	rs9807989	0.839	rs3771166	MIMAT0019927	hsa-miR-4772-3p	-4.06	5.82e-05	-0.18	-0.18	Asthma;	chr2:102369762	chr2:102432336~102432357:+
THCA	cis	rs7829975	0.742	rs12547493	MIMAT0019728	hsa-miR-4660	-4.05	5.88e-05	-0.24	-0.18	Mood instability;	chr8:8804024	chr8:9048453~9048475:+
THCA	cis	rs7897654	0.579	rs12766187	MIMAT0005951	hsa-miR-1307-3p	4.05	5.97e-05	0.15	0.18	Schizophrenia;	chr10:103007117	chr10:103394301~103394322:-
THCA	cis	rs7897654	0.651	rs12783467	MIMAT0005951	hsa-miR-1307-3p	4.05	5.99e-05	0.15	0.18	Schizophrenia;	chr10:102948555	chr10:103394301~103394322:-
THCA	cis	rs4919694	0.908	rs11191523	MIMAT0005951	hsa-miR-1307-3p	4.05	6.01e-05	0.22	0.18	Arsenic metabolism;	chr10:103032643	chr10:103394301~103394322:-
THCA	cis	rs4919694	1	rs11191525	MIMAT0005951	hsa-miR-1307-3p	4.05	6.01e-05	0.22	0.18	Arsenic metabolism;	chr10:103033678	chr10:103394301~103394322:-
THCA	cis	rs4919694	1	rs12252500	MIMAT0005951	hsa-miR-1307-3p	4.05	6.01e-05	0.22	0.18	Arsenic metabolism;	chr10:103035227	chr10:103394301~103394322:-
THCA	cis	rs17604090	0.775	rs73090343	MIMAT0004800	hsa-miR-550a-5p	4.05	6.02e-05	0.26	0.18	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29649152	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.775	rs73090343	MIMAT0004800_1	hsa-miR-550a-5p	4.05	6.02e-05	0.26	0.18	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29649152	chr7:32733002~32733024:+
THCA	cis	rs943466	0.537	rs2296329	MIMAT0022975	hsa-miR-3934-3p	-4.05	6.03e-05	-0.26	-0.18	Body mass index (joint analysis main effects and physical activity interaction);Body mass index;	chr6:33682966	chr6:33698191~33698212:+
THCA	cis	rs7897654	0.61	rs12764154	MIMAT0005951	hsa-miR-1307-3p	4.05	6.06e-05	0.15	0.18	Schizophrenia;	chr10:102997952	chr10:103394301~103394322:-
THCA	cis	rs7897654	0.61	rs10883819	MIMAT0005951	hsa-miR-1307-3p	4.05	6.06e-05	0.15	0.18	Schizophrenia;	chr10:103003551	chr10:103394301~103394322:-
THCA	cis	rs4919687	0.55	rs7907503	MIMAT0005951	hsa-miR-1307-3p	4.05	6.1e-05	0.14	0.18	Colorectal cancer;	chr10:102680293	chr10:103394301~103394322:-
THCA	cis	rs17604090	0.938	rs10253264	MIMAT0004800	hsa-miR-550a-5p	4.05	6.11e-05	0.28	0.18	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29652927	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.938	rs10253264	MIMAT0004800_1	hsa-miR-550a-5p	4.05	6.11e-05	0.28	0.18	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29652927	chr7:32733002~32733024:+
THCA	cis	rs17604090	1	rs17661896	MIMAT0004800	hsa-miR-550a-5p	4.05	6.11e-05	0.28	0.18	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29653092	chr7:30289815~30289837:+
THCA	cis	rs17604090	1	rs17661896	MIMAT0004800_1	hsa-miR-550a-5p	4.05	6.11e-05	0.28	0.18	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29653092	chr7:32733002~32733024:+
THCA	cis	rs4919694	0.611	rs75182663	MIMAT0005951	hsa-miR-1307-3p	4.04	6.21e-05	0.19	0.18	Arsenic metabolism;	chr10:103298347	chr10:103394301~103394322:-
THCA	cis	rs4919694	0.611	rs2271750	MIMAT0005951	hsa-miR-1307-3p	-4.04	6.25e-05	-0.18	-0.18	Arsenic metabolism;	chr10:103415112	chr10:103394301~103394322:-
THCA	cis	rs74233809	0.636	rs284861	MIMAT0022727	hsa-miR-1307-5p	4.04	6.25e-05	0.2	0.18	Birth weight;	chr10:102812519	chr10:103394341~103394361:-
THCA	cis	rs999943	0.774	rs10947421	MIMAT0022975	hsa-miR-3934-3p	-4.04	6.27e-05	-0.22	-0.18	Obesity (extreme);	chr6:33643501	chr6:33698191~33698212:+
THCA	cis	rs999943	0.846	rs10947422	MIMAT0022975	hsa-miR-3934-3p	-4.04	6.27e-05	-0.22	-0.18	Obesity (extreme);	chr6:33643574	chr6:33698191~33698212:+
THCA	cis	rs6695223	0.571	rs4907133	MIMAT0019232	hsa-miR-4423-5p	-4.04	6.27e-05	-0.25	-0.18	Venous thromboembolism (SNP x SNP interaction);	chr1:85073264	chr1:85133806~85133827:+
THCA	cis	rs4800353	0.64	rs1871511	MIMAT0000427	hsa-miR-133a-3p	-4.04	6.29e-05	-0.24	-0.18	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22009191	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.64	rs1871511	MIMAT0000427_1	hsa-miR-133a-3p	-4.04	6.29e-05	-0.24	-0.18	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22009191	chr20:62564970~62564991:+
THCA	cis	rs4919687	0.514	rs12241712	MIMAT0005951	hsa-miR-1307-3p	4.04	6.32e-05	0.14	0.18	Colorectal cancer;	chr10:102648515	chr10:103394301~103394322:-
THCA	cis	rs6555855	0.521	rs1559075	MIMAT0026618	hsa-miR-585-5p	4.04	6.32e-05	0.24	0.18	Menarche (age at onset);	chr5:169283017	chr5:169263649~169263670:-
THCA	cis	rs4919694	1	rs78893207	MIMAT0005951	hsa-miR-1307-3p	4.03	6.47e-05	0.22	0.18	Arsenic metabolism;	chr10:103036381	chr10:103394301~103394322:-
THCA	cis	rs4919694	1	rs58317752	MIMAT0005951	hsa-miR-1307-3p	4.03	6.47e-05	0.22	0.18	Arsenic metabolism;	chr10:103039510	chr10:103394301~103394322:-
THCA	cis	rs4919694	1	rs58700372	MIMAT0005951	hsa-miR-1307-3p	4.03	6.47e-05	0.22	0.18	Arsenic metabolism;	chr10:103040448	chr10:103394301~103394322:-
THCA	cis	rs4919694	1	rs12257935	MIMAT0005951	hsa-miR-1307-3p	4.03	6.47e-05	0.22	0.18	Arsenic metabolism;	chr10:103043305	chr10:103394301~103394322:-
THCA	cis	rs4919694	1	rs12266291	MIMAT0005951	hsa-miR-1307-3p	4.03	6.47e-05	0.22	0.18	Arsenic metabolism;	chr10:103047127	chr10:103394301~103394322:-
THCA	cis	rs4919694	1	rs7099987	MIMAT0005951	hsa-miR-1307-3p	4.03	6.47e-05	0.22	0.18	Arsenic metabolism;	chr10:103048169	chr10:103394301~103394322:-
THCA	cis	rs4919694	1	rs12246689	MIMAT0005951	hsa-miR-1307-3p	4.03	6.47e-05	0.22	0.18	Arsenic metabolism;	chr10:103057274	chr10:103394301~103394322:-
THCA	cis	rs4919694	1	rs77827514	MIMAT0005951	hsa-miR-1307-3p	4.03	6.47e-05	0.22	0.18	Arsenic metabolism;	chr10:103062252	chr10:103394301~103394322:-
THCA	cis	rs4919694	1	rs78214351	MIMAT0005951	hsa-miR-1307-3p	4.03	6.47e-05	0.22	0.18	Arsenic metabolism;	chr10:103062931	chr10:103394301~103394322:-
THCA	cis	rs4919694	1	rs12257941	MIMAT0005951	hsa-miR-1307-3p	4.03	6.47e-05	0.22	0.18	Arsenic metabolism;	chr10:103073404	chr10:103394301~103394322:-
THCA	cis	rs4919694	1	rs17727391	MIMAT0005951	hsa-miR-1307-3p	4.03	6.47e-05	0.22	0.18	Arsenic metabolism;	chr10:103076344	chr10:103394301~103394322:-
THCA	cis	rs4919694	1	rs4917382	MIMAT0005951	hsa-miR-1307-3p	4.03	6.47e-05	0.22	0.18	Arsenic metabolism;	chr10:103078753	chr10:103394301~103394322:-
THCA	cis	rs4800353	0.673	rs8097659	MIMAT0000427	hsa-miR-133a-3p	-4.03	6.52e-05	-0.24	-0.18	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22013040	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.673	rs8097659	MIMAT0000427_1	hsa-miR-133a-3p	-4.03	6.52e-05	-0.24	-0.18	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22013040	chr20:62564970~62564991:+
THCA	cis	rs7829975	0.681	rs2271342	MIMAT0019728	hsa-miR-4660	4.03	6.53e-05	0.24	0.18	Mood instability;	chr8:8786428	chr8:9048453~9048475:+
THCA	cis	rs950880	0.56	rs1362350	MIMAT0019927	hsa-miR-4772-3p	4.03	6.54e-05	0.16	0.18	Serum protein levels (sST2);	chr2:102335338	chr2:102432336~102432357:+
THCA	cis	rs6120849	0.901	rs6088733	MIMAT0004772	hsa-miR-499a-3p	-4.03	6.59e-05	-0.25	-0.18	Protein C levels;	chr20:35157101	chr20:34990445~34990466:+
THCA	cis	rs977145	0.812	rs72674979	MIMAT0000456	hsa-miR-186-5p	4.02	6.65e-05	0.12	0.18	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71432373	chr1:71067681~71067702:-
THCA	cis	rs7897654	0.651	rs11191465	MIMAT0005951	hsa-miR-1307-3p	4.02	6.67e-05	0.15	0.18	Schizophrenia;	chr10:102925346	chr10:103394301~103394322:-
THCA	cis	rs7897654	0.651	rs34572965	MIMAT0005951	hsa-miR-1307-3p	4.02	6.67e-05	0.15	0.18	Schizophrenia;	chr10:102925780	chr10:103394301~103394322:-
THCA	cis	rs6981523	0.553	rs11783045	MIMAT0003266	hsa-miR-598-3p	4.02	6.7e-05	0.17	0.18	Neuroticism;	chr8:11198666	chr8:11035221~11035242:-
THCA	cis	rs950880	0.542	rs1558621	MIMAT0019927	hsa-miR-4772-3p	4.02	6.78e-05	0.16	0.18	Serum protein levels (sST2);	chr2:102313847	chr2:102432336~102432357:+
THCA	cis	rs950880	0.56	rs6733174	MIMAT0019927	hsa-miR-4772-3p	4.02	6.79e-05	0.16	0.18	Serum protein levels (sST2);	chr2:102312552	chr2:102432336~102432357:+
THCA	cis	rs4713675	0.553	rs943465	MIMAT0018349	hsa-miR-3934-5p	-4.02	6.84e-05	-0.24	-0.18	Plateletcrit;	chr6:33763886	chr6:33698152~33698173:+
THCA	cis	rs6163	0.508	rs12776506	MIMAT0005951	hsa-miR-1307-3p	4.02	6.84e-05	0.14	0.18	Waist circumference;Hip circumference;	chr10:102773071	chr10:103394301~103394322:-
THCA	cis	rs6841433	0.615	rs7434753	MIMAT0003242	hsa-miR-577	4.02	6.86e-05	0.25	0.18	Hemoglobin concentration;	chr4:114596387	chr4:114656774~114656794:+
THCA	cis	rs4919694	1	rs35159404	MIMAT0005951	hsa-miR-1307-3p	4.02	6.89e-05	0.22	0.18	Arsenic metabolism;	chr10:103045853	chr10:103394301~103394322:-
THCA	cis	rs6537837	0.793	rs12045311	MIMAT0000227	hsa-miR-197-3p	-4.01	6.94e-05	-0.17	-0.18	Major depressive disorder;	chr1:109544783	chr1:109598940~109598961:+
THCA	cis	rs6120849	0.901	rs6088738	MIMAT0004772	hsa-miR-499a-3p	4.01	6.95e-05	0.25	0.18	Protein C levels;	chr20:35159528	chr20:34990445~34990466:+
THCA	cis	rs7897654	0.651	rs7073179	MIMAT0005951	hsa-miR-1307-3p	4.01	7.05e-05	0.15	0.18	Schizophrenia;	chr10:102963334	chr10:103394301~103394322:-
THCA	cis	rs953492	0.644	rs12124014	MIMAT0019761	hsa-miR-4677-3p	-4.01	7.07e-05	-0.2	-0.18	Diastolic blood pressure;	chr1:243213455	chr1:243346225~243346246:+
THCA	cis	rs7829975	0.777	rs486781	MIMAT0019728	hsa-miR-4660	-4.01	7.08e-05	-0.23	-0.18	Mood instability;	chr8:8782230	chr8:9048453~9048475:+
THCA	cis	rs17604090	0.628	rs875263	MIMAT0004800	hsa-miR-550a-5p	4.01	7.09e-05	0.22	0.18	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29671450	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.628	rs875263	MIMAT0004800_1	hsa-miR-550a-5p	4.01	7.09e-05	0.22	0.18	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29671450	chr7:32733002~32733024:+
THCA	cis	rs17604090	0.793	rs10226095	MIMAT0004800	hsa-miR-550a-5p	-4.01	7.12e-05	-0.25	-0.18	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29650443	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.793	rs10226095	MIMAT0004800_1	hsa-miR-550a-5p	-4.01	7.12e-05	-0.25	-0.18	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29650443	chr7:32733002~32733024:+
THCA	cis	rs2274459	0.673	rs35366046	MIMAT0022975	hsa-miR-3934-3p	4.01	7.13e-05	0.26	0.18	Obesity (extreme);	chr6:33764212	chr6:33698191~33698212:+
THCA	cis	rs950880	0.56	rs1558619	MIMAT0019927	hsa-miR-4772-3p	4.01	7.15e-05	0.16	0.18	Serum protein levels (sST2);	chr2:102315090	chr2:102432336~102432357:+
THCA	cis	rs950880	0.56	rs1997466	MIMAT0019927	hsa-miR-4772-3p	4.01	7.18e-05	0.16	0.18	Serum protein levels (sST2);	chr2:102335007	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.811	rs4485584	MIMAT0019927	hsa-miR-4772-3p	-4.01	7.18e-05	-0.18	-0.18	Asthma;	chr2:102354290	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.811	rs4485585	MIMAT0019927	hsa-miR-4772-3p	-4.01	7.18e-05	-0.18	-0.18	Asthma;	chr2:102354299	chr2:102432336~102432357:+
THCA	cis	rs9807989	1	rs9807989	MIMAT0019927	hsa-miR-4772-3p	-4.01	7.18e-05	-0.18	-0.18	Asthma;	chr2:102354740	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.839	rs9808453	MIMAT0019927	hsa-miR-4772-3p	-4.01	7.18e-05	-0.18	-0.18	Asthma;	chr2:102354846	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.839	rs4851565	MIMAT0019927	hsa-miR-4772-3p	-4.01	7.18e-05	-0.18	-0.18	Asthma;	chr2:102355021	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.765	rs9807962	MIMAT0019927	hsa-miR-4772-3p	-4.01	7.18e-05	-0.18	-0.18	Asthma;	chr2:102355204	chr2:102432336~102432357:+
THCA	cis	rs9394169	0.514	rs1886355	MIMAT0022975	hsa-miR-3934-3p	-4	7.22e-05	-0.2	-0.18	Essential tremor;	chr6:33809100	chr6:33698191~33698212:+
THCA	cis	rs9807989	0.801	rs11123925	MIMAT0019927	hsa-miR-4772-3p	-4	7.23e-05	-0.17	-0.18	Asthma;	chr2:102361051	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.839	rs10204837	MIMAT0019927	hsa-miR-4772-3p	-4	7.23e-05	-0.17	-0.18	Asthma;	chr2:102361270	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.839	rs3755276	MIMAT0019927	hsa-miR-4772-3p	-4	7.23e-05	-0.17	-0.18	Asthma;	chr2:102361999	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.839	rs9308857	MIMAT0019927	hsa-miR-4772-3p	-4	7.23e-05	-0.17	-0.18	Asthma;	chr2:102363164	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.839	rs1420099	MIMAT0019927	hsa-miR-4772-3p	-4	7.23e-05	-0.17	-0.18	Asthma;	chr2:102364083	chr2:102432336~102432357:+
THCA	cis	rs4919694	0.901	rs79331374	MIMAT0005951	hsa-miR-1307-3p	4	7.28e-05	0.22	0.18	Arsenic metabolism;	chr10:103123156	chr10:103394301~103394322:-
THCA	cis	rs9807989	0.729	rs10170583	MIMAT0019927	hsa-miR-4772-3p	-4	7.28e-05	-0.17	-0.18	Asthma;	chr2:102358304	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.801	rs10173193	MIMAT0019927	hsa-miR-4772-3p	-4	7.28e-05	-0.17	-0.18	Asthma;	chr2:102358590	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.801	rs10176664	MIMAT0019927	hsa-miR-4772-3p	-4	7.28e-05	-0.17	-0.18	Asthma;	chr2:102359712	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.839	rs6543123	MIMAT0019927	hsa-miR-4772-3p	-4	7.28e-05	-0.17	-0.18	Asthma;	chr2:102360736	chr2:102432336~102432357:+
THCA	cis	rs6537837	0.838	rs3737182	MIMAT0000227	hsa-miR-197-3p	-4	7.3e-05	-0.17	-0.18	Major depressive disorder;	chr1:109548649	chr1:109598940~109598961:+
THCA	cis	rs977145	1	rs9787180	MIMAT0000456	hsa-miR-186-5p	4	7.32e-05	0.12	0.18	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71459820	chr1:71067681~71067702:-
THCA	cis	rs284844	0.748	rs2482507	MIMAT0022727	hsa-miR-1307-5p	4	7.39e-05	0.18	0.18	Mean arterial pressure (long-term average);Diastolic blood pressure (long-term average);Systolic blood pressure (long-term average);	chr10:102801599	chr10:103394341~103394361:-
THCA	cis	rs950880	0.56	rs1420102	MIMAT0019927	hsa-miR-4772-3p	4	7.44e-05	0.16	0.18	Serum protein levels (sST2);	chr2:102332359	chr2:102432336~102432357:+
THCA	cis	rs9394169	0.875	rs1547669	MIMAT0022975	hsa-miR-3934-3p	-4	7.45e-05	-0.2	-0.18	Essential tremor;	chr6:33807864	chr6:33698191~33698212:+
THCA	cis	rs9394169	0.875	rs1547670	MIMAT0022975	hsa-miR-3934-3p	-4	7.45e-05	-0.2	-0.18	Essential tremor;	chr6:33808091	chr6:33698191~33698212:+
THCA	cis	rs284844	0.748	rs2482507	MIMAT0005951	hsa-miR-1307-3p	4	7.48e-05	0.16	0.18	Mean arterial pressure (long-term average);Diastolic blood pressure (long-term average);Systolic blood pressure (long-term average);	chr10:102801599	chr10:103394301~103394322:-
THCA	cis	rs453301	0.538	rs7830804	MIMAT0019728	hsa-miR-4660	-4	7.5e-05	-0.23	-0.18	Joint mobility (Beighton score);	chr8:9113252	chr8:9048453~9048475:+
THCA	cis	rs9807989	0.839	rs7603730	MIMAT0019927	hsa-miR-4772-3p	-3.99	7.64e-05	-0.17	-0.18	Asthma;	chr2:102357911	chr2:102432336~102432357:+
THCA	cis	rs4919687	0.544	rs12764219	MIMAT0005951	hsa-miR-1307-3p	3.99	7.64e-05	0.15	0.18	Colorectal cancer;	chr10:102639138	chr10:103394301~103394322:-
THCA	cis	rs10248839	0.518	rs1317741	MIMAT0004800	hsa-miR-550a-5p	3.99	7.66e-05	0.22	0.18	Facial emotion recognition (angry faces);	chr7:29671533	chr7:30289815~30289837:+
THCA	cis	rs10248839	0.518	rs1317741	MIMAT0004800_1	hsa-miR-550a-5p	3.99	7.66e-05	0.22	0.18	Facial emotion recognition (angry faces);	chr7:29671533	chr7:32733002~32733024:+
THCA	cis	rs7649443	0.959	rs35112822	MIMAT0019973	hsa-miR-4797-3p	3.99	7.67e-05	0.24	0.18	Nonsyndromic cleft lip with cleft palate;	chr3:197249598	chr3:197293888~197293908:-
THCA	cis	rs9807989	0.839	rs1974675	MIMAT0019927	hsa-miR-4772-3p	-3.99	7.68e-05	-0.18	-0.18	Asthma;	chr2:102369915	chr2:102432336~102432357:+
THCA	cis	rs950880	0.56	rs10183388	MIMAT0019927	hsa-miR-4772-3p	3.99	7.69e-05	0.16	0.18	Serum protein levels (sST2);	chr2:102315787	chr2:102432336~102432357:+
THCA	cis	rs6537837	0.793	rs17575742	MIMAT0000227	hsa-miR-197-3p	-3.99	7.69e-05	-0.17	-0.18	Major depressive disorder;	chr1:109540981	chr1:109598940~109598961:+
THCA	cis	rs4713675	0.624	rs482786	MIMAT0022975	hsa-miR-3934-3p	3.99	7.69e-05	0.22	0.18	Plateletcrit;	chr6:33739822	chr6:33698191~33698212:+
THCA	cis	rs9807989	0.839	rs10192036	MIMAT0019927	hsa-miR-4772-3p	-3.99	7.77e-05	-0.18	-0.18	Asthma;	chr2:102351751	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.839	rs10204137	MIMAT0019927	hsa-miR-4772-3p	-3.99	7.77e-05	-0.18	-0.18	Asthma;	chr2:102351752	chr2:102432336~102432357:+
THCA	cis	rs10851411	0.657	rs62022307	MIMAT0026623	hsa-miR-627-3p	-3.99	7.77e-05	-0.33	-0.18	Glucose homeostasis traits;	chr15:42434412	chr15:42199593~42199612:-
THCA	cis	rs950880	0.56	rs11685424	MIMAT0019927	hsa-miR-4772-3p	3.99	7.78e-05	0.16	0.18	Serum protein levels (sST2);	chr2:102310521	chr2:102432336~102432357:+
THCA	cis	rs950880	0.56	rs11679191	MIMAT0019927	hsa-miR-4772-3p	3.99	7.79e-05	0.16	0.18	Serum protein levels (sST2);	chr2:102310340	chr2:102432336~102432357:+
THCA	cis	rs950880	0.56	rs6721346	MIMAT0019927	hsa-miR-4772-3p	3.99	7.79e-05	0.16	0.18	Serum protein levels (sST2);	chr2:102309860	chr2:102432336~102432357:+
THCA	cis	rs4919687	0.544	rs34269636	MIMAT0005951	hsa-miR-1307-3p	3.99	7.81e-05	0.15	0.18	Colorectal cancer;	chr10:102650842	chr10:103394301~103394322:-
THCA	cis	rs4800353	0.714	rs7243918	MIMAT0000427	hsa-miR-133a-3p	-3.98	7.82e-05	-0.23	-0.18	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22014884	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.714	rs7243918	MIMAT0000427_1	hsa-miR-133a-3p	-3.98	7.82e-05	-0.23	-0.18	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22014884	chr20:62564970~62564991:+
THCA	cis	rs6537837	0.793	rs12023963	MIMAT0000227	hsa-miR-197-3p	3.98	7.86e-05	0.16	0.18	Major depressive disorder;	chr1:109542205	chr1:109598940~109598961:+
THCA	cis	rs7829975	0.591	rs12677543	MIMAT0019728	hsa-miR-4660	3.98	7.89e-05	0.23	0.18	Mood instability;	chr8:8786764	chr8:9048453~9048475:+
THCA	cis	rs9807989	0.811	rs11688559	MIMAT0019927	hsa-miR-4772-3p	-3.98	8.01e-05	-0.17	-0.18	Asthma;	chr2:102353453	chr2:102432336~102432357:+
THCA	cis	rs74233809	0.71	rs4147157	MIMAT0005951	hsa-miR-1307-3p	-3.98	8.01e-05	-0.19	-0.18	Birth weight;	chr10:102776603	chr10:103394301~103394322:-
THCA	cis	rs10947487	0.623	rs6924682	MIMAT0005929	hsa-miR-1275	3.98	8.05e-05	0.28	0.18	Body mass index;	chr6:34322756	chr6:34000018~34000034:-
THCA	cis	rs2274459	0.841	rs13204162	MIMAT0022975	hsa-miR-3934-3p	3.98	8.09e-05	0.26	0.18	Obesity (extreme);	chr6:33728354	chr6:33698191~33698212:+
THCA	cis	rs2274459	0.841	rs12661400	MIMAT0022975	hsa-miR-3934-3p	3.98	8.09e-05	0.26	0.18	Obesity (extreme);	chr6:33728700	chr6:33698191~33698212:+
THCA	cis	rs953492	0.83	rs2484639	MIMAT0019761	hsa-miR-4677-3p	-3.97	8.15e-05	-0.19	-0.18	Diastolic blood pressure;	chr1:243299065	chr1:243346225~243346246:+
THCA	cis	rs7897654	0.651	rs12355897	MIMAT0005951	hsa-miR-1307-3p	3.97	8.15e-05	0.15	0.18	Schizophrenia;	chr10:102926900	chr10:103394301~103394322:-
THCA	cis	rs977145	0.868	rs1105985	MIMAT0000456	hsa-miR-186-5p	-3.97	8.18e-05	-0.11	-0.18	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71487440	chr1:71067681~71067702:-
THCA	cis	rs9807989	0.765	rs13424006	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.18e-05	-0.17	-0.18	Asthma;	chr2:102350776	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.765	rs6751967	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.18e-05	-0.17	-0.18	Asthma;	chr2:102350953	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.765	rs6751977	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.18e-05	-0.17	-0.18	Asthma;	chr2:102350970	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.765	rs6704565	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.18e-05	-0.17	-0.18	Asthma;	chr2:102350971	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.839	rs6749114	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.18e-05	-0.17	-0.18	Asthma;	chr2:102351127	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.801	rs6752482	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.18e-05	-0.17	-0.18	Asthma;	chr2:102351398	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.839	rs4988956	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.18e-05	-0.17	-0.18	Asthma;	chr2:102351547	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.839	rs4988958	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.18e-05	-0.17	-0.18	Asthma;	chr2:102351825	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.839	rs10192157	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.18e-05	-0.17	-0.18	Asthma;	chr2:102351896	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.839	rs10206753	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.18e-05	-0.17	-0.18	Asthma;	chr2:102351902	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.773	rs72823661	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.18e-05	-0.17	-0.18	Asthma;	chr2:102352256	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.801	rs72823663	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.18e-05	-0.17	-0.18	Asthma;	chr2:102352278	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.811	rs67088699	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.18e-05	-0.17	-0.18	Asthma;	chr2:102352291	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.773	rs5010059	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.18e-05	-0.17	-0.18	Asthma;	chr2:102352366	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.839	rs11695627	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.18e-05	-0.17	-0.18	Asthma;	chr2:102353645	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.801	rs7558339	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.18e-05	-0.17	-0.18	Asthma;	chr2:102353783	chr2:102432336~102432357:+
THCA	cis	rs2274459	0.841	rs2281919	MIMAT0022975	hsa-miR-3934-3p	3.97	8.22e-05	0.25	0.18	Obesity (extreme);	chr6:33695394	chr6:33698191~33698212:+
THCA	cis	rs2274459	0.749	rs12190155	MIMAT0022975	hsa-miR-3934-3p	3.97	8.22e-05	0.25	0.18	Obesity (extreme);	chr6:33695464	chr6:33698191~33698212:+
THCA	cis	rs79387448	0.638	rs7600961	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.25e-05	-0.25	-0.18	Gut microbiota (bacterial taxa);	chr2:102418995	chr2:102432336~102432357:+
THCA	cis	rs999943	0.774	rs10947421	MIMAT0018349	hsa-miR-3934-5p	-3.97	8.25e-05	-0.23	-0.18	Obesity (extreme);	chr6:33643501	chr6:33698152~33698173:+
THCA	cis	rs999943	0.846	rs10947422	MIMAT0018349	hsa-miR-3934-5p	-3.97	8.25e-05	-0.23	-0.18	Obesity (extreme);	chr6:33643574	chr6:33698152~33698173:+
THCA	cis	rs9807989	0.811	rs7608638	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.29e-05	-0.17	-0.18	Asthma;	chr2:102353829	chr2:102432336~102432357:+
THCA	cis	rs8041447	0.832	rs7350775	MIMAT0000458	hsa-miR-190a-5p	3.97	8.35e-05	0.18	0.18	Immature fraction of reticulocytes;	chr15:62763960	chr15:62823971~62823992:+
THCA	cis	rs953492	0.83	rs2636321	MIMAT0019761	hsa-miR-4677-3p	-3.97	8.44e-05	-0.19	-0.18	Diastolic blood pressure;	chr1:243301114	chr1:243346225~243346246:+
THCA	cis	rs2274459	1	rs12662447	MIMAT0022975	hsa-miR-3934-3p	3.97	8.47e-05	0.28	0.18	Obesity (extreme);	chr6:33746896	chr6:33698191~33698212:+
THCA	cis	rs953492	0.574	rs2087563	MIMAT0019761	hsa-miR-4677-3p	-3.97	8.48e-05	-0.2	-0.18	Diastolic blood pressure;	chr1:243254761	chr1:243346225~243346246:+
THCA	cis	rs2485376	0.967	rs2273555	MIMAT0004766	hsa-miR-146b-3p	-3.96	8.49e-05	-0.11	-0.18	QT interval;	chr10:102367414	chr10:102436557~102436578:+
THCA	cis	rs4919687	0.55	rs11191372	MIMAT0005951	hsa-miR-1307-3p	3.96	8.5e-05	0.14	0.18	Colorectal cancer;	chr10:102702430	chr10:103394301~103394322:-
THCA	cis	rs999943	0.846	rs10947420	MIMAT0022975	hsa-miR-3934-3p	-3.96	8.61e-05	-0.22	-0.18	Obesity (extreme);	chr6:33643284	chr6:33698191~33698212:+
THCA	cis	rs950880	0.56	rs4142132	MIMAT0019927	hsa-miR-4772-3p	3.95	8.85e-05	0.16	0.18	Serum protein levels (sST2);	chr2:102321022	chr2:102432336~102432357:+
THCA	cis	rs950880	0.56	rs10189711	MIMAT0019927	hsa-miR-4772-3p	3.95	9.05e-05	0.16	0.18	Serum protein levels (sST2);	chr2:102314421	chr2:102432336~102432357:+
THCA	cis	rs7819412	0.521	rs11777887	MIMAT0003266	hsa-miR-598-3p	-3.95	9.05e-05	-0.17	-0.18	Triglycerides;	chr8:11179290	chr8:11035221~11035242:-
THCA	cis	rs840163	0.571	rs840160	MIMAT0004805	hsa-miR-616-3p	3.95	9.13e-05	0.25	0.18	Alzheimer's disease (survival time);	chr12:56930712	chr12:57519183~57519204:-
THCA	cis	rs6120849	0.901	rs13037296	MIMAT0004772	hsa-miR-499a-3p	-3.94	9.2e-05	-0.25	-0.18	Protein C levels;	chr20:35161425	chr20:34990445~34990466:+
THCA	cis	rs7829975	0.564	rs2976855	MIMAT0019728	hsa-miR-4660	3.94	9.22e-05	0.23	0.18	Mood instability;	chr8:8444284	chr8:9048453~9048475:+
THCA	cis	rs950880	0.56	rs12476925	MIMAT0019927	hsa-miR-4772-3p	3.94	9.23e-05	0.16	0.18	Serum protein levels (sST2);	chr2:102308089	chr2:102432336~102432357:+
THCA	cis	rs950880	0.56	rs12476968	MIMAT0019927	hsa-miR-4772-3p	3.94	9.23e-05	0.16	0.18	Serum protein levels (sST2);	chr2:102308202	chr2:102432336~102432357:+
THCA	cis	rs1867631	0.565	rs10749764	MIMAT0014979	hsa-miR-3117-3p	-3.94	9.28e-05	-0.22	-0.18	Menopause (age at onset);	chr1:66684023	chr1:66628485~66628505:+
THCA	cis	rs2274459	0.841	rs2281918	MIMAT0022975	hsa-miR-3934-3p	3.94	9.28e-05	0.25	0.18	Obesity (extreme);	chr6:33695278	chr6:33698191~33698212:+
THCA	cis	rs6537837	0.887	rs17024195	MIMAT0000227	hsa-miR-197-3p	-3.94	9.28e-05	-0.16	-0.18	Major depressive disorder;	chr1:109601133	chr1:109598940~109598961:+
THCA	cis	rs7649443	0.959	rs61394945	MIMAT0019973	hsa-miR-4797-3p	3.94	9.38e-05	0.24	0.18	Nonsyndromic cleft lip with cleft palate;	chr3:197247731	chr3:197293888~197293908:-
THCA	cis	rs4711350	0.749	rs7752348	MIMAT0022975	hsa-miR-3934-3p	-3.94	9.41e-05	-0.24	-0.18	Schizophrenia;	chr6:33750475	chr6:33698191~33698212:+
THCA	cis	rs953492	0.672	rs10926964	MIMAT0019761	hsa-miR-4677-3p	-3.94	9.45e-05	-0.2	-0.18	Diastolic blood pressure;	chr1:243196045	chr1:243346225~243346246:+
THCA	cis	rs953492	0.831	rs2783966	MIMAT0019761	hsa-miR-4677-3p	-3.94	9.47e-05	-0.19	-0.18	Diastolic blood pressure;	chr1:243336645	chr1:243346225~243346246:+
THCA	cis	rs6841433	0.615	rs56149980	MIMAT0003242	hsa-miR-577	3.94	9.51e-05	0.25	0.18	Hemoglobin concentration;	chr4:114576580	chr4:114656774~114656794:+
THCA	cis	rs6120849	0.901	rs6060278	MIMAT0004772	hsa-miR-499a-3p	-3.94	9.51e-05	-0.25	-0.18	Protein C levels;	chr20:35165459	chr20:34990445~34990466:+
THCA	cis	rs6841433	0.615	rs13127912	MIMAT0003242	hsa-miR-577	3.94	9.53e-05	0.25	0.18	Hemoglobin concentration;	chr4:114546019	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs10516603	MIMAT0003242	hsa-miR-577	3.94	9.53e-05	0.25	0.18	Hemoglobin concentration;	chr4:114546303	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs34685786	MIMAT0003242	hsa-miR-577	3.94	9.53e-05	0.25	0.18	Hemoglobin concentration;	chr4:114549280	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs13120552	MIMAT0003242	hsa-miR-577	3.94	9.53e-05	0.25	0.18	Hemoglobin concentration;	chr4:114552518	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs13101831	MIMAT0003242	hsa-miR-577	3.94	9.53e-05	0.25	0.18	Hemoglobin concentration;	chr4:114552771	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.66	rs13127941	MIMAT0003242	hsa-miR-577	3.94	9.53e-05	0.25	0.18	Hemoglobin concentration;	chr4:114553520	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs13147198	MIMAT0003242	hsa-miR-577	3.94	9.53e-05	0.25	0.18	Hemoglobin concentration;	chr4:114553935	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs35594431	MIMAT0003242	hsa-miR-577	3.94	9.53e-05	0.25	0.18	Hemoglobin concentration;	chr4:114554497	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs34403145	MIMAT0003242	hsa-miR-577	3.94	9.53e-05	0.25	0.18	Hemoglobin concentration;	chr4:114554629	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs12643074	MIMAT0003242	hsa-miR-577	3.94	9.53e-05	0.25	0.18	Hemoglobin concentration;	chr4:114555226	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs2100783	MIMAT0003242	hsa-miR-577	3.94	9.53e-05	0.25	0.18	Hemoglobin concentration;	chr4:114555821	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs12650115	MIMAT0003242	hsa-miR-577	3.94	9.53e-05	0.25	0.18	Hemoglobin concentration;	chr4:114560232	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs12644238	MIMAT0003242	hsa-miR-577	3.94	9.53e-05	0.25	0.18	Hemoglobin concentration;	chr4:114560598	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.571	rs1903365	MIMAT0003242	hsa-miR-577	3.94	9.53e-05	0.25	0.18	Hemoglobin concentration;	chr4:114561897	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs13110751	MIMAT0003242	hsa-miR-577	3.94	9.53e-05	0.25	0.18	Hemoglobin concentration;	chr4:114563572	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs13105144	MIMAT0003242	hsa-miR-577	3.94	9.53e-05	0.25	0.18	Hemoglobin concentration;	chr4:114563873	chr4:114656774~114656794:+
THCA	cis	rs7819412	0.521	rs2409720	MIMAT0003266	hsa-miR-598-3p	3.93	9.59e-05	0.16	0.18	Triglycerides;	chr8:11180394	chr8:11035221~11035242:-
THCA	cis	rs950880	0.56	rs12466380	MIMAT0019927	hsa-miR-4772-3p	3.93	9.66e-05	0.16	0.18	Serum protein levels (sST2);	chr2:102332479	chr2:102432336~102432357:+
THCA	cis	rs950880	0.517	rs1420088	MIMAT0019927	hsa-miR-4772-3p	3.93	9.67e-05	0.16	0.18	Serum protein levels (sST2);	chr2:102322974	chr2:102432336~102432357:+
THCA	cis	rs950880	0.56	rs11123920	MIMAT0019927	hsa-miR-4772-3p	3.93	9.67e-05	0.16	0.18	Serum protein levels (sST2);	chr2:102323373	chr2:102432336~102432357:+
THCA	cis	rs950880	0.56	rs11676075	MIMAT0019927	hsa-miR-4772-3p	3.93	9.67e-05	0.16	0.18	Serum protein levels (sST2);	chr2:102324755	chr2:102432336~102432357:+
THCA	cis	rs950880	0.518	rs12996772	MIMAT0019927	hsa-miR-4772-3p	3.93	9.67e-05	0.16	0.18	Serum protein levels (sST2);	chr2:102330741	chr2:102432336~102432357:+
THCA	cis	rs6695223	1	rs7527292	MIMAT0019232	hsa-miR-4423-5p	3.93	9.73e-05	0.3	0.18	Venous thromboembolism (SNP x SNP interaction);	chr1:85072207	chr1:85133806~85133827:+
THCA	cis	rs9807989	0.839	rs4988957	MIMAT0019927	hsa-miR-4772-3p	3.93	9.75e-05	0.17	0.18	Asthma;	chr2:102351615	chr2:102432336~102432357:+
THCA	cis	rs999943	0.846	rs9357162	MIMAT0022975	hsa-miR-3934-3p	-3.93	9.82e-05	-0.22	-0.18	Obesity (extreme);	chr6:33645567	chr6:33698191~33698212:+
THCA	cis	rs189798	0.592	rs10111263	MIMAT0019728	hsa-miR-4660	-3.93	9.84e-05	-0.22	-0.18	Myopia (pathological);	chr8:9111923	chr8:9048453~9048475:+
THCA	cis	rs9807989	0.801	rs4851566	MIMAT0019927	hsa-miR-4772-3p	-3.93	9.87e-05	-0.17	-0.18	Asthma;	chr2:102356339	chr2:102432336~102432357:+
THCA	cis	rs4919687	0.55	rs7904396	MIMAT0005951	hsa-miR-1307-3p	3.93	9.91e-05	0.14	0.18	Colorectal cancer;	chr10:102697081	chr10:103394301~103394322:-
THCA	cis	rs10021731	0.546	rs12503437	MIMAT0003242	hsa-miR-577	-3.93	9.92e-05	-0.19	-0.18	Optic disc area;	chr4:114534955	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.546	rs12503481	MIMAT0003242	hsa-miR-577	-3.93	9.92e-05	-0.19	-0.18	Optic disc area;	chr4:114535080	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.546	rs7668023	MIMAT0003242	hsa-miR-577	-3.93	9.92e-05	-0.19	-0.18	Optic disc area;	chr4:114535366	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs7437576	MIMAT0003242	hsa-miR-577	3.92	1e-04	0.25	0.18	Hemoglobin concentration;	chr4:114595467	chr4:114656774~114656794:+
THCA	cis	rs6120849	0.901	rs6088735	MIMAT0004772	hsa-miR-499a-3p	-3.92	1e-04	-0.25	-0.18	Protein C levels;	chr20:35157873	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.901	rs6088737	MIMAT0004772	hsa-miR-499a-3p	-3.92	1e-04	-0.25	-0.18	Protein C levels;	chr20:35158135	chr20:34990445~34990466:+
THCA	cis	rs6695223	1	rs4907130	MIMAT0019232	hsa-miR-4423-5p	-3.92	1e-04	-0.3	-0.18	Venous thromboembolism (SNP x SNP interaction);	chr1:85071196	chr1:85133806~85133827:+
THCA	cis	rs4919687	0.55	rs10437480	MIMAT0005951	hsa-miR-1307-3p	3.92	0.000101	0.14	0.18	Colorectal cancer;	chr10:102693267	chr10:103394301~103394322:-
THCA	cis	rs4919687	0.55	rs4264100	MIMAT0005951	hsa-miR-1307-3p	3.92	0.000101	0.14	0.18	Colorectal cancer;	chr10:102694356	chr10:103394301~103394322:-
THCA	cis	rs953492	0.765	rs10926981	MIMAT0019761	hsa-miR-4677-3p	-3.92	0.000102	-0.19	-0.18	Diastolic blood pressure;	chr1:243288103	chr1:243346225~243346246:+
THCA	cis	rs4146429	0.561	rs4919643	MIMAT0005951	hsa-miR-1307-3p	-3.92	0.000102	-0.17	-0.18	Body mass index (joint analysis main effects and physical activity interaction);Body mass index in physically active individuals;Body mass index;	chr10:102462620	chr10:103394301~103394322:-
THCA	cis	rs4919687	0.55	rs11191371	MIMAT0005951	hsa-miR-1307-3p	3.92	0.000103	0.14	0.18	Colorectal cancer;	chr10:102700140	chr10:103394301~103394322:-
THCA	cis	rs7897654	0.62	rs7073716	MIMAT0005951	hsa-miR-1307-3p	3.92	0.000103	0.15	0.18	Schizophrenia;	chr10:102933604	chr10:103394301~103394322:-
THCA	cis	rs7897654	0.651	rs7093461	MIMAT0005951	hsa-miR-1307-3p	3.92	0.000103	0.15	0.18	Schizophrenia;	chr10:102933722	chr10:103394301~103394322:-
THCA	cis	rs6555855	0.514	rs4339366	MIMAT0003250	hsa-miR-585-3p	-3.92	0.000103	-0.21	-0.18	Menarche (age at onset);	chr5:169288938	chr5:169263616~169263634:-
THCA	cis	rs950880	0.56	rs2110660	MIMAT0019927	hsa-miR-4772-3p	3.92	0.000103	0.16	0.18	Serum protein levels (sST2);	chr2:102302141	chr2:102432336~102432357:+
THCA	cis	rs4919687	0.55	rs7904252	MIMAT0005951	hsa-miR-1307-3p	-3.91	0.000105	-0.14	-0.18	Colorectal cancer;	chr10:102696968	chr10:103394301~103394322:-
THCA	cis	rs7851726	0.585	rs7870160	MIMAT0019208	hsa-miR-3074-5p	-3.91	0.000105	-0.14	-0.18	Urinary albumin-to-creatinine ratio;	chr9:94950249	chr9:95086063~95086083:-
THCA	cis	rs6120849	0.802	rs6087681	MIMAT0004772	hsa-miR-499a-3p	-3.91	0.000105	-0.25	-0.18	Protein C levels;	chr20:35165093	chr20:34990445~34990466:+
THCA	cis	rs6120849	0.802	rs6087682	MIMAT0004772	hsa-miR-499a-3p	-3.91	0.000105	-0.25	-0.18	Protein C levels;	chr20:35165094	chr20:34990445~34990466:+
THCA	cis	rs7210990	0.931	rs11650427	MIMAT0005942	hsa-miR-1288-3p	3.91	0.000106	0.24	0.18	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16255460	chr17:16282058~16282078:+
THCA	cis	rs4919669	0.697	rs8354	MIMAT0005951	hsa-miR-1307-3p	-3.91	0.000106	-0.18	-0.18	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102676884	chr10:103394301~103394322:-
THCA	cis	rs6841433	0.615	rs12648803	MIMAT0003242	hsa-miR-577	-3.91	0.000106	-0.25	-0.18	Hemoglobin concentration;	chr4:114546228	chr4:114656774~114656794:+
THCA	cis	rs10851411	0.647	rs62022300	MIMAT0026623	hsa-miR-627-3p	-3.91	0.000107	-0.32	-0.18	Glucose homeostasis traits;	chr15:42417800	chr15:42199593~42199612:-
THCA	cis	rs950880	0.56	rs1558622	MIMAT0019927	hsa-miR-4772-3p	3.91	0.000107	0.15	0.18	Serum protein levels (sST2);	chr2:102313687	chr2:102432336~102432357:+
THCA	cis	rs950880	0.56	rs10189202	MIMAT0019927	hsa-miR-4772-3p	3.91	0.000107	0.15	0.18	Serum protein levels (sST2);	chr2:102313920	chr2:102432336~102432357:+
THCA	cis	rs950880	0.56	rs10191914	MIMAT0019927	hsa-miR-4772-3p	3.91	0.000107	0.15	0.18	Serum protein levels (sST2);	chr2:102314197	chr2:102432336~102432357:+
THCA	cis	rs72819454	0.522	rs4917399	MIMAT0022727	hsa-miR-1307-5p	3.91	0.000108	0.21	0.18	Interleukin-9 levels;	chr10:103769861	chr10:103394341~103394361:-
THCA	cis	rs4919687	0.55	rs10748828	MIMAT0005951	hsa-miR-1307-3p	-3.9	0.000108	-0.14	-0.18	Colorectal cancer;	chr10:102697037	chr10:103394301~103394322:-
THCA	cis	rs1870653	1	rs1870653	MIMAT0003242	hsa-miR-577	-3.9	0.00011	-0.3	-0.18	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);	chr4:114477044	chr4:114656774~114656794:+
THCA	cis	rs977145	1	rs1155175	MIMAT0000456	hsa-miR-186-5p	-3.9	0.00011	-0.12	-0.18	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71460243	chr1:71067681~71067702:-
THCA	cis	rs999943	0.846	rs9348923	MIMAT0018349	hsa-miR-3934-5p	-3.9	0.00011	-0.22	-0.18	Obesity (extreme);	chr6:33650147	chr6:33698152~33698173:+
THCA	cis	rs1870653	0.516	rs9995562	MIMAT0003242	hsa-miR-577	3.9	0.00011	0.31	0.18	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);	chr4:114491077	chr4:114656774~114656794:+
THCA	cis	rs840163	0.528	rs863459	MIMAT0004805	hsa-miR-616-3p	3.9	0.000112	0.25	0.18	Alzheimer's disease (survival time);	chr12:56932400	chr12:57519183~57519204:-
THCA	cis	rs840163	0.571	rs719750	MIMAT0004805	hsa-miR-616-3p	3.9	0.000112	0.25	0.18	Alzheimer's disease (survival time);	chr12:56932537	chr12:57519183~57519204:-
THCA	cis	rs840163	0.571	rs719749	MIMAT0004805	hsa-miR-616-3p	3.9	0.000112	0.25	0.18	Alzheimer's disease (survival time);	chr12:56932654	chr12:57519183~57519204:-
THCA	cis	rs6555855	0.868	rs1592818	MIMAT0026618	hsa-miR-585-5p	-3.9	0.000112	-0.25	-0.18	Menarche (age at onset);	chr5:169314520	chr5:169263649~169263670:-
THCA	cis	rs17604090	0.529	rs10239226	MIMAT0004800	hsa-miR-550a-5p	3.89	0.000113	0.22	0.18	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29676696	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.529	rs10239226	MIMAT0004800_1	hsa-miR-550a-5p	3.89	0.000113	0.22	0.18	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29676696	chr7:32733002~32733024:+
THCA	cis	rs17604090	0.557	rs10279965	MIMAT0004800	hsa-miR-550a-5p	3.89	0.000113	0.22	0.18	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29677466	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.557	rs10279965	MIMAT0004800_1	hsa-miR-550a-5p	3.89	0.000113	0.22	0.18	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29677466	chr7:32733002~32733024:+
THCA	cis	rs4919694	1	rs111622998	MIMAT0005951	hsa-miR-1307-3p	3.89	0.000113	0.21	0.18	Arsenic metabolism;	chr10:103193264	chr10:103394301~103394322:-
THCA	cis	rs72819454	0.522	rs72817647	MIMAT0022727	hsa-miR-1307-5p	3.89	0.000113	0.21	0.18	Interleukin-9 levels;	chr10:103768946	chr10:103394341~103394361:-
THCA	cis	rs72819454	0.522	rs11191800	MIMAT0022727	hsa-miR-1307-5p	3.89	0.000113	0.21	0.18	Interleukin-9 levels;	chr10:103771521	chr10:103394341~103394361:-
THCA	cis	rs72819454	0.522	rs911544	MIMAT0022727	hsa-miR-1307-5p	3.89	0.000113	0.21	0.18	Interleukin-9 levels;	chr10:103771936	chr10:103394341~103394361:-
THCA	cis	rs943466	0.537	rs2296329	MIMAT0018349	hsa-miR-3934-5p	-3.89	0.000113	-0.26	-0.18	Body mass index (joint analysis main effects and physical activity interaction);Body mass index;	chr6:33682966	chr6:33698152~33698173:+
THCA	cis	rs7829975	0.774	rs1703982	MIMAT0019728	hsa-miR-4660	-3.89	0.000114	-0.23	-0.18	Mood instability;	chr8:8740878	chr8:9048453~9048475:+
THCA	cis	rs4919694	1	rs17727044	MIMAT0005951	hsa-miR-1307-3p	3.89	0.000114	0.23	0.18	Arsenic metabolism;	chr10:103061499	chr10:103394301~103394322:-
THCA	cis	rs10851411	0.647	rs11639355	MIMAT0026623	hsa-miR-627-3p	-3.89	0.000114	-0.31	-0.18	Glucose homeostasis traits;	chr15:42431209	chr15:42199593~42199612:-
THCA	cis	rs10851411	0.606	rs12438845	MIMAT0026623	hsa-miR-627-3p	-3.89	0.000114	-0.31	-0.18	Glucose homeostasis traits;	chr15:42432440	chr15:42199593~42199612:-
THCA	cis	rs10851411	0.647	rs12438846	MIMAT0026623	hsa-miR-627-3p	-3.89	0.000114	-0.31	-0.18	Glucose homeostasis traits;	chr15:42432441	chr15:42199593~42199612:-
THCA	cis	rs10851411	0.647	rs11638754	MIMAT0026623	hsa-miR-627-3p	-3.89	0.000114	-0.31	-0.18	Glucose homeostasis traits;	chr15:42433844	chr15:42199593~42199612:-
THCA	cis	rs6695223	1	rs4907131	MIMAT0019232	hsa-miR-4423-5p	3.89	0.000115	0.3	0.18	Venous thromboembolism (SNP x SNP interaction);	chr1:85071819	chr1:85133806~85133827:+
THCA	cis	rs1870653	0.516	rs6852269	MIMAT0003242	hsa-miR-577	3.89	0.000115	0.3	0.18	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);	chr4:114481622	chr4:114656774~114656794:+
THCA	cis	rs453301	0.686	rs3989373	MIMAT0019728	hsa-miR-4660	-3.89	0.000116	-0.23	-0.18	Joint mobility (Beighton score);	chr8:9053798	chr8:9048453~9048475:+
THCA	cis	rs17783634	0.509	rs11775489	MIMAT0003266	hsa-miR-598-3p	3.89	0.000116	0.16	0.18	Subjective well-being;	chr8:11179334	chr8:11035221~11035242:-
THCA	cis	rs9807989	0.801	rs6734742	MIMAT0019927	hsa-miR-4772-3p	-3.88	0.000117	-0.17	-0.18	Asthma;	chr2:102351397	chr2:102432336~102432357:+
THCA	cis	rs2274459	0.673	rs35328423	MIMAT0018349	hsa-miR-3934-5p	3.88	0.000118	0.24	0.18	Obesity (extreme);	chr6:33763815	chr6:33698152~33698173:+
THCA	cis	rs8041447	0.832	rs2030040	MIMAT0000458	hsa-miR-190a-5p	3.88	0.000118	0.18	0.18	Immature fraction of reticulocytes;	chr15:62762240	chr15:62823971~62823992:+
THCA	cis	rs9807989	0.839	rs10182710	MIMAT0019927	hsa-miR-4772-3p	-3.88	0.000118	-0.17	-0.18	Asthma;	chr2:102364846	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.839	rs13392100	MIMAT0019927	hsa-miR-4772-3p	-3.88	0.000118	-0.17	-0.18	Asthma;	chr2:102365634	chr2:102432336~102432357:+
THCA	cis	rs950880	0.542	rs12996505	MIMAT0019927	hsa-miR-4772-3p	3.88	0.000119	0.15	0.18	Serum protein levels (sST2);	chr2:102315342	chr2:102432336~102432357:+
THCA	cis	rs840163	0.571	rs2629413	MIMAT0004805	hsa-miR-616-3p	3.88	0.000119	0.25	0.18	Alzheimer's disease (survival time);	chr12:56931793	chr12:57519183~57519204:-
THCA	cis	rs950880	0.56	rs11685480	MIMAT0019927	hsa-miR-4772-3p	3.88	0.000119	0.15	0.18	Serum protein levels (sST2);	chr2:102310626	chr2:102432336~102432357:+
THCA	cis	rs76886731	1	rs76886731	MIMAT0019927	hsa-miR-4772-3p	3.88	0.000119	0.16	0.18	Leprosy;	chr2:102328956	chr2:102432336~102432357:+
THCA	cis	rs950880	0.56	rs13020793	MIMAT0019927	hsa-miR-4772-3p	3.88	0.000119	0.15	0.18	Serum protein levels (sST2);	chr2:102315466	chr2:102432336~102432357:+
THCA	cis	rs950880	0.517	rs1968170	MIMAT0019927	hsa-miR-4772-3p	3.88	0.000119	0.15	0.18	Serum protein levels (sST2);	chr2:102317342	chr2:102432336~102432357:+
THCA	cis	rs950880	0.56	rs11123918	MIMAT0019927	hsa-miR-4772-3p	3.88	0.000119	0.15	0.18	Serum protein levels (sST2);	chr2:102318777	chr2:102432336~102432357:+
THCA	cis	rs950880	0.56	rs11690443	MIMAT0019927	hsa-miR-4772-3p	3.88	0.000119	0.15	0.18	Serum protein levels (sST2);	chr2:102319671	chr2:102432336~102432357:+
THCA	cis	rs950880	0.56	rs12712136	MIMAT0019927	hsa-miR-4772-3p	3.88	0.00012	0.15	0.18	Serum protein levels (sST2);	chr2:102319906	chr2:102432336~102432357:+
THCA	cis	rs4919687	0.55	rs12259058	MIMAT0005951	hsa-miR-1307-3p	3.88	0.000121	0.14	0.18	Colorectal cancer;	chr10:102725042	chr10:103394301~103394322:-
THCA	cis	rs4919687	0.55	rs12775883	MIMAT0005951	hsa-miR-1307-3p	3.88	0.000121	0.14	0.18	Colorectal cancer;	chr10:102725544	chr10:103394301~103394322:-
THCA	cis	rs10851411	0.647	rs72707477	MIMAT0026623	hsa-miR-627-3p	-3.88	0.000121	-0.31	-0.18	Glucose homeostasis traits;	chr15:42436766	chr15:42199593~42199612:-
THCA	cis	rs10851411	0.606	rs12438745	MIMAT0026623	hsa-miR-627-3p	-3.88	0.000121	-0.31	-0.18	Glucose homeostasis traits;	chr15:42437966	chr15:42199593~42199612:-
THCA	cis	rs950880	0.56	rs974389	MIMAT0019927	hsa-miR-4772-3p	-3.88	0.000121	-0.15	-0.18	Serum protein levels (sST2);	chr2:102320521	chr2:102432336~102432357:+
THCA	cis	rs3850699	0.926	rs7094325	MIMAT0005951	hsa-miR-1307-3p	3.88	0.000121	0.14	0.18	Prostate cancer;	chr10:102669989	chr10:103394301~103394322:-
THCA	cis	rs999943	1	rs999943	MIMAT0022975	hsa-miR-3934-3p	-3.87	0.000122	-0.21	-0.18	Obesity (extreme);	chr6:33656956	chr6:33698191~33698212:+
THCA	cis	rs7894407	0.522	rs2274341	MIMAT0022727	hsa-miR-1307-5p	3.87	0.000122	0.19	0.18	White matter hyperintensity burden;	chr10:103093746	chr10:103394341~103394361:-
THCA	cis	rs7917772	0.555	rs2244524	MIMAT0005951	hsa-miR-1307-3p	-3.87	0.000122	-0.13	-0.18	Waist-to-hip ratio adjusted for body mass index;White blood cell count;Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);	chr10:102727217	chr10:103394301~103394322:-
THCA	cis	rs17604090	0.715	rs73088359	MIMAT0004800	hsa-miR-550a-5p	3.87	0.000122	0.23	0.18	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29608062	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.715	rs73088359	MIMAT0004800_1	hsa-miR-550a-5p	3.87	0.000122	0.23	0.18	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29608062	chr7:32733002~32733024:+
THCA	cis	rs6951245	0.505	rs56117635	MIMAT0004702	hsa-miR-339-3p	-3.87	0.000123	-0.28	-0.18	C-reactive protein levels or total cholesterol levels (pleiotropy);	chr7:990398	chr7:1022955~1022977:-
THCA	cis	rs7649443	0.796	rs2340433	MIMAT0019973	hsa-miR-4797-3p	3.87	0.000124	0.23	0.18	Nonsyndromic cleft lip with cleft palate;	chr3:197250008	chr3:197293888~197293908:-
THCA	cis	rs7649443	0.959	rs62282105	MIMAT0019973	hsa-miR-4797-3p	3.87	0.000124	0.23	0.18	Nonsyndromic cleft lip with cleft palate;	chr3:197251848	chr3:197293888~197293908:-
THCA	cis	rs7649443	0.797	rs35665404	MIMAT0019973	hsa-miR-4797-3p	3.87	0.000124	0.23	0.18	Nonsyndromic cleft lip with cleft palate;	chr3:197254900	chr3:197293888~197293908:-
THCA	cis	rs7477	0.555	rs1476810	MIMAT0005942	hsa-miR-1288-3p	3.87	0.000124	0.23	0.18	Amyotrophic lateral sclerosis;	chr17:16329903	chr17:16282058~16282078:+
THCA	cis	rs4919687	0.55	rs12784517	MIMAT0005951	hsa-miR-1307-3p	3.87	0.000124	0.14	0.18	Colorectal cancer;	chr10:102705213	chr10:103394301~103394322:-
THCA	cis	rs4919687	0.55	rs12761195	MIMAT0005951	hsa-miR-1307-3p	3.87	0.000124	0.14	0.18	Colorectal cancer;	chr10:102705617	chr10:103394301~103394322:-
THCA	cis	rs950880	0.56	rs971764	MIMAT0019927	hsa-miR-4772-3p	3.87	0.000124	0.15	0.18	Serum protein levels (sST2);	chr2:102321875	chr2:102432336~102432357:+
THCA	cis	rs950880	0.56	rs6706844	MIMAT0019927	hsa-miR-4772-3p	3.87	0.000124	0.15	0.18	Serum protein levels (sST2);	chr2:102323952	chr2:102432336~102432357:+
THCA	cis	rs10851411	0.647	rs17708630	MIMAT0026623	hsa-miR-627-3p	-3.87	0.000124	-0.31	-0.18	Glucose homeostasis traits;	chr15:42417979	chr15:42199593~42199612:-
THCA	cis	rs7649443	0.759	rs36035383	MIMAT0019973	hsa-miR-4797-3p	3.87	0.000125	0.24	0.18	Nonsyndromic cleft lip with cleft palate;	chr3:197243260	chr3:197293888~197293908:-
THCA	cis	rs7649443	0.959	rs3915512	MIMAT0019973	hsa-miR-4797-3p	3.87	0.000125	0.23	0.18	Nonsyndromic cleft lip with cleft palate;	chr3:197295369	chr3:197293888~197293908:-
THCA	cis	rs12145833	0.679	rs6429425	MIMAT0019761	hsa-miR-4677-3p	3.87	0.000125	0.28	0.18	Obesity (early onset extreme);	chr1:243427688	chr1:243346225~243346246:+
THCA	cis	rs10993397	0.528	rs356665	MIMAT0019208	hsa-miR-3074-5p	-3.87	0.000125	-0.13	-0.18	Polycystic ovary syndrome;	chr9:95298349	chr9:95086063~95086083:-
THCA	cis	rs6681460	0.866	rs996123	MIMAT0014979	hsa-miR-3117-3p	-3.87	0.000126	-0.23	-0.18	Presence of antiphospholipid antibodies;	chr1:66559660	chr1:66628485~66628505:+
THCA	cis	rs3850699	0.926	rs12570611	MIMAT0005951	hsa-miR-1307-3p	3.87	0.000126	0.13	0.18	Prostate cancer;	chr10:102661922	chr10:103394301~103394322:-
THCA	cis	rs9807989	0.811	rs11688568	MIMAT0019927	hsa-miR-4772-3p	-3.87	0.000127	-0.17	-0.18	Asthma;	chr2:102353489	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.811	rs11688573	MIMAT0019927	hsa-miR-4772-3p	-3.87	0.000127	-0.17	-0.18	Asthma;	chr2:102353511	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.811	rs11689730	MIMAT0019927	hsa-miR-4772-3p	-3.87	0.000127	-0.17	-0.18	Asthma;	chr2:102353524	chr2:102432336~102432357:+
THCA	cis	rs7819412	0.54	rs11777355	MIMAT0003266	hsa-miR-598-3p	3.86	0.000127	0.16	0.18	Triglycerides;	chr8:11187180	chr8:11035221~11035242:-
THCA	cis	rs7649443	0.759	rs3903682	MIMAT0019973	hsa-miR-4797-3p	-3.86	0.000127	-0.24	-0.18	Nonsyndromic cleft lip with cleft palate;	chr3:197280675	chr3:197293888~197293908:-
THCA	cis	rs6429422	0.725	rs2787232	MIMAT0019761	hsa-miR-4677-3p	3.86	0.000127	0.19	0.18	Cognitive ability (multi-trait analysis);	chr1:243143173	chr1:243346225~243346246:+
THCA	cis	rs6163	0.54	rs11191385	MIMAT0005951	hsa-miR-1307-3p	3.86	0.000127	0.14	0.18	Waist circumference;Hip circumference;	chr10:102753292	chr10:103394301~103394322:-
THCA	cis	rs17710780	0.803	rs17654621	MIMAT0000731	hsa-miR-378a-5p	-3.86	0.000128	-0.2	-0.18	Major depressive disorder;	chr5:149709271	chr5:149732829~149732850:+
THCA	cis	rs9807989	0.839	rs1362348	MIMAT0019927	hsa-miR-4772-3p	-3.86	0.00013	-0.17	-0.17	Asthma;	chr2:102368164	chr2:102432336~102432357:+
THCA	cis	rs7897654	0.651	rs7922349	MIMAT0005951	hsa-miR-1307-3p	3.86	0.00013	0.14	0.17	Schizophrenia;	chr10:102929701	chr10:103394301~103394322:-
THCA	cis	rs7897654	0.651	rs12416441	MIMAT0005951	hsa-miR-1307-3p	3.86	0.00013	0.14	0.17	Schizophrenia;	chr10:102930233	chr10:103394301~103394322:-
THCA	cis	rs953492	0.635	rs2802725	MIMAT0019761	hsa-miR-4677-3p	-3.86	0.00013	-0.19	-0.17	Diastolic blood pressure;	chr1:243332293	chr1:243346225~243346246:+
THCA	cis	rs72819454	0.579	rs112995165	MIMAT0022727	hsa-miR-1307-5p	3.86	0.000131	0.2	0.17	Interleukin-9 levels;	chr10:103773216	chr10:103394341~103394361:-
THCA	cis	rs6537837	0.887	rs1889470	MIMAT0000227	hsa-miR-197-3p	-3.86	0.000131	-0.16	-0.17	Major depressive disorder;	chr1:109598799	chr1:109598940~109598961:+
THCA	cis	rs72819454	0.522	rs17115934	MIMAT0022727	hsa-miR-1307-5p	3.86	0.000131	0.2	0.17	Interleukin-9 levels;	chr10:103769986	chr10:103394341~103394361:-
THCA	cis	rs72819454	0.522	rs911546	MIMAT0022727	hsa-miR-1307-5p	-3.86	0.000131	-0.2	-0.17	Interleukin-9 levels;	chr10:103771232	chr10:103394341~103394361:-
THCA	cis	rs7819412	0.521	rs10110684	MIMAT0003266	hsa-miR-598-3p	3.86	0.000132	0.16	0.17	Triglycerides;	chr8:11181650	chr8:11035221~11035242:-
THCA	cis	rs12712133	0.514	rs10188022	MIMAT0019927	hsa-miR-4772-3p	3.85	0.000132	0.16	0.17	Primary biliary cholangitis;	chr2:102258406	chr2:102432336~102432357:+
THCA	cis	rs6681460	0.898	rs1032635	MIMAT0014979	hsa-miR-3117-3p	3.85	0.000133	0.21	0.17	Presence of antiphospholipid antibodies;	chr1:66729501	chr1:66628485~66628505:+
THCA	cis	rs6981523	0.532	rs1987190	MIMAT0003266	hsa-miR-598-3p	3.85	0.000134	0.16	0.17	Neuroticism;	chr8:11196005	chr8:11035221~11035242:-
THCA	cis	rs953492	0.624	rs4469702	MIMAT0019761	hsa-miR-4677-3p	-3.85	0.000135	-0.19	-0.17	Diastolic blood pressure;	chr1:243201894	chr1:243346225~243346246:+
THCA	cis	rs6120849	0.851	rs13040631	MIMAT0004772	hsa-miR-499a-3p	-3.85	0.000135	-0.24	-0.17	Protein C levels;	chr20:35159911	chr20:34990445~34990466:+
THCA	cis	rs999943	0.846	rs9357162	MIMAT0018349	hsa-miR-3934-5p	-3.85	0.000135	-0.22	-0.17	Obesity (extreme);	chr6:33645567	chr6:33698152~33698173:+
THCA	cis	rs4919694	1	rs11191545	MIMAT0005951	hsa-miR-1307-3p	3.85	0.000136	0.22	0.17	Arsenic metabolism;	chr10:103070036	chr10:103394301~103394322:-
THCA	cis	rs74233809	0.605	rs999867	MIMAT0005951	hsa-miR-1307-3p	-3.85	0.000137	-0.18	-0.17	Birth weight;	chr10:102744807	chr10:103394301~103394322:-
THCA	cis	rs4800353	0.673	rs7229372	MIMAT0000427	hsa-miR-133a-3p	-3.85	0.000137	-0.23	-0.17	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22006864	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.673	rs7229372	MIMAT0000427_1	hsa-miR-133a-3p	-3.85	0.000137	-0.23	-0.17	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22006864	chr20:62564970~62564991:+
THCA	cis	rs7649443	0.759	rs7624684	MIMAT0019973	hsa-miR-4797-3p	3.85	0.000137	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197244290	chr3:197293888~197293908:-
THCA	cis	rs6537837	1	rs6537837	MIMAT0000227	hsa-miR-197-3p	-3.84	0.000138	-0.16	-0.17	Major depressive disorder;	chr1:109577110	chr1:109598940~109598961:+
THCA	cis	rs840163	0.571	rs864541	MIMAT0004805	hsa-miR-616-3p	3.84	0.000139	0.25	0.17	Alzheimer's disease (survival time);	chr12:56931934	chr12:57519183~57519204:-
THCA	cis	rs12355831	0.881	rs2255740	MIMAT0025841	hsa-miR-6715a-3p	3.84	0.000139	0.24	0.17	Migraine;	chr10:112421925	chr10:112299660~112299680:+
THCA	cis	rs4919694	1	rs74749600	MIMAT0005951	hsa-miR-1307-3p	3.83	0.000143	0.22	0.17	Arsenic metabolism;	chr10:102973239	chr10:103394301~103394322:-
THCA	cis	rs4919694	1	rs112240253	MIMAT0005951	hsa-miR-1307-3p	3.83	0.000143	0.22	0.17	Arsenic metabolism;	chr10:102993969	chr10:103394301~103394322:-
THCA	cis	rs12712133	1	rs12712133	MIMAT0019927	hsa-miR-4772-3p	3.83	0.000144	0.15	0.17	Primary biliary cholangitis;	chr2:102249813	chr2:102432336~102432357:+
THCA	cis	rs6537837	0.838	rs12046010	MIMAT0000227	hsa-miR-197-3p	-3.83	0.000144	-0.16	-0.17	Major depressive disorder;	chr1:109561567	chr1:109598940~109598961:+
THCA	cis	rs6163	0.508	rs11191381	MIMAT0005951	hsa-miR-1307-3p	3.83	0.000145	0.14	0.17	Waist circumference;Hip circumference;	chr10:102733687	chr10:103394301~103394322:-
THCA	cis	rs6981523	0.553	rs11783890	MIMAT0003266	hsa-miR-598-3p	3.83	0.000145	0.16	0.17	Neuroticism;	chr8:11198879	chr8:11035221~11035242:-
THCA	cis	rs950880	0.56	rs10182639	MIMAT0019927	hsa-miR-4772-3p	3.83	0.000145	0.15	0.17	Serum protein levels (sST2);	chr2:102319345	chr2:102432336~102432357:+
THCA	cis	rs7649443	0.959	rs10489880	MIMAT0019973	hsa-miR-4797-3p	3.83	0.000146	0.24	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197234315	chr3:197293888~197293908:-
THCA	cis	rs6120849	0.901	rs6060273	MIMAT0004772	hsa-miR-499a-3p	-3.83	0.000146	-0.24	-0.17	Protein C levels;	chr20:35156520	chr20:34990445~34990466:+
THCA	cis	rs7649443	0.959	rs6782349	MIMAT0019973	hsa-miR-4797-3p	3.83	0.000146	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197221936	chr3:197293888~197293908:-
THCA	cis	rs7649443	0.959	rs2044861	MIMAT0019973	hsa-miR-4797-3p	3.83	0.000146	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197222693	chr3:197293888~197293908:-
THCA	cis	rs7649443	0.959	rs2044860	MIMAT0019973	hsa-miR-4797-3p	3.83	0.000146	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197222999	chr3:197293888~197293908:-
THCA	cis	rs6841433	0.615	rs35082726	MIMAT0003242	hsa-miR-577	3.83	0.000148	0.24	0.17	Hemoglobin concentration;	chr4:114566777	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.571	rs17047238	MIMAT0003242	hsa-miR-577	3.83	0.000148	0.24	0.17	Hemoglobin concentration;	chr4:114568870	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs13144260	MIMAT0003242	hsa-miR-577	3.83	0.000148	0.24	0.17	Hemoglobin concentration;	chr4:114573271	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs12642541	MIMAT0003242	hsa-miR-577	3.83	0.000148	0.24	0.17	Hemoglobin concentration;	chr4:114579576	chr4:114656774~114656794:+
THCA	cis	rs6681460	0.966	rs4655506	MIMAT0014979	hsa-miR-3117-3p	-3.83	0.000148	-0.22	-0.17	Presence of antiphospholipid antibodies;	chr1:66685128	chr1:66628485~66628505:+
THCA	cis	rs953492	0.644	rs3896337	MIMAT0019761	hsa-miR-4677-3p	-3.83	0.000148	-0.19	-0.17	Diastolic blood pressure;	chr1:243250764	chr1:243346225~243346246:+
THCA	cis	rs4919694	0.615	rs78384860	MIMAT0005951	hsa-miR-1307-3p	3.83	0.000148	0.21	0.17	Arsenic metabolism;	chr10:103243262	chr10:103394301~103394322:-
THCA	cis	rs3850699	0.666	rs7905481	MIMAT0005951	hsa-miR-1307-3p	3.82	0.000148	0.13	0.17	Prostate cancer;	chr10:102716535	chr10:103394301~103394322:-
THCA	cis	rs6537837	0.838	rs12023950	MIMAT0000227	hsa-miR-197-3p	-3.82	0.000149	-0.16	-0.17	Major depressive disorder;	chr1:109557236	chr1:109598940~109598961:+
THCA	cis	rs7649443	0.704	rs34381158	MIMAT0019973	hsa-miR-4797-3p	3.82	0.00015	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197219776	chr3:197293888~197293908:-
THCA	cis	rs999943	0.774	rs12212284	MIMAT0018349	hsa-miR-3934-5p	-3.82	0.00015	-0.25	-0.17	Obesity (extreme);	chr6:33673097	chr6:33698152~33698173:+
THCA	cis	rs10851411	0.647	rs17765354	MIMAT0026623	hsa-miR-627-3p	-3.82	0.000152	-0.31	-0.17	Glucose homeostasis traits;	chr15:42426719	chr15:42199593~42199612:-
THCA	cis	rs10851411	0.647	rs3742999	MIMAT0026623	hsa-miR-627-3p	-3.82	0.000153	-0.31	-0.17	Glucose homeostasis traits;	chr15:42424383	chr15:42199593~42199612:-
THCA	cis	rs4919687	0.55	rs12780827	MIMAT0005951	hsa-miR-1307-3p	3.82	0.000153	0.13	0.17	Colorectal cancer;	chr10:102708197	chr10:103394301~103394322:-
THCA	cis	rs6537837	0.838	rs71657105	MIMAT0000227	hsa-miR-197-3p	-3.82	0.000154	-0.16	-0.17	Major depressive disorder;	chr1:109571500	chr1:109598940~109598961:+
THCA	cis	rs950880	0.542	rs1420091	MIMAT0019927	hsa-miR-4772-3p	3.81	0.000155	0.15	0.17	Serum protein levels (sST2);	chr2:102300774	chr2:102432336~102432357:+
THCA	cis	rs950880	0.56	rs4399750	MIMAT0019927	hsa-miR-4772-3p	3.81	0.000155	0.15	0.17	Serum protein levels (sST2);	chr2:102301328	chr2:102432336~102432357:+
THCA	cis	rs6681460	1	rs6656912	MIMAT0014979	hsa-miR-3117-3p	-3.81	0.000156	-0.21	-0.17	Presence of antiphospholipid antibodies;	chr1:66617988	chr1:66628485~66628505:+
THCA	cis	rs6681460	0.866	rs1856318	MIMAT0014979	hsa-miR-3117-3p	-3.81	0.000156	-0.22	-0.17	Presence of antiphospholipid antibodies;	chr1:66558532	chr1:66628485~66628505:+
THCA	cis	rs12712133	0.552	rs10469856	MIMAT0019927	hsa-miR-4772-3p	-3.81	0.000156	-0.16	-0.17	Primary biliary cholangitis;	chr2:102272369	chr2:102432336~102432357:+
THCA	cis	rs2274459	0.778	rs2281917	MIMAT0018349	hsa-miR-3934-5p	3.81	0.000157	0.25	0.17	Obesity (extreme);	chr6:33687951	chr6:33698152~33698173:+
THCA	cis	rs953492	0.7	rs3904682	MIMAT0019761	hsa-miR-4677-3p	-3.81	0.000157	-0.19	-0.17	Diastolic blood pressure;	chr1:243256127	chr1:243346225~243346246:+
THCA	cis	rs4919694	0.667	rs117927731	MIMAT0005951	hsa-miR-1307-3p	3.81	0.000158	0.19	0.17	Arsenic metabolism;	chr10:103353095	chr10:103394301~103394322:-
THCA	cis	rs6681460	0.866	rs485521	MIMAT0014979	hsa-miR-3117-3p	3.81	0.000158	0.21	0.17	Presence of antiphospholipid antibodies;	chr1:66743879	chr1:66628485~66628505:+
THCA	cis	rs7649443	0.917	rs13077565	MIMAT0019973	hsa-miR-4797-3p	3.81	0.000159	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197239949	chr3:197293888~197293908:-
THCA	cis	rs4711350	0.734	rs4713676	MIMAT0022975	hsa-miR-3934-3p	3.81	0.000159	0.22	0.17	Schizophrenia;	chr6:33754321	chr6:33698191~33698212:+
THCA	cis	rs6555855	0.83	rs1592817	MIMAT0026618	hsa-miR-585-5p	3.81	0.000159	0.24	0.17	Menarche (age at onset);	chr5:169317298	chr5:169263649~169263670:-
THCA	cis	rs7829975	0.711	rs12682352	MIMAT0019728	hsa-miR-4660	3.81	0.000159	0.22	0.17	Mood instability;	chr8:8788736	chr8:9048453~9048475:+
THCA	cis	rs7649443	0.959	rs4491876	MIMAT0019973	hsa-miR-4797-3p	3.81	0.00016	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197190701	chr3:197293888~197293908:-
THCA	cis	rs7649443	0.959	rs3821714	MIMAT0019973	hsa-miR-4797-3p	3.81	0.00016	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197191199	chr3:197293888~197293908:-
THCA	cis	rs7649443	0.959	rs34207201	MIMAT0019973	hsa-miR-4797-3p	3.81	0.00016	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197195220	chr3:197293888~197293908:-
THCA	cis	rs6951245	0.608	rs10252234	MIMAT0004702	hsa-miR-339-3p	-3.81	0.00016	-0.18	-0.17	C-reactive protein levels or total cholesterol levels (pleiotropy);	chr7:1074745	chr7:1022955~1022977:-
THCA	cis	rs7649443	0.959	rs7624764	MIMAT0019973	hsa-miR-4797-3p	3.81	0.00016	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197244326	chr3:197293888~197293908:-
THCA	cis	rs72819454	0.522	rs11191803	MIMAT0022727	hsa-miR-1307-5p	3.81	0.00016	0.21	0.17	Interleukin-9 levels;	chr10:103775289	chr10:103394341~103394361:-
THCA	cis	rs74233809	0.591	rs284853	MIMAT0022727	hsa-miR-1307-5p	3.8	0.000161	0.18	0.17	Birth weight;	chr10:102814885	chr10:103394341~103394361:-
THCA	cis	rs2274459	0.841	rs35698850	MIMAT0022975	hsa-miR-3934-3p	3.8	0.000161	0.25	0.17	Obesity (extreme);	chr6:33732355	chr6:33698191~33698212:+
THCA	cis	rs977145	0.868	rs1112456	MIMAT0000456	hsa-miR-186-5p	3.8	0.000162	0.11	0.17	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71486072	chr1:71067681~71067702:-
THCA	cis	rs3850699	0.886	rs12773833	MIMAT0005951	hsa-miR-1307-3p	3.8	0.000163	0.13	0.17	Prostate cancer;	chr10:102658593	chr10:103394301~103394322:-
THCA	cis	rs4919694	1	rs11191439	MIMAT0005951	hsa-miR-1307-3p	-3.8	0.000163	-0.21	-0.17	Arsenic metabolism;	chr10:102878966	chr10:103394301~103394322:-
THCA	cis	rs7829975	0.564	rs2921057	MIMAT0019728	hsa-miR-4660	3.8	0.000165	0.23	0.17	Mood instability;	chr8:8461157	chr8:9048453~9048475:+
THCA	cis	rs953492	0.517	rs2247527	MIMAT0019761	hsa-miR-4677-3p	3.8	0.000165	0.19	0.17	Diastolic blood pressure;	chr1:243146681	chr1:243346225~243346246:+
THCA	cis	rs1870653	0.516	rs73848130	MIMAT0003242	hsa-miR-577	3.8	0.000166	0.3	0.17	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);	chr4:114489234	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs12641516	MIMAT0003242	hsa-miR-577	3.79	0.000168	0.24	0.17	Hemoglobin concentration;	chr4:114556972	chr4:114656774~114656794:+
THCA	cis	rs4919694	1	rs17787717	MIMAT0005951	hsa-miR-1307-3p	3.79	0.000168	0.22	0.17	Arsenic metabolism;	chr10:102935942	chr10:103394301~103394322:-
THCA	cis	rs4919694	1	rs77318450	MIMAT0005951	hsa-miR-1307-3p	3.79	0.000168	0.22	0.17	Arsenic metabolism;	chr10:102973341	chr10:103394301~103394322:-
THCA	cis	rs6575793	0.532	rs11849489	MIMAT0004921	hsa-miR-889-3p	3.79	0.000169	0.11	0.17	Menarche (age at onset);	chr14:100571425	chr14:101047949~101047969:+
THCA	cis	rs7829975	0.84	rs572366	MIMAT0019728	hsa-miR-4660	3.79	0.000169	0.23	0.17	Mood instability;	chr8:8721284	chr8:9048453~9048475:+
THCA	cis	rs6841433	0.615	rs17047201	MIMAT0003242	hsa-miR-577	3.79	0.000169	0.24	0.17	Hemoglobin concentration;	chr4:114544945	chr4:114656774~114656794:+
THCA	cis	rs4919694	0.667	rs75890466	MIMAT0005951	hsa-miR-1307-3p	3.79	0.00017	0.2	0.17	Arsenic metabolism;	chr10:103316626	chr10:103394301~103394322:-
THCA	cis	rs6088590	0.93	rs6087618	MIMAT0004772	hsa-miR-499a-3p	-3.79	0.00017	-0.2	-0.17	Coronary artery disease;	chr20:34700603	chr20:34990445~34990466:+
THCA	cis	rs6088590	0.965	rs6087619	MIMAT0004772	hsa-miR-499a-3p	-3.79	0.00017	-0.2	-0.17	Coronary artery disease;	chr20:34700707	chr20:34990445~34990466:+
THCA	cis	rs4919694	1	rs77969925	MIMAT0005951	hsa-miR-1307-3p	3.79	0.000171	0.2	0.17	Arsenic metabolism;	chr10:102889600	chr10:103394301~103394322:-
THCA	cis	rs6841433	0.615	rs10516604	MIMAT0003242	hsa-miR-577	3.79	0.000172	0.24	0.17	Hemoglobin concentration;	chr4:114546112	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs13135560	MIMAT0003242	hsa-miR-577	3.79	0.000172	0.24	0.17	Hemoglobin concentration;	chr4:114547331	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs35777558	MIMAT0003242	hsa-miR-577	3.79	0.000172	0.24	0.17	Hemoglobin concentration;	chr4:114548111	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs79776742	MIMAT0003242	hsa-miR-577	3.79	0.000172	0.24	0.17	Hemoglobin concentration;	chr4:114550195	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs57059575	MIMAT0003242	hsa-miR-577	3.79	0.000172	0.24	0.17	Hemoglobin concentration;	chr4:114551237	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs13147106	MIMAT0003242	hsa-miR-577	3.79	0.000172	0.24	0.17	Hemoglobin concentration;	chr4:114552206	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs13147485	MIMAT0003242	hsa-miR-577	3.79	0.000172	0.24	0.17	Hemoglobin concentration;	chr4:114552321	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs35252674	MIMAT0003242	hsa-miR-577	3.79	0.000172	0.24	0.17	Hemoglobin concentration;	chr4:114556583	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs71606719	MIMAT0003242	hsa-miR-577	3.79	0.000172	0.24	0.17	Hemoglobin concentration;	chr4:114557814	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.511	rs13125495	MIMAT0003242	hsa-miR-577	3.79	0.000172	0.24	0.17	Hemoglobin concentration;	chr4:114558326	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.571	rs13129837	MIMAT0003242	hsa-miR-577	3.79	0.000172	0.24	0.17	Hemoglobin concentration;	chr4:114563925	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs1380932	MIMAT0003242	hsa-miR-577	3.79	0.000172	0.24	0.17	Hemoglobin concentration;	chr4:114565923	chr4:114656774~114656794:+
THCA	cis	rs9807989	0.839	rs4988955	MIMAT0019927	hsa-miR-4772-3p	-3.79	0.000173	-0.17	-0.17	Asthma;	chr2:102351468	chr2:102432336~102432357:+
THCA	cis	rs4919687	0.55	rs17784294	MIMAT0005951	hsa-miR-1307-3p	3.79	0.000173	0.13	0.17	Colorectal cancer;	chr10:102719628	chr10:103394301~103394322:-
THCA	cis	rs4919694	1	rs75219158	MIMAT0005951	hsa-miR-1307-3p	3.78	0.000174	0.22	0.17	Arsenic metabolism;	chr10:102987837	chr10:103394301~103394322:-
THCA	cis	rs6841433	0.615	rs17047198	MIMAT0003242	hsa-miR-577	3.78	0.000174	0.24	0.17	Hemoglobin concentration;	chr4:114544338	chr4:114656774~114656794:+
THCA	cis	rs6681460	0.834	rs2916	MIMAT0014979	hsa-miR-3117-3p	3.78	0.000174	0.21	0.17	Presence of antiphospholipid antibodies;	chr1:66751014	chr1:66628485~66628505:+
THCA	cis	rs6681460	0.834	rs1280310	MIMAT0014979	hsa-miR-3117-3p	3.78	0.000174	0.21	0.17	Presence of antiphospholipid antibodies;	chr1:66751140	chr1:66628485~66628505:+
THCA	cis	rs6120849	0.901	rs6088739	MIMAT0004772	hsa-miR-499a-3p	-3.78	0.000174	-0.24	-0.17	Protein C levels;	chr20:35160921	chr20:34990445~34990466:+
THCA	cis	rs7649443	0.918	rs7619429	MIMAT0019973	hsa-miR-4797-3p	3.78	0.000175	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197272219	chr3:197293888~197293908:-
THCA	cis	rs7649443	0.959	rs1073726	MIMAT0019973	hsa-miR-4797-3p	3.78	0.000175	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197274137	chr3:197293888~197293908:-
THCA	cis	rs7649443	0.959	rs34121928	MIMAT0019973	hsa-miR-4797-3p	3.78	0.000175	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197275998	chr3:197293888~197293908:-
THCA	cis	rs7649443	0.959	rs6779689	MIMAT0019973	hsa-miR-4797-3p	3.78	0.000175	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197287302	chr3:197293888~197293908:-
THCA	cis	rs7649443	0.758	rs34305944	MIMAT0019973	hsa-miR-4797-3p	3.78	0.000175	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197288547	chr3:197293888~197293908:-
THCA	cis	rs7649443	0.917	rs6782876	MIMAT0019973	hsa-miR-4797-3p	3.78	0.000175	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197294275	chr3:197293888~197293908:-
THCA	cis	rs10021731	0.645	rs7698524	MIMAT0003242	hsa-miR-577	-3.78	0.000175	-0.18	-0.17	Optic disc area;	chr4:114492417	chr4:114656774~114656794:+
THCA	cis	rs4919669	0.668	rs10786701	MIMAT0005951	hsa-miR-1307-3p	-3.78	0.000175	-0.18	-0.17	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102652551	chr10:103394301~103394322:-
THCA	cis	rs2048672	0.816	rs7798603	MIMAT0004503	hsa-miR-29a-5p	-3.78	0.000176	-0.12	-0.17	Breast cancer;	chr7:130968768	chr7:130876786~130876807:-
THCA	cis	rs12712133	0.552	rs10200945	MIMAT0019927	hsa-miR-4772-3p	3.78	0.000178	0.16	0.17	Primary biliary cholangitis;	chr2:102268297	chr2:102432336~102432357:+
THCA	cis	rs10021731	0.809	rs7655987	MIMAT0003242	hsa-miR-577	3.78	0.000179	0.18	0.17	Optic disc area;	chr4:114596146	chr4:114656774~114656794:+
THCA	cis	rs950880	0.56	rs4090473	MIMAT0019927	hsa-miR-4772-3p	3.78	0.000179	0.15	0.17	Serum protein levels (sST2);	chr2:102306527	chr2:102432336~102432357:+
THCA	cis	rs950880	0.56	rs1420090	MIMAT0019927	hsa-miR-4772-3p	3.78	0.000179	0.15	0.17	Serum protein levels (sST2);	chr2:102302845	chr2:102432336~102432357:+
THCA	cis	rs950880	0.56	rs7565653	MIMAT0019927	hsa-miR-4772-3p	3.78	0.000179	0.15	0.17	Serum protein levels (sST2);	chr2:102302966	chr2:102432336~102432357:+
THCA	cis	rs7649443	0.959	rs2341184	MIMAT0019973	hsa-miR-4797-3p	3.78	0.00018	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197203910	chr3:197293888~197293908:-
THCA	cis	rs7649443	1	rs7649443	MIMAT0019973	hsa-miR-4797-3p	3.78	0.00018	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197204950	chr3:197293888~197293908:-
THCA	cis	rs7649443	0.959	rs12632727	MIMAT0019973	hsa-miR-4797-3p	3.78	0.00018	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197205191	chr3:197293888~197293908:-
THCA	cis	rs7819412	0.502	rs4841499	MIMAT0003266	hsa-miR-598-3p	3.77	0.000181	0.16	0.17	Triglycerides;	chr8:11130628	chr8:11035221~11035242:-
THCA	cis	rs6841433	0.615	rs34948407	MIMAT0003242	hsa-miR-577	3.77	0.000181	0.24	0.17	Hemoglobin concentration;	chr4:114575280	chr4:114656774~114656794:+
THCA	cis	rs17604090	0.529	rs2392128	MIMAT0004800	hsa-miR-550a-5p	-3.77	0.000181	-0.21	-0.17	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29671523	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.529	rs2392128	MIMAT0004800_1	hsa-miR-550a-5p	-3.77	0.000181	-0.21	-0.17	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29671523	chr7:32733002~32733024:+
THCA	cis	rs7819412	0.54	rs2409725	MIMAT0003266	hsa-miR-598-3p	3.77	0.000182	0.16	0.17	Triglycerides;	chr8:11184152	chr8:11035221~11035242:-
THCA	cis	rs7819412	0.54	rs2409726	MIMAT0003266	hsa-miR-598-3p	3.77	0.000182	0.16	0.17	Triglycerides;	chr8:11185629	chr8:11035221~11035242:-
THCA	cis	rs6841433	0.615	rs13136602	MIMAT0003242	hsa-miR-577	3.77	0.000182	0.24	0.17	Hemoglobin concentration;	chr4:114541864	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs12649943	MIMAT0003242	hsa-miR-577	3.77	0.000182	0.24	0.17	Hemoglobin concentration;	chr4:114542460	chr4:114656774~114656794:+
THCA	cis	rs72819454	0.522	rs55909417	MIMAT0022727	hsa-miR-1307-5p	3.77	0.000182	0.2	0.17	Interleukin-9 levels;	chr10:103767403	chr10:103394341~103394361:-
THCA	cis	rs950880	0.56	rs1558620	MIMAT0019927	hsa-miR-4772-3p	3.77	0.000183	0.15	0.17	Serum protein levels (sST2);	chr2:102314935	chr2:102432336~102432357:+
THCA	cis	rs3850699	0.886	rs12773600	MIMAT0005951	hsa-miR-1307-3p	3.77	0.000183	0.14	0.17	Prostate cancer;	chr10:102658471	chr10:103394301~103394322:-
THCA	cis	rs6011674	1	rs6011674	MIMAT0016888	hsa-miR-4326	3.77	0.000184	0.3	0.17	Response to cytadine analogues (cytosine arabinoside);	chr20:63223100	chr20:63286818~63286837:+
THCA	cis	rs10851411	0.697	rs11544099	MIMAT0026623	hsa-miR-627-3p	-3.77	0.000184	-0.31	-0.17	Glucose homeostasis traits;	chr15:42428090	chr15:42199593~42199612:-
THCA	cis	rs10851411	0.606	rs62022306	MIMAT0026623	hsa-miR-627-3p	-3.77	0.000184	-0.31	-0.17	Glucose homeostasis traits;	chr15:42430760	chr15:42199593~42199612:-
THCA	cis	rs6841433	0.615	rs77422558	MIMAT0003242	hsa-miR-577	3.77	0.000184	0.24	0.17	Hemoglobin concentration;	chr4:114540944	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs17047239	MIMAT0003242	hsa-miR-577	3.77	0.000185	0.24	0.17	Hemoglobin concentration;	chr4:114570559	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.571	rs17047244	MIMAT0003242	hsa-miR-577	3.77	0.000185	0.24	0.17	Hemoglobin concentration;	chr4:114571532	chr4:114656774~114656794:+
THCA	cis	rs4919687	0.679	rs12762176	MIMAT0005951	hsa-miR-1307-3p	3.77	0.000185	0.13	0.17	Colorectal cancer;	chr10:102739475	chr10:103394301~103394322:-
THCA	cis	rs4919687	0.577	rs12765459	MIMAT0005951	hsa-miR-1307-3p	3.77	0.000186	0.14	0.17	Colorectal cancer;	chr10:102705930	chr10:103394301~103394322:-
THCA	cis	rs4919694	0.536	rs12256506	MIMAT0005951	hsa-miR-1307-3p	3.77	0.000186	0.18	0.17	Arsenic metabolism;	chr10:103203861	chr10:103394301~103394322:-
THCA	cis	rs7649443	0.876	rs12630261	MIMAT0019973	hsa-miR-4797-3p	3.77	0.000186	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197198405	chr3:197293888~197293908:-
THCA	cis	rs4800353	0.684	rs4633811	MIMAT0000427	hsa-miR-133a-3p	-3.77	0.000187	-0.23	-0.17	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:21986609	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.684	rs4633811	MIMAT0000427_1	hsa-miR-133a-3p	-3.77	0.000187	-0.23	-0.17	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:21986609	chr20:62564970~62564991:+
THCA	cis	rs6841433	0.615	rs6813229	MIMAT0003242	hsa-miR-577	3.77	0.000187	0.24	0.17	Hemoglobin concentration;	chr4:114582721	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.571	rs6839189	MIMAT0003242	hsa-miR-577	3.77	0.000187	0.24	0.17	Hemoglobin concentration;	chr4:114582848	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs35789595	MIMAT0003242	hsa-miR-577	3.77	0.000187	0.24	0.17	Hemoglobin concentration;	chr4:114594055	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.571	rs35578985	MIMAT0003242	hsa-miR-577	3.77	0.000187	0.24	0.17	Hemoglobin concentration;	chr4:114594500	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs34001486	MIMAT0003242	hsa-miR-577	3.77	0.000187	0.24	0.17	Hemoglobin concentration;	chr4:114594792	chr4:114656774~114656794:+
THCA	cis	rs72819454	0.579	rs2013456	MIMAT0022727	hsa-miR-1307-5p	3.76	0.000189	0.2	0.17	Interleukin-9 levels;	chr10:103771634	chr10:103394341~103394361:-
THCA	cis	rs6841433	0.615	rs17047246	MIMAT0003242	hsa-miR-577	3.76	0.00019	0.24	0.17	Hemoglobin concentration;	chr4:114571876	chr4:114656774~114656794:+
THCA	cis	rs9394169	0.536	rs3998115	MIMAT0022975	hsa-miR-3934-3p	-3.76	0.00019	-0.19	-0.17	Essential tremor;	chr6:33817056	chr6:33698191~33698212:+
THCA	cis	rs751728	0.965	rs756137	MIMAT0018349	hsa-miR-3934-5p	-3.76	0.00019	-0.21	-0.17	Crohn's disease;	chr6:33788113	chr6:33698152~33698173:+
THCA	cis	rs751728	0.965	rs4713683	MIMAT0018349	hsa-miR-3934-5p	-3.76	0.00019	-0.21	-0.17	Crohn's disease;	chr6:33789773	chr6:33698152~33698173:+
THCA	cis	rs4800353	0.684	rs9951554	MIMAT0000427	hsa-miR-133a-3p	-3.76	0.00019	-0.23	-0.17	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22003969	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.684	rs9951554	MIMAT0000427_1	hsa-miR-133a-3p	-3.76	0.00019	-0.23	-0.17	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22003969	chr20:62564970~62564991:+
THCA	cis	rs7649443	0.959	rs10461048	MIMAT0019973	hsa-miR-4797-3p	3.76	0.00019	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197226420	chr3:197293888~197293908:-
THCA	cis	rs953492	0.701	rs1796846	MIMAT0019761	hsa-miR-4677-3p	-3.76	0.000191	-0.18	-0.17	Diastolic blood pressure;	chr1:243143622	chr1:243346225~243346246:+
THCA	cis	rs74233809	0.636	rs284861	MIMAT0005951	hsa-miR-1307-3p	3.76	0.000191	0.16	0.17	Birth weight;	chr10:102812519	chr10:103394301~103394322:-
THCA	cis	rs6537837	0.838	rs6663547	MIMAT0000227	hsa-miR-197-3p	-3.76	0.000192	-0.16	-0.17	Major depressive disorder;	chr1:109571607	chr1:109598940~109598961:+
THCA	cis	rs4919694	0.901	rs74376228	MIMAT0005951	hsa-miR-1307-3p	3.76	0.000192	0.22	0.17	Arsenic metabolism;	chr10:102917905	chr10:103394301~103394322:-
THCA	cis	rs3850699	0.926	rs12262998	MIMAT0005951	hsa-miR-1307-3p	3.76	0.000192	0.13	0.17	Prostate cancer;	chr10:102668959	chr10:103394301~103394322:-
THCA	cis	rs10021731	0.756	rs35235288	MIMAT0003242	hsa-miR-577	-3.76	0.000193	-0.18	-0.17	Optic disc area;	chr4:114547620	chr4:114656774~114656794:+
THCA	cis	rs7649443	0.959	rs13081715	MIMAT0019973	hsa-miR-4797-3p	3.76	0.000193	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197180419	chr3:197293888~197293908:-
THCA	cis	rs7649443	0.759	rs6805920	MIMAT0019973	hsa-miR-4797-3p	3.76	0.000193	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197235458	chr3:197293888~197293908:-
THCA	cis	rs17109512	0.826	rs4619078	MIMAT0005878	hsa-miR-1287-5p	3.76	0.000193	0.31	0.17	Aspartate aminotransferase levels;	chr10:98391904	chr10:98395271~98395292:-
THCA	cis	rs7649443	0.921	rs35624335	MIMAT0019973	hsa-miR-4797-3p	3.76	0.000194	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197156210	chr3:197293888~197293908:-
THCA	cis	rs4917833	0.51	rs754586	MIMAT0005878	hsa-miR-1287-5p	-3.75	0.000195	-0.14	-0.17	Pediatric bone mineral density (femoral neck);	chr10:98464605	chr10:98395271~98395292:-
THCA	cis	rs12712133	0.552	rs11123915	MIMAT0019927	hsa-miR-4772-3p	3.75	0.000195	0.15	0.17	Primary biliary cholangitis;	chr2:102264363	chr2:102432336~102432357:+
THCA	cis	rs7819412	0.521	rs10100660	MIMAT0003266	hsa-miR-598-3p	3.75	0.000196	0.16	0.17	Triglycerides;	chr8:11181376	chr8:11035221~11035242:-
THCA	cis	rs4800353	0.673	rs16961918	MIMAT0000427	hsa-miR-133a-3p	-3.75	0.000197	-0.22	-0.17	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:21998093	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.673	rs16961918	MIMAT0000427_1	hsa-miR-133a-3p	-3.75	0.000197	-0.22	-0.17	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:21998093	chr20:62564970~62564991:+
THCA	cis	rs6555855	0.909	rs4432908	MIMAT0026618	hsa-miR-585-5p	3.75	0.000198	0.26	0.17	Menarche (age at onset);	chr5:169294188	chr5:169263649~169263670:-
THCA	cis	rs7829975	0.627	rs876954	MIMAT0019728	hsa-miR-4660	3.75	0.000199	0.23	0.17	Mood instability;	chr8:8453413	chr8:9048453~9048475:+
THCA	cis	rs953492	0.644	rs12145759	MIMAT0019761	hsa-miR-4677-3p	-3.75	0.000199	-0.19	-0.17	Diastolic blood pressure;	chr1:243248103	chr1:243346225~243346246:+
THCA	cis	rs6841433	0.615	rs6813283	MIMAT0003242	hsa-miR-577	3.75	2e-04	0.24	0.17	Hemoglobin concentration;	chr4:114582806	chr4:114656774~114656794:+
THCA	cis	rs12712133	0.552	rs1115281	MIMAT0019927	hsa-miR-4772-3p	3.75	0.000201	0.16	0.17	Primary biliary cholangitis;	chr2:102274647	chr2:102432336~102432357:+
THCA	cis	rs7477	0.652	rs9890867	MIMAT0005942	hsa-miR-1288-3p	3.75	0.000201	0.23	0.17	Amyotrophic lateral sclerosis;	chr17:16327176	chr17:16282058~16282078:+
THCA	cis	rs10947487	0.623	rs4713777	MIMAT0005929	hsa-miR-1275	3.75	0.000202	0.27	0.17	Body mass index;	chr6:34412360	chr6:34000018~34000034:-
THCA	cis	rs6555855	0.909	rs6896194	MIMAT0026618	hsa-miR-585-5p	3.74	0.000203	0.26	0.17	Menarche (age at onset);	chr5:169294044	chr5:169263649~169263670:-
THCA	cis	rs7385804	0.761	rs507392	MIMAT0027650	hsa-miR-6875-5p	3.74	0.000203	0.23	0.17	Iron status biomarkers (iron levels);Iron status biomarkers (transferrin saturation);Hematocrit;Mean corpuscular hemoglobin;Hematological parameters;Red blood cell count;Mean corpuscular volume;Iron status biomarkers;	chr7:100722313	chr7:100868041~100868061:+
THCA	cis	rs4800353	0.673	rs7234874	MIMAT0000427	hsa-miR-133a-3p	-3.74	0.000204	-0.22	-0.17	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:21985067	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.673	rs7234874	MIMAT0000427_1	hsa-miR-133a-3p	-3.74	0.000204	-0.22	-0.17	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:21985067	chr20:62564970~62564991:+
THCA	cis	rs7649443	0.842	rs6797085	MIMAT0019973	hsa-miR-4797-3p	3.74	0.000204	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197221457	chr3:197293888~197293908:-
THCA	cis	rs4919669	0.668	rs11191359	MIMAT0005951	hsa-miR-1307-3p	-3.74	0.000207	-0.18	-0.17	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102641729	chr10:103394301~103394322:-
THCA	cis	rs2494663	0.61	rs11265099	MIMAT0022491	hsa-miR-5698	-3.74	0.000207	-0.22	-0.17	Mean platelet volume;	chr1:154108481	chr1:154104562~154104583:-
THCA	cis	rs10099338	0.63	rs57653855	MIMAT0019728	hsa-miR-4660	-3.74	0.000207	-0.3	-0.17	Glomerular filtration rate;	chr8:9394838	chr8:9048453~9048475:+
THCA	cis	rs62084913	0.511	rs895690	MIMAT0017994	hsa-miR-3615	-3.74	0.00021	-0.18	-0.17	Breast cancer;	chr17:74788510	chr17:74748663~74748683:+
THCA	cis	rs6575793	0.553	rs7140556	MIMAT0004921	hsa-miR-889-3p	3.74	0.00021	0.1	0.17	Menarche (age at onset);	chr14:100570121	chr14:101047949~101047969:+
THCA	cis	rs6841433	0.615	rs17047236	MIMAT0003242	hsa-miR-577	3.73	0.000213	0.24	0.17	Hemoglobin concentration;	chr4:114564575	chr4:114656774~114656794:+
THCA	cis	rs999943	0.846	rs9348923	MIMAT0022975	hsa-miR-3934-3p	-3.73	0.000213	-0.21	-0.17	Obesity (extreme);	chr6:33650147	chr6:33698191~33698212:+
THCA	cis	rs2274459	0.749	rs2281831	MIMAT0022975	hsa-miR-3934-3p	3.73	0.000213	0.25	0.17	Obesity (extreme);	chr6:33728038	chr6:33698191~33698212:+
THCA	cis	rs17604090	0.887	rs7795109	MIMAT0004800	hsa-miR-550a-5p	3.73	0.000214	0.24	0.17	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29626628	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.887	rs7795109	MIMAT0004800_1	hsa-miR-550a-5p	3.73	0.000214	0.24	0.17	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29626628	chr7:32733002~32733024:+
THCA	cis	rs4146429	0.527	rs17114534	MIMAT0005951	hsa-miR-1307-3p	-3.73	0.000215	-0.16	-0.17	Body mass index (joint analysis main effects and physical activity interaction);Body mass index in physically active individuals;Body mass index;	chr10:102461772	chr10:103394301~103394322:-
THCA	cis	rs1468333	0.964	rs10479180	MIMAT0026718	hsa-miR-874-5p	-3.73	0.000216	-0.13	-0.17	Resting heart rate;	chr5:138246212	chr5:137647618~137647640:-
THCA	cis	rs7649443	0.759	rs13066853	MIMAT0019973	hsa-miR-4797-3p	3.73	0.000217	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197180445	chr3:197293888~197293908:-
THCA	cis	rs7829975	0.871	rs7829826	MIMAT0019728	hsa-miR-4660	-3.73	0.000218	-0.22	-0.17	Mood instability;	chr8:8720610	chr8:9048453~9048475:+
THCA	cis	rs10099338	1	rs7828601	MIMAT0019728	hsa-miR-4660	-3.72	0.000219	-0.3	-0.17	Glomerular filtration rate;	chr8:9395665	chr8:9048453~9048475:+
THCA	cis	rs6681460	0.8	rs485543	MIMAT0014979	hsa-miR-3117-3p	3.72	0.000222	0.21	0.17	Presence of antiphospholipid antibodies;	chr1:66728689	chr1:66628485~66628505:+
THCA	cis	rs7649443	0.959	rs6782621	MIMAT0019973	hsa-miR-4797-3p	3.72	0.000222	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197112157	chr3:197293888~197293908:-
THCA	cis	rs7649443	0.921	rs12631361	MIMAT0019973	hsa-miR-4797-3p	3.72	0.000222	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197114703	chr3:197293888~197293908:-
THCA	cis	rs10099338	0.822	rs17149962	MIMAT0019728	hsa-miR-4660	-3.72	0.000223	-0.31	-0.17	Glomerular filtration rate;	chr8:9389224	chr8:9048453~9048475:+
THCA	cis	rs6088590	1	rs2378256	MIMAT0004772	hsa-miR-499a-3p	-3.72	0.000224	-0.2	-0.17	Coronary artery disease;	chr20:34704323	chr20:34990445~34990466:+
THCA	cis	rs6088590	0.965	rs910869	MIMAT0004772	hsa-miR-499a-3p	-3.72	0.000224	-0.2	-0.17	Coronary artery disease;	chr20:34704973	chr20:34990445~34990466:+
THCA	cis	rs9527	0.535	rs4917999	MIMAT0022727	hsa-miR-1307-5p	-3.72	0.000224	-0.15	-0.17	Arsenic metabolism;	chr10:103203294	chr10:103394341~103394361:-
THCA	cis	rs2274459	1	rs12199132	MIMAT0022975	hsa-miR-3934-3p	3.72	0.000224	0.25	0.17	Obesity (extreme);	chr6:33740473	chr6:33698191~33698212:+
THCA	cis	rs6841433	0.615	rs79261962	MIMAT0003242	hsa-miR-577	3.72	0.000227	0.24	0.17	Hemoglobin concentration;	chr4:114539953	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.571	rs12649041	MIMAT0003242	hsa-miR-577	3.72	0.000227	0.24	0.17	Hemoglobin concentration;	chr4:114541220	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs12649963	MIMAT0003242	hsa-miR-577	3.72	0.000227	0.24	0.17	Hemoglobin concentration;	chr4:114542537	chr4:114656774~114656794:+
THCA	cis	rs12145833	1	rs12145004	MIMAT0019761	hsa-miR-4677-3p	3.71	0.000228	0.27	0.17	Obesity (early onset extreme);	chr1:243320063	chr1:243346225~243346246:+
THCA	cis	rs6918981	0.539	rs7768978	MIMAT0005929	hsa-miR-1275	-3.71	0.000229	-0.21	-0.17	Height;	chr6:34436859	chr6:34000018~34000034:-
THCA	cis	rs1468333	0.964	rs10479180	MIMAT0004911	hsa-miR-874-3p	-3.71	0.00023	-0.11	-0.17	Resting heart rate;	chr5:138246212	chr5:137647582~137647603:-
THCA	cis	rs4800353	0.673	rs4800342	MIMAT0000427	hsa-miR-133a-3p	-3.71	0.000231	-0.22	-0.17	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:21990659	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.673	rs4800342	MIMAT0000427_1	hsa-miR-133a-3p	-3.71	0.000231	-0.22	-0.17	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:21990659	chr20:62564970~62564991:+
THCA	cis	rs7897654	0.651	rs12783467	MIMAT0022727	hsa-miR-1307-5p	3.71	0.000232	0.16	0.17	Schizophrenia;	chr10:102948555	chr10:103394341~103394361:-
THCA	cis	rs4919694	0.711	rs113361908	MIMAT0005951	hsa-miR-1307-3p	3.71	0.000233	0.2	0.17	Arsenic metabolism;	chr10:103218369	chr10:103394301~103394322:-
THCA	cis	rs10021731	0.756	rs28787070	MIMAT0003242	hsa-miR-577	-3.71	0.000233	-0.18	-0.17	Optic disc area;	chr4:114556918	chr4:114656774~114656794:+
THCA	cis	rs7385804	0.727	rs551238	MIMAT0027650	hsa-miR-6875-5p	3.71	0.000233	0.23	0.17	Iron status biomarkers (iron levels);Iron status biomarkers (transferrin saturation);Hematocrit;Mean corpuscular hemoglobin;Hematological parameters;Red blood cell count;Mean corpuscular volume;Iron status biomarkers;	chr7:100723905	chr7:100868041~100868061:+
THCA	cis	rs6841433	0.615	rs57930571	MIMAT0003242	hsa-miR-577	3.71	0.000235	0.24	0.17	Hemoglobin concentration;	chr4:114580433	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs35732213	MIMAT0003242	hsa-miR-577	3.71	0.000235	0.24	0.17	Hemoglobin concentration;	chr4:114581427	chr4:114656774~114656794:+
THCA	cis	rs6841433	0.615	rs35936834	MIMAT0003242	hsa-miR-577	3.71	0.000235	0.24	0.17	Hemoglobin concentration;	chr4:114581520	chr4:114656774~114656794:+
THCA	cis	rs1760803	0.574	rs12408458	MIMAT0022491	hsa-miR-5698	-3.7	0.000238	-0.21	-0.17	Nicotine dependence;	chr1:154214442	chr1:154104562~154104583:-
THCA	cis	rs7829975	0.806	rs2428	MIMAT0019728	hsa-miR-4660	3.7	0.000238	0.21	0.17	Mood instability;	chr8:8783635	chr8:9048453~9048475:+
THCA	cis	rs4919687	0.55	rs12783444	MIMAT0005951	hsa-miR-1307-3p	3.7	0.000239	0.13	0.17	Colorectal cancer;	chr10:102720902	chr10:103394301~103394322:-
THCA	cis	rs4919669	0.719	rs12573474	MIMAT0005951	hsa-miR-1307-3p	-3.7	0.000239	-0.18	-0.17	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102633749	chr10:103394301~103394322:-
THCA	cis	rs7210990	0.764	rs9907313	MIMAT0005942	hsa-miR-1288-3p	3.7	0.00024	0.21	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16145776	chr17:16282058~16282078:+
THCA	cis	rs59372292	0.642	rs2277987	MIMAT0021017	hsa-miR-4999-5p	3.7	0.000242	0.25	0.17	Coronary artery disease;	chr19:8487389	chr19:8389340~8389360:-
THCA	cis	rs4919669	0.719	rs17114803	MIMAT0005951	hsa-miR-1307-3p	-3.7	0.000242	-0.17	-0.17	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102627177	chr10:103394301~103394322:-
THCA	cis	rs7477	0.875	rs62074191	MIMAT0005942	hsa-miR-1288-3p	3.7	0.000243	0.22	0.17	Amyotrophic lateral sclerosis;	chr17:16341539	chr17:16282058~16282078:+
THCA	cis	rs2274459	0.778	rs2296737	MIMAT0018349	hsa-miR-3934-5p	3.7	0.000245	0.24	0.17	Obesity (extreme);	chr6:33688639	chr6:33698152~33698173:+
THCA	cis	rs79387448	0.745	rs74560841	MIMAT0019927	hsa-miR-4772-3p	-3.69	0.000247	-0.24	-0.17	Gut microbiota (bacterial taxa);	chr2:102532751	chr2:102432336~102432357:+
THCA	cis	rs6681460	0.901	rs1373911	MIMAT0014979	hsa-miR-3117-3p	-3.69	0.000247	-0.21	-0.17	Presence of antiphospholipid antibodies;	chr1:66575382	chr1:66628485~66628505:+
THCA	cis	rs7477	0.818	rs3112524	MIMAT0005942	hsa-miR-1288-3p	3.69	0.000248	0.21	0.17	Amyotrophic lateral sclerosis;	chr17:16342464	chr17:16282058~16282078:+
THCA	cis	rs4919694	1	rs10509760	MIMAT0005951	hsa-miR-1307-3p	3.69	0.000248	0.21	0.17	Arsenic metabolism;	chr10:102874350	chr10:103394301~103394322:-
THCA	cis	rs7829975	0.711	rs4841051	MIMAT0019728	hsa-miR-4660	-3.69	0.00025	-0.22	-0.17	Mood instability;	chr8:8828136	chr8:9048453~9048475:+
THCA	cis	rs953492	0.644	rs10926976	MIMAT0019761	hsa-miR-4677-3p	-3.69	0.00025	-0.18	-0.17	Diastolic blood pressure;	chr1:243239419	chr1:243346225~243346246:+
THCA	cis	rs17604090	0.887	rs850013	MIMAT0004800	hsa-miR-550a-5p	3.69	0.000251	0.23	0.17	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29626914	chr7:30289815~30289837:+
THCA	cis	rs17604090	0.887	rs850013	MIMAT0004800_1	hsa-miR-550a-5p	3.69	0.000251	0.23	0.17	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29626914	chr7:32733002~32733024:+
THCA	cis	rs74233809	0.591	rs284853	MIMAT0005951	hsa-miR-1307-3p	3.69	0.000253	0.15	0.17	Birth weight;	chr10:102814885	chr10:103394301~103394322:-
THCA	cis	rs2274459	0.841	rs3818526	MIMAT0018349	hsa-miR-3934-5p	3.69	0.000254	0.24	0.17	Obesity (extreme);	chr6:33693196	chr6:33698152~33698173:+
THCA	cis	rs2921036	0.545	rs4840975	MIMAT0019728	hsa-miR-4660	-3.68	0.000256	-0.25	-0.17	Neuroticism;	chr8:8505748	chr8:9048453~9048475:+
THCA	cis	rs2274459	0.841	rs3818532	MIMAT0022975	hsa-miR-3934-3p	-3.68	0.000256	-0.24	-0.17	Obesity (extreme);	chr6:33712030	chr6:33698191~33698212:+
THCA	cis	rs4919694	1	rs76892505	MIMAT0005951	hsa-miR-1307-3p	3.68	0.000256	0.22	0.17	Arsenic metabolism;	chr10:102959533	chr10:103394301~103394322:-
THCA	cis	rs7829975	0.593	rs2921051	MIMAT0019728	hsa-miR-4660	3.68	0.000257	0.22	0.17	Mood instability;	chr8:8462594	chr8:9048453~9048475:+
THCA	cis	rs6681460	0.8	rs539014	MIMAT0014979	hsa-miR-3117-3p	3.68	0.000257	0.21	0.17	Presence of antiphospholipid antibodies;	chr1:66746204	chr1:66628485~66628505:+
THCA	cis	rs11976180	0.517	rs6949375	MIMAT0027684	hsa-miR-6892-5p	3.68	0.000257	0.25	0.17	Obesity-related traits;	chr7:144076758	chr7:143382686~143382706:+
THCA	cis	rs6703335	0.687	rs4658560	MIMAT0019761	hsa-miR-4677-3p	3.68	0.000258	0.18	0.17	Schizophrenia;Schizophrenia, schizoaffective disorder or bipolar disorder;	chr1:243355389	chr1:243346225~243346246:+
THCA	cis	rs6681460	0.898	rs2483704	MIMAT0014979	hsa-miR-3117-3p	3.68	0.000258	0.21	0.17	Presence of antiphospholipid antibodies;	chr1:66729670	chr1:66628485~66628505:+
THCA	cis	rs7829975	0.902	rs485107	MIMAT0019728	hsa-miR-4660	-3.68	0.000258	-0.22	-0.17	Mood instability;	chr8:8723898	chr8:9048453~9048475:+
THCA	cis	rs7210990	0.831	rs545738	MIMAT0005942	hsa-miR-1288-3p	3.68	0.000261	0.21	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16187858	chr17:16282058~16282078:+
THCA	cis	rs59372292	0.642	rs1599870	MIMAT0021017	hsa-miR-4999-5p	3.68	0.000264	0.25	0.17	Coronary artery disease;	chr19:8488516	chr19:8389340~8389360:-
THCA	cis	rs7897654	0.651	rs3897402	MIMAT0005951	hsa-miR-1307-3p	3.68	0.000264	0.14	0.17	Schizophrenia;	chr10:102945655	chr10:103394301~103394322:-
THCA	cis	rs7829975	0.871	rs572307	MIMAT0019728	hsa-miR-4660	-3.68	0.000265	-0.22	-0.17	Mood instability;	chr8:8721301	chr8:9048453~9048475:+
THCA	cis	rs4800353	0.517	rs16962059	MIMAT0000427	hsa-miR-133a-3p	-3.67	0.000266	-0.23	-0.17	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22005646	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.517	rs16962059	MIMAT0000427_1	hsa-miR-133a-3p	-3.67	0.000266	-0.23	-0.17	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22005646	chr20:62564970~62564991:+
THCA	cis	rs3850699	0.926	rs2002916	MIMAT0005951	hsa-miR-1307-3p	3.67	0.000266	0.13	0.17	Prostate cancer;	chr10:102672296	chr10:103394301~103394322:-
THCA	cis	rs2274459	0.841	rs2281919	MIMAT0018349	hsa-miR-3934-5p	3.67	0.000266	0.24	0.17	Obesity (extreme);	chr6:33695394	chr6:33698152~33698173:+
THCA	cis	rs2274459	0.749	rs12190155	MIMAT0018349	hsa-miR-3934-5p	3.67	0.000266	0.24	0.17	Obesity (extreme);	chr6:33695464	chr6:33698152~33698173:+
THCA	cis	rs840163	0.571	rs7970701	MIMAT0004805	hsa-miR-616-3p	3.67	0.000267	0.23	0.17	Alzheimer's disease (survival time);	chr12:56929604	chr12:57519183~57519204:-
THCA	cis	rs7649443	0.878	rs7642604	MIMAT0019973	hsa-miR-4797-3p	3.67	0.000268	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197165115	chr3:197293888~197293908:-
THCA	cis	rs7649443	0.878	rs7634994	MIMAT0019973	hsa-miR-4797-3p	3.67	0.000268	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197165142	chr3:197293888~197293908:-
THCA	cis	rs6088590	1	rs6120750	MIMAT0004772	hsa-miR-499a-3p	-3.67	0.000269	-0.19	-0.17	Coronary artery disease;	chr20:34877486	chr20:34990445~34990466:+
THCA	cis	rs6088765	0.606	rs2425024	MIMAT0004772	hsa-miR-499a-3p	3.67	0.00027	0.2	0.17	Ulcerative colitis;	chr20:35257135	chr20:34990445~34990466:+
THCA	cis	rs7649443	0.959	rs1868891	MIMAT0019973	hsa-miR-4797-3p	3.67	0.00027	0.23	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197174821	chr3:197293888~197293908:-
THCA	cis	rs7829975	0.807	rs519019	MIMAT0019728	hsa-miR-4660	-3.67	0.000271	-0.22	-0.17	Mood instability;	chr8:8737594	chr8:9048453~9048475:+
THCA	cis	rs10947487	0.623	rs7752035	MIMAT0005929	hsa-miR-1275	3.67	0.000271	0.26	0.17	Body mass index;	chr6:34343637	chr6:34000018~34000034:-
THCA	cis	rs10099338	0.822	rs10101571	MIMAT0019728	hsa-miR-4660	-3.67	0.000272	-0.31	-0.17	Glomerular filtration rate;	chr8:9392317	chr8:9048453~9048475:+
THCA	cis	rs10021731	0.668	rs7698363	MIMAT0003242	hsa-miR-577	-3.67	0.000272	-0.18	-0.17	Optic disc area;	chr4:114492418	chr4:114656774~114656794:+
THCA	cis	rs4919669	0.777	rs10883765	MIMAT0005951	hsa-miR-1307-3p	-3.67	0.000274	-0.17	-0.17	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102696929	chr10:103394301~103394322:-
THCA	cis	rs6537837	0.838	rs6537830	MIMAT0000227	hsa-miR-197-3p	-3.67	0.000275	-0.15	-0.17	Major depressive disorder;	chr1:109564422	chr1:109598940~109598961:+
THCA	cis	rs7429990	0.965	rs62260764	MIMAT0018961	hsa-miR-4443	3.66	0.000276	0.19	0.17	Educational attainment (years of education);	chr3:47949010	chr3:48196572~48196588:+
THCA	cis	rs4919694	1	rs76255497	MIMAT0005951	hsa-miR-1307-3p	3.66	0.000279	0.19	0.17	Arsenic metabolism;	chr10:102892198	chr10:103394301~103394322:-
THCA	cis	rs4919694	1	rs75691516	MIMAT0005951	hsa-miR-1307-3p	3.66	0.000279	0.19	0.17	Arsenic metabolism;	chr10:102892288	chr10:103394301~103394322:-
THCA	cis	rs2594714	0.538	rs895819	MIMAT0000084	hsa-miR-27a-3p	-3.66	0.00028	-0.09	-0.17	Breast cancer;	chr19:13836478	chr19:13836447~13836467:-
THCA	cis	rs17109512	1	rs942812	MIMAT0026738	hsa-miR-1287-3p	3.66	0.00028	0.22	0.17	Aspartate aminotransferase levels;	chr10:98393907	chr10:98395232~98395253:-
THCA	cis	rs17109512	1	rs7073497	MIMAT0026738	hsa-miR-1287-3p	3.66	0.00028	0.22	0.17	Aspartate aminotransferase levels;	chr10:98393931	chr10:98395232~98395253:-
THCA	cis	rs12145833	0.679	rs12037698	MIMAT0019761	hsa-miR-4677-3p	3.66	0.00028	0.26	0.17	Obesity (early onset extreme);	chr1:243421043	chr1:243346225~243346246:+
THCA	cis	rs7210990	0.836	rs2051736	MIMAT0005942	hsa-miR-1288-3p	3.66	0.00028	0.2	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16086699	chr17:16282058~16282078:+
THCA	cis	rs7210990	0.866	rs178820	MIMAT0005942	hsa-miR-1288-3p	3.66	0.000281	0.21	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16187471	chr17:16282058~16282078:+
THCA	cis	rs9434723	0.844	rs9435148	MIMAT0000255	hsa-miR-34a-5p	-3.66	0.000282	-0.19	-0.17	Height;	chr1:9240903	chr1:9151735~9151756:-
THCA	cis	rs1870653	0.516	rs1870654	MIMAT0003242	hsa-miR-577	-3.66	0.000282	-0.28	-0.17	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);	chr4:114482074	chr4:114656774~114656794:+
THCA	cis	rs9434723	0.92	rs2239560	MIMAT0000255	hsa-miR-34a-5p	-3.66	0.000282	-0.19	-0.17	Height;	chr1:9244672	chr1:9151735~9151756:-
THCA	cis	rs74233809	0.534	rs284841	MIMAT0022727	hsa-miR-1307-5p	3.66	0.000282	0.18	0.17	Birth weight;	chr10:102790322	chr10:103394341~103394361:-
THCA	cis	rs4919669	0.777	rs5011218	MIMAT0005951	hsa-miR-1307-3p	-3.66	0.000283	-0.17	-0.17	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102641461	chr10:103394301~103394322:-
THCA	cis	rs4919669	0.668	rs4146429	MIMAT0005951	hsa-miR-1307-3p	-3.66	0.000283	-0.17	-0.17	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102641875	chr10:103394301~103394322:-
THCA	cis	rs4919669	0.668	rs4146428	MIMAT0005951	hsa-miR-1307-3p	-3.66	0.000283	-0.17	-0.17	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102641964	chr10:103394301~103394322:-
THCA	cis	rs4919669	0.668	rs10883761	MIMAT0005951	hsa-miR-1307-3p	-3.66	0.000284	-0.17	-0.17	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102660261	chr10:103394301~103394322:-
THCA	cis	rs7829975	0.593	rs2921061	MIMAT0019728	hsa-miR-4660	3.66	0.000284	0.22	0.17	Mood instability;	chr8:8460105	chr8:9048453~9048475:+
THCA	cis	rs10099338	1	rs7843045	MIMAT0019728	hsa-miR-4660	-3.66	0.000285	-0.3	-0.17	Glomerular filtration rate;	chr8:9395118	chr8:9048453~9048475:+
THCA	cis	rs7897654	0.59	rs7092593	MIMAT0005951	hsa-miR-1307-3p	3.66	0.000285	0.14	0.17	Schizophrenia;	chr10:102976594	chr10:103394301~103394322:-
THCA	cis	rs9434723	0.844	rs9434729	MIMAT0000255	hsa-miR-34a-5p	-3.65	0.000286	-0.19	-0.17	Height;	chr1:9243881	chr1:9151735~9151756:-
THCA	cis	rs2274459	1	rs12193658	MIMAT0022975	hsa-miR-3934-3p	3.65	0.000287	0.25	0.17	Obesity (extreme);	chr6:33737751	chr6:33698191~33698212:+
THCA	cis	rs943466	0.666	rs11755421	MIMAT0022975	hsa-miR-3934-3p	-3.65	0.000289	-0.24	-0.17	Body mass index (joint analysis main effects and physical activity interaction);Body mass index;	chr6:33747546	chr6:33698191~33698212:+
THCA	cis	rs943466	0.704	rs11759971	MIMAT0022975	hsa-miR-3934-3p	-3.65	0.000289	-0.24	-0.17	Body mass index (joint analysis main effects and physical activity interaction);Body mass index;	chr6:33747547	chr6:33698191~33698212:+
THCA	cis	rs1468333	1	rs17171770	MIMAT0026718	hsa-miR-874-5p	-3.65	0.00029	-0.13	-0.17	Resting heart rate;	chr5:138179126	chr5:137647618~137647640:-
THCA	cis	rs7210990	0.866	rs7216834	MIMAT0005942	hsa-miR-1288-3p	-3.65	0.000293	-0.2	-0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16129451	chr17:16282058~16282078:+
THCA	cis	rs7210990	0.836	rs178829	MIMAT0005942	hsa-miR-1288-3p	3.65	0.000293	0.21	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16179875	chr17:16282058~16282078:+
THCA	cis	rs7210990	0.836	rs3815038	MIMAT0005942	hsa-miR-1288-3p	3.65	0.000293	0.2	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16065235	chr17:16282058~16282078:+
THCA	cis	rs7819412	0.522	rs10088853	MIMAT0003266	hsa-miR-598-3p	3.65	0.000294	0.15	0.17	Triglycerides;	chr8:11130457	chr8:11035221~11035242:-
THCA	cis	rs7210990	0.836	rs1126148	MIMAT0005942	hsa-miR-1288-3p	3.65	0.000294	0.2	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16112265	chr17:16282058~16282078:+
THCA	cis	rs7210990	0.831	rs35622628	MIMAT0005942	hsa-miR-1288-3p	3.65	0.000294	0.2	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16116714	chr17:16282058~16282078:+
THCA	cis	rs7210990	0.831	rs11078332	MIMAT0005942	hsa-miR-1288-3p	3.65	0.000294	0.2	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16122754	chr17:16282058~16282078:+
THCA	cis	rs7897654	0.578	rs11191506	MIMAT0005951	hsa-miR-1307-3p	-3.65	0.000294	-0.13	-0.17	Schizophrenia;	chr10:103008877	chr10:103394301~103394322:-
THCA	cis	rs1468333	1	rs2864	MIMAT0026718	hsa-miR-874-5p	-3.65	0.000295	-0.13	-0.17	Resting heart rate;	chr5:138187741	chr5:137647618~137647640:-
THCA	cis	rs1468333	1	rs4552585	MIMAT0026718	hsa-miR-874-5p	-3.65	0.000295	-0.13	-0.17	Resting heart rate;	chr5:138197470	chr5:137647618~137647640:-
THCA	cis	rs1468333	1	rs2967784	MIMAT0026718	hsa-miR-874-5p	-3.65	0.000295	-0.13	-0.17	Resting heart rate;	chr5:138203550	chr5:137647618~137647640:-
THCA	cis	rs1468333	1	rs2906127	MIMAT0026718	hsa-miR-874-5p	-3.65	0.000295	-0.13	-0.17	Resting heart rate;	chr5:138203777	chr5:137647618~137647640:-
THCA	cis	rs10947487	0.702	rs4713789	MIMAT0005929	hsa-miR-1275	3.65	0.000296	0.27	0.17	Body mass index;	chr6:34437140	chr6:34000018~34000034:-
THCA	cis	rs2274459	0.841	rs12203688	MIMAT0018349	hsa-miR-3934-5p	-3.65	0.000296	-0.24	-0.17	Obesity (extreme);	chr6:33725847	chr6:33698152~33698173:+
THCA	cis	rs6841433	0.615	rs13114989	MIMAT0003242	hsa-miR-577	3.64	0.000297	0.24	0.17	Hemoglobin concentration;	chr4:114538869	chr4:114656774~114656794:+
THCA	cis	rs7210990	0.836	rs11078330	MIMAT0005942	hsa-miR-1288-3p	3.64	0.000299	0.2	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16073691	chr17:16282058~16282078:+
THCA	cis	rs9807989	0.708	rs6543124	MIMAT0019927	hsa-miR-4772-3p	-3.64	3e-04	-0.16	-0.17	Asthma;	chr2:102370999	chr2:102432336~102432357:+
THCA	cis	rs6120849	0.95	rs6088732	MIMAT0004772	hsa-miR-499a-3p	3.64	0.000301	0.23	0.17	Protein C levels;	chr20:35156331	chr20:34990445~34990466:+
THCA	cis	rs2274459	1	rs877187	MIMAT0022975	hsa-miR-3934-3p	-3.64	0.000301	-0.24	-0.17	Obesity (extreme);	chr6:33738434	chr6:33698191~33698212:+
THCA	cis	rs4919694	1	rs12245779	MIMAT0005951	hsa-miR-1307-3p	3.64	0.000303	0.2	0.17	Arsenic metabolism;	chr10:102886187	chr10:103394301~103394322:-
THCA	cis	rs4919694	1	rs11191445	MIMAT0005951	hsa-miR-1307-3p	3.64	0.000303	0.2	0.17	Arsenic metabolism;	chr10:102891298	chr10:103394301~103394322:-
THCA	cis	rs4919669	1	rs4919669	MIMAT0005951	hsa-miR-1307-3p	-3.64	0.000304	-0.17	-0.17	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102712218	chr10:103394301~103394322:-
THCA	cis	rs2274459	1	rs12189725	MIMAT0022975	hsa-miR-3934-3p	3.64	0.000305	0.24	0.17	Obesity (extreme);	chr6:33735617	chr6:33698191~33698212:+
THCA	cis	rs4919669	0.668	rs17114808	MIMAT0005951	hsa-miR-1307-3p	-3.64	0.000307	-0.16	-0.17	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102631528	chr10:103394301~103394322:-
THCA	cis	rs7594645	0.59	rs61258471	MIMAT0014995	hsa-miR-3130-5p	3.64	0.000308	0.27	0.17	Episodic memory;	chr2:206751133	chr2:206783276~206783296:-
THCA	cis	rs7594645	0.59	rs61258471	MIMAT0014995_1	hsa-miR-3130-5p	3.64	0.000308	0.27	0.17	Episodic memory;	chr2:206751133	chr2:206783246~206783266:+
THCA	cis	rs7819412	0.521	rs9329238	MIMAT0003266	hsa-miR-598-3p	3.64	0.000308	0.15	0.17	Triglycerides;	chr8:11176228	chr8:11035221~11035242:-
THCA	cis	rs7594645	0.59	rs73068058	MIMAT0014995	hsa-miR-3130-5p	3.63	0.00031	0.27	0.16	Episodic memory;	chr2:206752613	chr2:206783276~206783296:-
THCA	cis	rs7594645	0.59	rs73068058	MIMAT0014995_1	hsa-miR-3130-5p	3.63	0.00031	0.27	0.16	Episodic memory;	chr2:206752613	chr2:206783246~206783266:+
THCA	cis	rs7210990	0.68	rs178801	MIMAT0005942	hsa-miR-1288-3p	3.63	0.00031	0.21	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16205150	chr17:16282058~16282078:+
THCA	cis	rs4800353	0.852	rs66863981	MIMAT0000427	hsa-miR-133a-3p	-3.63	0.00031	-0.24	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22033687	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.852	rs66863981	MIMAT0000427_1	hsa-miR-133a-3p	-3.63	0.00031	-0.24	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22033687	chr20:62564970~62564991:+
THCA	cis	rs9434723	0.844	rs2268174	MIMAT0000255	hsa-miR-34a-5p	-3.63	0.000312	-0.19	-0.16	Height;	chr1:9240609	chr1:9151735~9151756:-
THCA	cis	rs4800353	0.929	rs7230938	MIMAT0000427	hsa-miR-133a-3p	-3.63	0.000313	-0.24	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22034439	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.929	rs7230938	MIMAT0000427_1	hsa-miR-133a-3p	-3.63	0.000313	-0.24	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22034439	chr20:62564970~62564991:+
THCA	cis	rs4919669	0.777	rs11191375	MIMAT0005951	hsa-miR-1307-3p	-3.63	0.000314	-0.17	-0.16	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102704900	chr10:103394301~103394322:-
THCA	cis	rs4919669	0.777	rs10883766	MIMAT0005951	hsa-miR-1307-3p	-3.63	0.000314	-0.17	-0.16	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102705006	chr10:103394301~103394322:-
THCA	cis	rs6537837	0.793	rs17575798	MIMAT0000227	hsa-miR-197-3p	-3.63	0.000314	-0.16	-0.16	Major depressive disorder;	chr1:109543829	chr1:109598940~109598961:+
THCA	cis	rs7649443	0.959	rs3796263	MIMAT0019973	hsa-miR-4797-3p	-3.63	0.000314	-0.22	-0.16	Nonsyndromic cleft lip with cleft palate;	chr3:197079929	chr3:197293888~197293908:-
THCA	cis	rs2274459	0.841	rs13214874	MIMAT0018349	hsa-miR-3934-5p	3.63	0.000315	0.24	0.16	Obesity (extreme);	chr6:33718591	chr6:33698152~33698173:+
THCA	cis	rs113745635	1	rs113745635	MIMAT0004700	hsa-miR-331-5p	3.63	0.000315	0.24	0.16	Lung function (FEV1/FVC);	chr12:95160995	chr12:95308445~95308466:+
THCA	cis	rs4061073	0.509	rs688259	MIMAT0019943	hsa-miR-4781-3p	-3.63	0.000317	-0.22	-0.16	Body mass index;	chr1:54234763	chr1:54054124~54054145:+
THCA	cis	rs2485376	1	rs772030	MIMAT0004766	hsa-miR-146b-3p	-3.63	0.000317	-0.1	-0.16	QT interval;	chr10:102264114	chr10:102436557~102436578:+
THCA	cis	rs2494663	0.61	rs6427457	MIMAT0022491	hsa-miR-5698	3.63	0.000317	0.21	0.16	Mean platelet volume;	chr1:154106815	chr1:154104562~154104583:-
THCA	cis	rs1468333	0.897	rs6888877	MIMAT0026718	hsa-miR-874-5p	3.63	0.000318	0.13	0.16	Resting heart rate;	chr5:138174668	chr5:137647618~137647640:-
THCA	cis	rs7210990	0.866	rs178659	MIMAT0005942	hsa-miR-1288-3p	3.63	0.000319	0.2	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16153128	chr17:16282058~16282078:+
THCA	cis	rs10099338	0.915	rs59755096	MIMAT0019728	hsa-miR-4660	-3.62	0.000321	-0.29	-0.16	Glomerular filtration rate;	chr8:9394663	chr8:9048453~9048475:+
THCA	cis	rs999943	1	rs999943	MIMAT0018349	hsa-miR-3934-5p	-3.62	0.000321	-0.2	-0.16	Obesity (extreme);	chr6:33656956	chr6:33698152~33698173:+
THCA	cis	rs10099338	0.915	rs10110128	MIMAT0019728	hsa-miR-4660	-3.62	0.000322	-0.3	-0.16	Glomerular filtration rate;	chr8:9394183	chr8:9048453~9048475:+
THCA	cis	rs453301	0.686	rs17702602	MIMAT0019728	hsa-miR-4660	-3.62	0.000324	-0.22	-0.16	Joint mobility (Beighton score);	chr8:9051086	chr8:9048453~9048475:+
THCA	cis	rs7829975	0.514	rs2979151	MIMAT0019728	hsa-miR-4660	-3.62	0.000324	-0.21	-0.16	Mood instability;	chr8:8400509	chr8:9048453~9048475:+
THCA	cis	rs1468333	0.929	rs2107682	MIMAT0026718	hsa-miR-874-5p	-3.62	0.000324	-0.13	-0.16	Resting heart rate;	chr5:138207446	chr5:137647618~137647640:-
THCA	cis	rs4800353	0.684	rs8088667	MIMAT0000427	hsa-miR-133a-3p	3.62	0.000324	0.22	0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:21998394	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.684	rs8088667	MIMAT0000427_1	hsa-miR-133a-3p	3.62	0.000324	0.22	0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:21998394	chr20:62564970~62564991:+
THCA	cis	rs1468333	0.619	rs191968	MIMAT0026718	hsa-miR-874-5p	-3.62	0.000325	-0.14	-0.16	Resting heart rate;	chr5:138125423	chr5:137647618~137647640:-
THCA	cis	rs7210990	0.866	rs4791662	MIMAT0005942	hsa-miR-1288-3p	3.62	0.000326	0.2	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16105558	chr17:16282058~16282078:+
THCA	cis	rs1468333	0.894	rs217276	MIMAT0026718	hsa-miR-874-5p	-3.62	0.000326	-0.13	-0.16	Resting heart rate;	chr5:138123780	chr5:137647618~137647640:-
THCA	cis	rs1468333	0.964	rs217277	MIMAT0026718	hsa-miR-874-5p	-3.62	0.000326	-0.13	-0.16	Resting heart rate;	chr5:138124694	chr5:137647618~137647640:-
THCA	cis	rs7649443	0.959	rs56309312	MIMAT0019973	hsa-miR-4797-3p	3.62	0.000326	0.22	0.16	Nonsyndromic cleft lip with cleft palate;	chr3:197103636	chr3:197293888~197293908:-
THCA	cis	rs7649443	0.878	rs3906480	MIMAT0019973	hsa-miR-4797-3p	3.62	0.000326	0.22	0.16	Nonsyndromic cleft lip with cleft palate;	chr3:197106424	chr3:197293888~197293908:-
THCA	cis	rs2274459	0.591	rs10947427	MIMAT0018349	hsa-miR-3934-5p	-3.62	0.000326	-0.22	-0.16	Obesity (extreme);	chr6:33676476	chr6:33698152~33698173:+
THCA	cis	rs4800353	0.778	rs8086768	MIMAT0000427	hsa-miR-133a-3p	3.62	0.000327	0.25	0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22058349	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.778	rs8086768	MIMAT0000427_1	hsa-miR-133a-3p	3.62	0.000327	0.25	0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22058349	chr20:62564970~62564991:+
THCA	cis	rs7210990	0.701	rs178802	MIMAT0005942	hsa-miR-1288-3p	3.62	0.000328	0.21	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16203731	chr17:16282058~16282078:+
THCA	cis	rs2274459	0.841	rs2281918	MIMAT0018349	hsa-miR-3934-5p	3.62	0.000328	0.24	0.16	Obesity (extreme);	chr6:33695278	chr6:33698152~33698173:+
THCA	cis	rs1468333	0.592	rs217272	MIMAT0026718	hsa-miR-874-5p	-3.62	0.000328	-0.14	-0.16	Resting heart rate;	chr5:138150737	chr5:137647618~137647640:-
THCA	cis	rs7819412	0.668	rs4841507	MIMAT0003266	hsa-miR-598-3p	3.62	0.00033	0.15	0.16	Triglycerides;	chr8:11188885	chr8:11035221~11035242:-
THCA	cis	rs1468333	1	rs2906128	MIMAT0026718	hsa-miR-874-5p	-3.62	0.00033	-0.13	-0.16	Resting heart rate;	chr5:138214365	chr5:137647618~137647640:-
THCA	cis	rs6681460	0.671	rs628655	MIMAT0014979	hsa-miR-3117-3p	3.62	0.00033	0.2	0.16	Presence of antiphospholipid antibodies;	chr1:66747890	chr1:66628485~66628505:+
THCA	cis	rs453301	0.606	rs6601279	MIMAT0019728	hsa-miR-4660	-3.62	0.000332	-0.21	-0.16	Joint mobility (Beighton score);	chr8:9050721	chr8:9048453~9048475:+
THCA	cis	rs453301	0.606	rs6981060	MIMAT0019728	hsa-miR-4660	-3.62	0.000332	-0.21	-0.16	Joint mobility (Beighton score);	chr8:9050725	chr8:9048453~9048475:+
THCA	cis	rs13326165	0.76	rs11714402	MIMAT0004595	hsa-miR-135a-3p	-3.61	0.000333	-0.23	-0.16	HDL cholesterol;HDL cholesterol levels;	chr3:52357719	chr3:52294232~52294253:-
THCA	cis	rs7819412	0.521	rs4451268	MIMAT0003266	hsa-miR-598-3p	3.61	0.000333	0.15	0.16	Triglycerides;	chr8:11177350	chr8:11035221~11035242:-
THCA	cis	rs6695223	0.929	rs2165076	MIMAT0019232	hsa-miR-4423-5p	-3.61	0.000333	-0.29	-0.16	Venous thromboembolism (SNP x SNP interaction);	chr1:85069369	chr1:85133806~85133827:+
THCA	cis	rs6575836	0.571	rs2400993	MIMAT0004606	hsa-miR-136-3p	-3.61	0.000335	-0.13	-0.16	Tuberculosis;	chr14:101207836	chr14:100884750~100884771:+
THCA	cis	rs12145833	0.679	rs10927010	MIMAT0019761	hsa-miR-4677-3p	-3.61	0.000335	-0.26	-0.16	Obesity (early onset extreme);	chr1:243415510	chr1:243346225~243346246:+
THCA	cis	rs10947428	0.522	rs6457740	MIMAT0018349	hsa-miR-3934-5p	-3.61	0.000335	-0.2	-0.16	Allergic disease (asthma, hay fever or eczema);	chr6:33729348	chr6:33698152~33698173:+
THCA	cis	rs10248839	0.518	rs34011864	MIMAT0004800	hsa-miR-550a-5p	3.61	0.000336	0.2	0.16	Facial emotion recognition (angry faces);	chr7:29658883	chr7:30289815~30289837:+
THCA	cis	rs10248839	0.518	rs34011864	MIMAT0004800_1	hsa-miR-550a-5p	3.61	0.000336	0.2	0.16	Facial emotion recognition (angry faces);	chr7:29658883	chr7:32733002~32733024:+
THCA	cis	rs7829975	0.628	rs1109618	MIMAT0019728	hsa-miR-4660	-3.61	0.000336	-0.23	-0.16	Mood instability;	chr8:8713854	chr8:9048453~9048475:+
THCA	cis	rs2274459	1	rs729376	MIMAT0022975	hsa-miR-3934-3p	3.61	0.000336	0.24	0.16	Obesity (extreme);	chr6:33737046	chr6:33698191~33698212:+
THCA	cis	rs4800353	0.517	rs754086	MIMAT0000427	hsa-miR-133a-3p	-3.61	0.000336	-0.23	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22015229	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.517	rs754086	MIMAT0000427_1	hsa-miR-133a-3p	-3.61	0.000336	-0.23	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22015229	chr20:62564970~62564991:+
THCA	cis	rs8041447	0.896	rs11635027	MIMAT0000458	hsa-miR-190a-5p	-3.61	0.000338	-0.17	-0.16	Immature fraction of reticulocytes;	chr15:62775339	chr15:62823971~62823992:+
THCA	cis	rs72819454	0.522	rs9665618	MIMAT0022727	hsa-miR-1307-5p	3.61	0.000338	0.21	0.16	Interleukin-9 levels;	chr10:103764550	chr10:103394341~103394361:-
THCA	cis	rs10021731	0.692	rs10516602	MIMAT0003242	hsa-miR-577	-3.61	0.000339	-0.17	-0.16	Optic disc area;	chr4:114486174	chr4:114656774~114656794:+
THCA	cis	rs7649443	0.876	rs6804327	MIMAT0019973	hsa-miR-4797-3p	3.61	0.000339	0.22	0.16	Nonsyndromic cleft lip with cleft palate;	chr3:197143866	chr3:197293888~197293908:-
THCA	cis	rs7649443	0.876	rs6771091	MIMAT0019973	hsa-miR-4797-3p	3.61	0.000339	0.22	0.16	Nonsyndromic cleft lip with cleft palate;	chr3:197144124	chr3:197293888~197293908:-
THCA	cis	rs7829975	0.633	rs2979181	MIMAT0019728	hsa-miR-4660	3.61	0.00034	0.22	0.16	Mood instability;	chr8:8465578	chr8:9048453~9048475:+
THCA	cis	rs1468333	1	rs2967781	MIMAT0026718	hsa-miR-874-5p	-3.61	0.000341	-0.13	-0.16	Resting heart rate;	chr5:138221920	chr5:137647618~137647640:-
THCA	cis	rs2274459	0.915	rs77577915	MIMAT0022975	hsa-miR-3934-3p	3.61	0.000341	0.25	0.16	Obesity (extreme);	chr6:33765027	chr6:33698191~33698212:+
THCA	cis	rs6555855	0.909	rs1422030	MIMAT0026618	hsa-miR-585-5p	3.61	0.000342	0.25	0.16	Menarche (age at onset);	chr5:169303825	chr5:169263649~169263670:-
THCA	cis	rs4919669	0.668	rs4244354	MIMAT0005951	hsa-miR-1307-3p	-3.61	0.000342	-0.17	-0.16	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102666420	chr10:103394301~103394322:-
THCA	cis	rs4919669	0.668	rs74558061	MIMAT0005951	hsa-miR-1307-3p	-3.61	0.000343	-0.17	-0.16	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102624580	chr10:103394301~103394322:-
THCA	cis	rs55637147	0.553	rs894450	MIMAT0000425	hsa-miR-130a-3p	3.61	0.000344	0.12	0.16	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes;	chr11:57365897	chr11:57641252~57641273:+
THCA	cis	rs55637147	0.553	rs10896611	MIMAT0000425	hsa-miR-130a-3p	3.61	0.000344	0.12	0.16	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes;	chr11:57368818	chr11:57641252~57641273:+
THCA	cis	rs4919694	1	rs80327774	MIMAT0005951	hsa-miR-1307-3p	3.61	0.000344	0.2	0.16	Arsenic metabolism;	chr10:102896914	chr10:103394301~103394322:-
THCA	cis	rs1760803	0.737	rs1212352	MIMAT0022491	hsa-miR-5698	3.61	0.000345	0.19	0.16	Nicotine dependence;	chr1:154266807	chr1:154104562~154104583:-
THCA	cis	rs4919669	0.668	rs10883763	MIMAT0005951	hsa-miR-1307-3p	-3.6	0.000348	-0.17	-0.16	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102668068	chr10:103394301~103394322:-
THCA	cis	rs2274459	0.841	rs34778247	MIMAT0018349	hsa-miR-3934-5p	3.6	0.000348	0.25	0.16	Obesity (extreme);	chr6:33690775	chr6:33698152~33698173:+
THCA	cis	rs4800353	0.571	rs9961451	MIMAT0000427	hsa-miR-133a-3p	3.6	0.000349	0.21	0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:21977131	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.571	rs9961451	MIMAT0000427_1	hsa-miR-133a-3p	3.6	0.000349	0.21	0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:21977131	chr20:62564970~62564991:+
THCA	cis	rs751728	1	rs6904991	MIMAT0018349	hsa-miR-3934-5p	-3.6	0.000349	-0.2	-0.16	Crohn's disease;	chr6:33764485	chr6:33698152~33698173:+
THCA	cis	rs751728	1	rs4342423	MIMAT0018349	hsa-miR-3934-5p	-3.6	0.000349	-0.2	-0.16	Crohn's disease;	chr6:33764902	chr6:33698152~33698173:+
THCA	cis	rs4800353	0.929	rs9949770	MIMAT0000427	hsa-miR-133a-3p	-3.6	0.00035	-0.24	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22035702	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.929	rs9949770	MIMAT0000427_1	hsa-miR-133a-3p	-3.6	0.00035	-0.24	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22035702	chr20:62564970~62564991:+
THCA	cis	rs4800353	0.866	rs9967487	MIMAT0000427	hsa-miR-133a-3p	-3.6	0.00035	-0.24	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22036072	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.866	rs9967487	MIMAT0000427_1	hsa-miR-133a-3p	-3.6	0.00035	-0.24	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22036072	chr20:62564970~62564991:+
THCA	cis	rs7210990	0.866	rs4791661	MIMAT0005942	hsa-miR-1288-3p	3.6	0.000351	0.2	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16105394	chr17:16282058~16282078:+
THCA	cis	rs2485376	0.967	rs2273555	MIMAT0002809	hsa-miR-146b-5p	-3.6	0.000352	-0.1	-0.16	QT interval;	chr10:102367414	chr10:102436520~102436542:+
THCA	cis	rs4800353	0.929	rs7243005	MIMAT0000427	hsa-miR-133a-3p	-3.6	0.000352	-0.24	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22032326	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.929	rs7243005	MIMAT0000427_1	hsa-miR-133a-3p	-3.6	0.000352	-0.24	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22032326	chr20:62564970~62564991:+
THCA	cis	rs1870653	0.516	rs28555162	MIMAT0003242	hsa-miR-577	3.6	0.000353	0.29	0.16	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);	chr4:114517408	chr4:114656774~114656794:+
THCA	cis	rs751728	1	rs755496	MIMAT0018349	hsa-miR-3934-5p	-3.6	0.000354	-0.2	-0.16	Crohn's disease;	chr6:33766599	chr6:33698152~33698173:+
THCA	cis	rs4800353	0.64	rs10502433	MIMAT0000427	hsa-miR-133a-3p	-3.6	0.000354	-0.24	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22092714	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.64	rs10502433	MIMAT0000427_1	hsa-miR-133a-3p	-3.6	0.000354	-0.24	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22092714	chr20:62564970~62564991:+
THCA	cis	rs7210990	0.766	rs9909697	MIMAT0005942	hsa-miR-1288-3p	3.6	0.000355	0.2	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16116664	chr17:16282058~16282078:+
THCA	cis	rs7210990	0.831	rs10852833	MIMAT0005942	hsa-miR-1288-3p	3.6	0.000355	0.2	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16124047	chr17:16282058~16282078:+
THCA	cis	rs4919694	0.572	rs4917995	MIMAT0005951	hsa-miR-1307-3p	-3.6	0.000357	-0.17	-0.16	Arsenic metabolism;	chr10:103085686	chr10:103394301~103394322:-
THCA	cis	rs10021731	0.692	rs6834235	MIMAT0003242	hsa-miR-577	-3.6	0.000357	-0.17	-0.16	Optic disc area;	chr4:114531582	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.718	rs1599320	MIMAT0003242	hsa-miR-577	-3.6	0.000357	-0.17	-0.16	Optic disc area;	chr4:114532227	chr4:114656774~114656794:+
THCA	cis	rs4919669	0.777	rs12415043	MIMAT0005951	hsa-miR-1307-3p	3.6	0.000358	0.16	0.16	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102707852	chr10:103394301~103394322:-
THCA	cis	rs10099338	0.915	rs10096387	MIMAT0019728	hsa-miR-4660	-3.59	0.000359	-0.3	-0.16	Glomerular filtration rate;	chr8:9393830	chr8:9048453~9048475:+
THCA	cis	rs10099338	0.915	rs10106249	MIMAT0019728	hsa-miR-4660	-3.59	0.000359	-0.3	-0.16	Glomerular filtration rate;	chr8:9393911	chr8:9048453~9048475:+
THCA	cis	rs10099338	0.732	rs75312491	MIMAT0019728	hsa-miR-4660	-3.59	0.000359	-0.3	-0.16	Glomerular filtration rate;	chr8:9394143	chr8:9048453~9048475:+
THCA	cis	rs6555855	0.909	rs1422029	MIMAT0026618	hsa-miR-585-5p	3.59	0.000359	0.25	0.16	Menarche (age at onset);	chr5:169303705	chr5:169263649~169263670:-
THCA	cis	rs1468333	1	rs4835671	MIMAT0026718	hsa-miR-874-5p	-3.59	0.000362	-0.13	-0.16	Resting heart rate;	chr5:138176112	chr5:137647618~137647640:-
THCA	cis	rs74233809	0.534	rs284844	MIMAT0022727	hsa-miR-1307-5p	3.59	0.000363	0.18	0.16	Birth weight;	chr10:102794772	chr10:103394341~103394361:-
THCA	cis	rs2485376	0.967	rs72845670	MIMAT0004766	hsa-miR-146b-3p	-3.59	0.000364	-0.1	-0.16	QT interval;	chr10:102346443	chr10:102436557~102436578:+
THCA	cis	rs4778581	0.707	rs4778752	MIMAT0000454	hsa-miR-184	-3.59	0.000365	-0.19	-0.16	Reticulocyte count;Reticulocyte fraction of red cells;	chr15:80112314	chr15:79209840~79209861:+
THCA	cis	rs8041447	0.896	rs11853366	MIMAT0000458	hsa-miR-190a-5p	-3.59	0.000365	-0.17	-0.16	Immature fraction of reticulocytes;	chr15:62776189	chr15:62823971~62823992:+
THCA	cis	rs7829975	0.711	rs1039916	MIMAT0019728	hsa-miR-4660	3.59	0.000365	0.21	0.16	Mood instability;	chr8:8828344	chr8:9048453~9048475:+
THCA	cis	rs1468333	1	rs7735635	MIMAT0026718	hsa-miR-874-5p	3.59	0.000366	0.13	0.16	Resting heart rate;	chr5:138172647	chr5:137647618~137647640:-
THCA	cis	rs7829975	0.688	rs6995407	MIMAT0019728	hsa-miR-4660	3.59	0.000366	0.22	0.16	Mood instability;	chr8:8527137	chr8:9048453~9048475:+
THCA	cis	rs7210990	0.866	rs1989856	MIMAT0005942	hsa-miR-1288-3p	3.59	0.000367	0.2	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16140337	chr17:16282058~16282078:+
THCA	cis	rs7829975	0.593	rs2921077	MIMAT0019728	hsa-miR-4660	3.59	0.000367	0.21	0.16	Mood instability;	chr8:8446992	chr8:9048453~9048475:+
THCA	cis	rs12355831	0.881	rs4572070	MIMAT0025841	hsa-miR-6715a-3p	3.59	0.000367	0.23	0.16	Migraine;	chr10:112406024	chr10:112299660~112299680:+
THCA	cis	rs7829975	0.84	rs555617	MIMAT0019728	hsa-miR-4660	-3.59	0.00037	-0.21	-0.16	Mood instability;	chr8:8735335	chr8:9048453~9048475:+
THCA	cis	rs6681460	0.8	rs481681	MIMAT0014979	hsa-miR-3117-3p	3.59	0.00037	0.2	0.16	Presence of antiphospholipid antibodies;	chr1:66728695	chr1:66628485~66628505:+
THCA	cis	rs4919669	0.668	rs7086898	MIMAT0005951	hsa-miR-1307-3p	-3.59	0.00037	-0.16	-0.16	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102626395	chr10:103394301~103394322:-
THCA	cis	rs4919669	0.668	rs10786700	MIMAT0005951	hsa-miR-1307-3p	-3.59	0.00037	-0.16	-0.16	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102627978	chr10:103394301~103394322:-
THCA	cis	rs4919669	0.623	rs2298278	MIMAT0005951	hsa-miR-1307-3p	-3.59	0.00037	-0.16	-0.16	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102630546	chr10:103394301~103394322:-
THCA	cis	rs4919669	0.719	rs11818043	MIMAT0005951	hsa-miR-1307-3p	-3.59	0.00037	-0.16	-0.16	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102631870	chr10:103394301~103394322:-
THCA	cis	rs4778581	0.9	rs2866367	MIMAT0000454	hsa-miR-184	-3.59	0.000371	-0.19	-0.16	Reticulocyte count;Reticulocyte fraction of red cells;	chr15:80073403	chr15:79209840~79209861:+
THCA	cis	rs7594645	1	rs73070048	MIMAT0014995	hsa-miR-3130-5p	3.59	0.000372	0.27	0.16	Episodic memory;	chr2:206776670	chr2:206783276~206783296:-
THCA	cis	rs7594645	1	rs73070048	MIMAT0014995_1	hsa-miR-3130-5p	3.59	0.000372	0.27	0.16	Episodic memory;	chr2:206776670	chr2:206783246~206783266:+
THCA	cis	rs7594645	0.59	rs879472	MIMAT0014995	hsa-miR-3130-5p	-3.59	0.000372	-0.27	-0.16	Episodic memory;	chr2:206787058	chr2:206783276~206783296:-
THCA	cis	rs7594645	0.59	rs879472	MIMAT0014995_1	hsa-miR-3130-5p	-3.59	0.000372	-0.27	-0.16	Episodic memory;	chr2:206787058	chr2:206783246~206783266:+
THCA	cis	rs10021731	0.718	rs1460772	MIMAT0003242	hsa-miR-577	-3.58	0.000372	-0.17	-0.16	Optic disc area;	chr4:114487028	chr4:114656774~114656794:+
THCA	cis	rs4919669	0.668	rs10883760	MIMAT0005951	hsa-miR-1307-3p	-3.58	0.000372	-0.16	-0.16	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102659708	chr10:103394301~103394322:-
THCA	cis	rs2274459	1	rs35445446	MIMAT0022975	hsa-miR-3934-3p	3.58	0.000373	0.26	0.16	Obesity (extreme);	chr6:33748968	chr6:33698191~33698212:+
THCA	cis	rs4919694	0.808	rs80020194	MIMAT0005951	hsa-miR-1307-3p	3.58	0.000373	0.21	0.16	Arsenic metabolism;	chr10:103276197	chr10:103394301~103394322:-
THCA	cis	rs17109512	0.826	rs17109539	MIMAT0005878	hsa-miR-1287-5p	3.58	0.000373	0.3	0.16	Aspartate aminotransferase levels;	chr10:98371701	chr10:98395271~98395292:-
THCA	cis	rs1468333	1	rs13356202	MIMAT0026718	hsa-miR-874-5p	-3.58	0.000374	-0.13	-0.16	Resting heart rate;	chr5:138228899	chr5:137647618~137647640:-
THCA	cis	rs4919669	0.668	rs10883757	MIMAT0005951	hsa-miR-1307-3p	-3.58	0.000375	-0.16	-0.16	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102640376	chr10:103394301~103394322:-
THCA	cis	rs7210990	0.585	rs12939418	MIMAT0005942	hsa-miR-1288-3p	3.58	0.000376	0.2	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16127720	chr17:16282058~16282078:+
THCA	cis	rs9527	0.59	rs7073323	MIMAT0022727	hsa-miR-1307-5p	3.58	0.000378	0.15	0.16	Arsenic metabolism;	chr10:103037666	chr10:103394341~103394361:-
THCA	cis	rs7649443	0.876	rs11185466	MIMAT0019973	hsa-miR-4797-3p	3.58	0.000378	0.22	0.16	Nonsyndromic cleft lip with cleft palate;	chr3:197142056	chr3:197293888~197293908:-
THCA	cis	rs2921073	0.509	rs2976931	MIMAT0019728	hsa-miR-4660	3.58	0.000379	0.2	0.16	Parkinson's disease;	chr8:8399807	chr8:9048453~9048475:+
THCA	cis	rs7829975	0.514	rs2976929	MIMAT0019728	hsa-miR-4660	3.58	0.00038	0.2	0.16	Mood instability;	chr8:8401202	chr8:9048453~9048475:+
THCA	cis	rs6681460	0.898	rs1032634	MIMAT0014979	hsa-miR-3117-3p	3.58	0.000381	0.2	0.16	Presence of antiphospholipid antibodies;	chr1:66729509	chr1:66628485~66628505:+
THCA	cis	rs7210990	0.836	rs9908031	MIMAT0005942	hsa-miR-1288-3p	3.58	0.000381	0.2	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16035376	chr17:16282058~16282078:+
THCA	cis	rs1468333	0.894	rs435570	MIMAT0026718	hsa-miR-874-5p	-3.58	0.000382	-0.13	-0.16	Resting heart rate;	chr5:138132946	chr5:137647618~137647640:-
THCA	cis	rs1468333	1	rs423258	MIMAT0026718	hsa-miR-874-5p	-3.58	0.000382	-0.13	-0.16	Resting heart rate;	chr5:138140098	chr5:137647618~137647640:-
THCA	cis	rs4919694	0.808	rs4918001	MIMAT0005951	hsa-miR-1307-3p	-3.58	0.000383	-0.19	-0.16	Arsenic metabolism;	chr10:103253390	chr10:103394301~103394322:-
THCA	cis	rs10099338	0.915	rs10109288	MIMAT0019728	hsa-miR-4660	-3.58	0.000383	-0.3	-0.16	Glomerular filtration rate;	chr8:9394156	chr8:9048453~9048475:+
THCA	cis	rs1468333	0.514	rs10515498	MIMAT0026718	hsa-miR-874-5p	-3.58	0.000385	-0.14	-0.16	Resting heart rate;	chr5:138250641	chr5:137647618~137647640:-
THCA	cis	rs6537837	1	rs3768486	MIMAT0000227	hsa-miR-197-3p	-3.58	0.000385	-0.15	-0.16	Major depressive disorder;	chr1:109581349	chr1:109598940~109598961:+
THCA	cis	rs6537837	0.762	rs6691984	MIMAT0000227	hsa-miR-197-3p	-3.58	0.000386	-0.15	-0.16	Major depressive disorder;	chr1:109601402	chr1:109598940~109598961:+
THCA	cis	rs7385804	0.761	rs568733	MIMAT0027650	hsa-miR-6875-5p	3.57	0.000387	0.21	0.16	Iron status biomarkers (iron levels);Iron status biomarkers (transferrin saturation);Hematocrit;Mean corpuscular hemoglobin;Hematological parameters;Red blood cell count;Mean corpuscular volume;Iron status biomarkers;	chr7:100714039	chr7:100868041~100868061:+
THCA	cis	rs7385804	0.761	rs1734908	MIMAT0027650	hsa-miR-6875-5p	3.57	0.000387	0.21	0.16	Iron status biomarkers (iron levels);Iron status biomarkers (transferrin saturation);Hematocrit;Mean corpuscular hemoglobin;Hematological parameters;Red blood cell count;Mean corpuscular volume;Iron status biomarkers;	chr7:100716145	chr7:100868041~100868061:+
THCA	cis	rs4800353	0.929	rs16962484	MIMAT0000427	hsa-miR-133a-3p	-3.57	0.000387	-0.24	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22033269	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.929	rs16962484	MIMAT0000427_1	hsa-miR-133a-3p	-3.57	0.000387	-0.24	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22033269	chr20:62564970~62564991:+
THCA	cis	rs1468333	0.824	rs10952	MIMAT0004911	hsa-miR-874-3p	-3.57	0.000387	-0.1	-0.16	Resting heart rate;	chr5:138252651	chr5:137647582~137647603:-
THCA	cis	rs7829975	0.5	rs7841082	MIMAT0019728	hsa-miR-4660	-3.57	0.000388	-0.22	-0.16	Mood instability;	chr8:8311465	chr8:9048453~9048475:+
THCA	cis	rs2485376	0.967	rs772014	MIMAT0004766	hsa-miR-146b-3p	-3.57	0.000388	-0.09	-0.16	QT interval;	chr10:102302737	chr10:102436557~102436578:+
THCA	cis	rs10021731	0.718	rs13103158	MIMAT0003242	hsa-miR-577	-3.57	0.000388	-0.17	-0.16	Optic disc area;	chr4:114493188	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.692	rs13127680	MIMAT0003242	hsa-miR-577	-3.57	0.000388	-0.17	-0.16	Optic disc area;	chr4:114493217	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.693	rs4834415	MIMAT0003242	hsa-miR-577	-3.57	0.000388	-0.17	-0.16	Optic disc area;	chr4:114493245	chr4:114656774~114656794:+
THCA	cis	rs7649443	0.876	rs62282106	MIMAT0019973	hsa-miR-4797-3p	3.57	0.000389	0.22	0.16	Nonsyndromic cleft lip with cleft palate;	chr3:197270277	chr3:197293888~197293908:-
THCA	cis	rs7210990	0.866	rs11078333	MIMAT0005942	hsa-miR-1288-3p	3.57	0.000392	0.2	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16146312	chr17:16282058~16282078:+
THCA	cis	rs751728	1	rs6925273	MIMAT0018349	hsa-miR-3934-5p	-3.57	0.000395	-0.2	-0.16	Crohn's disease;	chr6:33764671	chr6:33698152~33698173:+
THCA	cis	rs8041447	0.864	rs937414	MIMAT0000458	hsa-miR-190a-5p	-3.57	0.000397	-0.17	-0.16	Immature fraction of reticulocytes;	chr15:62771413	chr15:62823971~62823992:+
THCA	cis	rs7649443	0.788	rs13070238	MIMAT0019973	hsa-miR-4797-3p	3.57	0.000397	0.22	0.16	Nonsyndromic cleft lip with cleft palate;	chr3:197229496	chr3:197293888~197293908:-
THCA	cis	rs453301	0.506	rs686189	MIMAT0019728	hsa-miR-4660	-3.57	0.000397	-0.21	-0.16	Joint mobility (Beighton score);	chr8:8766127	chr8:9048453~9048475:+
THCA	cis	rs9807989	0.507	rs6758936	MIMAT0019927	hsa-miR-4772-3p	3.57	0.000397	0.15	0.16	Asthma;	chr2:102374909	chr2:102432336~102432357:+
THCA	cis	rs10021731	0.782	rs7437569	MIMAT0003242	hsa-miR-577	-3.57	0.000398	-0.17	-0.16	Optic disc area;	chr4:114595431	chr4:114656774~114656794:+
THCA	cis	rs977145	0.951	rs56028840	MIMAT0000456	hsa-miR-186-5p	3.57	0.000399	0.11	0.16	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71479632	chr1:71067681~71067702:-
THCA	cis	rs7829975	0.871	rs777709	MIMAT0019728	hsa-miR-4660	-3.57	0.000399	-0.21	-0.16	Mood instability;	chr8:8726362	chr8:9048453~9048475:+
THCA	cis	rs13326165	0.76	rs6800707	MIMAT0004595	hsa-miR-135a-3p	-3.57	4e-04	-0.23	-0.16	HDL cholesterol;HDL cholesterol levels;	chr3:52482277	chr3:52294232~52294253:-
THCA	cis	rs7851726	0.628	rs12338409	MIMAT0019208	hsa-miR-3074-5p	3.57	0.000401	0.13	0.16	Urinary albumin-to-creatinine ratio;	chr9:94928807	chr9:95086063~95086083:-
THCA	cis	rs950880	0.71	rs4851011	MIMAT0019927	hsa-miR-4772-3p	-3.56	0.000401	-0.17	-0.16	Serum protein levels (sST2);	chr2:102473219	chr2:102432336~102432357:+
THCA	cis	rs55637147	0.553	rs2276040	MIMAT0000425	hsa-miR-130a-3p	-3.56	0.000401	-0.11	-0.16	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes;	chr11:57369823	chr11:57641252~57641273:+
THCA	cis	rs2274459	0.915	rs6925337	MIMAT0018349	hsa-miR-3934-5p	3.56	0.000402	0.23	0.16	Obesity (extreme);	chr6:33764442	chr6:33698152~33698173:+
THCA	cis	rs4919694	0.808	rs77521106	MIMAT0005951	hsa-miR-1307-3p	3.56	0.000403	0.2	0.16	Arsenic metabolism;	chr10:103220969	chr10:103394301~103394322:-
THCA	cis	rs7210990	0.529	rs35799415	MIMAT0005942	hsa-miR-1288-3p	3.56	0.000403	0.2	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16127586	chr17:16282058~16282078:+
THCA	cis	rs9426935	0.505	rs4077168	MIMAT0022491	hsa-miR-5698	3.56	0.000403	0.21	0.16	Lentiform nucleus volume;	chr1:153802541	chr1:154104562~154104583:-
THCA	cis	rs2274459	0.915	rs6925337	MIMAT0022975	hsa-miR-3934-3p	3.56	0.000404	0.22	0.16	Obesity (extreme);	chr6:33764442	chr6:33698191~33698212:+
THCA	cis	rs2274459	0.908	rs13207666	MIMAT0022975	hsa-miR-3934-3p	3.56	0.000406	0.24	0.16	Obesity (extreme);	chr6:33739450	chr6:33698191~33698212:+
THCA	cis	rs9807989	0.507	rs2058659	MIMAT0019927	hsa-miR-4772-3p	3.56	0.000407	0.15	0.16	Asthma;	chr2:102438096	chr2:102432336~102432357:+
THCA	cis	rs2274459	0.659	rs35095444	MIMAT0022975	hsa-miR-3934-3p	3.56	0.000408	0.24	0.16	Obesity (extreme);	chr6:33684198	chr6:33698191~33698212:+
THCA	cis	rs6088590	1	rs6087632	MIMAT0004772	hsa-miR-499a-3p	-3.56	0.000409	-0.19	-0.16	Coronary artery disease;	chr20:34819901	chr20:34990445~34990466:+
THCA	cis	rs6088590	0.931	rs6088617	MIMAT0004772	hsa-miR-499a-3p	-3.56	0.000409	-0.19	-0.16	Coronary artery disease;	chr20:34820233	chr20:34990445~34990466:+
THCA	cis	rs12355831	0.881	rs4918747	MIMAT0025841	hsa-miR-6715a-3p	-3.56	0.000409	-0.21	-0.16	Migraine;	chr10:112393875	chr10:112299660~112299680:+
THCA	cis	rs1468333	1	rs10479179	MIMAT0004911	hsa-miR-874-3p	-3.56	0.000411	-0.1	-0.16	Resting heart rate;	chr5:138228426	chr5:137647582~137647603:-
THCA	cis	rs7829975	0.606	rs10112585	MIMAT0019728	hsa-miR-4660	-3.56	0.000411	-0.21	-0.16	Mood instability;	chr8:8937520	chr8:9048453~9048475:+
THCA	cis	rs1870653	0.516	rs7698886	MIMAT0003242	hsa-miR-577	-3.56	0.000414	-0.27	-0.16	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);	chr4:114481859	chr4:114656774~114656794:+
THCA	cis	rs6575793	0.512	rs6575791	MIMAT0004921	hsa-miR-889-3p	-3.56	0.000414	-0.09	-0.16	Menarche (age at onset);	chr14:100562866	chr14:101047949~101047969:+
THCA	cis	rs10021731	0.644	rs7665675	MIMAT0003242	hsa-miR-577	-3.56	0.000414	-0.17	-0.16	Optic disc area;	chr4:114480704	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.718	rs7692571	MIMAT0003242	hsa-miR-577	-3.56	0.000414	-0.17	-0.16	Optic disc area;	chr4:114480792	chr4:114656774~114656794:+
THCA	cis	rs7210990	0.866	rs12150017	MIMAT0005942	hsa-miR-1288-3p	3.56	0.000416	0.2	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16120780	chr17:16282058~16282078:+
THCA	cis	rs4800353	0.929	rs899640	MIMAT0000427	hsa-miR-133a-3p	-3.55	0.000416	-0.24	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22028025	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.929	rs899640	MIMAT0000427_1	hsa-miR-133a-3p	-3.55	0.000416	-0.24	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22028025	chr20:62564970~62564991:+
THCA	cis	rs4800353	0.929	rs899639	MIMAT0000427	hsa-miR-133a-3p	-3.55	0.000416	-0.24	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22028151	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.929	rs899639	MIMAT0000427_1	hsa-miR-133a-3p	-3.55	0.000416	-0.24	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22028151	chr20:62564970~62564991:+
THCA	cis	rs4919669	0.668	rs11191343	MIMAT0005951	hsa-miR-1307-3p	-3.55	0.000417	-0.17	-0.16	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102585468	chr10:103394301~103394322:-
THCA	cis	rs4919669	0.668	rs3934495	MIMAT0005951	hsa-miR-1307-3p	-3.55	0.000417	-0.17	-0.16	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102601954	chr10:103394301~103394322:-
THCA	cis	rs9807989	0.507	rs6734762	MIMAT0019927	hsa-miR-4772-3p	-3.55	0.00042	-0.15	-0.16	Asthma;	chr2:102446466	chr2:102432336~102432357:+
THCA	cis	rs10021731	0.756	rs1460783	MIMAT0003242	hsa-miR-577	-3.55	0.00042	-0.17	-0.16	Optic disc area;	chr4:114540109	chr4:114656774~114656794:+
THCA	cis	rs12145833	0.596	rs61833913	MIMAT0019761	hsa-miR-4677-3p	3.55	0.000422	0.27	0.16	Obesity (early onset extreme);	chr1:243276726	chr1:243346225~243346246:+
THCA	cis	rs12145833	0.596	rs12026068	MIMAT0019761	hsa-miR-4677-3p	3.55	0.000422	0.27	0.16	Obesity (early onset extreme);	chr1:243277050	chr1:243346225~243346246:+
THCA	cis	rs12145833	0.596	rs12134228	MIMAT0019761	hsa-miR-4677-3p	3.55	0.000422	0.27	0.16	Obesity (early onset extreme);	chr1:243284316	chr1:243346225~243346246:+
THCA	cis	rs2274459	0.841	rs12205398	MIMAT0018349	hsa-miR-3934-5p	3.55	0.000424	0.24	0.16	Obesity (extreme);	chr6:33733766	chr6:33698152~33698173:+
THCA	cis	rs7325116	0.519	rs9523466	MIMAT0004491	hsa-miR-19b-1-5p	3.55	0.000424	0.12	0.16	Blood protein levels;	chr13:91985106	chr13:91351207~91351229:+
THCA	cis	rs7210990	0.866	rs7207889	MIMAT0005942	hsa-miR-1288-3p	3.55	0.000425	0.2	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16101054	chr17:16282058~16282078:+
THCA	cis	rs840163	0.528	rs1872436	MIMAT0004805	hsa-miR-616-3p	3.55	0.000426	0.22	0.16	Alzheimer's disease (survival time);	chr12:56928708	chr12:57519183~57519204:-
THCA	cis	rs17109512	1	rs17109512	MIMAT0026738	hsa-miR-1287-3p	3.55	0.000427	0.22	0.16	Aspartate aminotransferase levels;	chr10:98367794	chr10:98395232~98395253:-
THCA	cis	rs7213347	0.581	rs7209460	MIMAT0000426	hsa-miR-132-3p	3.55	0.000427	0.17	0.16	Total body bone mineral density;	chr17:2145419	chr17:2049929~2049950:-
THCA	cis	rs4800353	0.866	rs9952434	MIMAT0000427	hsa-miR-133a-3p	-3.55	0.000427	-0.24	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22036064	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.866	rs9952434	MIMAT0000427_1	hsa-miR-133a-3p	-3.55	0.000427	-0.24	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22036064	chr20:62564970~62564991:+
THCA	cis	rs1468333	0.824	rs10952	MIMAT0026718	hsa-miR-874-5p	-3.55	0.000427	-0.12	-0.16	Resting heart rate;	chr5:138252651	chr5:137647618~137647640:-
THCA	cis	rs4778581	0.798	rs12903445	MIMAT0000454	hsa-miR-184	-3.55	0.00043	-0.19	-0.16	Reticulocyte count;Reticulocyte fraction of red cells;	chr15:80061684	chr15:79209840~79209861:+
THCA	cis	rs2274459	0.841	rs10947432	MIMAT0018349	hsa-miR-3934-5p	-3.55	0.000431	-0.23	-0.16	Obesity (extreme);	chr6:33708779	chr6:33698152~33698173:+
THCA	cis	rs10021731	0.692	rs13147488	MIMAT0003242	hsa-miR-577	-3.55	0.000431	-0.17	-0.16	Optic disc area;	chr4:114494051	chr4:114656774~114656794:+
THCA	cis	rs6088590	1	rs2236270	MIMAT0004772	hsa-miR-499a-3p	-3.54	0.000434	-0.19	-0.16	Coronary artery disease;	chr20:34935352	chr20:34990445~34990466:+
THCA	cis	rs9434723	0.92	rs9434725	MIMAT0000255	hsa-miR-34a-5p	-3.54	0.000437	-0.19	-0.16	Height;	chr1:9233802	chr1:9151735~9151756:-
THCA	cis	rs950880	0.56	rs66780767	MIMAT0019927	hsa-miR-4772-3p	3.54	0.000438	0.14	0.16	Serum protein levels (sST2);	chr2:102323249	chr2:102432336~102432357:+
THCA	cis	rs4919669	0.668	rs10883735	MIMAT0005951	hsa-miR-1307-3p	-3.54	0.000438	-0.17	-0.16	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102548689	chr10:103394301~103394322:-
THCA	cis	rs4919669	0.668	rs10883737	MIMAT0005951	hsa-miR-1307-3p	-3.54	0.000438	-0.17	-0.16	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102561141	chr10:103394301~103394322:-
THCA	cis	rs7851726	0.628	rs12344211	MIMAT0019208	hsa-miR-3074-5p	3.54	0.000439	0.13	0.16	Urinary albumin-to-creatinine ratio;	chr9:94928822	chr9:95086063~95086083:-
THCA	cis	rs13326165	0.76	rs61150019	MIMAT0004595	hsa-miR-135a-3p	3.54	0.00044	0.25	0.16	HDL cholesterol;HDL cholesterol levels;	chr3:52320360	chr3:52294232~52294253:-
THCA	cis	rs10099338	0.732	rs9329194	MIMAT0019728	hsa-miR-4660	-3.54	0.000441	-0.28	-0.16	Glomerular filtration rate;	chr8:9393301	chr8:9048453~9048475:+
THCA	cis	rs12145833	0.596	rs1060643	MIMAT0019761	hsa-miR-4677-3p	3.54	0.000441	0.27	0.16	Obesity (early onset extreme);	chr1:243266674	chr1:243346225~243346246:+
THCA	cis	rs6537837	1	rs2301229	MIMAT0000227	hsa-miR-197-3p	-3.54	0.000442	-0.15	-0.16	Major depressive disorder;	chr1:109594056	chr1:109598940~109598961:+
THCA	cis	rs6537837	1	rs3525	MIMAT0000227	hsa-miR-197-3p	-3.54	0.000442	-0.15	-0.16	Major depressive disorder;	chr1:109594224	chr1:109598940~109598961:+
THCA	cis	rs6681460	0.773	rs515944	MIMAT0014979	hsa-miR-3117-3p	3.54	0.000443	0.2	0.16	Presence of antiphospholipid antibodies;	chr1:66754297	chr1:66628485~66628505:+
THCA	cis	rs4919694	1	rs3740394	MIMAT0005951	hsa-miR-1307-3p	3.54	0.000443	0.2	0.16	Arsenic metabolism;	chr10:102874717	chr10:103394301~103394322:-
THCA	cis	rs7826238	0.564	rs2921053	MIMAT0019728	hsa-miR-4660	3.54	0.000443	0.21	0.16	Systolic blood pressure;	chr8:8462453	chr8:9048453~9048475:+
THCA	cis	rs72819454	0.522	rs56178332	MIMAT0022727	hsa-miR-1307-5p	3.54	0.000443	0.22	0.16	Interleukin-9 levels;	chr10:103763409	chr10:103394341~103394361:-
THCA	cis	rs7210990	0.836	rs9890012	MIMAT0005942	hsa-miR-1288-3p	3.54	0.000443	0.19	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16029313	chr17:16282058~16282078:+
THCA	cis	rs2485376	1	rs733283	MIMAT0004766	hsa-miR-146b-3p	-3.54	0.000444	-0.1	-0.16	QT interval;	chr10:102236819	chr10:102436557~102436578:+
THCA	cis	rs453301	0.658	rs12114954	MIMAT0019728	hsa-miR-4660	-3.54	0.000447	-0.21	-0.16	Joint mobility (Beighton score);	chr8:9047352	chr8:9048453~9048475:+
THCA	cis	rs72819454	0.522	rs55760245	MIMAT0022727	hsa-miR-1307-5p	3.54	0.000447	0.21	0.16	Interleukin-9 levels;	chr10:103763262	chr10:103394341~103394361:-
THCA	cis	rs4144743	0.641	rs67696888	MIMAT0026479	hsa-miR-152-5p	-3.54	0.000447	-0.24	-0.16	Body mass index;	chr17:47277750	chr17:48037210~48037232:-
THCA	cis	rs10021731	0.668	rs12512563	MIMAT0003242	hsa-miR-577	-3.54	0.000448	-0.17	-0.16	Optic disc area;	chr4:114493973	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.6	rs12504927	MIMAT0003242	hsa-miR-577	-3.54	0.000448	-0.17	-0.16	Optic disc area;	chr4:114493975	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.645	rs13147121	MIMAT0003242	hsa-miR-577	-3.54	0.000448	-0.17	-0.16	Optic disc area;	chr4:114493994	chr4:114656774~114656794:+
THCA	cis	rs7829975	0.509	rs7838674	MIMAT0019728	hsa-miR-4660	-3.53	0.000454	-0.21	-0.16	Mood instability;	chr8:8939563	chr8:9048453~9048475:+
THCA	cis	rs2274459	0.749	rs9469554	MIMAT0022975	hsa-miR-3934-3p	3.53	0.000455	0.23	0.16	Obesity (extreme);	chr6:33680320	chr6:33698191~33698212:+
THCA	cis	rs943466	0.826	rs3828783	MIMAT0022975	hsa-miR-3934-3p	-3.53	0.000458	-0.23	-0.16	Body mass index (joint analysis main effects and physical activity interaction);Body mass index;	chr6:33799950	chr6:33698191~33698212:+
THCA	cis	rs6555855	0.868	rs1119096	MIMAT0026618	hsa-miR-585-5p	3.53	0.000458	0.25	0.16	Menarche (age at onset);	chr5:169317362	chr5:169263649~169263670:-
THCA	cis	rs7210990	0.866	rs1160109	MIMAT0005942	hsa-miR-1288-3p	3.53	0.000458	0.2	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16129818	chr17:16282058~16282078:+
THCA	cis	rs7210990	0.866	rs9891646	MIMAT0005942	hsa-miR-1288-3p	3.53	0.000458	0.2	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16133547	chr17:16282058~16282078:+
THCA	cis	rs751728	1	rs11752297	MIMAT0018349	hsa-miR-3934-5p	-3.53	0.000459	-0.19	-0.16	Crohn's disease;	chr6:33767377	chr6:33698152~33698173:+
THCA	cis	rs10021731	0.718	rs13102706	MIMAT0003242	hsa-miR-577	-3.53	0.000459	-0.17	-0.16	Optic disc area;	chr4:114492998	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.718	rs13102910	MIMAT0003242	hsa-miR-577	-3.53	0.000459	-0.17	-0.16	Optic disc area;	chr4:114493049	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.718	rs13127839	MIMAT0003242	hsa-miR-577	-3.53	0.000459	-0.17	-0.16	Optic disc area;	chr4:114493059	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.718	rs4833458	MIMAT0003242	hsa-miR-577	-3.53	0.000459	-0.17	-0.16	Optic disc area;	chr4:114493571	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.718	rs4833459	MIMAT0003242	hsa-miR-577	-3.53	0.000459	-0.17	-0.16	Optic disc area;	chr4:114493734	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.718	rs12501292	MIMAT0003242	hsa-miR-577	-3.53	0.000459	-0.17	-0.16	Optic disc area;	chr4:114493876	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.622	rs12711027	MIMAT0003242	hsa-miR-577	-3.53	0.000459	-0.17	-0.16	Optic disc area;	chr4:114494204	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.718	rs13148430	MIMAT0003242	hsa-miR-577	-3.53	0.000459	-0.17	-0.16	Optic disc area;	chr4:114494469	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.718	rs6839599	MIMAT0003242	hsa-miR-577	-3.53	0.000459	-0.17	-0.16	Optic disc area;	chr4:114494754	chr4:114656774~114656794:+
THCA	cis	rs4919669	0.668	rs17114810	MIMAT0005951	hsa-miR-1307-3p	-3.53	0.00046	-0.16	-0.16	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102631788	chr10:103394301~103394322:-
THCA	cis	rs7210990	0.866	rs11650678	MIMAT0005942	hsa-miR-1288-3p	3.53	0.00046	0.2	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16124713	chr17:16282058~16282078:+
THCA	cis	rs7210990	0.866	rs11655773	MIMAT0005942	hsa-miR-1288-3p	3.53	0.00046	0.2	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16126985	chr17:16282058~16282078:+
THCA	cis	rs977145	0.951	rs975842	MIMAT0000456	hsa-miR-186-5p	-3.53	0.000462	-0.1	-0.16	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks);	chr1:71482303	chr1:71067681~71067702:-
THCA	cis	rs7829975	0.774	rs1039915	MIMAT0019728	hsa-miR-4660	3.53	0.000462	0.21	0.16	Mood instability;	chr8:8822104	chr8:9048453~9048475:+
THCA	cis	rs7829975	0.774	rs57312668	MIMAT0019728	hsa-miR-4660	3.53	0.000462	0.21	0.16	Mood instability;	chr8:8822967	chr8:9048453~9048475:+
THCA	cis	rs4988958	0.565	rs3755265	MIMAT0019927	hsa-miR-4772-3p	-3.53	0.000463	-0.15	-0.16	Asthma (childhood onset);	chr2:102436356	chr2:102432336~102432357:+
THCA	cis	rs6703335	0.687	rs10754803	MIMAT0019761	hsa-miR-4677-3p	-3.53	0.000465	-0.17	-0.16	Schizophrenia;Schizophrenia, schizoaffective disorder or bipolar disorder;	chr1:243349745	chr1:243346225~243346246:+
THCA	cis	rs1760803	0.553	rs11265353	MIMAT0022491	hsa-miR-5698	3.52	0.000466	0.2	0.16	Nicotine dependence;	chr1:154238739	chr1:154104562~154104583:-
THCA	cis	rs4919694	1	rs4917986	MIMAT0005951	hsa-miR-1307-3p	3.52	0.000467	0.18	0.16	Arsenic metabolism;	chr10:102870424	chr10:103394301~103394322:-
THCA	cis	rs4800353	0.587	rs34447069	MIMAT0000427	hsa-miR-133a-3p	-3.52	0.000468	-0.23	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:21973349	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.587	rs34447069	MIMAT0000427_1	hsa-miR-133a-3p	-3.52	0.000468	-0.23	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:21973349	chr20:62564970~62564991:+
THCA	cis	rs17109512	0.826	rs747022	MIMAT0005878	hsa-miR-1287-5p	3.52	0.00047	0.29	0.16	Aspartate aminotransferase levels;	chr10:98368416	chr10:98395271~98395292:-
THCA	cis	rs9807989	0.507	rs11465721	MIMAT0019927	hsa-miR-4772-3p	-3.52	0.00047	-0.15	-0.16	Asthma;	chr2:102446780	chr2:102432336~102432357:+
THCA	cis	rs10021731	0.718	rs62309866	MIMAT0003242	hsa-miR-577	-3.52	0.00047	-0.17	-0.16	Optic disc area;	chr4:114479583	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.718	rs7685549	MIMAT0003242	hsa-miR-577	-3.52	0.00047	-0.17	-0.16	Optic disc area;	chr4:114479772	chr4:114656774~114656794:+
THCA	cis	rs7210990	0.836	rs11651290	MIMAT0005942	hsa-miR-1288-3p	3.52	0.000471	0.2	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16048157	chr17:16282058~16282078:+
THCA	cis	rs7210990	0.836	rs3815039	MIMAT0005942	hsa-miR-1288-3p	3.52	0.000471	0.2	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16049274	chr17:16282058~16282078:+
THCA	cis	rs4960162	1	rs4960162	MIMAT0022472	hsa-miR-5683	3.52	0.000471	0.21	0.16	Night sleep phenotypes;	chr6:6065527	chr6:6169343~6169366:+
THCA	cis	rs4778581	0.9	rs1357335	MIMAT0000454	hsa-miR-184	3.52	0.000473	0.18	0.16	Reticulocyte count;Reticulocyte fraction of red cells;	chr15:80076521	chr15:79209840~79209861:+
THCA	cis	rs9434723	0.92	rs11801562	MIMAT0000255	hsa-miR-34a-5p	-3.52	0.000474	-0.19	-0.16	Height;	chr1:9233097	chr1:9151735~9151756:-
THCA	cis	rs4800353	0.517	rs1871510	MIMAT0000427	hsa-miR-133a-3p	-3.52	0.000475	-0.22	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22009375	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.517	rs1871510	MIMAT0000427_1	hsa-miR-133a-3p	-3.52	0.000475	-0.22	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22009375	chr20:62564970~62564991:+
THCA	cis	rs7210990	0.836	rs1125156	MIMAT0005942	hsa-miR-1288-3p	3.52	0.000475	0.2	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16091240	chr17:16282058~16282078:+
THCA	cis	rs2274459	0.841	rs10456075	MIMAT0018349	hsa-miR-3934-5p	3.52	0.000476	0.23	0.16	Obesity (extreme);	chr6:33713826	chr6:33698152~33698173:+
THCA	cis	rs7649443	0.959	rs59171696	MIMAT0019973	hsa-miR-4797-3p	3.52	0.000476	0.22	0.16	Nonsyndromic cleft lip with cleft palate;	chr3:197072503	chr3:197293888~197293908:-
THCA	cis	rs6537837	0.701	rs12021920	MIMAT0000227	hsa-miR-197-3p	-3.52	0.000479	-0.17	-0.16	Major depressive disorder;	chr1:109604665	chr1:109598940~109598961:+
THCA	cis	rs7385804	0.761	rs576236	MIMAT0027650	hsa-miR-6875-5p	3.52	0.000479	0.21	0.16	Iron status biomarkers (iron levels);Iron status biomarkers (transferrin saturation);Hematocrit;Mean corpuscular hemoglobin;Hematological parameters;Red blood cell count;Mean corpuscular volume;Iron status biomarkers;	chr7:100719352	chr7:100868041~100868061:+
THCA	cis	rs7385804	0.761	rs1617640	MIMAT0027650	hsa-miR-6875-5p	3.52	0.000479	0.21	0.16	Iron status biomarkers (iron levels);Iron status biomarkers (transferrin saturation);Hematocrit;Mean corpuscular hemoglobin;Hematological parameters;Red blood cell count;Mean corpuscular volume;Iron status biomarkers;	chr7:100719675	chr7:100868041~100868061:+
THCA	cis	rs7210990	0.866	rs178658	MIMAT0005942	hsa-miR-1288-3p	3.52	0.00048	0.2	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16154176	chr17:16282058~16282078:+
THCA	cis	rs7210990	0.866	rs178657	MIMAT0005942	hsa-miR-1288-3p	3.52	0.00048	0.2	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16154619	chr17:16282058~16282078:+
THCA	cis	rs13326165	0.76	rs13076890	MIMAT0004595	hsa-miR-135a-3p	3.52	0.00048	0.23	0.16	HDL cholesterol;HDL cholesterol levels;	chr3:52373917	chr3:52294232~52294253:-
THCA	cis	rs7213347	0.581	rs11657636	MIMAT0000426	hsa-miR-132-3p	3.52	0.00048	0.17	0.16	Total body bone mineral density;	chr17:2150626	chr17:2049929~2049950:-
THCA	cis	rs7897654	0.61	rs7916476	MIMAT0022727	hsa-miR-1307-5p	3.52	0.000481	0.16	0.16	Schizophrenia;	chr10:103055511	chr10:103394341~103394361:-
THCA	cis	rs7649443	0.917	rs3843374	MIMAT0019973	hsa-miR-4797-3p	3.52	0.000481	0.22	0.16	Nonsyndromic cleft lip with cleft palate;	chr3:197070329	chr3:197293888~197293908:-
THCA	cis	rs7649443	0.959	rs35260201	MIMAT0019973	hsa-miR-4797-3p	3.52	0.000481	0.22	0.16	Nonsyndromic cleft lip with cleft palate;	chr3:197071830	chr3:197293888~197293908:-
THCA	cis	rs7826238	0.524	rs2921055	MIMAT0019728	hsa-miR-4660	3.52	0.000482	0.21	0.16	Systolic blood pressure;	chr8:8461832	chr8:9048453~9048475:+
THCA	cis	rs4800353	0.516	rs67731061	MIMAT0000427	hsa-miR-133a-3p	-3.51	0.000483	-0.23	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:21961261	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.516	rs67731061	MIMAT0000427_1	hsa-miR-133a-3p	-3.51	0.000483	-0.23	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:21961261	chr20:62564970~62564991:+
THCA	cis	rs10021731	0.718	rs7686774	MIMAT0003242	hsa-miR-577	-3.51	0.000483	-0.17	-0.16	Optic disc area;	chr4:114480357	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.718	rs7687413	MIMAT0003242	hsa-miR-577	-3.51	0.000483	-0.17	-0.16	Optic disc area;	chr4:114480417	chr4:114656774~114656794:+
THCA	cis	rs780142	0.545	rs12592908	MIMAT0000458	hsa-miR-190a-5p	3.51	0.000483	0.19	0.16	Reticulocyte count;Reticulocyte fraction of red cells;	chr15:62560577	chr15:62823971~62823992:+
THCA	cis	rs10751667	0.621	rs7396049	MIMAT0006790	hsa-miR-675-3p	-3.51	0.000484	-0.14	-0.16	Alzheimer's disease (late onset);	chr11:1001561	chr11:1996768~1996787:-
THCA	cis	rs953492	0.863	rs2490395	MIMAT0019761	hsa-miR-4677-3p	-3.51	0.000485	-0.17	-0.16	Diastolic blood pressure;	chr1:243295620	chr1:243346225~243346246:+
THCA	cis	rs7210990	0.797	rs9903464	MIMAT0005942	hsa-miR-1288-3p	3.51	0.000485	0.2	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16149067	chr17:16282058~16282078:+
THCA	cis	rs7477	0.818	rs714285	MIMAT0005942	hsa-miR-1288-3p	-3.51	0.000485	-0.2	-0.16	Amyotrophic lateral sclerosis;	chr17:16341070	chr17:16282058~16282078:+
THCA	cis	rs7477	0.818	rs3112521	MIMAT0005942	hsa-miR-1288-3p	-3.51	0.000485	-0.2	-0.16	Amyotrophic lateral sclerosis;	chr17:16341343	chr17:16282058~16282078:+
THCA	cis	rs7210990	0.831	rs178809	MIMAT0005942	hsa-miR-1288-3p	3.51	0.000486	0.2	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16196459	chr17:16282058~16282078:+
THCA	cis	rs7210990	0.866	rs178805	MIMAT0005942	hsa-miR-1288-3p	3.51	0.000486	0.2	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16197814	chr17:16282058~16282078:+
THCA	cis	rs10021731	0.692	rs7662125	MIMAT0003242	hsa-miR-577	-3.51	0.000486	-0.17	-0.16	Optic disc area;	chr4:114495706	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.692	rs2054303	MIMAT0003242	hsa-miR-577	-3.51	0.000486	-0.17	-0.16	Optic disc area;	chr4:114495803	chr4:114656774~114656794:+
THCA	cis	rs12355831	0.708	rs6585151	MIMAT0025841	hsa-miR-6715a-3p	-3.51	0.000486	-0.21	-0.16	Migraine;	chr10:112351056	chr10:112299660~112299680:+
THCA	cis	rs7649443	0.759	rs12632536	MIMAT0019973	hsa-miR-4797-3p	3.51	0.000488	0.22	0.16	Nonsyndromic cleft lip with cleft palate;	chr3:197106779	chr3:197293888~197293908:-
THCA	cis	rs8041447	0.896	rs8033211	MIMAT0000458	hsa-miR-190a-5p	-3.51	0.000488	-0.16	-0.16	Immature fraction of reticulocytes;	chr15:62769688	chr15:62823971~62823992:+
THCA	cis	rs7477	0.84	rs11653585	MIMAT0005942	hsa-miR-1288-3p	3.51	0.000489	0.21	0.16	Amyotrophic lateral sclerosis;	chr17:16350723	chr17:16282058~16282078:+
THCA	cis	rs7649443	0.959	rs12374173	MIMAT0019973	hsa-miR-4797-3p	3.51	0.00049	0.22	0.16	Nonsyndromic cleft lip with cleft palate;	chr3:197089418	chr3:197293888~197293908:-
THCA	cis	rs1468333	0.861	rs10061967	MIMAT0026718	hsa-miR-874-5p	-3.51	0.00049	-0.12	-0.16	Resting heart rate;	chr5:138131744	chr5:137647618~137647640:-
THCA	cis	rs7210990	0.798	rs178798	MIMAT0005942	hsa-miR-1288-3p	3.51	0.000491	0.2	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16214045	chr17:16282058~16282078:+
THCA	cis	rs2980439	0.556	rs2921059	MIMAT0019728	hsa-miR-4660	3.51	0.000492	0.21	0.16	Neuroticism;	chr8:8460377	chr8:9048453~9048475:+
THCA	cis	rs7649443	0.959	rs12631126	MIMAT0019973	hsa-miR-4797-3p	3.51	0.000492	0.21	0.16	Nonsyndromic cleft lip with cleft palate;	chr3:197061567	chr3:197293888~197293908:-
THCA	cis	rs780142	0.504	rs61587000	MIMAT0000458	hsa-miR-190a-5p	3.51	0.000492	0.19	0.16	Reticulocyte count;Reticulocyte fraction of red cells;	chr15:62560753	chr15:62823971~62823992:+
THCA	cis	rs7210990	0.836	rs4791660	MIMAT0005942	hsa-miR-1288-3p	3.51	0.000494	0.19	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16056876	chr17:16282058~16282078:+
THCA	cis	rs7819412	0.505	rs17782554	MIMAT0003266	hsa-miR-598-3p	3.51	0.000494	0.15	0.16	Triglycerides;	chr8:11164596	chr8:11035221~11035242:-
THCA	cis	rs7819412	0.561	rs2001328	MIMAT0003266	hsa-miR-598-3p	3.51	0.000494	0.14	0.16	Triglycerides;	chr8:11129689	chr8:11035221~11035242:-
THCA	cis	rs4778581	0.9	rs1357336	MIMAT0000454	hsa-miR-184	-3.51	0.000495	-0.18	-0.16	Reticulocyte count;Reticulocyte fraction of red cells;	chr15:80076556	chr15:79209840~79209861:+
THCA	cis	rs9807989	0.507	rs3755266	MIMAT0019927	hsa-miR-4772-3p	-3.51	0.000495	-0.15	-0.16	Asthma;	chr2:102426252	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.507	rs2110659	MIMAT0019927	hsa-miR-4772-3p	-3.51	0.000495	-0.15	-0.16	Asthma;	chr2:102427407	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.507	rs7605284	MIMAT0019927	hsa-miR-4772-3p	-3.51	0.000495	-0.15	-0.16	Asthma;	chr2:102427715	chr2:102432336~102432357:+
THCA	cis	rs4988958	0.584	rs12712149	MIMAT0019927	hsa-miR-4772-3p	-3.51	0.000495	-0.15	-0.16	Asthma (childhood onset);	chr2:102428733	chr2:102432336~102432357:+
THCA	cis	rs4988958	0.584	rs7559845	MIMAT0019927	hsa-miR-4772-3p	-3.51	0.000495	-0.15	-0.16	Asthma (childhood onset);	chr2:102429754	chr2:102432336~102432357:+
THCA	cis	rs4919669	0.668	rs10883740	MIMAT0005951	hsa-miR-1307-3p	-3.51	0.000495	-0.17	-0.16	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102575065	chr10:103394301~103394322:-
THCA	cis	rs4919669	0.668	rs77630251	MIMAT0005951	hsa-miR-1307-3p	-3.51	0.000495	-0.17	-0.16	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102578613	chr10:103394301~103394322:-
THCA	cis	rs10021731	0.744	rs6814022	MIMAT0003242	hsa-miR-577	-3.51	0.000496	-0.17	-0.16	Optic disc area;	chr4:114528667	chr4:114656774~114656794:+
THCA	cis	rs7210990	0.836	rs9652828	MIMAT0005942	hsa-miR-1288-3p	3.51	0.000496	0.19	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16056400	chr17:16282058~16282078:+
THCA	cis	rs10021731	0.692	rs13103833	MIMAT0003242	hsa-miR-577	-3.51	0.000496	-0.17	-0.16	Optic disc area;	chr4:114495414	chr4:114656774~114656794:+
THCA	cis	rs7649443	0.959	rs2341225	MIMAT0019973	hsa-miR-4797-3p	3.51	0.000497	0.21	0.16	Nonsyndromic cleft lip with cleft palate;	chr3:197098527	chr3:197293888~197293908:-
THCA	cis	rs9807989	0.507	rs6755905	MIMAT0019927	hsa-miR-4772-3p	-3.51	0.000497	-0.15	-0.16	Asthma;	chr2:102431747	chr2:102432336~102432357:+
THCA	cis	rs4988958	0.527	rs6756161	MIMAT0019927	hsa-miR-4772-3p	-3.51	0.000497	-0.15	-0.16	Asthma (childhood onset);	chr2:102431957	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.507	rs6726985	MIMAT0019927	hsa-miR-4772-3p	-3.51	0.000497	-0.15	-0.16	Asthma;	chr2:102432120	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.507	rs2310300	MIMAT0019927	hsa-miR-4772-3p	-3.51	0.000497	-0.15	-0.16	Asthma;	chr2:102432614	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.507	rs7581119	MIMAT0019927	hsa-miR-4772-3p	-3.51	0.000497	-0.15	-0.16	Asthma;	chr2:102433405	chr2:102432336~102432357:+
THCA	cis	rs10021731	0.718	rs2054306	MIMAT0003242	hsa-miR-577	-3.51	0.000498	-0.17	-0.16	Optic disc area;	chr4:114496204	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.718	rs2035059	MIMAT0003242	hsa-miR-577	-3.51	0.000498	-0.17	-0.16	Optic disc area;	chr4:114496530	chr4:114656774~114656794:+
THCA	cis	rs13326165	0.616	rs82825	MIMAT0004595	hsa-miR-135a-3p	-3.51	5e-04	-0.23	-0.16	HDL cholesterol;HDL cholesterol levels;	chr3:52437926	chr3:52294232~52294253:-
THCA	cis	rs6537837	1	rs6682956	MIMAT0000227	hsa-miR-197-3p	-3.5	0.000502	-0.15	-0.16	Major depressive disorder;	chr1:109587642	chr1:109598940~109598961:+
THCA	cis	rs2274459	1	rs34139049	MIMAT0022975	hsa-miR-3934-3p	3.5	0.000502	0.25	0.16	Obesity (extreme);	chr6:33749007	chr6:33698191~33698212:+
THCA	cis	rs2274459	1	rs35274562	MIMAT0022975	hsa-miR-3934-3p	3.5	0.000502	0.25	0.16	Obesity (extreme);	chr6:33749054	chr6:33698191~33698212:+
THCA	cis	rs2274459	1	rs35646598	MIMAT0022975	hsa-miR-3934-3p	3.5	0.000502	0.25	0.16	Obesity (extreme);	chr6:33749639	chr6:33698191~33698212:+
THCA	cis	rs453301	0.658	rs6983877	MIMAT0019728	hsa-miR-4660	-3.5	0.000503	-0.21	-0.16	Joint mobility (Beighton score);	chr8:9047129	chr8:9048453~9048475:+
THCA	cis	rs8041447	0.864	rs938981	MIMAT0000458	hsa-miR-190a-5p	-3.5	0.000503	-0.17	-0.16	Immature fraction of reticulocytes;	chr15:62770703	chr15:62823971~62823992:+
THCA	cis	rs7210990	0.836	rs3785631	MIMAT0005942	hsa-miR-1288-3p	-3.5	0.000504	-0.19	-0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16042632	chr17:16282058~16282078:+
THCA	cis	rs1870653	0.516	rs80050223	MIMAT0003242	hsa-miR-577	3.5	0.000505	0.28	0.16	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);	chr4:114503554	chr4:114656774~114656794:+
THCA	cis	rs1870653	0.516	rs73848142	MIMAT0003242	hsa-miR-577	3.5	0.000505	0.28	0.16	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);	chr4:114506178	chr4:114656774~114656794:+
THCA	cis	rs1870653	0.516	rs7671567	MIMAT0003242	hsa-miR-577	3.5	0.000505	0.28	0.16	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);	chr4:114517952	chr4:114656774~114656794:+
THCA	cis	rs17604090	1	rs17604090	MIMAT0004800	hsa-miR-550a-5p	3.5	0.000505	0.24	0.16	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29651822	chr7:30289815~30289837:+
THCA	cis	rs17604090	1	rs17604090	MIMAT0004800_1	hsa-miR-550a-5p	3.5	0.000505	0.24	0.16	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29651822	chr7:32733002~32733024:+
THCA	cis	rs7866350	0.769	rs3780447	MIMAT0027608	hsa-miR-6854-5p	3.5	0.000506	0.22	0.16	Post-traumatic stress disorder;	chr9:98208007	chr9:98229189~98229212:-
THCA	cis	rs751728	1	rs6925273	MIMAT0022975	hsa-miR-3934-3p	-3.5	0.000507	-0.19	-0.16	Crohn's disease;	chr6:33764671	chr6:33698191~33698212:+
THCA	cis	rs7385804	0.761	rs504141	MIMAT0027650	hsa-miR-6875-5p	3.5	0.000507	0.21	0.16	Iron status biomarkers (iron levels);Iron status biomarkers (transferrin saturation);Hematocrit;Mean corpuscular hemoglobin;Hematological parameters;Red blood cell count;Mean corpuscular volume;Iron status biomarkers;	chr7:100711502	chr7:100868041~100868061:+
THCA	cis	rs7385804	0.761	rs1734910	MIMAT0027650	hsa-miR-6875-5p	3.5	0.000507	0.21	0.16	Iron status biomarkers (iron levels);Iron status biomarkers (transferrin saturation);Hematocrit;Mean corpuscular hemoglobin;Hematological parameters;Red blood cell count;Mean corpuscular volume;Iron status biomarkers;	chr7:100711921	chr7:100868041~100868061:+
THCA	cis	rs7385804	0.766	rs1734909	MIMAT0027650	hsa-miR-6875-5p	3.5	0.000507	0.21	0.16	Iron status biomarkers (iron levels);Iron status biomarkers (transferrin saturation);Hematocrit;Mean corpuscular hemoglobin;Hematological parameters;Red blood cell count;Mean corpuscular volume;Iron status biomarkers;	chr7:100711959	chr7:100868041~100868061:+
THCA	cis	rs10819861	0.621	rs7046587	MIMAT0000418	hsa-miR-23b-3p	3.5	0.00051	0.11	0.16	Electrocardiographic traits;	chr9:96085105	chr9:95085265~95085287:+
THCA	cis	rs6841433	0.615	rs33914856	MIMAT0003242	hsa-miR-577	3.5	0.00051	0.22	0.16	Hemoglobin concentration;	chr4:114564668	chr4:114656774~114656794:+
THCA	cis	rs6088590	1	rs10048849	MIMAT0004772	hsa-miR-499a-3p	-3.5	0.00051	-0.19	-0.16	Coronary artery disease;	chr20:34831877	chr20:34990445~34990466:+
THCA	cis	rs6575793	0.532	rs6575794	MIMAT0004921	hsa-miR-889-3p	3.5	0.000514	0.1	0.16	Menarche (age at onset);	chr14:100573387	chr14:101047949~101047969:+
THCA	cis	rs6555855	0.909	rs6864818	MIMAT0026618	hsa-miR-585-5p	-3.5	0.000514	-0.24	-0.16	Menarche (age at onset);	chr5:169307863	chr5:169263649~169263670:-
THCA	cis	rs7866350	1	rs10760206	MIMAT0027608	hsa-miR-6854-5p	3.5	0.000518	0.23	0.16	Post-traumatic stress disorder;	chr9:98222573	chr9:98229189~98229212:-
THCA	cis	rs1870653	0.516	rs115941533	MIMAT0003242	hsa-miR-577	3.49	0.00052	0.28	0.16	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);	chr4:114521099	chr4:114656774~114656794:+
THCA	cis	rs10751667	0.6	rs11246377	MIMAT0006790	hsa-miR-675-3p	-3.49	0.000521	-0.14	-0.16	Alzheimer's disease (late onset);	chr11:999796	chr11:1996768~1996787:-
THCA	cis	rs10021731	0.718	rs10857031	MIMAT0003242	hsa-miR-577	-3.49	0.000523	-0.17	-0.16	Optic disc area;	chr4:114527690	chr4:114656774~114656794:+
THCA	cis	rs7829975	0.774	rs11775523	MIMAT0019728	hsa-miR-4660	3.49	0.000524	0.21	0.16	Mood instability;	chr8:8821666	chr8:9048453~9048475:+
THCA	cis	rs6555855	0.909	rs1119097	MIMAT0026618	hsa-miR-585-5p	3.49	0.000524	0.24	0.16	Menarche (age at onset);	chr5:169317322	chr5:169263649~169263670:-
THCA	cis	rs6537837	0.838	rs6692804	MIMAT0000227	hsa-miR-197-3p	-3.49	0.000525	-0.15	-0.16	Major depressive disorder;	chr1:109566120	chr1:109598940~109598961:+
THCA	cis	rs9807989	0.507	rs2041739	MIMAT0019927	hsa-miR-4772-3p	3.49	0.000527	0.15	0.16	Asthma;	chr2:102377873	chr2:102432336~102432357:+
THCA	cis	rs2841277	0.738	rs1036713	MIMAT0019814	hsa-miR-203b-3p	-3.49	0.000528	-0.15	-0.16	Rheumatoid arthritis;	chr14:104930356	chr14:104117428~104117450:-
THCA	cis	rs6681460	0.834	rs544258	MIMAT0014979	hsa-miR-3117-3p	3.49	0.000528	0.2	0.16	Presence of antiphospholipid antibodies;	chr1:66753526	chr1:66628485~66628505:+
THCA	cis	rs4800353	0.778	rs34621724	MIMAT0000427	hsa-miR-133a-3p	-3.49	0.000529	-0.24	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22086188	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.778	rs34621724	MIMAT0000427_1	hsa-miR-133a-3p	-3.49	0.000529	-0.24	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22086188	chr20:62564970~62564991:+
THCA	cis	rs7829975	0.514	rs2920991	MIMAT0019728	hsa-miR-4660	3.49	0.00053	0.2	0.16	Mood instability;	chr8:8401607	chr8:9048453~9048475:+
THCA	cis	rs7829975	0.572	rs28446104	MIMAT0019728	hsa-miR-4660	-3.49	0.000532	-0.21	-0.16	Mood instability;	chr8:8938391	chr8:9048453~9048475:+
THCA	cis	rs1468333	0.892	rs184268	MIMAT0026718	hsa-miR-874-5p	-3.49	0.000532	-0.12	-0.16	Resting heart rate;	chr5:138126970	chr5:137647618~137647640:-
THCA	cis	rs4800353	0.929	rs56388616	MIMAT0000427	hsa-miR-133a-3p	-3.49	0.000532	-0.23	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22033122	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.929	rs56388616	MIMAT0000427_1	hsa-miR-133a-3p	-3.49	0.000532	-0.23	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22033122	chr20:62564970~62564991:+
THCA	cis	rs4800353	0.929	rs35687829	MIMAT0000427	hsa-miR-133a-3p	-3.49	0.000532	-0.23	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22033190	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.929	rs35687829	MIMAT0000427_1	hsa-miR-133a-3p	-3.49	0.000532	-0.23	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22033190	chr20:62564970~62564991:+
THCA	cis	rs2274459	0.915	rs12192035	MIMAT0022975	hsa-miR-3934-3p	3.49	0.000533	0.24	0.16	Obesity (extreme);	chr6:33752288	chr6:33698191~33698212:+
THCA	cis	rs11992186	0.505	rs7845203	MIMAT0019728	hsa-miR-4660	3.49	0.000533	0.21	0.16	Neuroticism;	chr8:8287918	chr8:9048453~9048475:+
THCA	cis	rs4919669	0.843	rs11191379	MIMAT0005951	hsa-miR-1307-3p	-3.49	0.000534	-0.16	-0.16	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102722573	chr10:103394301~103394322:-
THCA	cis	rs7829975	1	rs7829975	MIMAT0019728	hsa-miR-4660	-3.49	0.000534	-0.21	-0.16	Mood instability;	chr8:8690607	chr8:9048453~9048475:+
THCA	cis	rs7866350	0.769	rs10985454	MIMAT0027608	hsa-miR-6854-5p	3.49	0.000534	0.22	0.16	Post-traumatic stress disorder;	chr9:98211550	chr9:98229189~98229212:-
THCA	cis	rs1468333	1	rs217263	MIMAT0026718	hsa-miR-874-5p	-3.49	0.000536	-0.12	-0.16	Resting heart rate;	chr5:138144977	chr5:137647618~137647640:-
THCA	cis	rs4919669	0.668	rs17114641	MIMAT0005951	hsa-miR-1307-3p	-3.49	0.000537	-0.16	-0.16	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102527602	chr10:103394301~103394322:-
THCA	cis	rs4988958	0.565	rs6732138	MIMAT0019927	hsa-miR-4772-3p	-3.49	0.000538	-0.15	-0.16	Asthma (childhood onset);	chr2:102393202	chr2:102432336~102432357:+
THCA	cis	rs7829975	0.606	rs11776838	MIMAT0019728	hsa-miR-4660	-3.48	0.000538	-0.21	-0.16	Mood instability;	chr8:8937291	chr8:9048453~9048475:+
THCA	cis	rs7819412	0.645	rs10156356	MIMAT0003266	hsa-miR-598-3p	3.48	0.00054	0.14	0.16	Triglycerides;	chr8:11188700	chr8:11035221~11035242:-
THCA	cis	rs2755237	0.583	rs1923255	MIMAT0006764	hsa-miR-320d	3.48	0.000542	0.23	0.16	Central corneal thickness;	chr13:40513375	chr13:40727828~40727846:-
THCA	cis	rs2755237	0.583	rs1923255	MIMAT0006764_1	hsa-miR-320d	3.48	0.000542	0.23	0.16	Central corneal thickness;	chr13:40513375	chrX:140926172~140926190:-
THCA	cis	rs7897654	0.61	rs12570528	MIMAT0022727	hsa-miR-1307-5p	3.48	0.000542	0.16	0.16	Schizophrenia;	chr10:103070453	chr10:103394341~103394361:-
THCA	cis	rs10021731	0.718	rs10028232	MIMAT0003242	hsa-miR-577	-3.48	0.000542	-0.17	-0.16	Optic disc area;	chr4:114487644	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.718	rs7671026	MIMAT0003242	hsa-miR-577	-3.48	0.000542	-0.17	-0.16	Optic disc area;	chr4:114487736	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.692	rs10031142	MIMAT0003242	hsa-miR-577	-3.48	0.000542	-0.17	-0.16	Optic disc area;	chr4:114488433	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.718	rs17678686	MIMAT0003242	hsa-miR-577	-3.48	0.000542	-0.17	-0.16	Optic disc area;	chr4:114489100	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.718	rs28766989	MIMAT0003242	hsa-miR-577	-3.48	0.000542	-0.17	-0.16	Optic disc area;	chr4:114489752	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.692	rs11722125	MIMAT0003242	hsa-miR-577	-3.48	0.000542	-0.17	-0.16	Optic disc area;	chr4:114490374	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.692	rs11722162	MIMAT0003242	hsa-miR-577	-3.48	0.000542	-0.17	-0.16	Optic disc area;	chr4:114490460	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.668	rs11722201	MIMAT0003242	hsa-miR-577	-3.48	0.000542	-0.17	-0.16	Optic disc area;	chr4:114490577	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.718	rs1585447	MIMAT0003242	hsa-miR-577	-3.48	0.000542	-0.17	-0.16	Optic disc area;	chr4:114490912	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.692	rs1585448	MIMAT0003242	hsa-miR-577	-3.48	0.000542	-0.17	-0.16	Optic disc area;	chr4:114491050	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.718	rs1870655	MIMAT0003242	hsa-miR-577	-3.48	0.000542	-0.17	-0.16	Optic disc area;	chr4:114491625	chr4:114656774~114656794:+
THCA	cis	rs5749696	1	rs5749696	MIMAT0000691	hsa-miR-130b-3p	3.48	0.000543	0.15	0.16	Schizophrenia;	chr22:21709048	chr22:21653354~21653375:+
THCA	cis	rs2980439	0.557	rs2976876	MIMAT0019728	hsa-miR-4660	3.48	0.000544	0.21	0.16	Neuroticism;	chr8:8461340	chr8:9048453~9048475:+
THCA	cis	rs4409766	0.518	rs486955	MIMAT0022727	hsa-miR-1307-5p	3.48	0.000547	0.17	0.16	Systolic blood pressure;Diastolic blood pressure;Body mass index;Diastolic blood pressure (long-term average);Hypertension;Mean arterial pressure (long-term average);	chr10:102786527	chr10:103394341~103394361:-
THCA	cis	rs11250098	0.583	rs36030755	MIMAT0003266	hsa-miR-598-3p	3.48	0.000548	0.14	0.16	Morning vs. evening chronotype;	chr8:10959261	chr8:11035221~11035242:-
THCA	cis	rs2980439	0.557	rs2921056	MIMAT0019728	hsa-miR-4660	3.48	0.000548	0.21	0.16	Neuroticism;	chr8:8461672	chr8:9048453~9048475:+
THCA	cis	rs7829975	0.582	rs11783950	MIMAT0019728	hsa-miR-4660	-3.48	0.00055	-0.22	-0.16	Mood instability;	chr8:8740321	chr8:9048453~9048475:+
THCA	cis	rs730566	1	rs730566	MIMAT0001343	hsa-miR-425-3p	-3.48	0.00055	-0.15	-0.16	Prion diseases;	chr3:48445644	chr3:49020159~49020180:-
THCA	cis	rs10021731	0.718	rs2219591	MIMAT0003242	hsa-miR-577	-3.48	0.000552	-0.17	-0.16	Optic disc area;	chr4:114491902	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.718	rs2199310	MIMAT0003242	hsa-miR-577	-3.48	0.000552	-0.17	-0.16	Optic disc area;	chr4:114492246	chr4:114656774~114656794:+
THCA	cis	rs7829975	0.567	rs6601273	MIMAT0019728	hsa-miR-4660	-3.48	0.000553	-0.21	-0.16	Mood instability;	chr8:8939009	chr8:9048453~9048475:+
THCA	cis	rs6088590	0.965	rs6088620	MIMAT0004772	hsa-miR-499a-3p	-3.48	0.000553	-0.19	-0.16	Coronary artery disease;	chr20:34824219	chr20:34990445~34990466:+
THCA	cis	rs7829975	0.682	rs7013471	MIMAT0019728	hsa-miR-4660	-3.48	0.000554	-0.21	-0.16	Mood instability;	chr8:8829815	chr8:9048453~9048475:+
THCA	cis	rs9807989	0.507	rs6543133	MIMAT0019927	hsa-miR-4772-3p	-3.48	0.000557	-0.15	-0.16	Asthma;	chr2:102423717	chr2:102432336~102432357:+
THCA	cis	rs10751667	0.621	rs11246375	MIMAT0006790	hsa-miR-675-3p	-3.48	0.000557	-0.14	-0.16	Alzheimer's disease (late onset);	chr11:999620	chr11:1996768~1996787:-
THCA	cis	rs7819412	0.522	rs4841497	MIMAT0003266	hsa-miR-598-3p	3.48	0.000557	0.15	0.16	Triglycerides;	chr8:11127630	chr8:11035221~11035242:-
THCA	cis	rs7829975	0.501	rs2980769	MIMAT0019728	hsa-miR-4660	3.47	0.000559	0.2	0.16	Mood instability;	chr8:8462781	chr8:9048453~9048475:+
THCA	cis	rs7210990	0.836	rs8080706	MIMAT0005942	hsa-miR-1288-3p	3.47	0.00056	0.19	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16088246	chr17:16282058~16282078:+
THCA	cis	rs10021731	0.718	rs1460771	MIMAT0003242	hsa-miR-577	3.47	0.000562	0.16	0.16	Optic disc area;	chr4:114486755	chr4:114656774~114656794:+
THCA	cis	rs7649443	0.959	rs13070996	MIMAT0019973	hsa-miR-4797-3p	3.47	0.000562	0.21	0.16	Nonsyndromic cleft lip with cleft palate;	chr3:197179203	chr3:197293888~197293908:-
THCA	cis	rs1468333	1	rs2967781	MIMAT0004911	hsa-miR-874-3p	-3.47	0.000563	-0.1	-0.16	Resting heart rate;	chr5:138221920	chr5:137647582~137647603:-
THCA	cis	rs13326165	0.76	rs2016575	MIMAT0004595	hsa-miR-135a-3p	-3.47	0.000563	-0.23	-0.16	HDL cholesterol;HDL cholesterol levels;	chr3:52443064	chr3:52294232~52294253:-
THCA	cis	rs1932064	0.536	rs1334991	MIMAT0004612	hsa-miR-186-3p	-3.47	0.000564	-0.44	-0.16	Yu-Zhi constitution type in type 2 diabetes;	chr1:70656918	chr1:71067642~71067663:-
THCA	cis	rs9527	0.59	rs12355120	MIMAT0022727	hsa-miR-1307-5p	3.47	0.000565	0.14	0.16	Arsenic metabolism;	chr10:103092409	chr10:103394341~103394361:-
THCA	cis	rs751728	1	rs6920075	MIMAT0018349	hsa-miR-3934-5p	-3.47	0.000565	-0.19	-0.16	Crohn's disease;	chr6:33764020	chr6:33698152~33698173:+
THCA	cis	rs1468333	1	rs2906128	MIMAT0004911	hsa-miR-874-3p	-3.47	0.000566	-0.1	-0.16	Resting heart rate;	chr5:138214365	chr5:137647582~137647603:-
THCA	cis	rs1468333	0.824	rs9327809	MIMAT0026718	hsa-miR-874-5p	-3.47	0.000567	-0.12	-0.16	Resting heart rate;	chr5:138252117	chr5:137647618~137647640:-
THCA	cis	rs1468333	0.824	rs28704868	MIMAT0026718	hsa-miR-874-5p	-3.47	0.000567	-0.12	-0.16	Resting heart rate;	chr5:138255097	chr5:137647618~137647640:-
THCA	cis	rs9527	0.521	rs12259163	MIMAT0022727	hsa-miR-1307-5p	3.47	0.000568	0.14	0.16	Arsenic metabolism;	chr10:103201720	chr10:103394341~103394361:-
THCA	cis	rs2229637	1	rs2229637	MIMAT0022975	hsa-miR-3934-3p	-3.47	0.000568	-0.19	-0.16	Venous thromboembolism adjusted for sickle cell variant rs77121243-T;	chr6:33675781	chr6:33698191~33698212:+
THCA	cis	rs1468333	1	rs10479179	MIMAT0026718	hsa-miR-874-5p	-3.47	0.00057	-0.12	-0.16	Resting heart rate;	chr5:138228426	chr5:137647618~137647640:-
THCA	cis	rs6575793	0.512	rs7147982	MIMAT0004921	hsa-miR-889-3p	3.47	0.000571	0.1	0.16	Menarche (age at onset);	chr14:100580312	chr14:101047949~101047969:+
THCA	cis	rs7829975	0.744	rs2409092	MIMAT0019728	hsa-miR-4660	3.47	0.000571	0.21	0.16	Mood instability;	chr8:8824682	chr8:9048453~9048475:+
THCA	cis	rs10908557	0.915	rs11583896	MIMAT0022491	hsa-miR-5698	3.47	0.000574	0.21	0.16	Age at first birth;	chr1:153796506	chr1:154104562~154104583:-
THCA	cis	rs1468333	1	rs17171770	MIMAT0004911	hsa-miR-874-3p	-3.47	0.000575	-0.1	-0.16	Resting heart rate;	chr5:138179126	chr5:137647582~137647603:-
THCA	cis	rs4800353	0.929	rs4267422	MIMAT0000427	hsa-miR-133a-3p	-3.47	0.000576	-0.23	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22028342	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.929	rs4267422	MIMAT0000427_1	hsa-miR-133a-3p	-3.47	0.000576	-0.23	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22028342	chr20:62564970~62564991:+
THCA	cis	rs4800353	0.929	rs9952389	MIMAT0000427	hsa-miR-133a-3p	-3.47	0.000576	-0.23	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22028812	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.929	rs9952389	MIMAT0000427_1	hsa-miR-133a-3p	-3.47	0.000576	-0.23	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22028812	chr20:62564970~62564991:+
THCA	cis	rs4800353	0.929	rs7238695	MIMAT0000427	hsa-miR-133a-3p	-3.47	0.000576	-0.23	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22029663	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.929	rs7238695	MIMAT0000427_1	hsa-miR-133a-3p	-3.47	0.000576	-0.23	-0.16	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22029663	chr20:62564970~62564991:+
THCA	cis	rs9434723	0.765	rs2268171	MIMAT0000255	hsa-miR-34a-5p	-3.47	0.000576	-0.19	-0.16	Height;	chr1:9242256	chr1:9151735~9151756:-
THCA	cis	rs6088765	0.583	rs6058209	MIMAT0004772	hsa-miR-499a-3p	-3.47	0.000576	-0.2	-0.16	Ulcerative colitis;	chr20:35233774	chr20:34990445~34990466:+
THCA	cis	rs9434723	0.841	rs6685399	MIMAT0000255	hsa-miR-34a-5p	-3.47	0.000576	-0.19	-0.16	Height;	chr1:9239235	chr1:9151735~9151756:-
THCA	cis	rs17710780	0.803	rs62380635	MIMAT0000731	hsa-miR-378a-5p	-3.47	0.000576	-0.18	-0.16	Major depressive disorder;	chr5:149707536	chr5:149732829~149732850:+
THCA	cis	rs9426935	0.505	rs4595397	MIMAT0022491	hsa-miR-5698	3.47	0.000576	0.2	0.16	Lentiform nucleus volume;	chr1:153855604	chr1:154104562~154104583:-
THCA	cis	rs7210990	0.866	rs72833498	MIMAT0005942	hsa-miR-1288-3p	3.47	0.000576	0.19	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16092488	chr17:16282058~16282078:+
THCA	cis	rs7866350	0.71	rs10818609	MIMAT0027608	hsa-miR-6854-5p	3.47	0.000577	0.22	0.16	Post-traumatic stress disorder;	chr9:98206538	chr9:98229189~98229212:-
THCA	cis	rs17384381	0.861	rs34561661	MIMAT0019232	hsa-miR-4423-5p	-3.47	0.000577	-0.26	-0.16	Lobe attachment (rater-scored or self-reported);	chr1:85311567	chr1:85133806~85133827:+
THCA	cis	rs2274459	0.778	rs9296097	MIMAT0018349	hsa-miR-3934-5p	3.47	0.000577	0.23	0.16	Obesity (extreme);	chr6:33692366	chr6:33698152~33698173:+
THCA	cis	rs12355831	0.881	rs10736220	MIMAT0025841	hsa-miR-6715a-3p	3.46	0.00058	0.21	0.16	Migraine;	chr10:112394703	chr10:112299660~112299680:+
THCA	cis	rs6951245	0.745	rs79788515	MIMAT0004702	hsa-miR-339-3p	-3.46	0.000581	-0.23	-0.16	C-reactive protein levels or total cholesterol levels (pleiotropy);	chr7:1061443	chr7:1022955~1022977:-
THCA	cis	rs1468333	1	rs2864	MIMAT0004911	hsa-miR-874-3p	-3.46	0.000582	-0.1	-0.16	Resting heart rate;	chr5:138187741	chr5:137647582~137647603:-
THCA	cis	rs1468333	1	rs4552585	MIMAT0004911	hsa-miR-874-3p	-3.46	0.000582	-0.1	-0.16	Resting heart rate;	chr5:138197470	chr5:137647582~137647603:-
THCA	cis	rs1468333	1	rs2967784	MIMAT0004911	hsa-miR-874-3p	-3.46	0.000582	-0.1	-0.16	Resting heart rate;	chr5:138203550	chr5:137647582~137647603:-
THCA	cis	rs1468333	1	rs2906127	MIMAT0004911	hsa-miR-874-3p	-3.46	0.000582	-0.1	-0.16	Resting heart rate;	chr5:138203777	chr5:137647582~137647603:-
THCA	cis	rs13326165	0.76	rs67834575	MIMAT0004595	hsa-miR-135a-3p	3.46	0.000583	0.22	0.16	HDL cholesterol;HDL cholesterol levels;	chr3:52377913	chr3:52294232~52294253:-
THCA	cis	rs13326165	0.76	rs67248391	MIMAT0004595	hsa-miR-135a-3p	3.46	0.000583	0.22	0.16	HDL cholesterol;HDL cholesterol levels;	chr3:52377990	chr3:52294232~52294253:-
THCA	cis	rs7210990	0.836	rs1079533	MIMAT0005942	hsa-miR-1288-3p	-3.46	0.000585	-0.19	-0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16046884	chr17:16282058~16282078:+
THCA	cis	rs10021731	0.718	rs13104656	MIMAT0003242	hsa-miR-577	-3.46	0.000587	-0.17	-0.16	Optic disc area;	chr4:114495547	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.692	rs13104693	MIMAT0003242	hsa-miR-577	-3.46	0.000587	-0.17	-0.16	Optic disc area;	chr4:114495600	chr4:114656774~114656794:+
THCA	cis	rs2461751	0.929	rs16863192	MIMAT0004556	hsa-miR-10b-3p	3.46	0.000589	0.26	0.16	Electrocardiographic conduction measures;	chr2:175463347	chr2:176150368~176150389:+
THCA	cis	rs10021731	0.782	rs12650319	MIMAT0003242	hsa-miR-577	3.46	0.000591	0.17	0.16	Optic disc area;	chr4:114594734	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.809	rs12647519	MIMAT0003242	hsa-miR-577	3.46	0.000591	0.17	0.16	Optic disc area;	chr4:114594742	chr4:114656774~114656794:+
THCA	cis	rs9434723	0.841	rs12083129	MIMAT0000255	hsa-miR-34a-5p	-3.46	0.000591	-0.19	-0.16	Height;	chr1:9251264	chr1:9151735~9151756:-
THCA	cis	rs7829975	0.606	rs6422352	MIMAT0019728	hsa-miR-4660	-3.46	0.000596	-0.2	-0.16	Mood instability;	chr8:8936683	chr8:9048453~9048475:+
THCA	cis	rs7829975	0.606	rs891570	MIMAT0019728	hsa-miR-4660	-3.46	0.000596	-0.2	-0.16	Mood instability;	chr8:8936944	chr8:9048453~9048475:+
THCA	cis	rs1468333	0.964	rs2967786	MIMAT0026718	hsa-miR-874-5p	-3.46	0.000596	-0.12	-0.16	Resting heart rate;	chr5:138211986	chr5:137647618~137647640:-
THCA	cis	rs6681460	0.898	rs536527	MIMAT0014979	hsa-miR-3117-3p	-3.46	0.000597	-0.19	-0.16	Presence of antiphospholipid antibodies;	chr1:66728110	chr1:66628485~66628505:+
THCA	cis	rs7826238	0.535	rs2979179	MIMAT0019728	hsa-miR-4660	3.46	0.000597	0.2	0.16	Systolic blood pressure;	chr8:8462519	chr8:9048453~9048475:+
THCA	cis	rs4919669	0.668	rs12220810	MIMAT0005951	hsa-miR-1307-3p	-3.46	0.000597	-0.17	-0.16	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102545362	chr10:103394301~103394322:-
THCA	cis	rs7829975	0.522	rs6601689	MIMAT0019728	hsa-miR-4660	3.46	0.000598	0.21	0.16	Mood instability;	chr8:8314761	chr8:9048453~9048475:+
THCA	cis	rs751728	0.965	rs9394165	MIMAT0018349	hsa-miR-3934-5p	-3.46	0.000599	-0.19	-0.16	Crohn's disease;	chr6:33763631	chr6:33698152~33698173:+
THCA	cis	rs7829975	0.502	rs7820738	MIMAT0019728	hsa-miR-4660	-3.46	6e-04	-0.2	-0.16	Mood instability;	chr8:8845097	chr8:9048453~9048475:+
THCA	cis	rs453301	0.686	rs6601280	MIMAT0019728	hsa-miR-4660	3.45	0.000601	0.21	0.16	Joint mobility (Beighton score);	chr8:9051726	chr8:9048453~9048475:+
THCA	cis	rs1468333	1	rs2967782	MIMAT0026718	hsa-miR-874-5p	-3.45	0.000602	-0.12	-0.16	Resting heart rate;	chr5:138193993	chr5:137647618~137647640:-
THCA	cis	rs4711350	0.862	rs597723	MIMAT0022975	hsa-miR-3934-3p	3.45	0.000603	0.21	0.16	Schizophrenia;	chr6:33726302	chr6:33698191~33698212:+
THCA	cis	rs6681460	0.576	rs7354983	MIMAT0014979	hsa-miR-3117-3p	-3.45	0.000603	-0.21	-0.16	Presence of antiphospholipid antibodies;	chr1:66522466	chr1:66628485~66628505:+
THCA	cis	rs6681460	0.649	rs1415984	MIMAT0014979	hsa-miR-3117-3p	-3.45	0.000603	-0.22	-0.16	Presence of antiphospholipid antibodies;	chr1:66536434	chr1:66628485~66628505:+
THCA	cis	rs10441737	0.51	rs170235	MIMAT0030017	hsa-miR-7702	-3.45	0.000604	-0.16	-0.16	Menarche (age at onset);	chr9:111343883	chr9:111271193~111271214:-
THCA	cis	rs7829975	0.572	rs7005000	MIMAT0019728	hsa-miR-4660	-3.45	0.000605	-0.2	-0.16	Mood instability;	chr8:8939092	chr8:9048453~9048475:+
THCA	cis	rs1760803	0.574	rs7551128	MIMAT0022491	hsa-miR-5698	3.45	0.000605	0.19	0.16	Nicotine dependence;	chr1:154209936	chr1:154104562~154104583:-
THCA	cis	rs1760803	0.574	rs11265299	MIMAT0022491	hsa-miR-5698	3.45	0.000605	0.19	0.16	Nicotine dependence;	chr1:154213000	chr1:154104562~154104583:-
THCA	cis	rs1468333	0.824	rs9327809	MIMAT0004911	hsa-miR-874-3p	-3.45	0.000607	-0.1	-0.16	Resting heart rate;	chr5:138252117	chr5:137647582~137647603:-
THCA	cis	rs1468333	0.824	rs28704868	MIMAT0004911	hsa-miR-874-3p	-3.45	0.000607	-0.1	-0.16	Resting heart rate;	chr5:138255097	chr5:137647582~137647603:-
THCA	cis	rs55637147	0.553	rs55741081	MIMAT0000425	hsa-miR-130a-3p	3.45	0.000608	0.11	0.16	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes;	chr11:57361835	chr11:57641252~57641273:+
THCA	cis	rs13326165	0.76	rs13075370	MIMAT0004595	hsa-miR-135a-3p	3.45	0.000608	0.22	0.16	HDL cholesterol;HDL cholesterol levels;	chr3:52365262	chr3:52294232~52294253:-
THCA	cis	rs13326165	0.715	rs11709658	MIMAT0004595	hsa-miR-135a-3p	3.45	0.000608	0.22	0.16	HDL cholesterol;HDL cholesterol levels;	chr3:52365611	chr3:52294232~52294253:-
THCA	cis	rs3947	0.653	rs1293296	MIMAT0003266	hsa-miR-598-3p	3.45	0.00061	0.16	0.16	Blood protein levels;	chr8:11853648	chr8:11035221~11035242:-
THCA	cis	rs6555855	0.672	rs11134570	MIMAT0026618	hsa-miR-585-5p	3.45	0.00061	0.21	0.16	Menarche (age at onset);	chr5:169293215	chr5:169263649~169263670:-
THCA	cis	rs7210990	0.766	rs12942295	MIMAT0005942	hsa-miR-1288-3p	3.45	0.000611	0.19	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16070530	chr17:16282058~16282078:+
THCA	cis	rs9434723	0.844	rs2239561	MIMAT0000255	hsa-miR-34a-5p	3.45	0.000613	0.18	0.16	Height;	chr1:9244146	chr1:9151735~9151756:-
THCA	cis	rs10021731	0.756	rs1460782	MIMAT0003242	hsa-miR-577	-3.45	0.000613	-0.17	-0.16	Optic disc area;	chr4:114540002	chr4:114656774~114656794:+
THCA	cis	rs2841277	0.646	rs2819419	MIMAT0000264	hsa-miR-203a-3p	3.45	0.000615	0.15	0.16	Rheumatoid arthritis;	chr14:104939901	chr14:104117469~104117490:+
THCA	cis	rs10099338	0.722	rs13259232	MIMAT0019728	hsa-miR-4660	3.45	0.000616	0.26	0.16	Glomerular filtration rate;	chr8:9398417	chr8:9048453~9048475:+
THCA	cis	rs10021731	0.718	rs2054305	MIMAT0003242	hsa-miR-577	-3.45	0.000618	-0.16	-0.16	Optic disc area;	chr4:114496175	chr4:114656774~114656794:+
THCA	cis	rs7213347	0.581	rs4790881	MIMAT0000426	hsa-miR-132-3p	3.45	0.000621	0.17	0.16	Total body bone mineral density;	chr17:2165638	chr17:2049929~2049950:-
THCA	cis	rs10021731	0.718	rs7698391	MIMAT0003242	hsa-miR-577	-3.45	0.000621	-0.16	-0.16	Optic disc area;	chr4:114492457	chr4:114656774~114656794:+
THCA	cis	rs4919669	0.668	rs4919666	MIMAT0005951	hsa-miR-1307-3p	-3.44	0.000623	-0.16	-0.16	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102624272	chr10:103394301~103394322:-
THCA	cis	rs4919669	0.546	rs11191356	MIMAT0005951	hsa-miR-1307-3p	-3.44	0.000624	-0.16	-0.16	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102633732	chr10:103394301~103394322:-
THCA	cis	rs4908769	0.624	rs301818	MIMAT0000255	hsa-miR-34a-5p	-3.44	0.000625	-0.16	-0.16	Allergy;	chr1:8443182	chr1:9151735~9151756:-
THCA	cis	rs7829975	0.511	rs2980512	MIMAT0019728	hsa-miR-4660	3.44	0.000625	0.2	0.16	Mood instability;	chr8:8283379	chr8:9048453~9048475:+
THCA	cis	rs10021731	0.809	rs9884212	MIMAT0003242	hsa-miR-577	3.44	0.000626	0.16	0.16	Optic disc area;	chr4:114580888	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.744	rs2388976	MIMAT0003242	hsa-miR-577	3.44	0.000626	0.16	0.16	Optic disc area;	chr4:114581250	chr4:114656774~114656794:+
THCA	cis	rs13326165	0.76	rs3752819	MIMAT0004595	hsa-miR-135a-3p	3.44	0.000626	0.22	0.16	HDL cholesterol;HDL cholesterol levels;	chr3:52366724	chr3:52294232~52294253:-
THCA	cis	rs7851726	0.628	rs4744412	MIMAT0019208	hsa-miR-3074-5p	3.44	0.000627	0.13	0.16	Urinary albumin-to-creatinine ratio;	chr9:94928219	chr9:95086063~95086083:-
THCA	cis	rs7210990	0.836	rs8076864	MIMAT0005942	hsa-miR-1288-3p	-3.44	0.000629	-0.19	-0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16032956	chr17:16282058~16282078:+
THCA	cis	rs4400599	0.586	rs6671166	MIMAT0022491	hsa-miR-5698	3.44	0.000635	0.2	0.16	Platelet distribution width;	chr1:154121349	chr1:154104562~154104583:-
THCA	cis	rs6555855	0.909	rs9313455	MIMAT0026618	hsa-miR-585-5p	3.44	0.000636	0.24	0.16	Menarche (age at onset);	chr5:169309883	chr5:169263649~169263670:-
THCA	cis	rs6555855	0.868	rs11955497	MIMAT0026618	hsa-miR-585-5p	3.44	0.000636	0.24	0.16	Menarche (age at onset);	chr5:169311641	chr5:169263649~169263670:-
THCA	cis	rs4919669	0.591	rs10883731	MIMAT0005951	hsa-miR-1307-3p	-3.44	0.000636	-0.16	-0.16	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102533370	chr10:103394301~103394322:-
THCA	cis	rs1468333	0.93	rs2269954	MIMAT0026718	hsa-miR-874-5p	-3.44	0.000638	-0.12	-0.16	Resting heart rate;	chr5:138165314	chr5:137647618~137647640:-
THCA	cis	rs55637147	0.579	rs72923914	MIMAT0000425	hsa-miR-130a-3p	3.44	0.000639	0.11	0.16	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes;	chr11:57362377	chr11:57641252~57641273:+
THCA	cis	rs4400599	0.586	rs7535778	MIMAT0022491	hsa-miR-5698	3.44	0.000639	0.2	0.16	Platelet distribution width;	chr1:154146503	chr1:154104562~154104583:-
THCA	cis	rs7829975	0.742	rs882462	MIMAT0019728	hsa-miR-4660	3.44	0.00064	0.2	0.16	Mood instability;	chr8:8821020	chr8:9048453~9048475:+
THCA	cis	rs12145833	0.596	rs61833906	MIMAT0019761	hsa-miR-4677-3p	3.44	0.000641	0.27	0.16	Obesity (early onset extreme);	chr1:243256404	chr1:243346225~243346246:+
THCA	cis	rs12145833	0.665	rs78871868	MIMAT0019761	hsa-miR-4677-3p	3.44	0.000641	0.27	0.16	Obesity (early onset extreme);	chr1:243259020	chr1:243346225~243346246:+
THCA	cis	rs74233809	0.636	rs284851	MIMAT0005951	hsa-miR-1307-3p	-3.44	0.000641	-0.14	-0.16	Birth weight;	chr10:102818774	chr10:103394301~103394322:-
THCA	cis	rs751728	0.965	rs9394165	MIMAT0022975	hsa-miR-3934-3p	-3.44	0.000642	-0.18	-0.16	Crohn's disease;	chr6:33763631	chr6:33698191~33698212:+
THCA	cis	rs2274459	0.841	rs13204162	MIMAT0018349	hsa-miR-3934-5p	3.44	0.000642	0.23	0.16	Obesity (extreme);	chr6:33728354	chr6:33698152~33698173:+
THCA	cis	rs2274459	0.841	rs12661400	MIMAT0018349	hsa-miR-3934-5p	3.44	0.000642	0.23	0.16	Obesity (extreme);	chr6:33728700	chr6:33698152~33698173:+
THCA	cis	rs13326165	0.76	rs13059674	MIMAT0004595	hsa-miR-135a-3p	3.44	0.000644	0.22	0.16	HDL cholesterol;HDL cholesterol levels;	chr3:52337773	chr3:52294232~52294253:-
THCA	cis	rs10021731	0.681	rs11098254	MIMAT0003242	hsa-miR-577	3.44	0.000644	0.16	0.16	Optic disc area;	chr4:114531300	chr4:114656774~114656794:+
THCA	cis	rs6681460	0.8	rs693272	MIMAT0014979	hsa-miR-3117-3p	3.43	0.000646	0.2	0.16	Presence of antiphospholipid antibodies;	chr1:66755869	chr1:66628485~66628505:+
THCA	cis	rs453301	0.686	rs6601281	MIMAT0019728	hsa-miR-4660	-3.43	0.000647	-0.2	-0.16	Joint mobility (Beighton score);	chr8:9053494	chr8:9048453~9048475:+
THCA	cis	rs2540277	0.568	rs2732840	MIMAT0019926	hsa-miR-4772-5p	-3.43	0.000648	-0.23	-0.16	Schizophrenia;	chr2:102763300	chr2:102432300~102432321:+
THCA	cis	rs17710780	0.803	rs4705082	MIMAT0000731	hsa-miR-378a-5p	-3.43	0.000648	-0.17	-0.16	Major depressive disorder;	chr5:149710929	chr5:149732829~149732850:+
THCA	cis	rs17710780	0.803	rs4705081	MIMAT0000731	hsa-miR-378a-5p	-3.43	0.000648	-0.17	-0.16	Major depressive disorder;	chr5:149711066	chr5:149732829~149732850:+
THCA	cis	rs10021731	0.718	rs13117126	MIMAT0003242	hsa-miR-577	-3.43	0.000649	-0.16	-0.16	Optic disc area;	chr4:114526758	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.718	rs10857032	MIMAT0003242	hsa-miR-577	-3.43	0.000649	-0.16	-0.16	Optic disc area;	chr4:114527831	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.631	rs11098253	MIMAT0003242	hsa-miR-577	-3.43	0.000649	-0.16	-0.16	Optic disc area;	chr4:114527990	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.718	rs7655989	MIMAT0003242	hsa-miR-577	-3.43	0.000649	-0.16	-0.16	Optic disc area;	chr4:114528134	chr4:114656774~114656794:+
THCA	cis	rs7829975	0.606	rs7819827	MIMAT0019728	hsa-miR-4660	-3.43	0.00065	-0.21	-0.16	Mood instability;	chr8:8939545	chr8:9048453~9048475:+
THCA	cis	rs17384381	0.863	rs12140272	MIMAT0019232	hsa-miR-4423-5p	-3.43	0.000651	-0.25	-0.16	Lobe attachment (rater-scored or self-reported);	chr1:85324074	chr1:85133806~85133827:+
THCA	cis	rs7223535	1	rs7223535	MIMAT0004614	hsa-miR-193a-5p	3.43	0.000651	0.19	0.16	Breast cancer;	chr17:30884649	chr17:31560016~31560037:+
THCA	cis	rs17710780	0.685	rs56007731	MIMAT0000731	hsa-miR-378a-5p	-3.43	0.000652	-0.17	-0.16	Major depressive disorder;	chr5:149712814	chr5:149732829~149732850:+
THCA	cis	rs17710780	0.803	rs11745024	MIMAT0000731	hsa-miR-378a-5p	-3.43	0.000652	-0.17	-0.16	Major depressive disorder;	chr5:149713345	chr5:149732829~149732850:+
THCA	cis	rs17710780	1	rs72828383	MIMAT0000731	hsa-miR-378a-5p	-3.43	0.000652	-0.17	-0.16	Major depressive disorder;	chr5:149713586	chr5:149732829~149732850:+
THCA	cis	rs17710780	0.803	rs11745748	MIMAT0000731	hsa-miR-378a-5p	-3.43	0.000652	-0.17	-0.16	Major depressive disorder;	chr5:149713609	chr5:149732829~149732850:+
THCA	cis	rs17710780	0.803	rs72828384	MIMAT0000731	hsa-miR-378a-5p	-3.43	0.000652	-0.17	-0.16	Major depressive disorder;	chr5:149714172	chr5:149732829~149732850:+
THCA	cis	rs7809615	0.581	rs57980352	MIMAT0000081	hsa-miR-25-3p	-3.43	0.000652	-0.32	-0.16	Blood metabolite ratios;	chr7:99387785	chr7:100093571~100093592:-
THCA	cis	rs1468333	1	rs217274	MIMAT0026718	hsa-miR-874-5p	-3.43	0.000653	-0.12	-0.16	Resting heart rate;	chr5:138155285	chr5:137647618~137647640:-
THCA	cis	rs2274459	0.841	rs35698850	MIMAT0018349	hsa-miR-3934-5p	3.43	0.000654	0.23	0.16	Obesity (extreme);	chr6:33732355	chr6:33698152~33698173:+
THCA	cis	rs13326165	0.715	rs11718125	MIMAT0004595	hsa-miR-135a-3p	3.43	0.000655	0.22	0.16	HDL cholesterol;HDL cholesterol levels;	chr3:52345404	chr3:52294232~52294253:-
THCA	cis	rs780142	0.545	rs8028724	MIMAT0000458	hsa-miR-190a-5p	3.43	0.000655	0.19	0.16	Reticulocyte count;Reticulocyte fraction of red cells;	chr15:62566207	chr15:62823971~62823992:+
THCA	cis	rs780142	0.545	rs8028892	MIMAT0000458	hsa-miR-190a-5p	3.43	0.000655	0.19	0.16	Reticulocyte count;Reticulocyte fraction of red cells;	chr15:62566221	chr15:62823971~62823992:+
THCA	cis	rs6681460	0.7	rs984409	MIMAT0014979	hsa-miR-3117-3p	-3.43	0.00066	-0.21	-0.16	Presence of antiphospholipid antibodies;	chr1:66554757	chr1:66628485~66628505:+
THCA	cis	rs10021731	0.692	rs6840798	MIMAT0003242	hsa-miR-577	-3.43	0.00066	-0.16	-0.16	Optic disc area;	chr4:114495078	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.718	rs6817762	MIMAT0003242	hsa-miR-577	-3.43	0.00066	-0.16	-0.16	Optic disc area;	chr4:114495098	chr4:114656774~114656794:+
THCA	cis	rs950880	0.71	rs2287035	MIMAT0019927	hsa-miR-4772-3p	3.43	0.000661	0.17	0.16	Serum protein levels (sST2);	chr2:102394070	chr2:102432336~102432357:+
THCA	cis	rs2841277	0.738	rs1036713	MIMAT0000264	hsa-miR-203a-3p	-3.43	0.000663	-0.13	-0.16	Rheumatoid arthritis;	chr14:104930356	chr14:104117469~104117490:+
THCA	cis	rs7210990	0.766	rs3760298	MIMAT0005942	hsa-miR-1288-3p	3.43	0.000663	0.19	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16001876	chr17:16282058~16282078:+
THCA	cis	rs7829975	0.509	rs2945269	MIMAT0019728	hsa-miR-4660	3.43	0.000663	0.2	0.16	Mood instability;	chr8:8258056	chr8:9048453~9048475:+
THCA	cis	rs9527	0.59	rs10509766	MIMAT0022727	hsa-miR-1307-5p	3.43	0.000664	0.14	0.16	Arsenic metabolism;	chr10:103166577	chr10:103394341~103394361:-
THCA	cis	rs9527	0.64	rs35195396	MIMAT0022727	hsa-miR-1307-5p	3.43	0.000664	0.14	0.16	Arsenic metabolism;	chr10:103169013	chr10:103394341~103394361:-
THCA	cis	rs9527	0.614	rs11191589	MIMAT0022727	hsa-miR-1307-5p	3.43	0.000664	0.14	0.16	Arsenic metabolism;	chr10:103170625	chr10:103394341~103394361:-
THCA	cis	rs9527	0.59	rs3740386	MIMAT0022727	hsa-miR-1307-5p	3.43	0.000664	0.14	0.16	Arsenic metabolism;	chr10:103171294	chr10:103394341~103394361:-
THCA	cis	rs9527	0.59	rs10786741	MIMAT0022727	hsa-miR-1307-5p	3.43	0.000664	0.14	0.16	Arsenic metabolism;	chr10:103179425	chr10:103394341~103394361:-
THCA	cis	rs4778581	0.9	rs35863112	MIMAT0000454	hsa-miR-184	-3.43	0.000664	-0.18	-0.16	Reticulocyte count;Reticulocyte fraction of red cells;	chr15:80103964	chr15:79209840~79209861:+
THCA	cis	rs11662721	0.63	rs78054198	MIMAT0000427	hsa-miR-133a-3p	-3.43	0.000668	-0.27	-0.16	Phospholipid levels (plasma);	chr18:21489738	chr18:21825712~21825733:-
THCA	cis	rs11662721	0.63	rs78054198	MIMAT0000427_1	hsa-miR-133a-3p	-3.43	0.000668	-0.27	-0.16	Phospholipid levels (plasma);	chr18:21489738	chr20:62564970~62564991:+
THCA	cis	rs7829975	0.572	rs28730413	MIMAT0019728	hsa-miR-4660	-3.42	0.000669	-0.21	-0.16	Mood instability;	chr8:8937937	chr8:9048453~9048475:+
THCA	cis	rs7851726	0.565	rs10821413	MIMAT0019208	hsa-miR-3074-5p	-3.42	0.000673	-0.13	-0.16	Urinary albumin-to-creatinine ratio;	chr9:94907034	chr9:95086063~95086083:-
THCA	cis	rs7210990	0.866	rs11872032	MIMAT0005942	hsa-miR-1288-3p	3.42	0.000674	0.19	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16094459	chr17:16282058~16282078:+
THCA	cis	rs1760803	0.574	rs3828076	MIMAT0022491	hsa-miR-5698	3.42	0.000676	0.19	0.16	Nicotine dependence;	chr1:154238226	chr1:154104562~154104583:-
THCA	cis	rs7897654	0.651	rs7922349	MIMAT0022727	hsa-miR-1307-5p	3.42	0.000677	0.15	0.16	Schizophrenia;	chr10:102929701	chr10:103394341~103394361:-
THCA	cis	rs7897654	0.651	rs12416441	MIMAT0022727	hsa-miR-1307-5p	3.42	0.000677	0.15	0.16	Schizophrenia;	chr10:102930233	chr10:103394341~103394361:-
THCA	cis	rs28830936	0.51	rs2412640	MIMAT0026623	hsa-miR-627-3p	3.42	0.000677	0.18	0.16	Diastolic blood pressure;	chr15:41831884	chr15:42199593~42199612:-
THCA	cis	rs10090774	0.71	rs13275969	MIMAT0004697	hsa-miR-151a-5p	3.42	0.000679	0.12	0.16	Acute graft versus host disease in bone marrow transplantation (recipient effect);	chr8:140663317	chr8:140732623~140732643:-
THCA	cis	rs10021731	0.668	rs1599322	MIMAT0003242	hsa-miR-577	-3.42	0.000679	-0.16	-0.16	Optic disc area;	chr4:114531895	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.668	rs55968476	MIMAT0003242	hsa-miR-577	-3.42	0.000679	-0.16	-0.16	Optic disc area;	chr4:114532478	chr4:114656774~114656794:+
THCA	cis	rs7786877	0.761	rs11772705	MIMAT0027650	hsa-miR-6875-5p	-3.42	0.00068	-0.23	-0.16	Mean corpuscular volume;Mean corpuscular hemoglobin;	chr7:100701281	chr7:100868041~100868061:+
THCA	cis	rs17710780	0.803	rs4705361	MIMAT0000731	hsa-miR-378a-5p	-3.42	0.000681	-0.17	-0.16	Major depressive disorder;	chr5:149716913	chr5:149732829~149732850:+
THCA	cis	rs7213347	0.579	rs8072532	MIMAT0000426	hsa-miR-132-3p	3.42	0.000682	0.16	0.16	Total body bone mineral density;	chr17:2141979	chr17:2049929~2049950:-
THCA	cis	rs9527	0.545	rs12247514	MIMAT0022727	hsa-miR-1307-5p	3.42	0.000682	0.14	0.16	Arsenic metabolism;	chr10:103198309	chr10:103394341~103394361:-
THCA	cis	rs7649443	0.917	rs13099700	MIMAT0019973	hsa-miR-4797-3p	3.42	0.000683	0.21	0.16	Nonsyndromic cleft lip with cleft palate;	chr3:197091982	chr3:197293888~197293908:-
THCA	cis	rs11976180	0.569	rs12703565	MIMAT0027684	hsa-miR-6892-5p	3.42	0.000684	0.23	0.16	Obesity-related traits;	chr7:144057308	chr7:143382686~143382706:+
THCA	cis	rs55637147	0.553	rs4570598	MIMAT0000425	hsa-miR-130a-3p	3.42	0.000684	0.11	0.16	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes;	chr11:57356258	chr11:57641252~57641273:+
THCA	cis	rs9527	0.615	rs10883810	MIMAT0022727	hsa-miR-1307-5p	3.42	0.000685	0.14	0.16	Arsenic metabolism;	chr10:102967467	chr10:103394341~103394361:-
THCA	cis	rs9527	0.615	rs10883811	MIMAT0022727	hsa-miR-1307-5p	3.42	0.000685	0.14	0.16	Arsenic metabolism;	chr10:102967522	chr10:103394341~103394361:-
THCA	cis	rs6537837	0.642	rs6658641	MIMAT0000227	hsa-miR-197-3p	-3.42	0.000685	-0.17	-0.16	Major depressive disorder;	chr1:109610576	chr1:109598940~109598961:+
THCA	cis	rs6681460	0.576	rs7355221	MIMAT0014979	hsa-miR-3117-3p	-3.42	0.000686	-0.21	-0.16	Presence of antiphospholipid antibodies;	chr1:66520618	chr1:66628485~66628505:+
THCA	cis	rs12290811	0.506	rs968369	MIMAT0022270	hsa-miR-5579-3p	3.42	0.000687	0.31	0.16	Bipolar disorder;	chr11:79442036	chr11:79422169~79422190:-
THCA	cis	rs943466	0.911	rs111352628	MIMAT0022975	hsa-miR-3934-3p	-3.42	0.00069	-0.21	-0.16	Body mass index (joint analysis main effects and physical activity interaction);Body mass index;	chr6:33774713	chr6:33698191~33698212:+
THCA	cis	rs7594645	0.59	rs2359724	MIMAT0014995	hsa-miR-3130-5p	-3.42	0.00069	-0.25	-0.16	Episodic memory;	chr2:206750798	chr2:206783276~206783296:-
THCA	cis	rs7594645	0.59	rs2359724	MIMAT0014995_1	hsa-miR-3130-5p	-3.42	0.00069	-0.25	-0.16	Episodic memory;	chr2:206750798	chr2:206783246~206783266:+
THCA	cis	rs10021731	0.668	rs13112732	MIMAT0003242	hsa-miR-577	-3.42	0.00069	-0.16	-0.16	Optic disc area;	chr4:114483845	chr4:114656774~114656794:+
THCA	cis	rs999943	0.739	rs62407633	MIMAT0018349	hsa-miR-3934-5p	-3.42	0.000691	-0.22	-0.16	Obesity (extreme);	chr6:33641467	chr6:33698152~33698173:+
THCA	cis	rs7210990	0.836	rs9898313	MIMAT0005942	hsa-miR-1288-3p	3.42	0.000693	0.19	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16073818	chr17:16282058~16282078:+
THCA	cis	rs7210990	0.866	rs9902141	MIMAT0005942	hsa-miR-1288-3p	3.41	0.000695	0.19	0.16	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16131459	chr17:16282058~16282078:+
THCA	cis	rs9434723	0.841	rs9435152	MIMAT0000255	hsa-miR-34a-5p	-3.41	0.000695	-0.19	-0.16	Height;	chr1:9248190	chr1:9151735~9151756:-
THCA	cis	rs7617773	0.925	rs35942721	MIMAT0018961	hsa-miR-4443	3.41	0.000696	0.17	0.16	Coronary artery disease;	chr3:48131579	chr3:48196572~48196588:+
THCA	cis	rs10021731	0.718	rs11724670	MIMAT0003242	hsa-miR-577	-3.41	0.000696	-0.16	-0.16	Optic disc area;	chr4:114482122	chr4:114656774~114656794:+
THCA	cis	rs4774830	0.59	rs2008670	MIMAT0004809	hsa-miR-628-5p	-3.41	0.000704	-0.31	-0.16	Delta-5 desaturase activity;	chr15:55799676	chr15:55372991~55373012:-
THCA	cis	rs6681460	0.576	rs7354930	MIMAT0014979	hsa-miR-3117-3p	-3.41	0.000704	-0.2	-0.16	Presence of antiphospholipid antibodies;	chr1:66520694	chr1:66628485~66628505:+
THCA	cis	rs6681460	0.576	rs1338194	MIMAT0014979	hsa-miR-3117-3p	-3.41	0.000704	-0.2	-0.16	Presence of antiphospholipid antibodies;	chr1:66520793	chr1:66628485~66628505:+
THCA	cis	rs7829975	0.774	rs35431455	MIMAT0019728	hsa-miR-4660	3.41	0.000709	0.2	0.15	Mood instability;	chr8:8816226	chr8:9048453~9048475:+
THCA	cis	rs4778581	0.966	rs8042747	MIMAT0000454	hsa-miR-184	-3.41	0.00071	-0.18	-0.15	Reticulocyte count;Reticulocyte fraction of red cells;	chr15:80088421	chr15:79209840~79209861:+
THCA	cis	rs722611	0.52	rs62457124	MIMAT0003257	hsa-miR-550a-3p	-3.41	0.000711	-0.2	-0.15	Methadone dose in opioid dependence;	chr7:29516009	chr7:29680748~29680769:-
THCA	cis	rs722611	0.52	rs62457124	MIMAT0003257_1	hsa-miR-550a-3p	-3.41	0.000711	-0.2	-0.15	Methadone dose in opioid dependence;	chr7:29516009	chr7:30289854~30289875:+
THCA	cis	rs722611	0.52	rs62457124	MIMAT0003257_2	hsa-miR-550a-3p	-3.41	0.000711	-0.2	-0.15	Methadone dose in opioid dependence;	chr7:29516009	chr7:32733041~32733062:+
THCA	cis	rs4711350	0.734	rs4713676	MIMAT0018349	hsa-miR-3934-5p	3.41	0.000713	0.2	0.15	Schizophrenia;	chr6:33754321	chr6:33698152~33698173:+
THCA	cis	rs12145833	1	rs12145833	MIMAT0019761	hsa-miR-4677-3p	-3.41	0.000714	-0.21	-0.15	Obesity (early onset extreme);	chr1:243320452	chr1:243346225~243346246:+
THCA	cis	rs2274459	0.591	rs16868575	MIMAT0018349	hsa-miR-3934-5p	3.41	0.000717	0.2	0.15	Obesity (extreme);	chr6:33661269	chr6:33698152~33698173:+
THCA	cis	rs2229238	0.868	rs73018293	MIMAT0022491	hsa-miR-5698	3.4	0.00072	0.22	0.15	Coronary heart disease;	chr1:154493101	chr1:154104562~154104583:-
THCA	cis	rs2229238	0.911	rs59838898	MIMAT0022491	hsa-miR-5698	3.4	0.00072	0.22	0.15	Coronary heart disease;	chr1:154493825	chr1:154104562~154104583:-
THCA	cis	rs2229238	0.911	rs10047079	MIMAT0022491	hsa-miR-5698	3.4	0.00072	0.22	0.15	Coronary heart disease;	chr1:154495659	chr1:154104562~154104583:-
THCA	cis	rs6537837	0.701	rs6680537	MIMAT0000227	hsa-miR-197-3p	-3.4	0.00072	-0.17	-0.15	Major depressive disorder;	chr1:109612400	chr1:109598940~109598961:+
THCA	cis	rs1468333	1	rs13356202	MIMAT0004911	hsa-miR-874-3p	-3.4	0.00072	-0.1	-0.15	Resting heart rate;	chr5:138228899	chr5:137647582~137647603:-
THCA	cis	rs216303	0.841	rs2239160	MIMAT0004657	hsa-miR-200c-5p	3.4	0.000721	0.22	0.15	Low vWF levels;	chr12:6053588	chr12:6963703~6963724:+
THCA	cis	rs4711350	0.734	rs9380379	MIMAT0022975	hsa-miR-3934-3p	-3.4	0.000721	-0.19	-0.15	Schizophrenia;	chr6:33798354	chr6:33698191~33698212:+
THCA	cis	rs72848980	0.516	rs2296569	MIMAT0022727	hsa-miR-1307-5p	3.4	0.000721	0.2	0.15	White matter hyperintensity burden;	chr10:103076754	chr10:103394341~103394361:-
THCA	cis	rs17109512	0.826	rs17109539	MIMAT0026738	hsa-miR-1287-3p	3.4	0.000723	0.24	0.15	Aspartate aminotransferase levels;	chr10:98371701	chr10:98395232~98395253:-
THCA	cis	rs73198271	0.737	rs565203	MIMAT0019728	hsa-miR-4660	-3.4	0.000724	-0.22	-0.15	Bone ultrasound measurement (broadband ultrasound attenuation);	chr8:8775447	chr8:9048453~9048475:+
THCA	cis	rs10021731	0.692	rs62309904	MIMAT0003242	hsa-miR-577	-3.4	0.000726	-0.16	-0.15	Optic disc area;	chr4:114514011	chr4:114656774~114656794:+
THCA	cis	rs17710780	0.803	rs17711038	MIMAT0000731	hsa-miR-378a-5p	3.4	0.000726	0.17	0.15	Major depressive disorder;	chr5:149714883	chr5:149732829~149732850:+
THCA	cis	rs10021731	0.718	rs7669767	MIMAT0003242	hsa-miR-577	3.4	0.000727	0.16	0.15	Optic disc area;	chr4:114530264	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.718	rs12508960	MIMAT0003242	hsa-miR-577	3.4	0.000727	0.16	0.15	Optic disc area;	chr4:114531061	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.718	rs11098255	MIMAT0003242	hsa-miR-577	3.4	0.000727	0.16	0.15	Optic disc area;	chr4:114531393	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.718	rs7683270	MIMAT0003242	hsa-miR-577	3.4	0.000727	0.16	0.15	Optic disc area;	chr4:114532438	chr4:114656774~114656794:+
THCA	cis	rs6841948	1	rs4696662	MIMAT0000094	hsa-miR-95-3p	-3.4	0.000729	-0.17	-0.15	Post bronchodilator FEV1 in COPD;	chr4:7989860	chr4:8005312~8005333:-
THCA	cis	rs10021731	0.718	rs13104081	MIMAT0003242	hsa-miR-577	-3.4	0.00073	-0.16	-0.15	Optic disc area;	chr4:114532641	chr4:114656774~114656794:+
THCA	cis	rs943466	1	rs11754690	MIMAT0022975	hsa-miR-3934-3p	-3.4	0.00073	-0.21	-0.15	Body mass index (joint analysis main effects and physical activity interaction);Body mass index;	chr6:33776380	chr6:33698191~33698212:+
THCA	cis	rs943466	1	rs61662306	MIMAT0022975	hsa-miR-3934-3p	-3.4	0.00073	-0.21	-0.15	Body mass index (joint analysis main effects and physical activity interaction);Body mass index;	chr6:33778920	chr6:33698191~33698212:+
THCA	cis	rs7385804	0.796	rs10277087	MIMAT0027650	hsa-miR-6875-5p	3.4	0.000731	0.2	0.15	Iron status biomarkers (iron levels);Iron status biomarkers (transferrin saturation);Hematocrit;Mean corpuscular hemoglobin;Hematological parameters;Red blood cell count;Mean corpuscular volume;Iron status biomarkers;	chr7:100709915	chr7:100868041~100868061:+
THCA	cis	rs7210990	0.836	rs11657912	MIMAT0005942	hsa-miR-1288-3p	3.4	0.000731	0.19	0.15	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16052826	chr17:16282058~16282078:+
THCA	cis	rs7210990	0.836	rs9891379	MIMAT0005942	hsa-miR-1288-3p	3.4	0.000731	0.19	0.15	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16073244	chr17:16282058~16282078:+
THCA	cis	rs10021731	0.718	rs10002657	MIMAT0003242	hsa-miR-577	-3.4	0.000731	-0.16	-0.15	Optic disc area;	chr4:114483120	chr4:114656774~114656794:+
THCA	cis	rs1468333	1	rs7735635	MIMAT0004911	hsa-miR-874-3p	3.4	0.000733	0.1	0.15	Resting heart rate;	chr5:138172647	chr5:137647582~137647603:-
THCA	cis	rs7829975	0.714	rs4840362	MIMAT0019728	hsa-miR-4660	-3.4	0.000733	-0.2	-0.15	Mood instability;	chr8:8812572	chr8:9048453~9048475:+
THCA	cis	rs4711350	0.734	rs9380379	MIMAT0018349	hsa-miR-3934-5p	-3.4	0.000733	-0.2	-0.15	Schizophrenia;	chr6:33798354	chr6:33698152~33698173:+
THCA	cis	rs7829975	0.573	rs7842359	MIMAT0019728	hsa-miR-4660	-3.4	0.000734	-0.2	-0.15	Mood instability;	chr8:8939568	chr8:9048453~9048475:+
THCA	cis	rs1468333	0.897	rs6888877	MIMAT0004911	hsa-miR-874-3p	3.4	0.000735	0.1	0.15	Resting heart rate;	chr5:138174668	chr5:137647582~137647603:-
THCA	cis	rs74233809	0.605	rs999867	MIMAT0022727	hsa-miR-1307-5p	-3.4	0.000735	-0.19	-0.15	Birth weight;	chr10:102744807	chr10:103394341~103394361:-
THCA	cis	rs9426935	0.505	rs4845578	MIMAT0022491	hsa-miR-5698	3.4	0.000736	0.2	0.15	Lentiform nucleus volume;	chr1:153857517	chr1:154104562~154104583:-
THCA	cis	rs9426935	0.505	rs34805562	MIMAT0022491	hsa-miR-5698	3.4	0.000736	0.2	0.15	Lentiform nucleus volume;	chr1:153866569	chr1:154104562~154104583:-
THCA	cis	rs28830936	0.528	rs11630242	MIMAT0026623	hsa-miR-627-3p	-3.4	0.000736	-0.18	-0.15	Diastolic blood pressure;	chr15:41832445	chr15:42199593~42199612:-
THCA	cis	rs6537837	0.701	rs17595368	MIMAT0000227	hsa-miR-197-3p	-3.4	0.000737	-0.17	-0.15	Major depressive disorder;	chr1:109611768	chr1:109598940~109598961:+
THCA	cis	rs10021731	0.867	rs12507591	MIMAT0003242	hsa-miR-577	3.4	0.000738	0.16	0.15	Optic disc area;	chr4:114574339	chr4:114656774~114656794:+
THCA	cis	rs9891572	0.852	rs12450119	MIMAT0000077	hsa-miR-22-3p	3.4	0.000738	0.13	0.15	HDL cholesterol;	chr17:2517640	chr17:1713914~1713935:-
THCA	cis	rs9891572	0.929	rs56806829	MIMAT0000077	hsa-miR-22-3p	3.4	0.000738	0.13	0.15	HDL cholesterol;	chr17:2520438	chr17:1713914~1713935:-
THCA	cis	rs7829975	0.714	rs4841040	MIMAT0019728	hsa-miR-4660	3.4	0.000738	0.2	0.15	Mood instability;	chr8:8797017	chr8:9048453~9048475:+
THCA	cis	rs17710780	0.803	rs11738167	MIMAT0000731	hsa-miR-378a-5p	-3.4	0.00074	-0.18	-0.15	Major depressive disorder;	chr5:149755482	chr5:149732829~149732850:+
THCA	cis	rs9426935	0.505	rs4845576	MIMAT0022491	hsa-miR-5698	3.4	0.000743	0.2	0.15	Lentiform nucleus volume;	chr1:153852928	chr1:154104562~154104583:-
THCA	cis	rs4243849	0.809	rs7826138	MIMAT0000420	hsa-miR-30b-5p	-3.4	0.000743	-0.14	-0.15	Non-alcoholic fatty liver disease histology (other);	chr8:135705424	chr8:134800570~134800591:-
THCA	cis	rs2494663	0.61	rs11264974	MIMAT0022491	hsa-miR-5698	3.4	0.000744	0.2	0.15	Mean platelet volume;	chr1:154063657	chr1:154104562~154104583:-
THCA	cis	rs1468333	0.929	rs2107682	MIMAT0004911	hsa-miR-874-3p	-3.39	0.000745	-0.1	-0.15	Resting heart rate;	chr5:138207446	chr5:137647582~137647603:-
THCA	cis	rs13326165	0.76	rs34523877	MIMAT0004595	hsa-miR-135a-3p	3.39	0.000746	0.22	0.15	HDL cholesterol;HDL cholesterol levels;	chr3:52341695	chr3:52294232~52294253:-
THCA	cis	rs2494663	0.61	rs11264964	MIMAT0022491	hsa-miR-5698	3.39	0.000748	0.2	0.15	Mean platelet volume;	chr1:154056974	chr1:154104562~154104583:-
THCA	cis	rs7210990	0.831	rs178797	MIMAT0005942	hsa-miR-1288-3p	3.39	0.000749	0.2	0.15	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16215740	chr17:16282058~16282078:+
THCA	cis	rs13326165	0.76	rs11711934	MIMAT0004595	hsa-miR-135a-3p	3.39	0.000749	0.22	0.15	HDL cholesterol;HDL cholesterol levels;	chr3:52324101	chr3:52294232~52294253:-
THCA	cis	rs9527	0.545	rs11191602	MIMAT0022727	hsa-miR-1307-5p	3.39	0.00075	0.14	0.15	Arsenic metabolism;	chr10:103194462	chr10:103394341~103394361:-
THCA	cis	rs9527	0.545	rs7095304	MIMAT0022727	hsa-miR-1307-5p	3.39	0.00075	0.14	0.15	Arsenic metabolism;	chr10:103195038	chr10:103394341~103394361:-
THCA	cis	rs9527	0.545	rs7100369	MIMAT0022727	hsa-miR-1307-5p	3.39	0.00075	0.14	0.15	Arsenic metabolism;	chr10:103196461	chr10:103394341~103394361:-
THCA	cis	rs9527	0.545	rs12784384	MIMAT0022727	hsa-miR-1307-5p	3.39	0.00075	0.14	0.15	Arsenic metabolism;	chr10:103197837	chr10:103394341~103394361:-
THCA	cis	rs9527	0.545	rs10883847	MIMAT0022727	hsa-miR-1307-5p	3.39	0.00075	0.14	0.15	Arsenic metabolism;	chr10:103198527	chr10:103394341~103394361:-
THCA	cis	rs2125062	0.638	rs7911684	MIMAT0015031	hsa-miR-3157-5p	3.39	0.00075	0.19	0.15	Colorectal adenoma (advanced);	chr10:96212172	chr10:96064369~96064390:-
THCA	cis	rs6575836	0.571	rs17100016	MIMAT0004606	hsa-miR-136-3p	3.39	0.000751	0.12	0.15	Tuberculosis;	chr14:101203059	chr14:100884750~100884771:+
THCA	cis	rs6088590	1	rs6119530	MIMAT0004772	hsa-miR-499a-3p	-3.39	0.000752	-0.18	-0.15	Coronary artery disease;	chr20:34816127	chr20:34990445~34990466:+
THCA	cis	rs12355831	0.786	rs10787444	MIMAT0025841	hsa-miR-6715a-3p	3.39	0.000753	0.24	0.15	Migraine;	chr10:112349620	chr10:112299660~112299680:+
THCA	cis	rs7819412	0.502	rs4840548	MIMAT0003266	hsa-miR-598-3p	3.39	0.000754	0.15	0.15	Triglycerides;	chr8:11135373	chr8:11035221~11035242:-
THCA	cis	rs10021731	0.718	rs11724674	MIMAT0003242	hsa-miR-577	-3.39	0.000754	-0.16	-0.15	Optic disc area;	chr4:114482175	chr4:114656774~114656794:+
THCA	cis	rs9394169	0.536	rs3998115	MIMAT0018349	hsa-miR-3934-5p	-3.39	0.000759	-0.18	-0.15	Essential tremor;	chr6:33817056	chr6:33698152~33698173:+
THCA	cis	rs4919669	0.668	rs11191365	MIMAT0005951	hsa-miR-1307-3p	-3.39	0.000759	-0.16	-0.15	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102670494	chr10:103394301~103394322:-
THCA	cis	rs10021731	0.782	rs2388975	MIMAT0003242	hsa-miR-577	3.39	0.000761	0.16	0.15	Optic disc area;	chr4:114592899	chr4:114656774~114656794:+
THCA	cis	rs9426935	0.505	rs4520447	MIMAT0022491	hsa-miR-5698	3.39	0.000763	0.2	0.15	Lentiform nucleus volume;	chr1:153856913	chr1:154104562~154104583:-
THCA	cis	rs9426935	0.505	rs12041920	MIMAT0022491	hsa-miR-5698	3.39	0.000763	0.2	0.15	Lentiform nucleus volume;	chr1:153878630	chr1:154104562~154104583:-
THCA	cis	rs6088590	0.901	rs6087631	MIMAT0004772	hsa-miR-499a-3p	-3.39	0.000764	-0.18	-0.15	Coronary artery disease;	chr20:34815706	chr20:34990445~34990466:+
THCA	cis	rs7829975	0.539	rs35571782	MIMAT0019728	hsa-miR-4660	3.39	0.000766	0.2	0.15	Mood instability;	chr8:8284301	chr8:9048453~9048475:+
THCA	cis	rs9527	0.59	rs3861984	MIMAT0022727	hsa-miR-1307-5p	3.39	0.000767	0.14	0.15	Arsenic metabolism;	chr10:103157223	chr10:103394341~103394361:-
THCA	cis	rs72827839	0.779	rs72823592	MIMAT0000438	hsa-miR-152-3p	-3.39	0.000767	-0.13	-0.15	Ease of getting up in the morning;	chr17:48045642	chr17:48037174~48037194:-
THCA	cis	rs10090774	0.735	rs9324530	MIMAT0004697	hsa-miR-151a-5p	3.39	0.00077	0.12	0.15	Acute graft versus host disease in bone marrow transplantation (recipient effect);	chr8:140660808	chr8:140732623~140732643:-
THCA	cis	rs9891572	0.777	rs67061289	MIMAT0000077	hsa-miR-22-3p	3.39	0.00077	0.13	0.15	HDL cholesterol;	chr17:2515429	chr17:1713914~1713935:-
THCA	cis	rs13326165	0.76	rs11706001	MIMAT0004595	hsa-miR-135a-3p	3.39	0.000771	0.22	0.15	HDL cholesterol;HDL cholesterol levels;	chr3:52338112	chr3:52294232~52294253:-
THCA	cis	rs10947428	0.522	rs2967	MIMAT0018349	hsa-miR-3934-5p	3.38	0.000771	0.19	0.15	Allergic disease (asthma, hay fever or eczema);	chr6:33721757	chr6:33698152~33698173:+
THCA	cis	rs2274459	1	rs12199132	MIMAT0018349	hsa-miR-3934-5p	3.38	0.000772	0.23	0.15	Obesity (extreme);	chr6:33740473	chr6:33698152~33698173:+
THCA	cis	rs7477	0.818	rs3112518	MIMAT0005942	hsa-miR-1288-3p	-3.38	0.000774	-0.2	-0.15	Amyotrophic lateral sclerosis;	chr17:16340194	chr17:16282058~16282078:+
THCA	cis	rs10021731	0.718	rs2126028	MIMAT0003242	hsa-miR-577	-3.38	0.000777	-0.16	-0.15	Optic disc area;	chr4:114533453	chr4:114656774~114656794:+
THCA	cis	rs6537837	1	rs7371	MIMAT0000227	hsa-miR-197-3p	-3.38	0.000777	-0.15	-0.15	Major depressive disorder;	chr1:109592686	chr1:109598940~109598961:+
THCA	cis	rs953492	0.672	rs1766030	MIMAT0019761	hsa-miR-4677-3p	-3.38	0.000778	-0.17	-0.15	Diastolic blood pressure;	chr1:243151275	chr1:243346225~243346246:+
THCA	cis	rs7826238	0.623	rs2976893	MIMAT0019728	hsa-miR-4660	-3.38	0.00078	-0.2	-0.15	Systolic blood pressure;	chr8:8480709	chr8:9048453~9048475:+
THCA	cis	rs7647973	0.626	rs1491985	MIMAT0019957	hsa-miR-4787-3p	3.38	0.000781	0.2	0.15	Menarche (age at onset);	chr3:49702074	chr3:50675130~50675153:+
THCA	cis	rs9434723	1	rs9434723	MIMAT0000255	hsa-miR-34a-5p	-3.38	0.000781	-0.18	-0.15	Height;	chr1:9232223	chr1:9151735~9151756:-
THCA	cis	rs13326165	0.715	rs11716017	MIMAT0004595	hsa-miR-135a-3p	3.38	0.000782	0.22	0.15	HDL cholesterol;HDL cholesterol levels;	chr3:52346975	chr3:52294232~52294253:-
THCA	cis	rs13326165	0.715	rs34355561	MIMAT0004595	hsa-miR-135a-3p	3.38	0.000782	0.22	0.15	HDL cholesterol;HDL cholesterol levels;	chr3:52349104	chr3:52294232~52294253:-
THCA	cis	rs13326165	0.715	rs34908451	MIMAT0004595	hsa-miR-135a-3p	3.38	0.000782	0.22	0.15	HDL cholesterol;HDL cholesterol levels;	chr3:52351099	chr3:52294232~52294253:-
THCA	cis	rs1453160	0.536	rs12694076	MIMAT0019931	hsa-miR-4775	3.38	0.000783	0.28	0.15	Subcutaneous adipose tissue;	chr2:207103445	chr2:207754816~207754837:+
THCA	cis	rs6575793	0.512	rs1888581	MIMAT0004921	hsa-miR-889-3p	3.38	0.000784	0.1	0.15	Menarche (age at onset);	chr14:100576378	chr14:101047949~101047969:+
THCA	cis	rs17710780	0.803	rs17711074	MIMAT0000731	hsa-miR-378a-5p	-3.38	0.000787	-0.17	-0.15	Major depressive disorder;	chr5:149721379	chr5:149732829~149732850:+
THCA	cis	rs17710780	0.803	rs72828399	MIMAT0000731	hsa-miR-378a-5p	-3.38	0.000787	-0.17	-0.15	Major depressive disorder;	chr5:149721509	chr5:149732829~149732850:+
THCA	cis	rs17710780	0.803	rs17711098	MIMAT0000731	hsa-miR-378a-5p	-3.38	0.000787	-0.17	-0.15	Major depressive disorder;	chr5:149721807	chr5:149732829~149732850:+
THCA	cis	rs17710780	0.803	rs17654717	MIMAT0000731	hsa-miR-378a-5p	-3.38	0.000787	-0.17	-0.15	Major depressive disorder;	chr5:149722011	chr5:149732829~149732850:+
THCA	cis	rs9807989	0.507	rs4851004	MIMAT0019927	hsa-miR-4772-3p	3.38	0.000789	0.14	0.15	Asthma;	chr2:102393077	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.507	rs6745614	MIMAT0019927	hsa-miR-4772-3p	-3.38	0.00079	-0.14	-0.15	Asthma;	chr2:102374753	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.507	rs10208196	MIMAT0019927	hsa-miR-4772-3p	-3.38	0.00079	-0.14	-0.15	Asthma;	chr2:102379885	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.507	rs3213732	MIMAT0019927	hsa-miR-4772-3p	-3.38	0.00079	-0.14	-0.15	Asthma;	chr2:102381819	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.507	rs10204757	MIMAT0019927	hsa-miR-4772-3p	-3.38	0.00079	-0.14	-0.15	Asthma;	chr2:102382514	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.524	rs7591246	MIMAT0019927	hsa-miR-4772-3p	-3.38	0.00079	-0.14	-0.15	Asthma;	chr2:102382943	chr2:102432336~102432357:+
THCA	cis	rs4988958	0.565	rs6760621	MIMAT0019927	hsa-miR-4772-3p	-3.38	0.00079	-0.14	-0.15	Asthma (childhood onset);	chr2:102383492	chr2:102432336~102432357:+
THCA	cis	rs4988958	0.527	rs11465641	MIMAT0019927	hsa-miR-4772-3p	-3.38	0.00079	-0.14	-0.15	Asthma (childhood onset);	chr2:102384408	chr2:102432336~102432357:+
THCA	cis	rs4988958	0.525	rs3771159	MIMAT0019927	hsa-miR-4772-3p	-3.38	0.00079	-0.14	-0.15	Asthma (childhood onset);	chr2:102388498	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.501	rs11903946	MIMAT0019927	hsa-miR-4772-3p	-3.38	0.00079	-0.14	-0.15	Asthma;	chr2:102388870	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.507	rs6706002	MIMAT0019927	hsa-miR-4772-3p	-3.38	0.00079	-0.14	-0.15	Asthma;	chr2:102389644	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.507	rs6749014	MIMAT0019927	hsa-miR-4772-3p	-3.38	0.00079	-0.14	-0.15	Asthma;	chr2:102389988	chr2:102432336~102432357:+
THCA	cis	rs4988958	0.565	rs12712146	MIMAT0019927	hsa-miR-4772-3p	-3.38	0.00079	-0.14	-0.15	Asthma (childhood onset);	chr2:102392254	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.507	rs1420096	MIMAT0019927	hsa-miR-4772-3p	-3.38	0.00079	-0.14	-0.15	Asthma;	chr2:102394452	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.507	rs1420094	MIMAT0019927	hsa-miR-4772-3p	-3.38	0.00079	-0.14	-0.15	Asthma;	chr2:102399227	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.507	rs4851571	MIMAT0019927	hsa-miR-4772-3p	-3.38	0.00079	-0.14	-0.15	Asthma;	chr2:102402540	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.507	rs4851572	MIMAT0019927	hsa-miR-4772-3p	-3.38	0.00079	-0.14	-0.15	Asthma;	chr2:102402571	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.507	rs1035129	MIMAT0019927	hsa-miR-4772-3p	-3.38	0.00079	-0.14	-0.15	Asthma;	chr2:102403325	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.524	rs2110662	MIMAT0019927	hsa-miR-4772-3p	-3.38	0.00079	-0.14	-0.15	Asthma;	chr2:102403679	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.507	rs10439410	MIMAT0019927	hsa-miR-4772-3p	3.38	0.00079	0.14	0.15	Asthma;	chr2:102374328	chr2:102432336~102432357:+
THCA	cis	rs7829975	0.624	rs7823056	MIMAT0019728	hsa-miR-4660	3.38	0.00079	0.21	0.15	Mood instability;	chr8:8525195	chr8:9048453~9048475:+
THCA	cis	rs9807989	0.524	rs7594402	MIMAT0019927	hsa-miR-4772-3p	-3.38	0.00079	-0.14	-0.15	Asthma;	chr2:102404807	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.507	rs6710034	MIMAT0019927	hsa-miR-4772-3p	-3.38	0.00079	-0.14	-0.15	Asthma;	chr2:102407218	chr2:102432336~102432357:+
THCA	cis	rs4988958	0.565	rs10206291	MIMAT0019927	hsa-miR-4772-3p	-3.38	0.00079	-0.14	-0.15	Asthma (childhood onset);	chr2:102422403	chr2:102432336~102432357:+
THCA	cis	rs4988958	0.565	rs3771154	MIMAT0019927	hsa-miR-4772-3p	-3.38	0.00079	-0.14	-0.15	Asthma (childhood onset);	chr2:102422900	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.524	rs6759479	MIMAT0019927	hsa-miR-4772-3p	-3.38	0.00079	-0.14	-0.15	Asthma;	chr2:102423587	chr2:102432336~102432357:+
THCA	cis	rs7819412	0.522	rs4642600	MIMAT0003266	hsa-miR-598-3p	3.38	0.000791	0.14	0.15	Triglycerides;	chr8:11155515	chr8:11035221~11035242:-
THCA	cis	rs7210990	0.866	rs11871961	MIMAT0005942	hsa-miR-1288-3p	3.38	0.000794	0.19	0.15	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16094112	chr17:16282058~16282078:+
THCA	cis	rs10021731	0.735	rs9995962	MIMAT0003242	hsa-miR-577	3.38	0.000797	0.16	0.15	Optic disc area;	chr4:114551671	chr4:114656774~114656794:+
THCA	cis	rs17710780	0.803	rs72828366	MIMAT0000731	hsa-miR-378a-5p	-3.38	0.000797	-0.17	-0.15	Major depressive disorder;	chr5:149697605	chr5:149732829~149732850:+
THCA	cis	rs17710780	0.803	rs62382262	MIMAT0000731	hsa-miR-378a-5p	-3.38	0.000797	-0.17	-0.15	Major depressive disorder;	chr5:149718893	chr5:149732829~149732850:+
THCA	cis	rs17710780	0.772	rs62382263	MIMAT0000731	hsa-miR-378a-5p	-3.38	0.000797	-0.17	-0.15	Major depressive disorder;	chr5:149719055	chr5:149732829~149732850:+
THCA	cis	rs17710780	0.803	rs17654687	MIMAT0000731	hsa-miR-378a-5p	-3.38	0.000797	-0.17	-0.15	Major depressive disorder;	chr5:149719226	chr5:149732829~149732850:+
THCA	cis	rs11240341	0.506	rs4996932	MIMAT0004698	hsa-miR-135b-3p	-3.37	0.000799	-0.18	-0.15	Schizophrenia;	chr1:205049494	chr1:205448323~205448344:-
THCA	cis	rs28489187	0.558	rs1146382	MIMAT0019232	hsa-miR-4423-5p	3.37	0.000799	0.19	0.15	Serum dimethylarginine levels (asymmetric/symetric ratio);Asymmetrical dimethylarginine levels;	chr1:85452418	chr1:85133806~85133827:+
THCA	cis	rs4919694	0.808	rs112574306	MIMAT0005951	hsa-miR-1307-3p	3.37	0.000801	0.19	0.15	Arsenic metabolism;	chr10:103211402	chr10:103394301~103394322:-
THCA	cis	rs9807989	0.507	rs2287033	MIMAT0019927	hsa-miR-4772-3p	3.37	0.000801	0.14	0.15	Asthma;	chr2:102394777	chr2:102432336~102432357:+
THCA	cis	rs10908557	0.957	rs11590099	MIMAT0022491	hsa-miR-5698	3.37	0.000801	0.2	0.15	Age at first birth;	chr1:153875732	chr1:154104562~154104583:-
THCA	cis	rs17710780	0.803	rs113501980	MIMAT0000731	hsa-miR-378a-5p	-3.37	0.000801	-0.17	-0.15	Major depressive disorder;	chr5:149716259	chr5:149732829~149732850:+
THCA	cis	rs17710780	0.803	rs4705080	MIMAT0000731	hsa-miR-378a-5p	-3.37	0.000801	-0.17	-0.15	Major depressive disorder;	chr5:149716781	chr5:149732829~149732850:+
THCA	cis	rs17710780	0.685	rs62380642	MIMAT0000731	hsa-miR-378a-5p	-3.37	0.000801	-0.17	-0.15	Major depressive disorder;	chr5:149717583	chr5:149732829~149732850:+
THCA	cis	rs17710780	0.803	rs62380643	MIMAT0000731	hsa-miR-378a-5p	-3.37	0.000801	-0.17	-0.15	Major depressive disorder;	chr5:149717781	chr5:149732829~149732850:+
THCA	cis	rs17710780	0.803	rs34172303	MIMAT0000731	hsa-miR-378a-5p	-3.37	0.000801	-0.17	-0.15	Major depressive disorder;	chr5:149718602	chr5:149732829~149732850:+
THCA	cis	rs17384381	0.636	rs11161615	MIMAT0019232	hsa-miR-4423-5p	3.37	0.000803	0.22	0.15	Lobe attachment (rater-scored or self-reported);	chr1:85441133	chr1:85133806~85133827:+
THCA	cis	rs2485376	0.51	rs1410416	MIMAT0004766	hsa-miR-146b-3p	3.37	0.000803	0.09	0.15	QT interval;	chr10:102228118	chr10:102436557~102436578:+
THCA	cis	rs10751667	0.6	rs11246376	MIMAT0006790	hsa-miR-675-3p	-3.37	0.000804	-0.13	-0.15	Alzheimer's disease (late onset);	chr11:999622	chr11:1996768~1996787:-
THCA	cis	rs6537837	0.701	rs2304355	MIMAT0000227	hsa-miR-197-3p	-3.37	0.000807	-0.17	-0.15	Major depressive disorder;	chr1:109612902	chr1:109598940~109598961:+
THCA	cis	rs10751667	0.58	rs7396041	MIMAT0006790	hsa-miR-675-3p	-3.37	0.000807	-0.13	-0.15	Alzheimer's disease (late onset);	chr11:1001607	chr11:1996768~1996787:-
THCA	cis	rs10021731	0.668	rs28651771	MIMAT0003242	hsa-miR-577	-3.37	0.00081	-0.16	-0.15	Optic disc area;	chr4:114501291	chr4:114656774~114656794:+
THCA	cis	rs56887639	0.5	rs4780537	MIMAT0000710	hsa-miR-365a-3p	-3.37	0.00081	-0.17	-0.15	Depressive symptoms (multi-trait analysis);Depressive symptoms;	chr16:13684996	chr16:14309340~14309361:+
THCA	cis	rs1468333	0.592	rs13185930	MIMAT0026718	hsa-miR-874-5p	-3.37	0.000811	-0.13	-0.15	Resting heart rate;	chr5:138241824	chr5:137647618~137647640:-
THCA	cis	rs9807989	0.507	rs1420105	MIMAT0019927	hsa-miR-4772-3p	-3.37	0.000813	-0.14	-0.15	Asthma;	chr2:102418659	chr2:102432336~102432357:+
THCA	cis	rs6575793	0.553	rs12436130	MIMAT0004921	hsa-miR-889-3p	3.37	0.000813	0.1	0.15	Menarche (age at onset);	chr14:100564699	chr14:101047949~101047969:+
THCA	cis	rs10099338	0.722	rs10435712	MIMAT0019728	hsa-miR-4660	3.37	0.000814	0.25	0.15	Glomerular filtration rate;	chr8:9397740	chr8:9048453~9048475:+
THCA	cis	rs10435719	0.764	rs10103485	MIMAT0018201	hsa-miR-3926	-3.37	0.000814	-0.18	-0.15	C-reactive protein levels or triglyceride levels (pleiotropy);	chr8:11930054	chr8:12727274~12727294:-
THCA	cis	rs10435719	0.764	rs10103485	MIMAT0018201_1	hsa-miR-3926	-3.37	0.000814	-0.18	-0.15	C-reactive protein levels or triglyceride levels (pleiotropy);	chr8:11930054	chr8:12727242~12727262:+
THCA	cis	rs4919669	0.72	rs729025	MIMAT0005951	hsa-miR-1307-3p	-3.37	0.000814	-0.16	-0.15	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102582449	chr10:103394301~103394322:-
THCA	cis	rs4919669	0.668	rs3824756	MIMAT0005951	hsa-miR-1307-3p	-3.37	0.000814	-0.16	-0.15	Systolic blood pressure (long-term average);Mean arterial pressure (long-term average);	chr10:102599593	chr10:103394301~103394322:-
THCA	cis	rs17384381	1	rs71652696	MIMAT0019232	hsa-miR-4423-5p	-3.37	0.000816	-0.26	-0.15	Lobe attachment (rater-scored or self-reported);	chr1:85366109	chr1:85133806~85133827:+
THCA	cis	rs75358501	0.551	rs10171736	MIMAT0014995	hsa-miR-3130-5p	-3.37	0.000818	-0.18	-0.15	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206728167	chr2:206783276~206783296:-
THCA	cis	rs75358501	0.551	rs10171736	MIMAT0014995_1	hsa-miR-3130-5p	-3.37	0.000818	-0.18	-0.15	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206728167	chr2:206783246~206783266:+
THCA	cis	rs250677	0.687	rs384979	MIMAT0003249	hsa-miR-584-5p	-3.37	0.000818	-0.16	-0.15	Breast cancer;	chr5:149079704	chr5:149062373~149062394:-
THCA	cis	rs1818690	0.732	rs10928556	MIMAT0000424	hsa-miR-128-3p	-3.37	0.00082	-0.11	-0.15	Monocyte percentage of white cells;	chr2:136108327	chr2:135665446~135665466:+
THCA	cis	rs1818690	0.732	rs10928556	MIMAT0000424_1	hsa-miR-128-3p	-3.37	0.00082	-0.11	-0.15	Monocyte percentage of white cells;	chr2:136108327	chr3:35744527~35744547:+
THCA	cis	rs74233809	0.534	rs176185	MIMAT0022727	hsa-miR-1307-5p	3.37	0.000821	0.17	0.15	Birth weight;	chr10:102796297	chr10:103394341~103394361:-
THCA	cis	rs10099338	0.822	rs13272745	MIMAT0019728	hsa-miR-4660	3.37	0.000821	0.27	0.15	Glomerular filtration rate;	chr8:9391119	chr8:9048453~9048475:+
THCA	cis	rs1163656	1	rs1163656	MIMAT0003287	hsa-miR-618	-3.37	0.000822	-0.21	-0.15	Dental caries;	chr12:80943679	chr12:80935796~80935818:-
THCA	cis	rs11718455	0.767	rs13076333	MIMAT0004607	hsa-miR-138-1-3p	-3.37	0.000824	-0.17	-0.15	Coronary artery disease;	chr3:43913578	chr3:44114274~44114295:+
THCA	cis	rs10090774	0.687	rs13268978	MIMAT0004697	hsa-miR-151a-5p	3.37	0.000825	0.12	0.15	Acute graft versus host disease in bone marrow transplantation (recipient effect);	chr8:140669286	chr8:140732623~140732643:-
THCA	cis	rs2494663	0.61	rs11588942	MIMAT0022491	hsa-miR-5698	3.37	0.000826	0.2	0.15	Mean platelet volume;	chr1:154072067	chr1:154104562~154104583:-
THCA	cis	rs2494663	0.61	rs7514662	MIMAT0022491	hsa-miR-5698	3.37	0.000826	0.2	0.15	Mean platelet volume;	chr1:154072239	chr1:154104562~154104583:-
THCA	cis	rs6555855	0.624	rs72837981	MIMAT0026618	hsa-miR-585-5p	-3.36	0.00083	-0.28	-0.15	Menarche (age at onset);	chr5:169264856	chr5:169263649~169263670:-
THCA	cis	rs9426935	0.505	rs11585416	MIMAT0022491	hsa-miR-5698	3.36	0.000831	0.2	0.15	Lentiform nucleus volume;	chr1:153860628	chr1:154104562~154104583:-
THCA	cis	rs9426935	0.505	rs11583152	MIMAT0022491	hsa-miR-5698	3.36	0.000831	0.2	0.15	Lentiform nucleus volume;	chr1:153860677	chr1:154104562~154104583:-
THCA	cis	rs9426935	0.505	rs7552274	MIMAT0022491	hsa-miR-5698	3.36	0.000831	0.2	0.15	Lentiform nucleus volume;	chr1:153861115	chr1:154104562~154104583:-
THCA	cis	rs1468333	0.824	rs4835673	MIMAT0004911	hsa-miR-874-3p	-3.36	0.000831	-0.1	-0.15	Resting heart rate;	chr5:138271991	chr5:137647582~137647603:-
THCA	cis	rs7897654	0.59	rs7092593	MIMAT0022727	hsa-miR-1307-5p	3.36	0.000835	0.15	0.15	Schizophrenia;	chr10:102976594	chr10:103394341~103394361:-
THCA	cis	rs10099338	1	rs10099338	MIMAT0019728	hsa-miR-4660	3.36	0.000838	0.29	0.15	Glomerular filtration rate;	chr8:9400229	chr8:9048453~9048475:+
THCA	cis	rs1468333	1	rs4835671	MIMAT0004911	hsa-miR-874-3p	-3.36	0.000839	-0.1	-0.15	Resting heart rate;	chr5:138176112	chr5:137647582~137647603:-
THCA	cis	rs7325116	0.519	rs9301769	MIMAT0004491	hsa-miR-19b-1-5p	3.36	0.000841	0.11	0.15	Blood protein levels;	chr13:91989292	chr13:91351207~91351229:+
THCA	cis	rs7819412	0.595	rs2409712	MIMAT0003266	hsa-miR-598-3p	3.36	0.000842	0.13	0.15	Triglycerides;	chr8:11129327	chr8:11035221~11035242:-
THCA	cis	rs2485376	1	rs3802681	MIMAT0004766	hsa-miR-146b-3p	-3.36	0.000843	-0.09	-0.15	QT interval;	chr10:102354571	chr10:102436557~102436578:+
THCA	cis	rs7917772	0.582	rs3977756	MIMAT0005951	hsa-miR-1307-3p	3.36	0.000844	0.11	0.15	Waist-to-hip ratio adjusted for body mass index;White blood cell count;Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);	chr10:102638825	chr10:103394301~103394322:-
THCA	cis	rs10021731	0.718	rs2199312	MIMAT0003242	hsa-miR-577	-3.36	0.000845	-0.16	-0.15	Optic disc area;	chr4:114513322	chr4:114656774~114656794:+
THCA	cis	rs2921073	0.51	rs2976945	MIMAT0019728	hsa-miR-4660	3.36	0.000845	0.19	0.15	Parkinson's disease;	chr8:8413361	chr8:9048453~9048475:+
THCA	cis	rs6690583	0.538	rs963488	MIMAT0019232	hsa-miR-4423-5p	-3.36	0.000848	-0.21	-0.15	Serum sulfate level;	chr1:85077004	chr1:85133806~85133827:+
THCA	cis	rs1178968	1	rs12539763	MIMAT0003258	hsa-miR-590-5p	3.36	0.000848	0.18	0.15	Triglyceride levels;	chr7:73348420	chr7:74191213~74191234:+
THCA	cis	rs4778581	0.9	rs870185	MIMAT0000454	hsa-miR-184	-3.36	0.000851	-0.17	-0.15	Reticulocyte count;Reticulocyte fraction of red cells;	chr15:80098915	chr15:79209840~79209861:+
THCA	cis	rs5762534	0.723	rs5762448	MIMAT0015084	hsa-miR-3199	-3.36	0.000851	-0.23	-0.15	Menopause (age at onset);	chr22:28012456	chr22:27920581~27920603:-
THCA	cis	rs5762534	0.723	rs5762448	MIMAT0015084_1	hsa-miR-3199	-3.36	0.000851	-0.23	-0.15	Menopause (age at onset);	chr22:28012456	chr22:27920535~27920557:+
THCA	cis	rs6555855	0.672	rs754369	MIMAT0026618	hsa-miR-585-5p	3.36	0.000853	0.2	0.15	Menarche (age at onset);	chr5:169295320	chr5:169263649~169263670:-
THCA	cis	rs9807989	0.524	rs4851576	MIMAT0019927	hsa-miR-4772-3p	-3.36	0.000854	-0.14	-0.15	Asthma;	chr2:102412435	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.507	rs4851577	MIMAT0019927	hsa-miR-4772-3p	-3.36	0.000854	-0.14	-0.15	Asthma;	chr2:102412461	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.507	rs4851579	MIMAT0019927	hsa-miR-4772-3p	-3.36	0.000854	-0.14	-0.15	Asthma;	chr2:102412524	chr2:102432336~102432357:+
THCA	cis	rs4988958	0.584	rs7589142	MIMAT0019927	hsa-miR-4772-3p	-3.36	0.000856	-0.14	-0.15	Asthma (childhood onset);	chr2:102408200	chr2:102432336~102432357:+
THCA	cis	rs4988958	0.548	rs6543127	MIMAT0019927	hsa-miR-4772-3p	-3.36	0.000856	-0.14	-0.15	Asthma (childhood onset);	chr2:102411841	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.507	rs1592459	MIMAT0019927	hsa-miR-4772-3p	-3.36	0.000856	-0.14	-0.15	Asthma;	chr2:102415109	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.507	rs1592458	MIMAT0019927	hsa-miR-4772-3p	-3.36	0.000856	-0.14	-0.15	Asthma;	chr2:102415289	chr2:102432336~102432357:+
THCA	cis	rs4988958	0.565	rs1035125	MIMAT0019927	hsa-miR-4772-3p	-3.36	0.000856	-0.14	-0.15	Asthma (childhood onset);	chr2:102417379	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.507	rs2160201	MIMAT0019927	hsa-miR-4772-3p	-3.36	0.000856	-0.14	-0.15	Asthma;	chr2:102417501	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.507	rs1833174	MIMAT0019927	hsa-miR-4772-3p	-3.36	0.000856	-0.14	-0.15	Asthma;	chr2:102418383	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.507	rs2293224	MIMAT0019927	hsa-miR-4772-3p	-3.36	0.000856	-0.14	-0.15	Asthma;	chr2:102419319	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.507	rs6743516	MIMAT0019927	hsa-miR-4772-3p	-3.36	0.000856	-0.14	-0.15	Asthma;	chr2:102419875	chr2:102432336~102432357:+
THCA	cis	rs4988958	0.565	rs1420100	MIMAT0019927	hsa-miR-4772-3p	-3.36	0.000856	-0.14	-0.15	Asthma (childhood onset);	chr2:102420542	chr2:102432336~102432357:+
THCA	cis	rs4988958	0.527	rs3771155	MIMAT0019927	hsa-miR-4772-3p	-3.36	0.000856	-0.14	-0.15	Asthma (childhood onset);	chr2:102421366	chr2:102432336~102432357:+
THCA	cis	rs7210990	0.8	rs2041460	MIMAT0005942	hsa-miR-1288-3p	3.36	0.000856	0.19	0.15	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16003598	chr17:16282058~16282078:+
THCA	cis	rs9527	0.59	rs10786744	MIMAT0022727	hsa-miR-1307-5p	-3.36	0.000857	-0.14	-0.15	Arsenic metabolism;	chr10:103185271	chr10:103394341~103394361:-
THCA	cis	rs9527	0.59	rs7917650	MIMAT0022727	hsa-miR-1307-5p	3.36	0.000857	0.14	0.15	Arsenic metabolism;	chr10:103177343	chr10:103394341~103394361:-
THCA	cis	rs9665626	1	rs9665626	MIMAT0005951	hsa-miR-1307-3p	3.35	0.000859	0.16	0.15	Schizophrenia;	chr10:102540881	chr10:103394301~103394322:-
THCA	cis	rs9807989	0.507	rs10203558	MIMAT0019927	hsa-miR-4772-3p	-3.35	0.000859	-0.14	-0.15	Asthma;	chr2:102411180	chr2:102432336~102432357:+
THCA	cis	rs9807989	0.507	rs10200952	MIMAT0019927	hsa-miR-4772-3p	-3.35	0.000859	-0.14	-0.15	Asthma;	chr2:102411191	chr2:102432336~102432357:+
THCA	cis	rs9426935	0.505	rs59678326	MIMAT0022491	hsa-miR-5698	3.35	0.00086	0.19	0.15	Lentiform nucleus volume;	chr1:153870767	chr1:154104562~154104583:-
THCA	cis	rs9807989	0.524	rs6543126	MIMAT0019927	hsa-miR-4772-3p	-3.35	0.00086	-0.14	-0.15	Asthma;	chr2:102410644	chr2:102432336~102432357:+
THCA	cis	rs17710780	0.803	rs56073703	MIMAT0000731	hsa-miR-378a-5p	-3.35	0.00086	-0.18	-0.15	Major depressive disorder;	chr5:149705665	chr5:149732829~149732850:+
THCA	cis	rs17710780	0.803	rs4705083	MIMAT0000731	hsa-miR-378a-5p	-3.35	0.00086	-0.18	-0.15	Major depressive disorder;	chr5:149705876	chr5:149732829~149732850:+
THCA	cis	rs10021731	0.693	rs114243292	MIMAT0003242	hsa-miR-577	-3.35	0.000862	-0.16	-0.15	Optic disc area;	chr4:114516751	chr4:114656774~114656794:+
THCA	cis	rs7210990	0.8	rs2041459	MIMAT0005942	hsa-miR-1288-3p	3.35	0.000862	0.19	0.15	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16003332	chr17:16282058~16282078:+
THCA	cis	rs10980926	0.539	rs4978998	MIMAT0030017	hsa-miR-7702	-3.35	0.000863	-0.15	-0.15	Menarche (age at onset);Pubertal anthropometrics;	chr9:111456667	chr9:111271193~111271214:-
THCA	cis	rs7897654	0.61	rs10883822	MIMAT0022727	hsa-miR-1307-5p	3.35	0.000864	0.15	0.15	Schizophrenia;	chr10:103036895	chr10:103394341~103394361:-
THCA	cis	rs950880	0.767	rs6710885	MIMAT0019927	hsa-miR-4772-3p	-3.35	0.000864	-0.14	-0.15	Serum protein levels (sST2);	chr2:102361077	chr2:102432336~102432357:+
THCA	cis	rs9527	0.615	rs1556960	MIMAT0022727	hsa-miR-1307-5p	3.35	0.000865	0.13	0.15	Arsenic metabolism;	chr10:102966916	chr10:103394341~103394361:-
THCA	cis	rs10021731	0.668	rs66482879	MIMAT0003242	hsa-miR-577	-3.35	0.000867	-0.16	-0.15	Optic disc area;	chr4:114517522	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.718	rs28657376	MIMAT0003242	hsa-miR-577	-3.35	0.000867	-0.16	-0.15	Optic disc area;	chr4:114517650	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.668	rs7684322	MIMAT0003242	hsa-miR-577	-3.35	0.000867	-0.16	-0.15	Optic disc area;	chr4:114519788	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.718	rs12108520	MIMAT0003242	hsa-miR-577	-3.35	0.000867	-0.16	-0.15	Optic disc area;	chr4:114522087	chr4:114656774~114656794:+
THCA	cis	rs12145833	0.619	rs12132986	MIMAT0019761	hsa-miR-4677-3p	3.35	0.000869	0.24	0.15	Obesity (early onset extreme);	chr1:243429295	chr1:243346225~243346246:+
THCA	cis	rs1870653	0.516	rs7682565	MIMAT0003242	hsa-miR-577	3.35	0.000869	0.27	0.15	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);	chr4:114532315	chr4:114656774~114656794:+
THCA	cis	rs1870653	0.516	rs56228000	MIMAT0003242	hsa-miR-577	3.35	0.000869	0.27	0.15	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);	chr4:114533268	chr4:114656774~114656794:+
THCA	cis	rs12145833	0.538	rs10927014	MIMAT0019761	hsa-miR-4677-3p	3.35	0.000873	0.24	0.15	Obesity (early onset extreme);	chr1:243429374	chr1:243346225~243346246:+
THCA	cis	rs7210990	0.724	rs3785628	MIMAT0005942	hsa-miR-1288-3p	-3.35	0.000874	-0.18	-0.15	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16067368	chr17:16282058~16282078:+
THCA	cis	rs13326165	0.715	rs11707864	MIMAT0004595	hsa-miR-135a-3p	3.35	0.000875	0.22	0.15	HDL cholesterol;HDL cholesterol levels;	chr3:52358861	chr3:52294232~52294253:-
THCA	cis	rs7210990	0.866	rs178816	MIMAT0005942	hsa-miR-1288-3p	3.35	0.000879	0.19	0.15	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16189588	chr17:16282058~16282078:+
THCA	cis	rs9527	0.615	rs7917295	MIMAT0022727	hsa-miR-1307-5p	3.35	0.00088	0.13	0.15	Arsenic metabolism;	chr10:102941430	chr10:103394341~103394361:-
THCA	cis	rs7851726	0.933	rs2183958	MIMAT0019208	hsa-miR-3074-5p	3.35	0.00088	0.12	0.15	Urinary albumin-to-creatinine ratio;	chr9:94907391	chr9:95086063~95086083:-
THCA	cis	rs7647973	0.626	rs62260720	MIMAT0019957	hsa-miR-4787-3p	-3.35	0.000883	-0.2	-0.15	Menarche (age at onset);	chr3:49816363	chr3:50675130~50675153:+
THCA	cis	rs7647973	0.626	rs62260723	MIMAT0019957	hsa-miR-4787-3p	-3.35	0.000883	-0.2	-0.15	Menarche (age at onset);	chr3:49834691	chr3:50675130~50675153:+
THCA	cis	rs10021731	0.718	rs28736894	MIMAT0003242	hsa-miR-577	-3.35	0.000883	-0.16	-0.15	Optic disc area;	chr4:114514184	chr4:114656774~114656794:+
THCA	cis	rs10021731	0.718	rs17622270	MIMAT0003242	hsa-miR-577	-3.35	0.000883	-0.16	-0.15	Optic disc area;	chr4:114514205	chr4:114656774~114656794:+
THCA	cis	rs72819454	0.522	rs9665617	MIMAT0022727	hsa-miR-1307-5p	3.35	0.000883	0.2	0.15	Interleukin-9 levels;	chr10:103764487	chr10:103394341~103394361:-
THCA	cis	rs6537837	1	rs7355157	MIMAT0000227	hsa-miR-197-3p	-3.35	0.000885	-0.15	-0.15	Major depressive disorder;	chr1:109587213	chr1:109598940~109598961:+
THCA	cis	rs6951245	0.81	rs117800627	MIMAT0004702	hsa-miR-339-3p	-3.35	0.000885	-0.22	-0.15	C-reactive protein levels or total cholesterol levels (pleiotropy);	chr7:1041439	chr7:1022955~1022977:-
THCA	cis	rs1818690	0.945	rs2734871	MIMAT0000424	hsa-miR-128-3p	3.35	0.000887	0.11	0.15	Monocyte percentage of white cells;	chr2:136112303	chr2:135665446~135665466:+
THCA	cis	rs1818690	0.945	rs2734871	MIMAT0000424_1	hsa-miR-128-3p	3.35	0.000887	0.11	0.15	Monocyte percentage of white cells;	chr2:136112303	chr3:35744527~35744547:+
THCA	cis	rs9426935	0.505	rs4612664	MIMAT0022491	hsa-miR-5698	3.35	0.000887	0.2	0.15	Lentiform nucleus volume;	chr1:153850197	chr1:154104562~154104583:-
THCA	cis	rs7897654	0.651	rs12355897	MIMAT0022727	hsa-miR-1307-5p	3.34	0.00089	0.15	0.15	Schizophrenia;	chr10:102926900	chr10:103394341~103394361:-
THCA	cis	rs7866350	1	rs10985500	MIMAT0027608	hsa-miR-6854-5p	3.34	0.000895	0.22	0.15	Post-traumatic stress disorder;	chr9:98221909	chr9:98229189~98229212:-
THCA	cis	rs2274459	0.5	rs13220421	MIMAT0022975	hsa-miR-3934-3p	3.34	0.000895	0.22	0.15	Obesity (extreme);	chr6:33654391	chr6:33698191~33698212:+
THCA	cis	rs4800353	0.929	rs4389219	MIMAT0000427	hsa-miR-133a-3p	-3.34	0.000897	-0.22	-0.15	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22028373	chr18:21825712~21825733:-
THCA	cis	rs4800353	0.929	rs4389219	MIMAT0000427_1	hsa-miR-133a-3p	-3.34	0.000897	-0.22	-0.15	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);	chr18:22028373	chr20:62564970~62564991:+
THCA	cis	rs1468333	0.565	rs4507481	MIMAT0026718	hsa-miR-874-5p	-3.34	0.000898	-0.13	-0.15	Resting heart rate;	chr5:138237384	chr5:137647618~137647640:-
THCA	cis	rs10021731	0.692	rs13104685	MIMAT0003242	hsa-miR-577	-3.34	0.000898	-0.16	-0.15	Optic disc area;	chr4:114495590	chr4:114656774~114656794:+
THCA	cis	rs7325116	0.519	rs9560896	MIMAT0004491	hsa-miR-19b-1-5p	-3.34	0.000899	-0.11	-0.15	Blood protein levels;	chr13:92001788	chr13:91351207~91351229:+
THCA	cis	rs4778581	0.9	rs35654883	MIMAT0000454	hsa-miR-184	-3.34	9e-04	-0.18	-0.15	Reticulocyte count;Reticulocyte fraction of red cells;	chr15:80115462	chr15:79209840~79209861:+
THCA	cis	rs751728	1	rs755496	MIMAT0022975	hsa-miR-3934-3p	-3.34	0.000903	-0.18	-0.15	Crohn's disease;	chr6:33766599	chr6:33698191~33698212:+
THCA	cis	rs7649443	0.959	rs13072590	MIMAT0019973	hsa-miR-4797-3p	3.34	0.000904	0.21	0.15	Nonsyndromic cleft lip with cleft palate;	chr3:197284809	chr3:197293888~197293908:-
THCA	cis	rs7647973	0.593	rs28535523	MIMAT0019957	hsa-miR-4787-3p	-3.34	0.000906	-0.2	-0.15	Menarche (age at onset);	chr3:49810981	chr3:50675130~50675153:+
THCA	cis	rs7897654	0.548	rs7917547	MIMAT0022727	hsa-miR-1307-5p	3.34	0.000906	0.15	0.15	Schizophrenia;	chr10:103052295	chr10:103394341~103394361:-
THCA	cis	rs6681460	0.649	rs6691033	MIMAT0014979	hsa-miR-3117-3p	-3.34	0.000907	-0.2	-0.15	Presence of antiphospholipid antibodies;	chr1:66541746	chr1:66628485~66628505:+
THCA	cis	rs950880	0.767	rs2287037	MIMAT0019927	hsa-miR-4772-3p	3.34	0.000908	0.14	0.15	Serum protein levels (sST2);	chr2:102362568	chr2:102432336~102432357:+
THCA	cis	rs9527	0.518	rs10883802	MIMAT0022727	hsa-miR-1307-5p	-3.34	0.000908	-0.17	-0.15	Arsenic metabolism;	chr10:102920605	chr10:103394341~103394361:-
THCA	cis	rs453301	0.686	rs11787026	MIMAT0019728	hsa-miR-4660	3.34	0.000908	0.2	0.15	Joint mobility (Beighton score);	chr8:9044861	chr8:9048453~9048475:+
THCA	cis	rs9527	0.518	rs7899608	MIMAT0022727	hsa-miR-1307-5p	3.34	0.00091	0.18	0.15	Arsenic metabolism;	chr10:102967547	chr10:103394341~103394361:-
THCA	cis	rs6555855	0.909	rs9762927	MIMAT0026618	hsa-miR-585-5p	3.34	0.000911	0.23	0.15	Menarche (age at onset);	chr5:169316294	chr5:169263649~169263670:-
THCA	cis	rs7210990	0.836	rs9899002	MIMAT0005942	hsa-miR-1288-3p	3.34	0.000912	0.19	0.15	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16018105	chr17:16282058~16282078:+
THCA	cis	rs7647973	0.626	rs11709734	MIMAT0019957	hsa-miR-4787-3p	3.34	0.000913	0.2	0.15	Menarche (age at onset);	chr3:49707802	chr3:50675130~50675153:+
THCA	cis	rs56176327	0.6	rs7628207	MIMAT0019957	hsa-miR-4787-3p	3.34	0.000913	0.2	0.15	Intelligence (multi-trait analysis);	chr3:49717537	chr3:50675130~50675153:+
THCA	cis	rs7647973	0.626	rs9870858	MIMAT0019957	hsa-miR-4787-3p	3.34	0.000913	0.2	0.15	Menarche (age at onset);	chr3:49731638	chr3:50675130~50675153:+
THCA	cis	rs56176327	0.532	rs9849038	MIMAT0019957	hsa-miR-4787-3p	3.34	0.000913	0.2	0.15	Intelligence (multi-trait analysis);	chr3:49734557	chr3:50675130~50675153:+
THCA	cis	rs4400599	0.586	rs72696227	MIMAT0022491	hsa-miR-5698	3.34	0.000913	0.19	0.15	Platelet distribution width;	chr1:154146761	chr1:154104562~154104583:-
THCA	cis	rs7210990	0.836	rs3785633	MIMAT0005942	hsa-miR-1288-3p	3.34	0.000914	0.19	0.15	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16022420	chr17:16282058~16282078:+
THCA	cis	rs7210990	0.836	rs12451075	MIMAT0005942	hsa-miR-1288-3p	3.34	0.000914	0.19	0.15	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16022719	chr17:16282058~16282078:+
THCA	cis	rs7894407	0.634	rs755577	MIMAT0022727	hsa-miR-1307-5p	3.34	0.000915	0.14	0.15	White matter hyperintensity burden;	chr10:103464309	chr10:103394341~103394361:-
THCA	cis	rs4774830	1	rs12439559	MIMAT0004809	hsa-miR-628-5p	-3.34	0.000916	-0.27	-0.15	Delta-5 desaturase activity;	chr15:55825977	chr15:55372991~55373012:-
THCA	cis	rs2303759	0.874	rs8108669	MIMAT0027497	hsa-miR-6798-3p	3.34	0.000917	0.19	0.15	Multiple sclerosis;	chr19:49342638	chr19:49009952~49009972:+
THCA	trans	rs963265	0.845	rs3780603	MIMAT0000074	hsa-miR-19b-3p	-6.87	2.08e-11	-0.18	-0.3	Migraine with aura;	chr9:70406579	chr13:91351245~91351267:+
THCA	trans	rs963265	0.845	rs3780603	MIMAT0000074_1	hsa-miR-19b-3p	-6.87	2.08e-11	-0.18	-0.3	Migraine with aura;	chr9:70406579	chrX:134169683~134169705:-
THCA	trans	rs6848139	0.892	rs62321743	MIMAT0004774	hsa-miR-501-3p	-6.39	3.96e-10	-0.48	-0.28	Alopecia areata;	chr4:122400190	chrX:50009772~50009793:+
THCA	trans	rs4920799	0.591	rs7717702	MIMAT0018120	hsa-miR-3691-5p	-6.21	1.19e-09	-0.5	-0.27	Echocardiographic traits;	chr5:85307677	chr6:5148286~5148308:-
THCA	trans	rs4920799	0.527	rs10462447	MIMAT0018120	hsa-miR-3691-5p	6.14	1.75e-09	0.5	0.27	Echocardiographic traits;	chr5:85224893	chr6:5148286~5148308:-
THCA	trans	rs4920799	0.527	rs6894774	MIMAT0018120	hsa-miR-3691-5p	-6.14	1.78e-09	-0.49	-0.27	Echocardiographic traits;	chr5:85289679	chr6:5148286~5148308:-
THCA	trans	rs4920799	0.536	rs12521313	MIMAT0018120	hsa-miR-3691-5p	6.11	2.15e-09	0.5	0.27	Echocardiographic traits;	chr5:85269371	chr6:5148286~5148308:-
THCA	trans	rs4920799	0.591	rs6452651	MIMAT0018120	hsa-miR-3691-5p	-6.09	2.29e-09	-0.49	-0.27	Echocardiographic traits;	chr5:85282928	chr6:5148286~5148308:-
THCA	trans	rs4920799	0.591	rs35749106	MIMAT0018120	hsa-miR-3691-5p	6	3.95e-09	0.49	0.27	Echocardiographic traits;	chr5:85243205	chr6:5148286~5148308:-
THCA	trans	rs4920799	0.591	rs6860079	MIMAT0018120	hsa-miR-3691-5p	-6	3.98e-09	-0.49	-0.27	Echocardiographic traits;	chr5:85244214	chr6:5148286~5148308:-
THCA	trans	rs4920799	0.591	rs4317363	MIMAT0018120	hsa-miR-3691-5p	6	3.98e-09	0.49	0.27	Echocardiographic traits;	chr5:85260136	chr6:5148286~5148308:-
THCA	trans	rs4920799	0.591	rs4327628	MIMAT0018120	hsa-miR-3691-5p	5.98	4.48e-09	0.49	0.27	Echocardiographic traits;	chr5:85263816	chr6:5148286~5148308:-
THCA	trans	rs4920799	0.591	rs4351184	MIMAT0018120	hsa-miR-3691-5p	5.98	4.48e-09	0.49	0.27	Echocardiographic traits;	chr5:85267480	chr6:5148286~5148308:-
THCA	trans	rs4920799	0.591	rs10462446	MIMAT0018120	hsa-miR-3691-5p	5.89	7.35e-09	0.48	0.26	Echocardiographic traits;	chr5:85224674	chr6:5148286~5148308:-
THCA	trans	rs4920799	0.591	rs7445289	MIMAT0018120	hsa-miR-3691-5p	5.87	8.11e-09	0.48	0.26	Echocardiographic traits;	chr5:85238300	chr6:5148286~5148308:-
THCA	trans	rs4920799	0.591	rs12516737	MIMAT0018120	hsa-miR-3691-5p	5.87	8.34e-09	0.48	0.26	Echocardiographic traits;	chr5:85215187	chr6:5148286~5148308:-
THCA	trans	rs34592089	0.786	rs13126505	MIMAT0004600	hsa-miR-144-5p	-5.78	1.39e-08	-0.63	-0.26	Crohn's disease;Intelligence (multi-trait analysis);	chr4:101944147	chr17:28861583~28861604:-
THCA	trans	rs6848139	0.655	rs9994851	MIMAT0004774	hsa-miR-501-3p	-5.67	2.44e-08	-0.37	-0.25	Alopecia areata;	chr4:122149939	chrX:50009772~50009793:+
THCA	trans	rs11712263	0.75	rs3850175	MIMAT0004680	hsa-miR-130b-5p	5.67	2.45e-08	0.21	0.25	Obesity-related traits;	chr3:172659277	chr22:21653316~21653336:+
THCA	trans	rs901683	0.702	rs4418752	MIMAT0000449	hsa-miR-146a-5p	-5.67	2.55e-08	-0.49	-0.25	Mean corpuscular volume;Red blood cell traits;	chr10:45607523	chr5:160485372~160485393:+
THCA	trans	rs4920799	0.536	rs12516189	MIMAT0018120	hsa-miR-3691-5p	5.66	2.59e-08	0.45	0.25	Echocardiographic traits;	chr5:85214965	chr6:5148286~5148308:-
THCA	trans	rs576674	1	rs576674	MIMAT0030418	hsa-miR-6516-3p	-5.66	2.64e-08	-0.39	-0.25	Type 2 diabetes;	chr13:32980164	chr17:77089469~77089490:+
THCA	trans	rs4920799	0.527	rs4920797	MIMAT0018120	hsa-miR-3691-5p	-5.64	2.87e-08	-0.44	-0.25	Echocardiographic traits;	chr5:85296772	chr6:5148286~5148308:-
THCA	trans	rs1348850	0.526	rs6718769	MIMAT0004606	hsa-miR-136-3p	5.64	2.93e-08	0.17	0.25	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);	chr2:177586181	chr14:100884750~100884771:+
THCA	trans	rs4920799	0.536	rs12517607	MIMAT0018120	hsa-miR-3691-5p	-5.63	3.03e-08	-0.45	-0.25	Echocardiographic traits;	chr5:85271157	chr6:5148286~5148308:-
THCA	trans	rs4920799	0.591	rs12518886	MIMAT0018120	hsa-miR-3691-5p	5.63	3.11e-08	0.45	0.25	Echocardiographic traits;	chr5:85218117	chr6:5148286~5148308:-
THCA	trans	rs1755271	0.522	rs10963360	MIMAT0004682	hsa-miR-361-3p	-5.62	3.18e-08	-0.44	-0.25	Obesity-related traits;	chr9:17956620	chrX:85903641~85903663:-
THCA	trans	rs4920799	0.591	rs1545940	MIMAT0018120	hsa-miR-3691-5p	-5.61	3.36e-08	-0.44	-0.25	Echocardiographic traits;	chr5:85293312	chr6:5148286~5148308:-
THCA	trans	rs11712263	0.724	rs9883329	MIMAT0004680	hsa-miR-130b-5p	-5.61	3.44e-08	-0.21	-0.25	Obesity-related traits;	chr3:172666800	chr22:21653316~21653336:+
THCA	trans	rs576674	1	rs488166	MIMAT0030418	hsa-miR-6516-3p	-5.58	4.01e-08	-0.38	-0.25	Type 2 diabetes;	chr13:32980214	chr17:77089469~77089490:+
THCA	trans	rs34592089	0.786	rs13126505	MIMAT0000436	hsa-miR-144-3p	-5.58	4.09e-08	-0.59	-0.25	Crohn's disease;Intelligence (multi-trait analysis);	chr4:101944147	chr17:28861548~28861567:-
THCA	trans	rs4920799	0.591	rs13161907	MIMAT0018120	hsa-miR-3691-5p	5.56	4.62e-08	0.45	0.25	Echocardiographic traits;	chr5:85219773	chr6:5148286~5148308:-
THCA	trans	rs4920799	0.591	rs4362973	MIMAT0018120	hsa-miR-3691-5p	5.56	4.62e-08	0.45	0.25	Echocardiographic traits;	chr5:85221776	chr6:5148286~5148308:-
THCA	trans	rs11633886	0.785	rs11637965	MIMAT0002814	hsa-miR-432-5p	5.56	4.64e-08	0.16	0.25	Diisocyanate-induced asthma;	chr15:45772645	chr14:100884496~100884518:+
THCA	trans	rs9886428	0.571	rs12680596	MIMAT0004503	hsa-miR-29a-5p	-5.55	4.67e-08	-0.17	-0.25	IgG glycosylation;	chr8:14192509	chr7:130876786~130876807:-
THCA	trans	rs4920799	0.527	rs4995521	MIMAT0018120	hsa-miR-3691-5p	5.55	4.78e-08	0.45	0.25	Echocardiographic traits;	chr5:85216660	chr6:5148286~5148308:-
THCA	trans	rs827382	0.857	rs827411	MIMAT0015085	hsa-miR-3200-3p	5.55	4.78e-08	0.24	0.25	Migraine;	chr10:8649631	chr22:30731610~30731631:+
THCA	trans	rs9886428	0.571	rs1478016	MIMAT0004503	hsa-miR-29a-5p	-5.54	4.91e-08	-0.17	-0.25	IgG glycosylation;	chr8:14196126	chr7:130876786~130876807:-
THCA	trans	rs4920799	0.591	rs4296832	MIMAT0018120	hsa-miR-3691-5p	5.54	5.02e-08	0.44	0.25	Echocardiographic traits;	chr5:85246039	chr6:5148286~5148308:-